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 Shiga toxin (Stx) is a bacteriophage (phage)-encoded virulence factor of the 
Enterohaemorrhagic Escherichia coli (EHEC) O157:H7 implicated in the pathogenesis of 
renal tissue damage and bloody diarrhoea in human. Cattle are the main asymptomatic 
reservoir for EHEC O157:H7 with the lymphoid-follicle rich areas of the terminal rectum 
identified as the primary colonisation site. However, the significance of Stx during bovine 
intestinal colonisation by EHEC O157:H7 remains unclear with mixed findings described in 
published studies. The objective of this study was to investigate if Stx and the Stx-encoding 
phage significantly contribute to EHEC O157:H7 colonisation particularly at the bovine 
terminal rectum. The expression of Stx receptor, Globotrioasylceramide (Gb3) at the bovine 
terminal rectum was analysed by fluorescence microscopy, revealing a similar pattern of 
Gb3 detection in the bovine colon with scattered positive detections limited to sub-epithelial, 
mesenchymal-associated cells. Purified Stx2 treatment of Gb3+ and Gb3- epithelial cell lines 
for 6 to 18 hours produced no effect on the cell cycle and proliferation. CD3+/CD8+, 
CD3+/γδ+ and CD21+ cells were significantly different between calves infected with EHEC 
O157:H7 Strain 9000 (Stx2a+/Stx2c+) and the uninfected calves, but not in calves with 
Strain 10671 (Stx2c+). Stx did not interfere with IFN-gamma (IFN-γ)-activation of the 
JAK/STAT1 pathway in epithelial cells. Bovine EHEC O157:H7 strains isolated from 
Scottish cattle farms in the IPRAVE study (Phage type 21/28 and 32) were used for a series 
of bacterial phenotypic characterisation assays. Total Stx production, Verocytotoxicity, 
growth in a competitive environment, epithelial cell adherence and Galleria mellonella 
virulence assay were performed to compare the IPRAVE EHEC O157:H7 strains (PT21/28 
and PT32) and the isogenic Stx-phage mutants. Stx levels produced by the bovine-originated 
EHEC O157:H7 strains were significantly lower than that of the human isolated strains. The 
absence of Gb3 on the bovine terminal rectal epithelium, the non-significant changes in the 
cell cycle along with the uninterrupted IFN-γ activation of the JAK/STAT1 pathway in 
intestinal epithelial cells and the minute quantities of Stx generated by EHEC O157:H7 
bovine strains suggest that the toxin is not involved in colonisation directly, at least at the 
intestinal epithelial level. Although future work is required to explain the mechanisms 
underlying the observed EHEC O157:H7 phenotypic changes particularly in the Stx-phage 
mutant strains, the work done has proven that the Stx-encoding phage indeed has the ability 
to exert changes in the bacterial cell leading to changes in bacterial phenotypes, which in 




Enterohaemorrhagic Escherichia coli O157:H7 (EHEC O157:H7) infection in 
human is associated with symptoms ranging from mild, watery to bloody diarrhoea 
accompanied with complications resulting in the loss of kidney functions that could 
end up being fatal. EHEC O157:H7 resides in the bovine intestine specifically at the 
terminal rectum and transmission to human is mainly through the food chain. EHEC 
O157:H7 carries genes of bacterial viruses (termed bacteriophage) enabling the 
bacteria to produce Shiga toxin (Stx). Stx is the major factor related to the more 
severe symptoms mentioned. Despite being colonised, cattle remain healthy and act 
as the source of bacterial cells propagated within the environment. This study aims to 
investigate how Stx and the Stx-bacteriophages could potentially influence EHEC 
O157:H7 colonisation at the bovine intestine. The bovine terminal rectum was 
microscopically examined for the presence of the Stx receptor, 
Globotriaosylceramide (Gb3). Gb3 was not detected on the cells lining the terminal 
rectum of cattle. In vitro assays testing the effects of Stx on epithelial cell lines 
proliferation and a vital pathway inside epithelial cells involved in initiating cellular 
defense against bacterial pathogens did not support the idea for a role for Stx during 
intestinal colonisation. The total production of Stx and toxicity on Vero cells (Stx-
sensitive cells), the competitive growth ability, the capacity to bind to epithelial cell 
lines and the ability to kill Galleria mellonella larvae were compared between the 
EHEC O157:H7 bovine strains possessing and not (mutant strains unable to produce 
toxin) possessing the Stx-bacteriophages. Differences were observed as a result of 
not possessing the Stx-bacteriophages suggesting that the viruses could potentially 
control the behaviour of the bacteria which may be important during EHEC O157:H7 
intestinal colonisation. Interestingly, EHEC O157:H7 strains isolated from cattle 
produced significantly lower levels of Stx than the human originated EHEC 
O157:H7 strains. In conclusion, direct involvement of Stx in bacterial colonisation of 
the bovine terminal rectal cells was not observed, while Stx-bacteriophages did affect 
certain bacterial traits commonly associated with colonisation. Future study is 
required to explain the underlying mechanisms of how the Stx-bacteriophages work 




























1.1 Escherichia coli (E. coli) 
 Escherichia coli is a diverse species of Gram negative, facultative anaerobic 
bacteria that was discovered back in 1885 by a German-Austrian paediatrician, 
Theodor Escherich.  He was investigating gastrointestinal infection in children when 
he came across rod-shaped, fast growing bacteria which he named Bacillus 
communis coli in the faeces of young patients. After his death, the bacterium name 
was changed to Escherichia coli (E. coli), to honour his discovery [1]. 
 
 A single E. coli cell is about 0.5 µm in width and up to 2 µm in length. As 
with other Gram negative bacteria, the outer membrane layer and inner cytoplasmic 
membrane are separated by a thin peptidoglycan wall (maximum 4 nm) [2]. The 
peptidoglycan wall of E. coli normally maintains a cylindrical shape during 
exponential growth, while in the stationary phase it changes into a more spherical 
shape [3, 4]. Serotyping is commonly carried out based on the ‘O’ antigen that is part 
of the outer membrane lipopolysaccharide (LPS) and flagellar (H) antigens, while 
sometimes the capsular (K) and fimbrial (F) antigens are also used to type the strains. 
 
 E. coli constitute a minor part of the microbiota along the intestinal tract in 
mammals and reptiles, and can contribute to the host’s resistance to colonisation by 
incoming pathogens by physically competing for attachment sites on intestinal cells 
as well as producing bacteriocins. In humans, E. coli normally resides within the 
thick mucus layer of the large intestinal tract, particularly the caecum and colon with 
approximately 107-109 colony-forming unit (C.F.U.) of E. coli present per gram of 
faeces. The thick mucus layer covering the large intestinal epithelium serves as the 
nutritional ecological niche, primarily providing gluconate and other mucus-derived 
sugars to the commensal E. coli [5]. In the early hours after birth, E. coli are among 
the first bacteria found to colonise the intestine of newborns, mainly as a result of 
exposure to maternal faecal bacteria and nurses based at the maternity wards [6, 7]. 
The population continues to grow until 2 years of age, when it starts to stabilise at 
108 C.F.U. per gram and then declines as individuals age [8, 9].  
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1.2 Pathogenic E. coli 
 E. coli can become opportunistic pathogens under certain circumstances such 
as in immunocompromised hosts or when the intestinal wall becomes perforated, 
exposing the normally ‘sterile’ parts of the abdomen to the intestinal contents. A 
subset of E. coli strains are considered pathogenic and these are associated with 
different types of diseases, sometimes refereed to as intestinal or extra-intestinal, 
depending on the site of infection.  Findings of phylogenetic analyses indicate that 
lateral transfer and acquisition of mobile genetic elements including plasmids and 
prophages encoding for virulence and colonisation factors or the loss of other sets of 
genomes to adapt to the colonisation niche in the host are associated with the 
evolution of E. coli pathotypes [10, 11]. Key pathotypes of intestinal E. coli include: 
Enterohaemorrhagic E. coli (EHEC) associated with bloody diarrhoea and severe 
complications including kidney failure [12], Enteropathogenic E. coli (EPEC) known 
for causing watery diarrhoea [13], Enterotoxigenic E. coli (ETEC) leading to profuse 
watery diarrhoea in children predominately an issue in underdeveloped countries 
[14], Enteroaggregative E. coli (EAEC) recently identified as an emerging cause of 
persistent diarrhoea in malnourished or immunosuppressed children [15], 
Enteroinvasive E. coli (EIEC) causing acute ulcerative intestinal infections [16] and 
the Diffusively adherent E. coli (DAEC) that has the characteristic of diffusive 
adherence to intestinal epithelium [17]. While Uropathogenic E. coli (UPEC) and the 
sepsis, meningitis-associated E. coli (MNEC) are two of the pathotypes involved in 
infection at extra-intestinal sites [18].  
1.3 EHEC as an emerging public health concern 
EHEC have been increasingly recognised as an emerging group of enteric 
pathogens implicated in diseases of humans [19, 20]. Of particular interest is EHEC 
O157:H7, the most common serotype associated with human cases in Great Britain 
[21] and is the focus of my thesis. Infection can result in mild to bloody diarrhoea 
(haemorrhagic colitis) accompanied by severe abdominal cramps which can progress 
to haemolytic uraemic syndrome (HUS) which is the leading cause of kidney failure 
in paediatric cases and occurs in about ten to fifteen percent of human EHEC 
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infections [12, 22]. The incubation period can range between three to eight days, and 
most patients recover within ten days. However, those that do not recover can 
progressively deteriorate into HUS defined by a triad of symptoms (haemolysis, 
anaemia and thrombocytopaenia) which could potentially lead to acute kidney failure 
especially in children [23]. The production and activity of Shiga toxin (Stx), a 
bacteriophage-encoded virulence factor is implicated in the more severe disease 
manifestations mentioned and is also the main subject of this thesis (a more in-depth 
review of Shiga toxin will be discussed later in section 1.7.1). Most individuals 
without underlying disease or immunosuppression will recover following the course 
of the disease, while in some other patients, severe renal tissue damage requires the 
patients to rely on lifetime supportive therapy mainly by dialysis and even blood 
transfusions [24]. About 90% of HUS cases in Scotland are associated with EHEC 
O157:H7 infection [25, 26]. EHEC are considered to have a low infectious dose (less 
than 100 C.F.U.), and possess an array of virulence factors that can lead to this 
serious and sometimes fatal infection. The lack of preventive measures to limit 
infections and sole reliance on supportive therapy in human patients means that this 
E. coli pathotype is of high public health importance in particular in countries 
experiencing outbreaks. These include many countries in the developed world and 
there is little data available with regard to EHEC epidemiology in many developing 
countries (further described below in sections 1.5 and 1.6).  
1.4 Reservoir and transmission of EHEC to humans 
 EHEC O157:H7 resides in the intestinal tract of healthy ruminants primarily 
cattle and to a lesser extent in sheep and goats [27, 28]. A national survey between 
January 1999 to January 2000 on EHEC O157:H7 prevalence in faeces at slaughter 
across Great Britain indicated that the annual prevalence was higher in cattle than 
sheep (4.7% and 1.7% respectively) [29]. The prevalence is even higher in the 
United States, with 28% of cattle found to be shedding EHEC O157:H7 [30]. Despite 
being colonised, cattle remain asymptomatic, with the exception of infected newborn 
calves or immunosuppressed animals [31, 32]. Naylor et al. proposed that the bovine 
terminal rectum, located from 0-15cm from the recto-anal junction is the principal 
colonisation site of EHEC O157:H7 in cattle [33]. EHEC O157:H7 tropism towards 
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the terminal rectum in its bovine host has yet to be fully understood although nutrient 
factors and adaptation to the environment within the rectal niche are thought to partly 
explain the affinity to the site. E. coli, as any other enteric bacteria, rely heavily on 
glycogen for internal storage of carbon and energy, with the inability to metabolise 
internal glycogen directly linked to poor colonisation [34]. As nutrient availability in 
the large intestine is limited, EHEC O157:H7 and other bacterial strains residing in 
the rectum are forced to adopt strategies to compete for nutrient and energy. One 
proposed strategy is that the bacterial strains living within  a niche in close proximity 
may require and utilise different types of nutrients [35]. Additionally, E. coli do not 
produce polysaccharide hydrolase for digestion of complex sugars from mucin (large 
glycoprotein components of mucus) forcing them to rely on free fragments of 
monosaccharides and disaccharides, e.g. fucose, released from digestion by 
hydrolase-producing anaerobic bacterial species (e.g. Bacteroides thetaiotaomicron) 
residing in the same niche as E. coli [5, 36]. EHEC O157:H7 may also be more 
efficient in nutrient utilization than the surrounding commensal or competing strains 
at the rectum, as previously described for the growth of EHEC O157 strain EDL 933 
in bovine small intestinal content, which coincided with stronger induction of genes 
required for enzymatic degradation of the sugars in EDL 933 than the commensal E. 
coli [37, 38]. The rectum also has relatively lower levels of acetate compared to the 
anterior parts of the bovine gut. Acetate is a short fatty acid known to inhibit the 
expression of the locus of enterocyte effacement (LEE) operon encoding the 
components of a type three secretion system (T3SS; refer below in section 1.7.2). 
Therefore it may be that the lower levels of acetate at the rectum, rather than the rest 
of the bovine gut, provides a less restrictive environment for EHEC to express the 
T3SS leading to stronger adherence at the rectal site [39, 40].  
 
 Transmission to humans is via the faecal-oral route, often associated with 
direct or indirect contact with contaminated faeces [21, 41]. Farm, domestic and wild 
animals have all been linked to transmission and outbreaks [27, 42]. This also 
includes visit to petting zoos which has been shown to be related to EHEC O157:H7 
infections particularly among children [43]. Apart from contact with contaminated 
cattle-related products, outbreaks could also be as a result of consuming water, 
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unpasteurised fruit juice and vegetables contaminated with ruminant faeces [44-47]. 
Environmental exposure to the bacteria is also another risk factor and mode of 
transmission [48]. Person-to-person transmission has also been observed, with 
approximately 20% of outbreaks in Britain, Canada, Ireland, Japan, USA and 
Scandinavia shown to involve some secondary transmission, with shedding from 
infected humans lasting for two to three weeks [49].  
1.5 Examples of EHEC O157:H7 outbreaks 
The first series of outbreak that lead to the recognition of EHEC O157:H7 as a 
human pathogen occurred in the United States from February through March and 
May to June, 1982 [50].  A total of fourty seven people dining at the restaurants of 
the same fast food chain in Oregon and Michigan were affected with severe crampy 
abdominal pain, accompanied with watery diarrhoea that progressed into bloody 
diarrhoea and the absence of fever. Examination of nine out of twelve stool samples 
identified for the presence of a non-invasive and non-enterotoxigenic E. coli 
O157:H7, which was considered as a 'rare' serotype to be isolated during that time. 
This bacterial strain was also isolated from beef patty sampled from the restaurant in 
Michigan [51]. In 1993, another large outbreak involving a fast food chain of 
restaurants occurred, this time around seven hundred individuals experienced severe 
abdominal pains and bloody diarrhoea, four children died and a high percentage of 
individuals developed HUS [52]. The 1993 multistate outbreak was traced back to 
undercooked hamburgers served in the restaurants, and EHEC O157 was isolated 
from patients and frozen beef patties [53]. In the UK, the first EHEC O157:H7 
outbreak was thought to have occurred in 1983 in the Wolverhampton area and it 
was reported to have been associated with an increase in incidence of HUS in 
children [54]. Another large outbreak involving more than a hundred individuals 
occurred in West Lothian in 1994 which was associated with contaminated 
pasteurised milk consumption, while in 1996 in central Scotland, epidemiological 
investigations identified meat from a butcher as the likely source for an outbreak that 
lead to 20 deaths, also the highest number of fatalities of all outbreaks recorded [55] 
until the atypical EHEC infection in North Germany in 2011 [56]. The largest EHEC 
O157:H7 epidemic to date occurred in July 1996 in Sakai City, Osaka, Japan 
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involving nearly ten thousand individuals, including several fatalities and similar 
disease manifestations, with contaminated white radish sprouts as the source of 
infection [47]. The strain isolated from this outbreak is known as EHEC O157:H7 
strain Sakai and is one of the two EHEC O157:H7 strains that were fully sequenced 
and annotated at the turn of the millennium [57]. The other fully sequenced strain is 
EDL 933, the EHEC O157:H7 strain isolated from the 1982 Michigan outbreak 
linked to ground beef [58]. 
 
1.6 EHEC O157:H7 Prevalence in Scotland 
In Scotland, the most common risk factors associated with human infection 
includes consumption of meat or other animal-based products and environmental 
exposure [41, 59]. Visit to farms, direct contact with contaminated faecal material 
and animal pasture used for recreational activities are among the ways humans can 
contract the bacteria through the environment [43]. In 2004, Health Protection 
Scotland and the Health Protection Agency reported that 209 out of 918 confirmed 
infections in Great Britain occurred in Scotland which makes the rate of infection per 
hundred thousand consistently higher in Scotland than most places in the rest of the 
world [60, 61]; other countries with relatively high rates of infections include 
Argentina and Ireland [62, 63].  
 
Surveys on faecal samples obtained from Scottish farms revealed about one in 
five of each sampled farm were confirmed positive for EHEC O157:H7 infection 
[64-66]. The first study sampled 12-30 month-old beef finishing cattle around 
Scotland identified 7.9% prevalence of O157-shedding animals, with 22.8% of farms 
estimated to have at least one animal shedding [65]. Prevalence of EHEC O157:H7 
was shown to be influenced by seasonality, with more faecal shedding detected 
during summer which corroborates with an increase in confirmed EHEC O157:H7 
clinical cases [29] [67]. 
 
Faecal samples obtained at slaughter from cattle and sheep were characterised 
to be of Phage Type (PT) 2, 8, 21/28 and 4, 32, respectively [29]. Analysis of data 
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from the Scottish Executive Environment Rural Affairs Department (SEERAD) 
(March 1998 until May 2000) and the International Partnership Research Award in 
Veterinary Epidemiology (IPRAVE) (February 2002 to February 2004) identified 
that over 50% of the positive cattle isolates and human cases, between 1998 to 2004 
were EHEC O157:H7 phage type (PT) PT 21/28. EHEC O157:H7 PT32 was 
detected at much lower levels in both cattle and human isolates (10% and 5%, 
respectively). EHEC O157:H7 PT21/28 generally contains both Stx2a and Stx2c-
encoding prophages, while bovine PT32 predominately contain only a Stx2c-
encoding phage. PT 21/28 is also associated with higher risk of developing HUS in 
Scottish children than other phage types [66, 68]. The more severe clinical outcomes 
have been associated with Stx2a production [69-71], with PT21/28 strains being 
capable of expressing this particular Stx2 variant based on the presence of stx2a gene 
(Figure 1.1).  
1.7 Virulence factors of EHEC O157:H7 
 Sequence and trait based analyses have determined that EHEC O157:H7 has 
evolved from E. coli O55:H7, a pathogenic clone isolated from an infant with 
diarrhoea [72]. Chronologically, E. coli O55:H7 began as a stx1+ strain, with the 
ability to ferment sorbitol and the presence of the Locus of Enterocyte Effacement 
(LEE) genes in the chromosome [73]. It then acquired genes to change the somatic 
‘O’ antigen to O157, gained Stx2-encoding bacteriophages, a large virulence 
plasmid, pO157 and acquired beta (β)-glucuronidase (GUD) activity. The strain 
eventually loss the ability to ferment sorbitol (sor-). Analysis by pulsed-field gel 
electrophoresis (PFGE) identified significant diversity among the EHEC O157:H7 
isolates with the existence of two distinct lineages; i) lineage I comprising EHEC 
O157:H7 isolated from both humans and cattle, and ii) lineage II consisting of EHEC 
O157:H7 isolated mostly from cattle and rarely from humans [74, 75]. Further 
genomic analyses suggested for the presence of another lineage termed lineage I/II or 
intermediate lineage, however the host ecology and associated phenotypes of isolates 
belonging to this lineage remains to be fully characterised [76]. Isolates clustered 
under lineage I are regarded as human/clinical-based associated with upregulated 
expression of virulence and colonisation factors and severe disease outcomes with 
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higher mortality rate compared to the bovine-biased isolates of lineage II [77] [11]. 
Virulence genes encoding for Stx1 and Stx2 were upregulated in human-isolated 
strains [78] and more importantly the presence or absence of the stx2a gene is 
regarded as significant determinant in explaining the differential virulence observed 
between human-biased and bovine-biased isolates [77]. Bovine-biased isolates were 
identified to contain specific genes associated with niche adaptation, for example 
higher resistance to acidic environment in the bovine gut, thereby facilitating the 
survival rate which was estimated to be better than clinical strains [11, 79]. Stx-
encoding phages (described below in section 1.7.1.2) are regarded as one of the 
major factors introducing diversification via lateral gene transfer into the genomes of 
the ancestral strains leading to the emergence of pathogenic Stx-producing E. coli 
strains [74, 75, 80-82], facilitated by its abundance in the environment [83] and high 
resistance to disinfectants and extreme conditions (heat treatment and chlorination) 
[84]. Part of my thesis focuses on the impact of these Stx-encoding phages on EHEC 
O157:H7 colonisation which will be further explained under section 1.9 below. 
Much more recent and ongoing analysis of EHEC O157 evolution in the UK has a 
different order of evolution in relation to the Stx phage acquisition and is 
summarized with permission of Dr. Tim Dallman (Public Health England) in Figure 












Figure 1.1 The evolution of EHEC O157 in the UK. The new evolutionary 
model on the origin of the current EHEC O157 strain presented was based on a 
phylogenetic analysis recently proposed [85]. The stepwise series of events was 
maintained from stx2c+ E. coli O55 to the beta-glucuronidase (GUD) positive last 
common ancestor (A5) that evolved into the contemporary lineage II. Three extant 
lineages of Lineage II : lineage IIa (ancestral branch), IIb (stx2c+) and IIc (acquired 
stx1, stx2c retained) were identified. A stx2c+ lineage I strain and a lineage I/II 
(stx2c+ stx2a+) evolved from the Lineage II stx2c+ branch (estimated to occur 125 
and 95 years ago, respectively). The lineage I (stx2c+) strain then evolved by 
acquiring the Stx2a phage 3 times (lineage Ia, Ib and Ic). Lineage Ib acquired the 
Stx1a phage and at the same time losing the Stx2c phage, while the Stx2c phage 
was also removed from the lineage Ic strain. The loss and gain of the Stx-encoding 
phages is believed to be dynamic but with the tendency for the phage(s) to be 





1.7.1 Shiga toxin 
1.7.1.1 The discovery of Shiga toxin (Stx)  
In 1897, Kiyoshi Shiga discovered the dysentery bacillus from stools and 
intestinal walls of infected patients. The aetiological agent which was initially termed 
as Bacillus dysenteriae, now known as Shigella dysenteriae, caused acute localised 
invasive colitis by the act of invading and proliferating inside intestinal epithelial 
cells and mucosal macrophages. Dr. Shiga also observed the production of toxic 
factors from the bacteria. Later Gerald T. Keusch discovered an enterotoxin 
produced by Shigella dysenteriae type I, which was later shown to be the same toxin 
associated with neurotoxic and cytotoxic activities [86, 87] now known as Shiga 
toxin (Stx) [88]. Stx was often associated with the development of HUS (acute 
haemolytic anaemia, thrombocytopaenia and acute renal failure) in diarrheagenic 
patients [89, 90]. Similarly, in EHEC O157:H7 infected patients, symptoms such as 
severe abdominal pain and bloody diarrhoea could then be followed by HUS, 
especially in children and the elderly. Later it was identified that EHEC O157:H7 
expresses similar AB5 toxins termed Shiga-like toxins, or Shiga toxin 1 (Stx1) and 2 
(Stx2). The genes encoding for Stx of S. dysenteriae are on the chromosome, while 
the Stx1 and Stx2 of STECs were shown to be encoded by phages with modular and 
mosaic gene arrangements similar to that of the lambdoid bacteriophages acquired 
via horizontal gene transfer [91, 92]. Since the role of Stx have been well 
characterised to be pivotal to the pathogenesis of EHEC O157:H7 in humans, the 
association of the toxin during colonisation of the cattle intestine by EHEC O157:H7 
is still poorly understood and therefore is examined in the current study (refer to 
section 1.9 below for thesis aims). 
1.7.1.2 Shiga toxin-encoding bacteriophages  
By definition, Stx-encoding bacteriophages or Stx phages are any bacterial-
infecting virus that carries a stx operon containing stx genes encoding for the A and 
B subunits of the toxin. Stx phages are morphologically diverse however were 
characterised to display similar gross appearance as members of the lambdoid phages 
with icosahedral heads (short or elongated) with long contractile or non-contractile 
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tails (of varying lengths) or short tails [93-95]. They undergo a temperate phage 
lifestyle containing two phases; the first is where the phage genes are integrated into 
the bacterial chromosome and remain ("lysogenisation" of the bacterial host phase) 
until conditions are in favour for reactivation of the phage resulting in the "lytic" 
cycle (Fig. 1.2). Lysogeny conversion is when the phage integrates into a strain; in 
the case of the Stx-phages these can convert a non-harmful bacteria to a potentially 
pathogenic strain. Phages capable of inducing lysogenic conversion are proposed as 
significant contributors to the ongoing evolution of pathogenic strains [96]. 
 
The genes encoding for Stx can be divided into two types; i) inducible 
prophages or ii) Stx-prophage remnants which persists as cryptic genes on the 
bacterial chromosome and lack the ability to induce Stx production, but are most 
likely able to contribute during recombination of phage genes driving evolution of 
bacterial strains [97, 98]. The genome size of most Stx phages characterised to date 
are larger than the typical lambdoid (λ) phages, however the function of the extra set 
of genes carried by the Stx phages has yet to be fully confirmed. Many studies have 
suggested that these extra or accessory sequences of the Stx phages are believed to 
contribute to the survival of not only the phages but also the bacterial host as well, 
such as that previously described for the bor gene of the λ coliphage [99]. This 
particular gene was expressed during lysogeny and encoded for factors that 
significantly increased for the survival of the E. coli host cell in animal serum. 
 
Stx-encoding bacteriophages persist not only within the bacterial host, but 
these viruses are also abundant in the extra-intestinal environment, even more so than 
their STEC hosts [83]. These phages resist several inactivation methods targeted at 
the bacterial population, thereby increasing their survivability and further potential 
propagation into other bacterial hosts [84]. The presence of persistent, infectious Stx-
phage particles that are readily available in the environment to infect new bacterial 
hosts may facilitate the capacity for Stx expression into new hosts, as seen in the 
2011 STEC outbreak in Germany involving the newly recognised atypical 
enterohaemorrhagic E. coli pathotype, Entero-aggregative Haemorrhagic E. coli 
(EAHEC) [100]. This emergent strain harboured a Stx2a-phage that was shown to be 
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similar to those present in bovine STEC strains [82]. This illustrates how mobile and 
adaptable these Stx-encoding phages are to be effectively spread among strains of 
different host species. Therefore it is important to study these Stx-encoding 
bacteriophages in order to understand how their lysogeny into the bacterial host 































Figure 1.2 Different phases in the life of a phage (taken from Fortier and 
Sekulovic) [96]. Virulent phages undergoing the lytic lifestyle upon infection of the 
host will immediately have its DNA replicated leading to lysis at the end of the cycle 
releasing assembled phage particles ready to infect other bacterial cells. Temperate 
phages, in contrast have two phases throughout their life cycle; i) Lysogenic cycle 
where the phage integrates its genome within the host chromosome and remains 
inactive, with the prophage DNA replicated together with the host cell thereby 
transmitting prophage DNA to the newly produced progeny cells. ii) Upon induction 
(e.g. Stressors inducing DNA damage) prophage is excised from the host 








1.7.1.3 Shiga toxin expression 
The transcription of stx1 genes could be initiated upon activation of the 
functional pStx1 promoter, regulated by the iron-dependent Fur transcription repressor 
[101]. A low iron concentration in the environment will trigger the cleavage and 
removal of the Fur repressor, which will then activate the pStx1 promoter and the 
consecutive stx1 genes, Fig. 1.3 [101]. Whereas Sung et al. had identified for a 
promoter-like sequence for stx2 transcription, however the sequence is considered 
vestigial as it does not contribute to Stx2 production and the presence of the 
sequence is thought as coincidental to the assimilation of the stx2AB genes into the 
late regulatory genes of the phage [102, 103]. Instead, Stx2 production occurs upon 
activation of the late phage genes, directed upon triggerring of the phage lytic cycle 
(Fig. 1.4). This phage-directed mechanism of stx gene transcription is also evident in 
the Stx1-encoding phage [104]. The stx genes are located within the late region of the 
phage genome which are only transcribed and translated once the phage is in the lytic 
phase following induction of the bacterial SOS response in the cell (Fig. 1.4, [105]). 
The SOS response is triggered by DNA damage and the appearance of single 
stranded DNA; this allows the formation of activated RecA which in turn catalyses 
the autocleavage of the LexA repressor governing expression of several SOS induced 
genes in the bacteria. The activated RecA also catalyses the auto-cleavage of the 
prophage cI repressor leading to expression of the bacteriophage lytic cycle. The 
toxin release is closely linked to bacterial lysis directed by the late phage genes, 
allowing efficient release of not only the toxin but also the phage particles, avoiding 
the need for a secretion system which may require more energy [106]. This does not 
rule out other induction or release mechanisms, but this is the understood primary 
route at this time. Moreover in vitro experiments comparing the production of Stx1 
by STEC O26 Strain H19 in the presence of SOS-inducing agent (Mitomycin C) and 
low iron medium strongly suggests that despite both conditions induced the 
production of Stx1, the release of the toxin could only be detected in the  supernatant 
of H19 cells grown in MMC [104]. The medium with low iron concentration 
stimulated the production of Stx1 but failed to induce lysis leading to accumulation 
of the Stx1 intracellularly. This mechanism also explains why antibiotic treatments, 
especially those targeting bacterial DNA, are often contraindicated in patients 
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infected with STECs as this will exacerbate the condition due to increased 






























Figure 1.3 The transcription of stx1 and stx2 genes, taken from Shimizu 
et al. [108]. Stx1 expression could be induced by activation of the functional pStx1 
promoter (located directly upstream from the stx1 gene sequence) regulated by 
environmental iron concentration via the Fur transcription repressor. In addition, the 
production of Stx1 could also be mediated by the phage late promoter, induced upon 
activation of the phage lytic cycle. Whereas the transcription of the stx2 genes occur 






Figure 1.4 Phage-mediated expression of the Shiga toxin 2 genes, taken 
from Sperandio and Pacheco [105]. In the quiescent state, the expression of 
phage genes are inhibited by the action of the cI repressor that bound to the 
operator sites, OL and OR. The terminator (T) downstream of the late right 
promoter, PR’ prevents the transcription of stxAB. The presence of signals inducing 
SOS response will immediately produce and activate RecA, that then promotes 
cleavage of the cI repressor. The depressed PR then leads to the expression of the 
anti-terminators N and Q. The Q anti-terminator will bind to PR’ and activate the late 
phage genes including stxAB, prior to bacterial lysis that will release Stx into the 
environment. 933W is the Stx2-encoding bacteriophage from EHEC O157:H7 Strain 




1.7.1.4 The structure of Shiga toxin 
 Shiga toxin 1 is 98% homologous to the amino acid sequence of the Stx of S. 
dysenteriae [110]. While Stx2 is quite distinct in its amino acid sequence with less 
than 60% similarity to the Stx1 [111]. To date, there have been several subtypes of 
Stx2 identified (Stx2a, Stx2c, Stx2d, Stx2e, Stx2f) [91]. The Stx structure is 
comprised of two subunits, A (32 kDa) and B pentamer ring (approximately 7.7 kDa 
per unit) (Fig. 1.5). The A moiety is comprised of two subunits linked by a single 
disulphide bond; A1 and A2. The former is presumed as the biologically active A 
subunit, while the latter moiety functions to primarily maintain the structure of the 
holotoxin and bridges between A1 and the B pentamer ring [112]. The B pentamer 
interacts with Stx receptor, Globotriaosylceramide (Gb3), surface expressed by Stx 
sensitive cells, allowing toxin binding and subsequent toxin internalisation by the 
cell. The A and B moieties are connected at the C-terminus of only three of the B 
subunits, allowing the A moiety to bend to the side opposite from the three B 

























Figure 1.5 The ribbon diagram illustrating the crystal structure of Shiga 
toxin 1. The A1 subunit is depicted in green, with the part of A1 interacting with 
ribosome shown in purple. The blue ribbon depicts the A2 subunit and the B 
pentamer is shown in orange. Active-site side chains are indicated in red (active 
residue 167) and other putative side chain (pale blue). The figure was drawn with 
PyMOL Molecular Graphics System, Version 1.5.0 Schrödinger, LLC. by Dr. James 




1.7.1.5 Globotriaoslyceramide (Gb3) as the receptor for Shiga toxins 
 The globotriaosylceramide [Galα(1-4), Galβ(1-4) glucosylceramide or Gb3] 
(Fig. 1.6) is the receptor for all Stx toxin types except for Stx2e which preferentially 
binds to the globotetraosylceramide (Gb4) [114, 115]. Gb3 is a variant of 
glycosphingolipid (GSL), the most abundant and diverse subtype of glycolipid in 
animals, plants, fungi, bacteria and invertebrates [116]. GSLs have many biological 
roles including membrane structure, host-pathogen interaction, intercellular 
communication and membrane protein function modulation. In host-pathogen 
interactions, GSL function as receptors for a variety of non-enveloped virus such as 
Norovirus and Rotavirus [117] and bacterial toxins including cholera toxin and Stx 
[118]. CD19 and Interferon-alpha 2 Receptor (IFNAR2) were among the 
physiological ligands suggested for Gb3 as it was shown that these two have 
sequence similarities with that of the Stx B subunit [119-121]. Binding of Gb3 to 
IFNAR2 will activate several transcription factors and growth inhibition, while 
interaction with CD19 mediates homotyping of cells which occurs at germinal 
centres in antigen-induced B cell differentiation [120, 122]. Gb3 has also been 
reported to be overexpressed on cancerous cell lines and human tumours, with 
examples including Burkitt’s lymphoma, leukemia, astrocytoma, colorectal, ovarian 
and breast cancers [123-127]. Gb3 expression has also been proposed to be 
significantly correlated with the metastatic potential of human colon cancer [128]. 
 
 The α1,4-galactosyltransferase (A4GALT) gene encodes the Gb3 synthase 
enzyme, which catalyses galactose ceramide transformation to lactosylceramide 
before the formation of Gb3 (Fig. 1.7) [129, 130]. The ability of the toxin to bind to 
its receptor is affected by the fatty acid chain length and the degree of unsaturation  
[131]. Stx1 preferentially binds to Gb3 with fatty acid chain containing more than 20 
carbons, while Stx2c has a preference towards shorter fatty acid chains [132]. The 
presence of unsaturated fatty acids enhances the Stx1 and Stx2c binding to Gb3, 
possibly associated with an increase in lateral mobility within the lipid bilayer [132]. 
Although Stx cytotoxicity has been shown to correlate with Gb3 synthase activity 
and Gb3 content [133], an earlier study argued that cell sensitivity towards the toxins 
do not entirely depend on total Gb3 concentration [131, 134]. The contradictory 
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findings may be partially explained by the association of Gb3 with 'lipid rafts', 
defined as detergent-resistant microdomains of the apical plasma membrane, 
enriched with clusters of glycolipid-cholesterol assembled with specific membrane 
proteins and signal transducers [135]. Majority of Gb3 studied were shown to reside 
within the lipid rafts and this was shown to be necessary for Stx1 binding and 
translocation across Caco-2 monolayer [111, 136]. Moreover, the clustering of Gb3 
within lipid rafts was identified as the main discriminator for pathology in vivo as 
shown by Khan et al. (2009). Despite the high presence of Gb3 within the nephron, 
the only part that is affected by Stx are the glomeruli since Gb3 are organised within 
the lipid rafts as compared to Gb3 in other parts of the nephron[135].  
 
 Several methods have been used for the analysis of Gb3 expression including 
flow cytometry, fluorescence microscopy and lipid chromatography while 
transcription and quantification of Gb3 synthase A4GALT could also be used an 
indicator of Gb3 expression as its expression levels have been correlated with Gb3 


















Figure 1.6 The structure of globotriaosylceramide (Gb3) (Adapted 
from [130]). Gb3 belongs to the globo-series (type 4) GSL core structure. Gb3 
is amphiphatic, composed of the hydrophobic ceramide (sphingosine; long chain 
amino alcohol containing amide linkage to fatty acid) and the hydrophilic 
carbohydrates (Gal; galactose α1-4, Glc; glucose β1-3). The carbohydrates 
typically lie on the plasma membrane, with the outer surface of carbohydrate 
chain exposed to the extracellular space and accessible for interaction with 





Figure 1.7 The synthesis pathway of globotriaosylceramide (Gb3). 
(Adapted from [130]). Gb3 is synthesised in the endoplasmic reticulum and 
Golgi apparatus beginning with sequential addition of individual carbohydrate 
units to the ceramide (glucose by ceramide glycosyltransferase) to synthesise 
glucosylceramide (GlcCer) and galactose  by lactosylceramide synthase 
producing lactosyleceramide (LacCer). Gb3 synthase then converts LacCer to 
Gb3 and transported to the cellular surface to incorporate with the plasma 
membrane [116] [138]. 
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1.7.1.6 Shiga toxin internalisation by eukaryotic cells via retrograde 
transport 
 Upon binding of Stx B subunit to the terminal galactose disaccharide moiety 
of its receptor, the globotriaosylceramide (Gb3) (or globotetraosylceramide, Gb4 for 
Stx2e) on the cell surface, the toxin-receptor complex is internalized by endocytosis 
in a clathrin-dependent manner [139]. The endosome containing the toxin is 
trafficked to the Golgi apparatus through the perinuclear endocyctic recycling 
compartment. From the Golgi apparatus, the toxin follows a retrograde pathway and 
is translocated to the endoplasmic reticulum [140]. The precise trafficking pathway is 
unclear but it is believed that the toxin follows the pre-existing route within the cell 
to reach endoplasmic reticulum (ER). An enhanced intracellular retrograde transport 
of the endocytosed toxin to the Golgi and endoplasmic reticulum were proven to 
increase cytotoxicity [141].   
 
 For resistant cells that express Gb3, it is considered that Stx will be 
transported to the lysosome for degradation [142]. Recent studies have elucidated the 
process of retrograde trafficking of the AB5 toxins with the involvement of ER-
associated degradation (ERAD) pathway [143]. Inside ER, the toxin associates to the 
large multi-chaperone complex causing it to partially unfold. The ER then recognizes 
the Stx as misfolded protein and excretes the toxin out into cytosol via the ERAD 
pathway. In normal situations, ERAD will cause the misfolded proteins to undergo 
proteosome degradation.  However, in the absence of lysine residues (as the site of 
ubiquitination in target protein), Stx escapes the proteosomal degradation process. 
Following cleavage of the disulphide bond between the A subunits by furin (a 
calcium-sensitive serine protease) in the trans-Golgi network. The A1 and A2 
subunits remain linked by a disulfide bond until it reaches the endoplasmic reticulum 
(ER) where the two subunits get separated allowing the A1 subunit to be translocated 
across the ER membrane to the cytoplasm before reaching its target, the ribosome to 
interfere with protein synthesis [144-146]. The A1 subunit has RNA N-glycosidase 
activity, targeting the adenosine within the 28S ribosomal RNA of the 60S ribosomal 
unit. This depurination interferes with the translation process, as adenosine is 
involved at the interaction site with Elongation-factor 2 (EF-2) ternary complex, 
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producing transfer RNAs that are unable to associate with the ribosomal complex, 
thereby inhibiting protein synthesis in target cells [113].  
1.7.1.7 Shiga toxin early interaction with and translocation across 
epithelial monolayers  
 Purified Stx2 introduced intravenously into baboons resulted in glomerular 
thrombotic microangiopathy, while baboons receiving purified Stx1 showed no 
blood profile or clinical signs indicating haemorrhagic uraemic syndrome (HUS) 
[147]. Such findings are in parallel with that of epidemiological studies where 
patients infected with STECs producing Stx2 as well as animal models treated with 
Stx2 to be closely associated with HUS [90, 148-150]. However, Stx1 is also able to 
cause mild damage to the mesangial cells of baboons [151]. Despite differences 
recorded in the potency of Stx subtypes (Stx2 is 400-fold more toxic than Stx1 in 
mice [152]), one fact remains that in order to exert renal tissue damage, the toxin 
must be expressed, transported across the epithelial monolayer of the intestine and 
remain bioactive until it reaches the target tissue. Stx expression in vivo and the 
consecutive events including crossing mucosal epithelium and entrance into the 
systemic circulation to reach target organs remain vague. Although one would 
suspect a receptor-mediated endocytosis by Gb3 to be the simplest way of explaining 
the translocation process, data from studies had indicated negative Gb3 expression 
by human colon epithelial and immortalised intestinal cells [153-155]. Furthermore, 
cells expressing Gb3 are at high risk of succumbing to cytotoxicity [156]. Therefore, 
mechanism(s) must exist to allow translocation of the toxins from intestinal lumen 
into the underlying beds of blood capillaries within the lamina propria and 
submucosal region. The route followed by the toxins must also protect its bioactivity 
until it reaches the blood and the distal target organs. 
 
 Stx1 was shown to travel across Caco-2 epithelial monolayers transcellularly 
without causing any disruption to the monolayer integrity and the movement being 
energy dependent [157]. This finding was further supported by another study which 
discovered that Stx1 were detected in cytoplasmic endosomes of T84 cells and none 
was present in the paracellular space [154]. Later Stx1 and Stx2 were shown to 
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translocate Caco-2 cells at a different rate, with 2.9% of Stx1 translocated the 
monolayer compared to only 0.07% of Stx2 [158]. In the same study, Stx1 was again 
shown to translocate in an energy-dependent, saturatable manner, whilst the 
movement of Stx2 was not. Stx1 also translocated faster across Gb3-negative T84 
cells than Caco-2 cells [159]. The presence of neutrophils promoted the translocation 
of Stxs across epithelial cells [160], however examination of sections from inflamed 
intestinal biopsies showed no difference in the binding pattern or translocation of 
Stx1 and Stx2 when compared to normal intestines [161]. 
 
 In a more recent publication, Stx1 and Stx2 were observed by confocal 
microscopy to be present inside the ileal and colonic epithelial cells of EHEC 
O157:H7-infected human samples [162]. In addition, both toxins were also present 
within lamina propria as well as within sloughed dead particles in the intestinal 
lumen. Similar observations were reported in in vitro organ culture (IVOC) of 
paediatric intestinal biopsies but with the absence of Stx binding to the epithelium 
[159].  
 
 A published study reported on Stx1 gaining entrance into T84 cells via 
macropinocytosis shed more light on Stx translocation [162]. Macropinocytosis is the 
process of uptaking solutes in extracellular fluid via macropinosomes (formed from 
ruffling of the cellular membrane via actin-filament dependent process, which later 
fuses against the other end of the cellular membrane and interacts with cytoplasmic 
lysosomes to release the contents or degraded via endocytic pathways). The Stx-B 
subunit was used to study toxin translocation across Gb3-negative T84 epithelial 
monolayer and revealed that Stx translocation occured via macropinocytosis 
mediated by the activation of Src. In addition, the macropinocytosis also increased 
the rate of transcytosis of the toxin across the cells. Interestingly, this Stx-uptake 
process was observed to be stimulated by the presence of EHEC colonies at the 
intestinal epithelium [163]. Other pathogenic enteric bacteria namely Salmonella 
Typhimurium was shown to stimulate macropinocytosis in HeLa and Caco-2 cells 
thereby gaining direct entrance route into the epithelial cells [164].  
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 Findings provided with regards to Stx interaction with epithelium to date 
mostly were deduced from experiments carried out under laboratory conditions. To 
investigate if such findings agree with events taking place in vivo, Trans and 
colleagues employed vertical diffusion chamber system with polarised T84 cells to 
simulate the microaerobic environment in the human intestine to study Stx 
expression and translocation during EHEC O157:H7 infection [165]. They reported 
that EHEC growth and Stx production were downregulated under a microaerobic 
environment, conditions which are considered to be more appropriate in investigating 
events occurring in vivo, compared to an aerobic environment which has routinely 
been used in most laboratory experiments. Despite the limited bacterial growth and 
toxin production, Stx2 of strain EDL 933 translocation was enhanced. Stx2 
translocation also relied on the presence of the bacteria since translocation rate of 
purified Stx2 was downregulated after a 5-hour incubation. Interestingly, it was also 
shown that Stx translocation occurred in a transcellular manner and not via 
macropinocytosis, in contrast to a previous report mentioned above [162]. 
 
 In cattle, purified Stx1 adhered to the epithelial crypts of the jejunum, mid-
ileum and caecum sections, but not to the endothelial cells within the submucosa 
[159]. Purified Stx2 neither bound to the epithelial nor endothelial structures of the 
bovine intestine. In addition, the crypt cells of bovine colon epithelium bound to and 
internalised purified Stx1 but remained resistant towards the toxicity as it was 
degraded via a lysosomal-dependent pathway [142]. Differential Gb3 expression and 
Stx binding pattern between human and cattle may partially explain the distinguished 
clinical outcomes (discussed in detail in Chapter 2, Introduction section 2.1).  
1.7.1.8 Shiga toxin in EHEC O157:H7 pathogenesis 
 Haemmorhagic colitis (HC), generally known as bloody diarrhoea is one of 
the clinical signs reported in most EHEC infections [51, 90, 166]. Prior to the 
presence of visible blood in the stool, infected individuals were reported to have 
severe abdominal cramps and watery diarrhoea, which may or may not be 
accompanied with low grade fever [22]. Blood content in stools varies from streaks 
of redness to absolute blood [89, 90, 166]. In a 2-year study of routine stools from 10 
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hospitals in the United States, 0.39% were positively identified for the presence of 
EHEC O157:H7 [167]. The positive isolation of EHEC O157:H7 is most likely from 
a bloody stool compared to a stool without visible blood and was also identified as 
the most common pathogen to be isolated from bloody stools yielding pathogenic 
enteric bacteria. Some studies also associated HC with a more prolonged shedding of 
EHEC O157:H7 [168].  
 
 It is believed that intimate EHEC adherence to the intestinal epithelium and 
more importantly, the subsequent Stx translocation to the underlying lamina propria 
containing small blood vessels initiates the occurrence of HC [22, 162]. Stx2 was 
shown to induce damage to the human intestinal cells of an in vitro organ culture 
(IVOC) [159]. Furthermore, Stx2 treatment resulted in intestinal epithelial extrusion 
and the binding of the toxin to the endothelial cells of the lamina propria. The Gb3-
enriched surfaces of intestinal microvascular endothelium confers for high sensitivity 
of the cells towards the action of Stx, particularly Stx2 [159]. Following Stx binding 
and uptake by the Gb3-positive endothelial cells, the toxin will then be translocated 
to the Golgi apparatus and nucleus resulting in full cytotoxicity [141, 169]. The dead 
endothelial cells detach from the microvascular structure, causing leakage of the 
capillary which may then seep out of the intestinal wall from disrupted intestinal 
barrier which resulted from the effect of A/E lesion as well as Stx epithelial extrusion 
[159]. 
 
 Human colon mounted in an Ussing chamber and treated with Stx positive 
EHEC strains resulted in interruption in water absorption across the mucosa 
accompanied with significant morphological changes including epithelial 
detachment, mononuclear infiltration and loss of mucus-secreting goblet cells [170]. 
The study showed Stx2  as the bacterial factor responsible for the damage induced, 
which was augmented in the presence of EHEC. Earlier, Stx2 was shown to inhibit 
water absorption across human colon in vitro and suggested that the toxin may 
specifically target the mature, absorptive villous enterocytes leading to loss of water 
absorption [171]. While Creydt et al. (2004) reported on the ability of Stx2 B subunit 
to inhibit the net fluid absorption across human colon as well as causing fluid 
 50 
accumulation in rat colon ligated loops [172]. Evidence so far provided indicated that 
the toxin, particularly Stx2 is highly involved in the pathological events leading to 
not only HC, but also watery diarrhoea.  
 
 Haemorrhagic uraemic syndrome (HUS) is the primary cause of acute renal 
failure in children infected with STECs [173]. Stx is the virulence factor from STECs 
associated with HUS following an STEC infection by targeting the endothelial cells 
of the glomeruli and initiating various dysfunctions of the endothelial cells leading to 
microangiopathy. Following Stx release from lysed bacterial cells in the intestine, the 
toxin will be translocated across the intestinal epithelial barrier to reach the 
underlying blood vessels [157, 165]. Once inside the blood vessel, it is thought that 
the toxin binds to Gb3-expressing blood cells, as previously observed in a study 
where the toxin binds to Gb3 on the surface of neutrophils of human and mice [174]. 
The Stx bound neutrophils will then circulate systemically until the cells reaches the 
microvascular endothelial cells of the glomeruli in the kidney. Here, the Stx is 
thought to dissociate from the neutrophil to bound to the Gb3-rich domain on the 
surface of endothelial cells of the glomeruli [175]. This Stx-endothelial cell 
association will trigger a pro-inflammatory and pro-thrombotic cascades resulting in 
thrombotic microangiopathy, characterised by vascular edema with detachment of 
the endothelial cells exposing the subendothelial matrix and deposition of the dead 
cells and debris, platelets aggregation and fibrin deposition [176]. Mechanisms 
underlying the endothelial dysregulation in the kidney of HUS patients is complex. 
Among the documented evidence includes an increase in the ratio of plasminogen 
activator inhibitor to the tissue plasminogen activator leading to stabilisation of the 
fibrin clots [177], higher release of tissue factor from endothelial cells [178], 
upregulation of the stromal cell-derived factor-1 (SDF-1) from endothelial cells 
which binds to the CXCR4 receptor leading to enhanced platelet activation and 
aggregation [179], release of higher levels of the platelet attractant, von Willebrand 
factor (vWF) [180] and increased secretion of endothelial adhesion molecules [181]. 
In addition, recent studies have elucidated the complement dysregulation as an 
important factor in determining the subsequent endothelial damaging consequences 
during HUS. Stx enhances the release of P-selectin, a cell adhesion molecule from 
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endothelial cells which triggers the release and activation of C3, an activator of the 
complement system via the alternative pathway. The presence of excessive C3 
further exaggerates the thrombogenic state through activation of the alternative 
complement pathway[182], which in turn increases the expression of P-selectin. 
 
An increase in the sensitivity of microvascular endothelium and proximal 
tubule cells in the kidney towards Stx has been suggested for the susceptibility of the 
renal cells to succumb to Shiga cytotoxicity. The basis for such an increased in 
sensitivity was shown to be directly related to the high Gb3 synthase and low alpha 
(α)-galactosidase levels in cultured human proximal tubule cells [183]. Post-
diarrhaeal HUS is generally more prevalent in children, presumably as a result of 
inverse correlation between Gb3 expression and age. This theory however was 
challenged by a study examining Gb3 expression in renal cryosections of individuals 
aged between infancy to 85 years old and identified similar Gb3 expression for all 
samples examined [184]. In addition, 3 hr of treatment with 500 ng/ml of Stx1 
resulted in similar binding rate across the frozen sections to both glomeruli and 
tubular cells, with no significant differences noted amongst the intensity of the anti-
Stx1-stained cryosections. Therefore, it is highly possible that the involvement of 
other factors in addition to Stx-Gb3 is required to explain the pre-dominance of HUS 
cases among the younger patients. This may include factors such as exposure of the 
glomeruli and tubular cells to bacterial LPS and cytokines which may potentiate the 
sensitivity levels towards the toxin [150, 185, 186].  
 
 Pathological localisation of STEC infection correlates to the distribution of 
Gb3. Since the endothelial cells of the cerebrum expresses Gb3, microangiopathic 
thrombi formation resulting in neurological symptoms could develop in certain 
individuals where the toxin is able to reach the brain via circulation [187]. Such 
lesions involving the nervous system could potentially be fatal and therefore early 
diagnosis of an STEC case is essential to prevent the toxin from reaching the brain. 
Interleukin-1 (IL-1) and Tumor Necrosis Factor (TNF), two inflammatory cytokines 
usually present during STEC infection, in synergy are able to upregulate the 
transcription of enzymes essential for Gb3 synthesis; ceramide glucosyltransferase 
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(CGT), lactosylceramide synthase (GalT2) and Gb3 synthase (GalT6) in human brain 
endothelial cells (HBEC) [137]. As a consequence, exacerbation of clinical 
symptoms follows due to increased sensitivity of the endothelial cells upon Gb3 
upregulation, leading to a poor prognosis for the patient.  
 
 Microvascular endothelial cells of the human colon are rich in Gb3 content 
and was shown to be able to bind to both Stx1 and Stx2 in vitro [188]. Although Stx1 
has a higher affinity to bind to Gb3, Stx2 was more toxic to the transformed human 
microvascular endothelial cells which correlates with findings from epidemiological 
studies which associates Stx2 with higher risk of developing HUS [90]. The 
intestinal epithelial cells, in contrast, were shown to not express Gb3 on the surface 
[153, 159, 189]. However in a more recent study, the authors detected mRNA of Gb3 
synthase from normal human colon tissue sections and human carcinoma cells (HCT-
8) [190]. Interestingly, a fraction of these cells do express surface Gb3 as detected by 
fluorescence microscopy, however the amount of cells readily detected with surface 
globotetraosylceramide (Gb4) outweighs Gb3 expression. Gb4 is biosynthesised 
from Gb3, mediated by Gb4 synthase and contains an additional N-
Acetylgalactosamine (GalNAc), attached to the Pk trisaccharide of Gb3 [191]. Gb4 is 
capable of binding to Stx, however the binding is much less efficient than Gb3 and 
Gb3 except for Stx2e (Stx variant in porcine edema disease) which preferentially 
binds to Gb4 [114, 115, 191]. Under circumstances where Gb4  predominates the 
intestinal epithelial surface area more than Gb3, it was suggested that more Stxs (all 
subtypes except for Stx2e) will have better chances of transcytosing the epithelial 
monolayer and skip the receptor binding step before entering the blood circulation to 
reach target organs expressing Gb3 [190]. Finally, it was also reported that Stx1 and 
Stx2 both bound to Paneth cells present within the crypts of Lieberkuhn in frozen 
sections of paediatric intestinal biopsies [161]. 
1.7.2 Type three secretion system (T3SS) 
 The ability to form attaching and effacement (A/E) lesions on intestinal 
epithelial cells distinguishes EHEC from many of the other E. coli strains that 
contain Stx-encoding bacteriophages and produce Stx. This phenotype plays a major 
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role in formation of bacterial microcolonies along the intestine and therefore in 
facilitating persistence within the host.  The type three secretion system (T3SS) is an 
organelle than can deliver proteins from inside the bacterium into a host eukaryotic 
cell.  The system includes basal structure, translocator and effector proteins, with the 
injection apparatus and many key delivered effector proteins expressed from a 
chromosomal pathogenicity island termed the locus of enterocyte effacement (LEE). 
The actual translocation structure on the surface of the bacterial cell may form before 
or during contact of the bacterium with the intestinal host epithelial cell, and is 
comprised of an EscF needle complex onto which is attached a polymerised EspA 
filament.  This filament connects to a pore formed in the host membrane by the EspD 
and EspB proteins. The full apparatus from basal units to the translocon allow 
effectors to be secreted between the cells in an ATP hydrolysis-dependent manner.  
Some of the earliest work in EPEC and EHEC demonstrated that a protein called the 
translocated intimin receptor (Tir) was transferred into the eukaryotic cell.  Intimin 
which is expressed from the LEE but exported in the standard sec-dependent manner 
into the bacterial outer membrane then binds to Tir that has become integrated into 
the eukaryotic cell membrane. This interaction initiates Tir clustering followed by 
signalling events leading to actin polymerisation and pedestal formation.  
 
 Multiple other effector proteins are now known to be involved in the re-
organisation of the cytoskeleton resulting in ‘intimate’ bacterial attachment [192]. 
The villi on the apical surface of the intestinal epithelial cells are then lost 
(effacement) with the bacteria firmly attached to the host cell forming the 
histopathological feature known as the A/E lesion. T3SS regulation is complex and 
involves a dynamic between the environment, signalling from nearby bacteria and 
the regulators itself including the master LEE-encoded regulator, ler [193, 194 ]. The 
complex nature of LEE regulation has been reviewed relatively recently [40] which 
encompasses multiple factors from the core regulators namely Ler and the second 
most important regulator, the global regulator of ler activation (GrlA) and repression 
(GrlR) feedback loop, as well as the bacterial nucleoid associated proteins. In 
addition, global regulators could be encoded both on the chromosome (such as the by 
the second T3SS; ETT2 of EDL 933 and Sakai that was suggested to affect bacterial 
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adherence and regulation genes encoding virulence factors in a yet undefined 
mechanism) [195] and by horizontally acquired genetic elements (for example 
homologs of the direct EPEC Ler activator PerC encoded on lambdoid prophages of 
EHEC O157:H7 required for full virulence [196]). Additionally, control by Hfq, 
initially identified as a host factor of the QB phage, which functions as an sRNA 
chaperone and is actively involved in post-transcriptional regulation of the LEE and 
T3S. Kendall et al. 2011 found that the Hfq regulates LEE expression in a strain-
dependent manner as it up-regulates T3SS in EHEC 86-24 but act as a negative 
regulator of LEE expression in EHEC O157:H7 EDL 933 [197]. Communication 
between bacterial species via chemical secretions resembling hormones or quorum 
sensing (QS) have also been described in modulating the LEE activity, for example 
the QseA transcriptional regulator capable of activating the LEE1 operon [198]. 
Furthermore, the microbiota residing near the colonisation niche (e.g. Bacteroides 
thetaiotaomicron, refer Section 1.4 above) [199] and nutrient availability/metabolism 
(e.g. butyrate/acetate, D-serine amino acid and fucose) [39, 200] were also shown to 
contribute to the regulation of the genes encoded by the LEE operon. An example 
could be illustrated by LEE regulation by interaction between two two-component 
systems (TCS); with the i) the fucose sensing kinase and fucose sensing response 
regulator (FUSKR) system (fucose sensing and metabolism) repressed by the ii) 
QseBC (flagella and motility) and QsEF (pedestal formation) QS regulatory cascades 
[201, 202]. The presence of fucose in the EHEC O157:H7 culture caused a complex 
interaction between the two systems mentioned resulting in a reduction in the 
expression of LEE [199, 203]. The T3SS is also positively regulated by high levels 
of bicarbonate ions in the culture medium [204], however this was not observed in a 
study reporting on an EspA-mediated enhanced EHEC binding to intestinal cells 
performed under microaerobic conditions to mimic the low oxygen levels in the 
intestine [205].   
 
The formation of the intimate attachment via the A/E lesion on the intestinal 
epithelium has been associated with disruption of the tight junctions between the 
enterocytes and dysregulated absorption of water and ions mediated by the secreted 
bacterial effector proteins leading to diarrhoea [206]. Previous studies on pathogens 
 55 
causing disruption of the barrier function were focused more on other bacterial 
strains possessing the T3SS apparatus namely the EPEC strains and Citrobacter 
rodentium, with only a few papers focusing on EHEC strains [206-209]. EspF, a 
mitochondrian-targeting effector protein leading to the activation of the 
mitochondrian death pathway [210], is secreted by the EPEC strains via the T3SS 
and was determined to be essential in disrupting the tight junctions of the small 
intestine [208]. The mechanism involved redistribution of one of the tight junction 
proteins, occludin intracellularly and an increase in the permeability of the epithelial 
monolayer leading to a significant reduction in the transepithelial electrical resistance 
(TER). In vivo study using A/E mouse model infected with C. rodentium indicated 
for the role of EspF as necessary to significantly disrupt the interepithelial cellular 
tight junctions with a marked increase in the colon lumenal water contents [207]. A 
study comparing the ability to disrupt the intestinal barrier function between EPEC 
and EHEC strains suggested for EPEC strains to be more efficient in reducing the 
TER post-infection in T84 cells, despite similar levels of occluding redistribution by 
strains of both pathotypes [209]. The study identified that the EspF expressed by 
EHEC was not able to fully mediate the intestinal barrier disruption, as shown for 
EPEC. Furthermore the espF mutant of EHEC was still able to reduce the TER of the 
T84 monolayer, suggesting for the presence of other mechanism(s) involved in 
EHEC to subvert the tight junction barrier. The ability for EHEC to significantly 
disrupt the intestinal barrier required for the expression of U-EspF, a redundant 
EspF-like homologue encoded by EHEC. In a more recent study of EPEC and tight 
junction disruption, the ability of the EspF protein to affect the tight junctions 
requires for the involvement of two other bacterial effector proteins secreted by the 
T3SS of EPEC; the mitochondrial-associated protein (MAP) and intimin [211]. 
Much is still unknown on the exact mechanism(s) and contribution of the T3SS 
effector proteins of EHEC O157:H7 in causing diarrhoea and further work is 











Figure 1.8 Schematic diagram of the type three secretion system of 
EHEC O157:H7 [212]. The apparatus is mainly comprised of two parts, the basal 
body (EscC) which connects the inner and outer bacterial membranes and the 
filament (EscF and polymerised EspA) that bridges the effector proteins from the 
bacteria into the host cell through the host cell plasma membrane. The basal body 
(EscC) is positioned in the bacterial outer membrane and is connected to the inner 
membrane ring structure (containing the  EscR, EscS, EscT, EscU, and EscV 
proteins) via the EscJ lipoprotein. EspB and EspD form the translocation pore in the 
host cell plasma membrane. The cytoplasmic ATPase EscN provides the energy to 
the system by hydrolyzing ATP molecules into ADP. SepD and SepL have been 




1.7.3 Other bacterial factors involved in adherence 
 Flagella are primarily composed of the flagellin (FliC) protein in E. coli and 
are known for providing motility to the bacteria by a propeller-like motion which 
generates additional torque through the presence of the hook structure. It has also 
been described to influence adherence as well as being an inducer of pro-
inflammatory responses in host cells as it is recognised by Toll-like receptor five 
(TLR-5)[213, 214]. H7 flagella specifically have been shown to play a role in EHEC 
O157:H7 adherence to bovine epithelial cells [215] and they are an effective target in 
developmental cattle vaccines to limit EHEC O157:H7 excretion form cattle [216]. 
 
 Other bacterial factors shown to facilitate bacterial adherence to host cells are 
fimbriae, hair-like structures projected from the bacterial cell. Most fimbrial genes 
are encoded on the chromosome. EHEC O157:H7 has been shown to produce 
haemorrhagic coli pili (HCP) which are associated with the type four pilus type and 
are implicated in forming connections between the bacteria and host cells via their 
long, bundled polar structure[217]. In addition, HCP is also a potent inducer of pro-
inflammatory cytokines including Interleukin-8 (IL-8) and Tumor Necrosis Factor-
alpha (TNF-α), thereby possibly contributing to haemorrhagic colitis [218]. The long 
polar fimbriae (Lpf) 1 is the EHEC O157:H7 homologue of the Lpf expressed by 
Salmonella enterica serovar typhimurium, an adhesin promoting adherence to the 
human intestine particularly at the Peyer's patch epithelium [219, 220]. Lpf1 has 
been implicated in promoting EHEC adherence to epithelial cells by interacting with 
the fibrinogen, collagen IV and laminin of Caco-2 and HeLa cells [221]. Similarly, 
curli, another adhesin composed of aggregated thin fibers, is also capable of 
interacting with the extracellular matrix of T84 cells and significantly contributes in 
EHEC binding to abiotic surfaces and lettuce leaves [220]. There are also the F9 
fimbriae and the E. coli common pilus (ECP) also known as Mat fimbriae. The F9 
fimbriae enhanced EHEC O157:H7 colonisation in the colon of young calves but not 
to bovine gastrointestinal explant tissue [222]. Mutation in the genes encoding for F9 
fimbriae resulted in a reduced shedding of EHEC O157:H7 in calves, but  the strain 
was still able to colonise the rectal epithelium suggesting that the fimbriae is not 
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implicated in the rectal tissue tropism. On the other hand, ECP is critical for EHEC 
O157:H7 adherence to HEp-2 and HeLa cells. The expression of ECP is enhanced in 
a low oxygen, high carbon dioxide environment, similar to that in the intestinal 
lumen [223]. Interestingly, many of the fimbrial operons present in EHEC O157 
appear to contain deletions indicating this serotype has lost the potential to express 
many common fimbrial types, including functional type 1 fimbriae; this has been 
proposed to contribute to the specific tropism of the organism in cattle as it may not 
have the capacity to easily adhere at other sites [13, 224].  
1.7.4 Plasmid encoding virulence factors 
 The large virulence plasmid O157 or pO157 is a 92kb plasmid detected in 
most  EHEC strains [225]. It encodes for EHEC-haemolysin, a type two secretion 
system (T2SS), catalase-peroxidase and a serine protease. The EHEC haemolysin is 
thought to contribute to EHEC virulence by providing iron upon interaction with 
haemoglobin [226]. T2SS contributes to EHEC pathogenicity by promoting 
adherence, in particular the secreted protein YodA, shown to be important in EHEC 
adherence to HeLa cells [227]. StcE, a zinc metalloprotease is also secreted via the 
T2SS and has been shown to remove glycoprotein 340 from the surface of host 
intestinal epithelial cells, reducing the viscosity and function of the protective mucus 
layer over the epithelium. This potentially allows intimate attachment of EHEC 
O157:H7 to the intestinal epithelial cells [228]. KatP, a bifunctional enzyme with 
catalase and peroxidase activities, is also encoded by pO157 and provides protection 
of the bacteria from oxidative stress [229]. The extra-cellular serine-protease (EspP), 
a member of the serine protease autotransporters of Enterobacteriaceae (SPATE) is 
secreted by EHEC O157:H7 via the plasmid encoded type V secretion system during 
the early phases of infection [230]. EspP was associated with actin remodelling for 
the formation of the A/E lesion [231] and recently was shown to target the 
protocadherin-24 and mucin-2, resulting in EHEC O157:H7 attachment to the 
intestinal epithelial cells and microvilli effacement in human stem cell-derived 
colonoids [232]. In human patients, it was reported to be associated with 
haemorrhagic intestinal mucosa [233] while in calves, EspP may be able to positively 
influence the intestinal colonisation by EHEC O157:H7 [234]. 
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1.8 Diagnosis of EHEC infection 
 Sorbitol MacConkey supplemented with Cefixime and Tellurite (CT-SMAC) 
agar has been routinely used to facilitate the selection for the growth of EHEC 
O157:H7 colonies which appear as colourless round colonies measuring from 2-3mm 
in diameter [16]. The suspected EHEC O157:H7 colonies are then confirmed by a 
Latex agglutination test, where latex beads coated with anti-O157 immunoglobulin 
are used.  In instances where the nature of the sample prevents sufficient amount of 
colonies to be isolated, the sample can be first cultured in enrichment broth and 
immuno-magnetic separation (IMS) carried out using magnetic beads coated with 
antibody to increase the chances of detection [235, 236]. This can then be followed 
up by plate-based detection as above. Another phenotype that can be assessed is the 
ability to produce Shiga toxins (Stxs), the primary virulence factors associated with 
EHEC O157 pathology in humans. Shiga toxin (Stx) can be semi-quantified by 
Enzyme-Linked Immuno-Assay (ELISA) kits or testing the supernatants from a 
bacterial culture on African Green Monkey Kidney (Vero) cells, known to be highly 
sensitive to the toxic activity of Stx [237]. Epidemiological studies often adopt phage 
typing to group EHEC O157:H7 based on the sensitivity of the isolates to a 
standardised group of bacteriophages designated with numbers, resulting in a 
particular isolate being sensitive to a certain phage type classified as PT, followed by 
the group number of bacteriophage that the isolate is sensitive to. Pulse Field Gel 
Electrophoresis (PFGE) is also used to confirm for the presence of EHEC O157:H7 
in the samples, however recent advances in pathogen detection had allowed for a 
more accurate, reliable molecular-based analyses such as microarray assays, Next 









1.9 Aims of the thesis 
1.9.1 Shiga toxin in EHEC O157:H7 colonisation of the 
intestine 
  It is already well established that Stx is the cardinal virulence factor 
expressed by EHEC O157:H7 that is implicated in the more severe disease 
manifestations in humans [240]. Moreover the presence of stx2 gene distinguishes 
the virulence levels particularly between EHEC O157:H7 isolates recovered from 
humans and cattle [11, 77]. The presence and persistence of EHEC O157:H7 were 
also correlated to lineage type with better colonisation observed in human-biased 
isolates (lineage I), which was enhanced in the presence of Stx2 [78, 241, 242]. It 
was also identified that the two lineages contained differences in the Q anti-
terminator gene found upstream of the stx2 operon [10], however it is unknown if 
this is the primary factor triggering different levels of virulence between strains 
belonging to the two lineages. The role of Stx during EHEC O157:H7 colonisation of 
the asymptomatic bovine intestine however remains ambiguous [241, 243-245] and 
forms the first aim of this thesis to investigate the role of Stx at the bovine terminal 
rectal epithelium the during EHEC O157:H7 colonisation. To achieve this, Chapter 2 
attempted to fill the knowledge gap in the Gb3 status at the bovine terminal 
rectum,followed by in vitro assays employing intestinal epithelial cells to investigate 
the effect of Stx on epithelial cell growth and proliferation. This is based on previous 
findings that the synthesis of Gb3 is regulated by the eukaryotic cell cycle and other 
published articles suggesting that the toxin interrupts the viability and proliferative 
aspects of intestinal epithelial cells [246-249]. An arrest at certain phases of the cell 
cycle may provide an advantage to EHEC as this could potentially extend the life 
span of the differentiated, matured enterocytes residing at the tip of the rectal crypts 
colonised by the bacteria. The importance of surface Gb3 expression and other 
factors in mediating cytotoxicity towards Stx are also discussed.  
 
 The next main aspect of my study shifted the focus to a broader view by 
investigating the consequences of an O157:H7 infection to several subtypes of 
immune cell populations within the bovine terminal rectal mucosa [250]. It is not 
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known how these sub-populations that lie closely under the epithelial mucosa 
specifically respond to EHEC O157:H7 colonisation at the rectal site. This set up the 
aims for the third chapter of this thesis; to compare bovine terminal rectal mucosal 
immune response between calves challenged with different EHEC O157:H7 types 
expressing different combination of Stx, against samples from unchallenged, control 
animals. Chapter three presents results derived from post-mortem samples of calves 
challenged with two different bovine EHEC O157:H7 strains, EHEC O157:H7 Strain 
9000 (PT21/28) and EHEC O157:H7 Strain 10671 (PT32), with the former strain 
possessing an extra Stx2a phage in addition to Stx2c phage (also present in PT32), 
associated with very high levels of shedding from the bovine host [60, 251]. It was 
anticipated that there will be different levels of immune responses between non-
infected and infected animals based on previous studies reporting for Stx1-mediated 
immuno-modulation in cattle [252, 253]. The presence of increased interferon-
gamma (IFN-γ), a predominant cytokine indicative of a cellular response to EHEC 
O157:H7 colonisation led to in vitro assays examining if IFN-γ is able to interrupt 
intestinal epithelial cells proliferation, which was shown to occur in the intestinal 
crypt cells in rats [254]. The findings could contribute to a better understanding of 
the interactions that occur among the intestinal epithelial cells and the underlying 
immune cells residing within the lamina propria at the principal site of EHEC 
O157:H7 colonisation in cattle.  
1.9.2 Shiga toxin-encoding bacteriophages and EHEC 
O157:H7 colonisation of the intestine 
 The following chapter focused on the bacteriophages encoding for Stx during 
EHEC O157:H7 colonisation of cattle intestine. Stx phages are major drivers of 
evolution in the emergence of new pathogenic strains of EHEC O157:H7 [98]. It has 
been described that Stx phages are involved in regulating virulence levels and 
colonising capacities according to the niche being occupied, for example the bovine-
biased isolates are able to withstand the adverse acidic environment in bovine gut 
better than human-isolates [11, 79]. Chapter 4 aims to understand how possession 
of different Stx phages by EHEC O157:H7 strains could impact on bacterial 
colonization- and virulence-associated traits. The availability of bovine associated 
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strains belonging to PT21/28 (Strain 9000) and PT32 (Strain 10671) with their 
isogenic Stx-phage mutants allowed assessment of specific phenotypes, namely: 
competitive growth, total Stx production, epithelial binding and virulence assessed in 
a larvae model (Galleria mellonella). The environment in which the bacteria colonise 
the bovine terminal rectum is complex with the presence of thick mucus lining to 
provide early protective barriers against incoming threats. Assays in Chapter 4 
utilised mucus harvested from the terminal rectum of calves as a growth medium for 
EHEC O157:H7 strains, allowing assessment of the bacterial phenotypic traits 
associated with colonisation and virulence in an environment that is less artificial 
than the common growth media used routinely in the laboratory. Moreover, the 
presence of stx genes within the chromosome of EHEC O157:H7 next to the genes 
regulating mucin (large glycoproteins of the mucus with 80% comprising of 
carbohydrates including N-acetylgalactosamine, N-acetylglucosamine, galactose, 
fucose, sialic acids, mannose) metabolism suggests an interaction between the genes 
which might provide growth advantage to the bacteria leading to significant 
differences between Stx phage+ and Stx phage negative strains [255]. Recent 
unpublished work [256] has established the growth curves of the same bovine strains 
in 10% bovine terminal rectal mucus, with evidence that EHEC O157:H7 Strain 
9000 (PT21/28) had a faster growth rate than Strain 10671 (PT32). It was anticipated 
that the observations obtained at the end of Chapter 4 would strongly reflect the type 
of Stx-prophage carried by the strain, with the presence and expression of the stx2a 
genes in Strain 9000 PT21/28 providing growth advantage in the bovine and 
probably human intestines, enhanced toxicity to epithelial cells and therefore 
virulence upon transmission into human hosts. This may further clarify why Stx-
phages are strongly retained in the bacterial chromosome throughout the evolution of 
EHEC O157:H7 particularly in successfully propagated, pathogenic strains. 
Information on the binding of these bovine associated EHEC O157:H7 isolates to 
epithelial cells would greatly enhance the current understanding on the already 
complex regulatory network governing bacterial adherence to eukaryotic epithelial 
cells, particularly in assessing the association between Stx-encoding phages and the 
T3SS expression. Lysogeny of EHEC O157:H7 was shown to repress LEE 
expression resulting in reduced ability to bind to host cells [257] which conflicts with 
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the expectation that Stx-phage possessing strains are superior in colonization which 
is reflected by the binding capacity. However the LEE repression was observed in 
artificial laboratory medium compared to the bovine terminal rectal mucus and 
therefore was tested in the current study. It may be that different combination of Stx-
encoding prophages function to control the balance of strategies for the bacterial host 
to colonise, propagate and transmit to susceptible hosts. 
 
 In summary, the early chapters (Chapter 2 and 3) examine the role of Shiga 
toxin bovine intestinal colonisation, by investigating several components present at 
the terminal rectum that might be the target for the toxin to enhance bacterial 
colonisation. Chapter 4 focuses on the Shiga toxin-encoding bacteriophages and how 
they could influence important colonisation phenotypes of the host, EHEC O157:H7 
organism. Chapter 5 provides a general discussion of the main findings and draws 
some conclusions about the contributions Stx and the phages that encode them to 
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2.1 Gb3 distribution in humans and cattle 
 Following the identification of the bovine terminal rectum as the principal 
EHEC O157:H7 colonisation site, no literature to date has studied the presence of 
Gb3 at the bovine terminal rectum. To address this knowledge gap, part of this 
chapter is aimed at investigating Gb3 expression and localisation among cells at the 
bovine terminal rectum as this may be one of the factors potentially contributing to 
the presence and maintenance of EHEC O157:H7 colonisation in cattle. Differential 
Gb3 distribution between humans and cattle have been postulated as one of the 
possible reasons why cattle do not show clinical symptoms as those described in 
EHEC O157:H7-infected humans.  
 
Human renal tissue contains zones rich in Gb3 expression associated with Stx-
induced injuries observed in patients with diarrheagenic HUS particularly on 
microvascular endothelial cells of the glomeruli, as well as the proximal and distal 
tubular epithelial cells and mesangial cells [7, 258-260]. Extra-renal Gb3 distribution 
in humans has also been described in the neurons [261] and blood vessels of the 
central nervous system [262]. Human intestinal epithelial cells do not express Gb3, 
rather the Stx receptor was detected on the microvascular endothelium of the lamina 
propria [263] and on intestinal pericryptal myofibroblasts [161]. By comparison, the 
Gb3 receptor is not present on the murine renal glomeruli [264], but is expressed by 
the murine epithelial cells of the distal colon [265] and endothelial cells of the brain 
[266]. Whereas Gb3 is highly expressed by the villous intestinal epithelial cells in 
rabbits, particularly of more than 16 days of age and correlates to the Stx 
enterotoxicity in rabbits that is associated with an inhibited sodium ion absorption 
[267]. Certain human immune cell populations have also been identified to express 
Gb3, including monocytes, activated platelets and germinal tonsillar B cells [122, 
268, 269].  
 
 In cattle, Gb3 was not detected in the bovine intestine according to a study 
[270], while others have reported the presence of Gb3 positive cells associated either 
with bovine colon epithelial crypts [142] or bovine mesenchymal-derived (non-
epithelial) regions [271, 272]. Primary bovine colon epithelial cell cultures harbour a 
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subset of Gb3-positive cells, however the receptor was identified to not be surface 
expressed, rather the receptor was shown to be localised intracellularly, conferring 
resistance against the cytotoxic effects of Stx1 and perturbations in the chemokine 
expression profile [272]. Diversion in Stx1 trafficking in the cytosol where Stx1 was 
localised into the lysosomes upon internalisation rather than following the retrograde 
route to the ribosome via the Golgi apparatus and endoplasmic reticulum were 
thought to account for the resistance of bovine colonic crypt epithelial cells to Stx1-
induced cytotoxicity [142, 273].  
 
 Bovine intra-epithelial leukocytes (IEL), B cells and mucosal macrophages 
are among the non-epithelial, mesenchymal-associated cells shown to express Gb3 
[253, 271, 272, 274]. Nearly 15% of bovine distal ileal intra-epithelial leukocytes 
(IEL) were Gb3-positive, predominantly CD3+ CD6+ CD8α+ T lymphocytes along 
with only a small proportion of CD4+ and B cells. Transformation of these cells to 
large blast cells was halted when exposed to Stx1 [275]. Mucosal macrophages, a 
term introduced by Stamm et al. (2008) to describe the Gb3 positive cells co-
expressing vimentin (mesenchymal cell marker), are present within the lamina 
propria of the bovine colon and these were shown to succumb to the cytotoxicity 
effect of Stx1 [272]. Bovine CD8+ cells from peripheral blood mononuclear cells 
(PBMC) were also able to express Gb3 following mitogenic stimulation with 
phytohaemagglutinin, lipopolysacharide and pokeweed mitogen [274]. In addition, 
Stx1 blocked the proliferation of bovine CD8+ and CD21+ lymphocytes of the 
PBMC [252]. 
2.2 Gb3 as a determinant for Stx cytotoxicity 
 The association between Gb3 presence and Stx cytotoxicity in different 
immortalised cell lines frequently used in in vitro studies were also assessed in this 
chapter. Although most of the cell lines used in my study have already been 
investigated for the expression of Gb3, recent findings suggest that these 
immortalised cell lines could respond differently to the toxin as a result of 
heterogeneous Gb3 expression across the same cell line in different laboratories 
[276]. This chapter will present and discuss the findings from different immortalised 
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cell lines (some of which are routinely used in Chapter 3 and Chapter 4) tested for 
both Gb3 expression and sensitivity towards Stx. Gb3 is generally regarded as a 
determinant for eukaryotic cells to succumb to the cytotoxic effects of Stx (Gb3 
expression [133] where Gb3 organisation within the plasma membrane of the host 
cell (e.g. lipid rafts) [135, 136] as well as the composition, length and saturation 
status of the hydrocarbon and fatty acid chain of Gb3 contributes to the binding and 
internalisation of the toxin by the cell [131, 132]). Despite this, pre-incubation of 
cells with Gb3 were shown to not be able to protect Vero cells from Stx2 cytotoxicity 
which lead them to suggest that Stx potency depends on more than just the presence 
of Gb3 [112, 191]. This includes the type of host cell (e.g. human microvascular 
endothelial cells or human macrovascular endothelial cells) [188], Stx subtype [69] 
and genotype [277], Stx affinity towards Gb3, toxin stability and binding mode 
[278], the structure of the toxins particularly the A subunit [279], intracellular 
trafficking  of the A subunit [158] and the furin cleavage of the A subunits into A1 
and A2 fragments for maximal toxin potency [280]. 
2.3 The mechanism of actions of Stx-induced cytotoxicity 
 The death of eukaryotic cells following exposure to Stx is thought to occur 
following depurination of the 28S rRNA of the ribosomal unit 60S component by the 
A1 fragment of the A subunit leading to protein synthesis inhibition. Injury to the 
renal microvascular endothelial cells is believed to be central to the development of 
HUS pathogenesis however details on the exact mechanism(s) linking protein 
synthesis inhibition and cellular death in these cells remains ambiguous. Several 
forms of cellular death have been described including apoptosis, necrosis, autophagy, 
anoikis and excitotoxicity [281, 282]. Apoptosis, a highly conserved mechanism in 
eukaryotic cells mediated by a family of cysteine proteases, Caspases, removes 
unwanted or defective cells via a sequence of events leading to cellular disintegration 
within an intact membrane plasma [283] and was suggested as the death pathway 
upon exposure to Stxs [156, 248, 249, 258, 284, 285]. The following paragraphs 
provide a brief review on Stx and apoptosis in different types of eukaryotic cells. 
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 A study on the cytotoxicity of Stx1 towards human glomerular endothelial 
cells resulted in a reduction in cell viability particularly among sub-confluent 
proliferating cells. Enhanced Stx1 toxicity was observed after stimulation of the 
glomerular endothelial cells with the pro-inflammatory cytokine, tumor necrosis 
factor-alpha (TNF-α) via upregulation of the toxin receptor, Gb3 [286]. Another 
study exposed rat primary glomeruli endothelial cells to Stx1 resulting in pathologic 
changes resembling those observed in human HUS however the lesions described 
were associated more with changes in the glomerular endothelial cell adhesion to the 
basement membrane and production of procoagulant vasoconstrictor arachidonic 
acid metabolites causing a significant increase in cell retraction and gap formation in 
the monolayer, rather than protein synthesis inhibition or reduction in cell viability 
[287]. Stx stimulation of primary human umbilical vein endothelial cells (HUVEC) 
lead to both protein inhibition and apoptosis, however the authors argued that these 
two events occurred by separate pathways as protein synthesis inhibition by 
cyclohexamide did not caused apoptosis or enhanced Stx cytotoxicity [285]. Protein 
synthesis inhibition and apoptosis induction were thought to occur via distinctive 
pathways since Stx1 was able to inhibit mitogenesis and protein synthesis without 
affecting the viability of human glomerular mesangial cells.[286].  
 
 In non-renal cell types, numerous reports have been published on Stx 
induction of cellular death via apoptosis. Stx purified from EHEC O157:H7 Strain 
EDL 933 were inoculated into rabbit ileal loops resulting in death by apoptosis of the 
mature, differentiated columnar absorptive epithelial cells [288]. Bhatacharjee et al 
demonstrated that Stx1 was able to mediate apoptosis in HCT116 human colon 
cancer cells by inducing overexpression of the growth arrest and DNA damage 
(GADD) family of genes leading to cell cycle arrest at the S phase [289] (refer 
Figure 2.1 for a brief description on eukaryotic cell cycle). Stx1 incubation of HCT-8 
cells (human colon carcinoma cell line) resulted in apoptosis via caspase 3 cleavage 
and DNA fragmentation [156]. The authors proposed that exposure to Stx1 resulted 
in ribotoxic stress response accompanied by increased levels of C-X-C chemokines 
including Interleukin-8 (IL-8), leading to the activation of the c-Jun (NH-2)-Terminal 
Kinase (JNK)/stress-activated protein kinase (SAPK) and p38 MAPK pathways 
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which in turn triggered apoptosis [156]. Treatment of HEp-2 cells with Stx1, Stx2 
and Stx2c induced apoptosis via activation of caspase-8 which eventually affects the 
Bcl-2 proteins (family of anti-apoptotic and pro-apoptotic proteins involved in 
controlling cell concomitant with apoptosis) and activation of caspase-9, resulting in 
apoptosis [249]. 
 
 In contrast, purified Stx2 from an EHEC O157:H7 strain prevented the 
spontaneous apoptosis of human neutrophils, thereby increasing the life span of the 
neutrophils to exert more damage to the surrounding tissues [290]. These 
observations suggests that Stx types are able to exert differential effects based on the 
type of host cell that the toxins encounter. 
 
  Apoptosis is also regulated by genes involved in cell cycle progression [291] 
and it has been suggested that some of the cell cycle regulatory effectors (Figure 2.1) 
may sensitise the cells to apoptosis, depending on the cellular context [292]. Toxins 
produced by certain bacteria are able to interrupt the eukaryotic cell cycle  [293].  
Examples include subtilase cytotoxin of STEC which was shown to degrade BiP (a 
member of the hsp70 family of stress-regulated proteins) causing downregulation of 
cyclin D1 leading to cell cycle arrest at G1 in Vero cells [294]. Another example is 
the cytolethal distending toxin of the sorbitol fermenting EHEC O157:H- which 
causes irreversible G2/M arrest [295]. It is not known if Stx is able to contribute to 
EHEC O157:H7 colonisation in vivo at the bovine intestine by interfering with the 
life cycle of the intestinal epithelial cells, athough most in vitro work described 
above suggested differential effects of Stx depending on the type of cell that 
internalises it. The following section introduces the final aspect investigated in this 
chapter in relation to assessing the effect of Stx on epithelial cell viability via cell 











Figure 2.1 The cell cycle regulation, taken from Niehrs and Acebron 
[296]. The cell cycle is a highly regulated process involving a family of protein 
kinases named cyclin-dependent kinases (CDKs) [297]. Cyclical changes in CDK 
levels are mostly under the control of cyclins [298]. Binding of cyclins to specific 
CDKs forms the cyclin-CDK complex which then activates protein kinase activity and 
triggers cell-cycle events. CDK activity ends upon cyclin degradation. Cyclin classes 
are present at these checkpoints: i) G1/S phase-cyclins which commits the cell to 
DNA replication, ii) S-phase cyclins required for DNA replication initiation and iii) M-
phase cyclins which promotes mitosis [292]. In G1, cyclin D initiates Rb complex 
phosphorylation, which derepresses E2F to induce cyclin E transcription. 
Components of this complex as well as p21 and p27 oppose these effects and can 
result in cell‐cycle exit to G0. After DNA replication in S phase, different quality 
controls ensure the integrity of the DNA, while a cyclin B/CDK1 complex 
orchestrates progression into mitosis. Chromosome abnormalities and DNA damage 
are reported to this complex via different pathways to delay or stop cell division 
[296]. Canonical Wnt signalling can regulate the cell cycle at the indicated levels, 
along with other pathways described in Fig. 2.2. 
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2.4 Stx and intestinal epithelial cell proliferation  
 The intestinal stem cells consistently proliferate at a high rate to rapidly 
restore depleted intestinal cells under normal circumstances or in response to injury 
and infection [299] (Fig. 2.2). It was estimated that the turnover of bovine terminal 
rectal epithelial cells is four days before sloughing off [300, 301]. Studies have also 
indicated that susceptibility of a cell to the toxin is correlated with certain phases of 
the eukaryotic cell cycle [246, 302]. It was identified that Stx1 bound to Gb3 on Vero 
cells only between the cell cycle phases of G2 to the telophase in mitosis, which 
correlated with maximal synthesis and expression of the glycosphingolipid receptor 
during the two phases mentioned [246]. It seems that Gb3 is surface expressed even 
before exiting the cell cycle via differentiation. It is most likely that the synthesis of 
Gb3 is partly dependent on butyrate, a volatile fatty acid normally present in 
mammalian intestinal lumen which is also a known inducer for cellular 
differentiation [303]. It is not known whether butyrate availability in bovine gut 
would have an impact on Gb3 expression in vivo during an EHEC O157:H7 presence 
[246, 304, 305]. Different feeding protocols aiming at reducing the transmission of 
pathogenic E. coli from cattle to humans have been tested, some regimes of which 
were thought to reduce bacterial survival by altering the intestinal lumenal 
fermentation conditions which directly affects volatile fatty acid concentrations, 
intestinal lumen pH and microbiota composition, all of which are required by the 
colonising bacteria [306, 307]. Another strategy to reduce the risk of bacterial 
survival and transmission to humans is by accelerating the proliferation rate of 
intestinal epithelial cells by manipulating cattle diet and shown to facilitate the 
clearance of EHEC O157:H7 from the bovine gut [308]. From one point of view, Stx 
may be useful to bacterial colonisation if, for some reason, it is capable of halting the 
cell cycle of the daughter cells progressing up the crypt-lumenal axis at the terminal 
rectum, thereby delaying the expulsion of bacterial-attached cells into the lumen. It 
has been previously reported that Salmonella enterica serovar Typhimurium is able to 
modulate the murine intestinal stem cells niche via its type three secretion system 
effector, AvrA which activates the beta-catenin/Wnt signalling pathways leading to 
an increased in cellular proliferative activity, showing that certain bacterial-secreted 
factors are capable of affecting epithelial layer homeostasis [309]. 
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 From a study that supported a role of Stx in positively influencing EHEC 
O157:H7 colonisation in both HEp-2 cells and mice intestine, the authors showed 
that the enhanced binding capacity of the bacteria was most probably due to the 
upregulated presence of Nucleolin following exposure to purified Stx2 at the cellular 
surface coinciding with bacterial attachment [241]. Nucleolin is the major nucleolar 
protein of growing eukaryotic cells associated with the intranucleolar chromatin and 
pre-ribosomal particles. It functions to induce chromatin decondensation and plays a 
role in pre-rRNA transcription and ribosome assembly. Nucleolin is also 
ubiqutiously distributed in the nucleus and sometimes cytoplasm of eukaryotic cells 
[310]. The mechanism linking Stx and nucleolin is still unknown, however the 
authors stressed that both proteins have similar affinity for ribosomal RNA. 
Secondly, nucleolin could be upregulated at the cellular surfaces of the bacterial 
bound cells as part of the cellular stress response to intoxication during pre-apoptotic 
stages. By upregulating nucleolin at the bacterial binding site within the cellular 
surface, it could also be speculated that Stx could target and manipulate eukaryotic 
proteins closely associated with the cell cycle machinery to the advantage of EHEC 
O157:H7 colonisation in the intestine.  
 
 DNA staining by propidium iodide (explained further in Chapter 2, Materials 
and Methods section 2.15) is a commonly used method to check for the distribution 
of cells across the different phases of the cell cycle [291]. This method was applied 
to experiments in this chapter on intestinal epithelial cells treated with Stx2, in 
addition to staining for the proliferating cellular nuclear antigen (PCNA), a 







Figure 2.2 Components of the proliferative-differentiative crypt-lumenal 
axis of the colon epithelium, modified from Medema et al. [312] and 
Kosinski et al [313].  All of the cell lineages of the intestinal epithelium originated 
from cells of the stem cell niche, the crypt base columnar cells (CBCC) and the +4 
stem cells (stem cell markers identified in human and mice). Transiently-proliferating 
progenitor cells arise from the stem cells that moves up the crypt and differentiate 
into either: absorptive enterocytes, enteroendocrine cells, mucus-secreting goblet 
cells, Tuft cells (produce opiods and enzymes for prostaglandin synthesis) [314] in 
the small intestine and the M cells (reviewed in Chapter 3, Introduction section 
3.11). Note the absence of the extended villi structure at the top of the colonic crypt, 
one of the feature that differentiates between the large and small intestines. 
Following differentiation, most of the matured cells will move up to the lumen before 
being shed (estimated around four days in the bovine gut) and expelled. 
Myofibroblasts are an integral component of the stem cell niche secreting factors 
that regulate intestinal stem cell function, including those belonging to the pro-
proliferation pathways; i) Wnt (Wingless integrated signalling pathway) ligands [315], 
ii) BMP (bone morphogenetics proteins) antagonists, such as Gremlin 1 and iii) the 
Notch pathway (proliferation of undifferentiated secretory lineage) proteins [316]. 
The Wnt protein family and BMP antagonists are expressed in a reciprocal gradient 
to the pro-differentiative, anti-proliferative bone morphogenetic proteins (BMP, blue 
circles) and Hedgehog (Hh, yellow squares) protein families along the crypt–villus 
axis. Hh is expressed by differentiated colonocytes and limits expression of Wnt 
target genes to the base of the crypts. Activation of Hh increases BMP signalling 
and inhibits the Wnt pathway. Myofibroblasts are Hh responsive and regulate the 
patterning of the crypt–villus axis. Inhibition of the Notch pathway leads to the 
differentiation of stem cells into the secretory lineage. The Notch ligand Jagged-1 is 
expressed in a reciprocal manner to the Notch-1, -2 and -3 receptors [313, 316]. In 
the small intestine, the highly specialised epithelial Paneth cells, are present at the 
bottom of the crypt areas and secretes various antimicrobial peptides and proteins. 
The Paneth cells also secrete factors involved in modulating the epithelial stem and 
progenitor cells of the small intestinal epithelium [317]. 
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 The questions raised in this chapter as well as the rest of the thesis are 
important as limited information is available on events taking place during 
colonisation of the bovine terminal rectum by EHEC O157:H7, particularly the lack 
of knowledge on the status of Gb3 expression at the principal EHEC O157:H7 
colonisation site and Stx production in vivo (if produced, at what quantity and how 
this affects the host and bacterial survival, refer Chapter 4). This chapter also 
explores other potential roles that could be ascribed to the repertoire of Stx functions 
in the mammalian gut, particularly on epithelial proliferating homeostasis. The 
objectives for this chapter were: 
 
1. To examine bovine terminal rectal mucosa for any presence of Gb3 by flow 
cytometry and fluorescence microscopy. In both methods, co-staining with 
epithelial or mesenchymal cell markers were undertaken to allow 
identification of Gb3 expressing cell types from a heterogeneous population  
2. To assess the association between Gb3 surface expression on different 
immortalised cell lines, some of which had or had not been reported for Gb3 
presence, and sensitivity towards Stx2 
3. To investigate if Stx2 influences the proliferation and subsequently cell cycle 
of intestinal epithelial cells by 
a. Comparing the levels of a proliferative marker, Proliferating Cellular 
Nuclear Antigen (PCNA) following epithelial cell exposure to Stx2 
b. Comparing the propidium iodide (PI)-DNA staining profiles of intestinal 



































2.1 Routine cell culture techniques  
All of the continuous cell lines used were maintained at 37°C, in an incubator 
with 5% CO2. Typically, the cells were revived from the liquid nitrogen-freezers 
prior to being propagated in the laboratory to check for viability before further use. 
Upon removing the cryotube containing cell suspension from the -175°C freezer, the 
cells were quickly thawed in a 37°C water bath before being transferred into a 10 ml 
Thermo Scientific™ Sterilin™ tube with screw cap containing 9 ml of complete cell 
culture medium (described below for each cell line). The cells were then centrifuged 
for 5 min, 260 relative centrifugal force (RCF or x g) (SciQuip, 3K15, Sigma 
Laboratory Centrifuges) before adding 5 ml of complete cell culture medium and 
transferred into a 25cm2 tissue culture flask. The cells were visually inspected daily 
for viability and the medium changed every 3 days. Upon reaching full confluence, 
the cells were washed in phosphate buffered saline (PBS) before being dissociated 
from the flask using TrypLE™ Express enzyme, (12563029, Life Technologies) for 
5 min at 37°C, 5% CO2 before diluting the enzymatic activity in complete culture 
medium at least 1:2. The cells were then centrifuged for 5 min, 260 x g and sub-
cultured in a ratio of 1:3, with a seeding density of 1x104 cells/ml to 1x105 cells/ml. 
Cells were counted using the TC20™ Automated Cell Counter (Bio-Rad), with 10 µl 
of cell suspension diluted in 0.2% Trypan Blue (17-942E, Lonza) added per chamber 
of the cell counting slide (Bio-Rad). 
 
For long term storage, the cells were pelleted before being slowly re-
suspended in cell freezing medium consisting of 70% of the basal medium specific to 
each cell line (mentioned below), 20% fetal calf serum (FCS) (F0643, Sigma)  and 
10% Dimethyl sulfoxide (DMSO) Hybri-Max™ (D2650, Sigma), 1 ml per cryotube 
which were then stored in cryogenic freezing container Mr Frosty™ (Thermo 
Scientific Nalgene) at -80°C overnight before transferring to the liquid nitrogen 




2.2 Vero cells 
Y.Yasamura and Y.Kawakita of Chiba University, Japan successfully derived 
Vero cells from the kidney of an adult African green monkey (Cercopithecus) in 
1962 [318]. These cells are well-characterised and are sensitive to a number of 
viruses and have successfully been used in development of vaccines, the poliovirus 
and inactivated rabies vaccines among others. The cells were purchased as Vero-B4 
(ACC33) from the DSMZ German Collection of Microorganisms and Cell Culture, 
Leibniz Institute (Braunschweig, Germany).  The cells were maintained in 90% 
Roswell Park Memorial Institute (RPMI)-1640 with HEPES modification (R5886 
Sigma), 10% FCS, 1% Penicillin-Streptomycin (10,000 U/ml, 15140-122, 
Invitrogen) and 1% Glutamax™ (35050-038, Life Technologies).  
2.3 Caco-2 cells 
Caco-2 cells are a derivative of a human colon carcinoma. The line has been 
shown to express Gb3 and is sensitive to Stx and mimics the differentiated cells on 
the villi of the small intestine [305]. The cells were maintained in 90% Dulbecco’s 
Modified Essential Medium (DMEM) (D5796, Sigma), 10% FCS and 1% Penicillin-
Streptomycin and 1% Glutamax™.    
2.4 T84 cells  
The T84 is a human colon adenocarcinoma-originated cell line which 
resembles the human adult colonic crypt epithelial cells and therefore has less-
developed brush border as compared to the Caco-2 cells. T84 cells were used as the 
‘Gb3-deficient’ cell line in this study [305]. T84 cells were maintained in 50% 
DMEM, 50% Ham’s F-12 Nutrient Mix (21765-037, Invitrogen), 10% FCS, 1% 
Glutamax™ and 1% Penicillin-Streptomycin.  
2.5 HeLa cells 
The HeLa cells were derived from the cervical cancer cells of Henrietta 
Lacks in late 1951 after she passed away [319]. Until present, these cells have been 
used in numerous studies across the world due to the cells being immortal and easy 
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to propagate in the laboratory. HeLa cells have been shown to be positive for Gb3 
surface expression as the Vero cells in previous studies and have therefore been used 
in comparative studies of Stx activity [133, 320] These cells were maintained in the 
same complete culture medium as described above for Caco-2 cells (refer to section 
2.3). 
2.6 EBL cells 
The Embryonic Bovine Lung (EBL) cell line was established from the lung 
of a 7-month old bovine fetus [321]. Since a well-characterised immortal cell line of 
the bovine intestine is yet to be established, EBL cells were included in this study 
owing to its epithelial-like phenotype and that the epithelial lining of the 
gastrointestinal tract and lungs are both derivatives of the same germ layer, the 
endoderm [322]. The complete cell culture medium used for the culture of EBL cells 
is as described above for Caco-2 and HeLa cells (refer to section 2.3). 
2.7 Chinese Hamster Ovary (CHO)-K1 cells 
The Chinese Hamster Ovary (CHO) cells were derived as a sub-clone from 
the parental CHO cell line initiated from a biopsy of an ovary of an adult Chinese 
hamster by T.T.Puck in 1957 . The cells are regularly used as a negative control for 
Gb3 expression experiments since they do not express Gb3 [323-325].  The cells 
were provided courtesy of Dr Carla Garcia-Morales, The Roslin Institute. The cells 
were maintained in 90% Ham’s F-12 Nutrient Mix with 10% FCS, 1% GlutaMAX™ 
supplement (35050-061, Gibco®, Life Technologies) and 1% Penicillin-
Streptomycin.  
2.8 Bovine primary terminal rectal cell culture 
The cells were prepared by Edith Paxton (Roslin Institute) according to the 
Cellular Microbiology Group standard operating procedures, CMG/SOP/01. Two to 
three cattle recta with intact anal canal were obtained from a local abattoir on the day 
of the procedure and were transported on ice in transport medium consisting of 
Hank’s Balanced Salt Solution (HBSS) (55021C, Sigma) containing 25 mg/ml of 
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Gentamicin (G1396, Sigma) to the post-mortem room at the Royal (Dick) School of 
Veterinary Studies. The recta were flushed to remove faecal material within the 
lumen. A longitudinal dissection was made into the mucosal layer. The terminal 
rectum, defined as the distal 4 cm part from the recto-anal junction was identified 
and carefully removed from the underlying connective tissue and immersed in HBBS 
with 5 µg/ml Fungizone (15290-018, Invitrogen). The tissue samples were then 
brought into a Containment Level 2 (CL2) laboratory to continue the process. Excess 
mucus was gently scraped off using the sides of a clean glass slide to expose the 
epithelial lining of the rectal mucosa layer.  A second scraping was then done, this 
time with more pressure to harvest approximately 15 g of scraped rectal mucosa and 
collected in 50 ml of HBSS. The tissue suspension was centrifuged at 260 x g for 2 
min. After decanting the supernatant, the washing process was repeated until the 
supernatant was clear, with large tissue pieces remaining in the pellet. In order to 
release the epithelial cells, particularly the crypts, the tissue was then digested in 25 
ml DMEM supplemented with 1% FCS, 1% Penicillin-Streptomycin (P4333, 
Sigma), 25 µg/ml Gentamicin (G1396, Sigma), 75 U/ml of Collagenase (C2674, 
Sigma) and 20 µg/ml of Dispase I Neutral Protease, Grade 1 (04942086001, Roche) 
at 37°C, 200 RPM for 80 min on a shaking incubator (INFORS HT Multitron 
Standard).  
 
Repeated steps of a differential centrifugation process (260 x g, 2 min) were 
then carried out in HBSS containing 2% sorbitol to enrich the isolated crypts from 
large, undigested materials and fibroblasts. At the end of the process, crypts have 
been visualized microscopically from the pellet and re-suspended in early culture 
medium (97.5% DMEM, 2.5% FCS, 0.25U Insulin, 10 ng/ml Epidermal growth 
factor (EGF), 25 µg/ml Gentamicin) to approximately 1000 crypts/ml. 800 µl of 
early culture medium with approximately 500-700 crypts was added to each 
collagen-coated well of a 24-well-plate and 2 ml with approximately 1200-1400 
crypts were added to the wells of a 6-well-plate. The cells were incubated at 37°C, at 
5% CO2. Twenty four hours post-seeding, the medium was replaced with complete 
culture medium (Minimum Essential Medium Eagle’s (MEM)-D-valine (M3795, 
Sigma) containing 1% FCS, 0.25U Insulin, 10 ng/ml EGF and 25 µg/ml of 
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Gentamicin). The cells were monitored on a daily basis via observation under the 
light microscope, ensuring zero percent of contamination (bacteria, yeast) and 
minimal presence of fibroblast. The cells were cultured to about 60 - 70% of 
confluence level (approximately 3 days post-seeding), before proceeding with 
experiments.  
2.9 Shiga toxin 
The purified Shiga toxin 1 (PStx1) and purified Shiga toxin 2 (PStx2) were 
purchased from Toxin Technology, Inc., Sarasota, Florida (STX-1, lot # 110308V1, 
STX-2, lot # 111108V2). Both purified toxins were reported to have toxicity of 
greater than 107 Units per milligram (mg) and purity level of approximately 50% 
confirmed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE). Upon arrival (delivery was under a strict process as Stx is under Schedule 5 
regulations), the toxins were dissolved in PBS to produce laboratory stock solution of 
10 µg/ml in PBS and stored at -80°C in a locked freezer.  
2.10 Shiga toxin cytotoxicity assay  
 To assess the sensitivity levels of the continuous cell lines used in this study 
towards purified Stx variants, cytotoxicity assays were conducted. Vero, Caco-2, 
CHO, EBL, T84 and HeLa cells were cultured in flat-bottomed, 96-well-plate with 
approximately 1x105 cells per well and incubated as described above. Once a 
confluent layer has been formed, the culture medium was removed and replaced with 
serum-free medium containing either  purified Stx1 or purified Stx2 (Toxin 
Technology, Inc.) diluted at 50 ng/ml, 100 ng/ml, 200 ng/ml and 400 ng/ml, with the 
exception of HeLa cells. Due to limited availability of the purified Shiga toxins, 
HeLa cells were treated with filtered lysates of bovine EHEC O157:H7 isolate Strain 
9000 (possessing phages encoding for Stx2a/Stx2c) and its isogenic Stx2a and Stx2c-
encoding phage mutant. A more detailed description on phenotypic characterisation 
and bacterial lysate preparation of these two EHEC bovine isolates are described in 
Chapter four (refer to Chapter 4, Materials and methods section 4.1 - 4.7). In brief, 
both EHEC O157:H7 Strain 9000 and its Stx2-phage negative mutant strain were 
grown in LB, for 18 h at 37°C, 200 R.P.M. The overnight cultures were then diluted 
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1:100 in fresh LB and left to grow until the optical density (O.D.) 600nm reading 
reached 0.2-0.25. 10 µg/ml of Mitomycin C (MMC) was added into the cultures to 
induce crosslinking of the deoxyribonucleic acid (DNA) of the bacterial cells thereby 
maximising the levels of Stx production and release from lysed bacterial cells 
(lysate). The MMC-supplemented cultures were further incubated overnight and 
filter-sterilised (Millex® GV-syringe filter unit membrane, pore size 0.22 µm, Merck 
Millipore) to collect cell-free lysate containing Stx (for EHEC O157:H7 Strain 
9000). The filtered-lysates of Strain 9000 (Stx positive) and Strain 9000 
ΔΦStx2a/ΦStx2c (Stx negative) were then diluted in DMEM (1:100) before being 
added to HeLa cells. Negative control cells received serum-free media (or LB in 
serum-free media for HeLa cells) while positive control cells were treated with 0.1% 
Triton™ X-100 (T8787, Sigma). The cells were placed in the incubator at 37°C, 5% 
CO2 for a maximum of 72 h. Daily checks of the cells were performed by observing 
the cells under light microscopy to determine if the cells were already responding to 
the toxin. After 72 h, the toxin containing serum-free media was discarded and the 
cells were gently washed in pre-warmed PBS (37°C) once.  
 
 65 µl of 2% formalin in PBS was added to each well for 1 min at room 
temperature to fix the cells. The fixative was replaced with 65 µl/well of crystal 
violet tissue culture stain (52 ml of 0.5% crystal violet (Sigma), 10 ml of absolute 
ethanol, 10.8 ml of 37% formaldehyde and 127.2 ml of PBS) and incubated at room 
temperature for 24 h. The fixed cells were then washed gently with distilled water 
until the water appeared clear and were air-dried. The plate was scanned for visual 
record. 100 µl of 10% acetic acid was added per well and the plate was placed on an 
orbital shaker for 15 min at room temperature to dissolve the crystal violet stain. The 
values of absorption at O.D. 595nm were obtained using a plate-reader (FLUOstar 







2.11 Flow cytometry  
2.11.1 Flow cytometry buffer 
The buffer consists of 2% FCS in PBS prepared fresh prior to the start of each 
experiment. 
2.11.2 Immuno-staining 
In general, upon cell harvesting, the cells were centrifuged at 260x g 
(SciQuip model 3K15, Sigma Laboratory Centrifuges) for 5 min and suspended in 
flow cytometry buffer (volume depends on the size of pellet obtained, could range 
from 2 ml to 10 ml). The cells were then distributed accordingly into wells of a ‘v’-
bottom shaped, 96-well-plate. The cells were washed again at 1200 R.P.M. (Jouan 
BR4i Multifunction Centrifuge, Thermo Electron Cooperation) for 2 min; the 
supernatants were removed and re-suspended in primary antibody solutions or flow 
cytometry buffer, at the appropriate concentrations. The cells were kept at 4°C for 30 
min, covered with aluminium foil if the primary antibody used were directly 
conjugated with fluorochrome. This was followed by two washes in flow cytometry 
buffer as described before incubating the cells with the appropriate conjugated 
secondary antibody(s) for 20 min at 4°C, protected from direct light. The cells were 
then washed as described for at least three times before adding 100 µl of the buffer 
into each well and transferring the cells into a labelled flow cytometry tube 
containing 400 µl of flow cytometry buffer. 
 
For intracellular staining which required the cells to be permeabilised, cells 
were added with BD Cytofix/CytoPerm™ reagent (554722, BD Biosciences) and 
incubated at 4°C for 20 min, protected from light before washing twice with 
BDPerm/Wash™ buffer (554723, BD Biosciences) (diluted 1:10 in distilled water). 
This was followed by the similar procedure for antibody staining as described above, 
with the exception of the buffer used to dilute the antibody(s). The antibody(s) were 
diluted in 1x BDPerm/Wash™ buffer, at the appropriate concentrations. All of the 
washes were also done using the 1x BDPerm/Wash™ buffer to maintain the cell 
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membrane in a permeabilised state. For instrumental settings of the flow cytometry 
machine, three types of controls were routinely used. This includes unstained cells, 
single stained cells of all the antibodies being used and cells that were stained with 
only the secondary antibody(s). The unstained cells were washed or suspended in 
flow cytometry buffer throughout the whole cell immune-staining procedure. 
2.11.3 Data acquisition and analyses 
The stained cells were acquired through the BD FACSCalibur™ (BD 
Biosciences) according to the general protocol of running the machine. The 
instrument settings were adjusted by its ampere and voltage gain so as to bring the 
population of cells of interest to be in the middle of the Forward Scatter (FSC)-Side 
Scatter (SSC) dot plot. Histograms of the appropriate channel for each fluorochrome-
conjugated-antibody(s) and two-colour dot plots were also plotted to perform 
compensation later on if necessary. Typically, 10,000 events within the gated region 
were collected across all samples. In the event of fewer cells available, as 
experienced when running bovine primary rectal cells, the total events acquired 
within the gated region was reduced to 5,000 cells. All acquired data were saved onto 
the network drive before analysis with FlowJo software (Treestar, Inc.). 
 
The antibodies (Table 2.1) were tested on cell lines that were either already 
established to be positive for cell surface Gb3 expression: Vero, Caco-2, T84, CHO, 
EBL and HeLa cells (Vero, Caco-2 and HeLa cells were previously regarded as Gb3 
positive cells, while T84 and CHO cells are regarded as the Gb3-negative cell lines) 
[131, 276, 305, 320, 323, 326, 327]. After the specificity and optimum 
concentrations of the antibodies were confirmed, a similar protocol was applied to 
the bovine terminal rectal cell cultures.  
 
The primary cells were used at day 3 to day 5 post-seeding from collagen-
coated 6-well-plates, with prior inspection of the morphology of the cells under light 
microscope to ensure that the cells in the culture were healthy and not overgrown by 
fibroblasts. The bovine primary terminal rectal cells were double stained with the 
epithelial cell marker; pan-cytokeratin (PCK) and the mesenchymal cell marker; 
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Vimentin [272]. This was done to selectively detect Gb3 positive cells, either of 
epithelial (double stained  Gb3+/PCK+ cells)  or mesenchymal origin (double stained 
Gb3+/Vimentin+) since the cells were derived from a highly heterogenous cell 



































Antibody Clone Isotype Concentration Source 
Rat anti-Gb3 
 






















V9 IgG1 1:50 Sigma (V6630) 
 
Goat anti-rat IgM-PE 
 





- - 1:100 Sigma (F2012) 
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2.12 Tissue section harvest and cryosection production  
The aim of these experiments was to detect Gb3 expression at the primary 
site of EHEC O157:H7 colonisation as this has not been previously investigated (in 
detail) in cattle. The tissue sections were obtained from the rectum of one calf 
involved in a separate study and were acquired by collaborators at the Moredun 
Research Institute (Pentlands Science Park, Midlothian, UK). The calf was 
previously screened to be free of EHEC O157:H7 infection by the Immuno-magnetic 
Separation (IMS) test and was one of the animals serving as a non-infected control in 
a study involving other infected calves. At the end of the study, the calf was 
humanely euthanised to allow post-mortem examination and sample extraction. The 
rectum was immediately acquired and processed where tissue strips of size 0.5 cm 
(width) x 4cm (length) were cut out of the terminal rectal area transversely 
(following the circular muscle orientation). To serve as comparison and tissue 
staining control, similar tissue sections were cut out of the colon mucosa as well as 
from the nasal mucosa. Colon mucosa has previously been shown to express Gb3 in 
random areas [272] as well as within the crypts [328] while the nasal mucosa is 
thought to include some of the Gb3-positive cells within its associated lymphoid 
tissue, since certain follicular B cell populations expresses Gb3 [122]. The tissue 
strips were rolled up to form a circular ring and were placed on individual cork discs. 
Then, the tissues were covered with Tissue-Tek™ CRYO-Optimum Cutting 
Temperature (OCT) Compound (14373-65, Andwin Scientific) before dipping into 
liquid nitrogen to flash freeze and stored at   -80°C freezer until use. The tissues were 
then sent to the Shared University Research Facilities (SuRF) at the Queen Margaret 
Research Institute (QMRI), University of Edinburgh to produce cryo-sections of 5 
µm thickness that were immediately fixed in cold ethanol (-20°C) and stored at -





2.13 Immuno-fluorescent staining of bovine cryo-sections 
The bovine cryo-sections were thawed at room temperature for approximately 
5 min. Using a hydrophobic wax pen, a border was drawn around the sections on 
each slide and the wax was left to dry (1 - 2 min). At this point, the sections were 
transferred into a moist humidified chamber (slide staining tray with lid, #11968004, 
Fisherbrand®,) filled up with distilled water (DH2O) to prevent the tissue sections 
from drying. Approximately 100 µl (depending on the size of the sections, could vary 
between 100 µl to 200 µl) of PBS was carefully dropped onto the edge of each 
section to re-hydrate the tissue for 30 min at room temperature. This was then 
followed by a blocking step to avoid non-specific binding of the antibodies. Tissue 
sections were  incubated in blocking buffer consisting of 1% bovine serum albumin 
(BSA) (A2153, Sigma), 2% normal goat serum (G9023, Sigma) and 0.125% Tween 
20-PBS (PBS-T) for 1 h at room temperature. Sections were then incubated in iT 
Signal Enhancer buffer (I36933, Life Technologies) for 30 min at room temperature, 
washed in 0.125% PBS-Tween 20 once before primary antibody incubation (all 
primary antibodies are indicated in Table 2.2, were diluted in staining buffer 
containing 1% BSA, 2% normal goat serum in 0.125% PBS-T, overnight, 4°C). The 
sections were washed in washing buffer (1% BSA in 0.125% PBS-T) once for 30 
seconds, followed by 3 x 5 min washes. Excess liquid was wiped and the sections 
were transferred back into the humidity chamber to continue with secondary 
antibody (Table 2.2) incubation in staining buffer at room temperature for 30 min, 
protected from light. Unstained control slide was left in staining buffer (1% BSA in 
PBS-T) throughout the staining under similar conditions with the rest of the slides. 
No primary antibody and rat IgM isotype controls were also included. The sections 
were washed in washing buffer as above. 12 µl of ProLong® Gold anti-fade 
mountant with DAPI (4',6-diamidino-2-phenylindole) (P-36931, Molecular Probes®, 
Life Technologies) was added on each cover slip before mounting the slides onto it, 
avoiding formation of air bubbles that might interfere with the microscopy 
examination further on. The mounted sections were kept in the slide holder box 
overnight, in dark conditions to adequately dry the mounting media. From then on 
the slides were either kept at 4°C or examined under fluorescence microscope (Leica 
DMLB) and images were taken with the Image processing and analysis in Java 
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Table 2.2 List of antibodies for Gb3 and cell lineage marker detection by 
fluorescence microscopy. 
 

















V9 1gG1 1:100 abcam® 
(ab8069) 
 
Mouse anti bovine 










Goat anti-rat IgM 
(µ) Alexa Fluor® 
594 
 




Purified rat IgM 
isotype control 
 

















Alexa Fluor® 488 




2.14  Haematoxylin and Eosin staining of cryo-sections 
The fixed bovine cryo-sections were thawed for 5 min at room temperature 
before inserting the sections into glass slide racks and loading into the Leica 
Autostainer XL V2.01 automated slide stainer. Briefly, the sections were dipped in 
Haematoxylin for 3 min, followed by two washes in water for 3 min, then in the 
blueing reagent, Scott’s tap water substitute (Leica Biosystems) for 2 min and then 
rinsed in water for 3 min. The sections were then transferred to the tank with Eosin 
(2 min), water for 45 seconds and dehydrated in 95% ethanol twice for 30 seconds 
and 100% ethanol for 1 min, twice. Next was a mixture of ethanol and xylene for 1 
min before completing the process with clearing in xylene (to minimise light 
diffraction and promotes nearly optically perfect images since xylene has a similar 
refractive index with the suffused fixed protein) twice for 1 min and a final dip in 
xylene. The glass slide racks were removed from the autostainer before adding 
ClearVue™ mountant (Thermo Scientific) onto individual cover slips to which the 
glass slides were mounted to. The finished H&E stained slides were dried on a flat 
surface, at room temperature, overnight to settle the mountant before examining the 
slides and taking images with an upright light microscope (Nikon Instruments 
Europe B.V.)  and analysed using ZEN blue edition (Carl Zeiss Microscopy GmbH).   
2.15 Stx and cell cycle/proliferation  
2.15.1 DNA staining solution 
1 ml of DNA staining solution (to stain one sample in a FACS tube) contains 
2 µl of Propidium iodide (PI, 1mg/ml, Biotium), 0.5 mg/ml of DNase free-
ribonuclease A (RNase A) from bovine pancreas (stock 10 mg/ml, Sigma) and 948 µl 
of PBS. The DNase-free RNase A was prepared according to the manufacturer’s 
instructions. 
2.15.2 Cell counting and fixation  
 At the end of each stimulation time point, cells were washed twice with 
sterile PBS and harvested with 1x TrypLE™ Express (600 µl of TrypLE™ Express 
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per well, incubated at 37°C for 5 min before stopping its action by diluting in 1 ml of 
PBS). The cells were pelleted at 260 x g for 5 min and re-suspended in 300 µl of 
PBS. 20 µl of cell suspension were added into equal volume of 0.2% Trypan Blue 
Stain (15250-061, Invitrogen) and left for 5 min at room temperature. 10 µl of the 
mixture was loaded into the counting chamber slides for cell counting using the 
TC20™ (Bio-Rad) automated cell counter. The cell concentration was then adjusted 
with PBS to obtain at least 1x105 cells in 300 µl per tube before adding 700 µl of 
100% ethanol (ice-cold) to fix the cells. The fixed cells were stored at 4°C for at least 
24 h before resuming with DNA staining. 
2.15.3 Shiga toxin cell stimulation 
 Caco-2 and T84 cells were maintained in T75 cell culture flasks at 37°C, 
5% CO2 until a confluence level of 50% were achieved. These cells were sub-
cultured and maintained under similar conditions until reaching 50% confluence for 
at least one cycle before the cells were sub-cultured into 6-well-plates at a low 
seeding density of 6 x103 cells/cm2 and incubated for 40 h. The purified Stx2 (Toxin 
Technology, Inc.) was diluted in normal cell medium to obtain a concentration of 
100 ng/ml. Control cells received normal culture medium. The cells were incubated 
at 37°C, 5% CO2 for either 6 h or 24 h.  
2.15.4 DNA staining and flow cytometry 
 After incubation of the ethanol-fixed cells at 4°C for 24 h, the cells were 
stained with DNA staining solution (details mentioned in 2.15.1). Prior to staining, 
the cells were centrifuged to wash off the ethanol at 5000 R.P.M., 5 min at 18°C. The 
supernatant (ethanol) was removed by tipping the tube downwards onto paper towels 
to absorb the ethanol. This prevents losing the cell pellet from the bottom of the tube. 
The cells were then re-suspended in 0.5% BSA in PBS, 1 ml per tube and centrifuged 
again as before. The BSA was added to promote the cells to pellet as they tend to 
float within the supernatant due to their size and weight. The supernatants were 
removed in similar manner as the ethanol. 1 ml of DNA staining solution was added 
into each tube with approximately 1x105 cells and incubated at 4°C for at least 24 h 
before acquiring data on a BD FACSCalibur™ machine.  
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2.15.5 Data acquisition and DNA content analysis by flow 
cytometry 
 DNA content of ethanol-fixed cells were analysed by detecting signal of 
propidium iodide staining under fluorescence channel-2 (FL-2). 10,000 events were 
collected with low flow rate to obtain better resolution of the DNA-PI histogram 
peaks for every sample with BD CELLQUEST™ (BD Biosciences). The presence of 
doublets or aggregates of cells upon crossing the laser beam during acquisition will 
result in the presence of extra peaks in the FL-2 (total fluorescence signal of PI) 
histogram, as opposed to the typical three peaks corresponding to DNA content in 
different phases of the cell cycle (Figure 2.1). An additional step was performed to 
exclude cell aggregates and debris by plotting an FL2-Width against FL2-Area dot 
plot (Fig. 2.2). Gating was then applied on the single cell population to derive the 
FL-2/PI histogram for analysis of total DNA content. The boundaries were manually 
set for G1, S and G2/M (with the guidance of an expert in cell cycle analysis by flow 
cytometry, Robert Fleming of the Bio-Imaging and Flow Cytometry facilities at 
Roslin Institute, UK), based on the typical histogram shape (Fig. 2.1) producing 
peaks corresponding to the proportion of cells within each phase of the cell cycle 
(G1, S, G2/M), based on the DNA content (refer to Fig. 2.1 and Fig. 2.2). Statistical 
analyses of the proportion of cells within each phase were performed in GraphPad 
Prism Version 6 (GraphPad, Inc.) with multiple t-test using Holm-Sidak method, 
alpha at 5.00%, without assuming similar standard deviation (S.D.) values to 












Figure 2.1 Histogram of propidium iodide (PI) staining detected by 
fluorescence channel 2 (FL-2) corresponding to total DNA content in 
different phases of the cell cycle in ethanol-fixed cells. The amount of 
DNA in phases of the cell cycle is reflected by total fluorescence of PI-stained 
nuclei. Quiescent, non-replicating cells contain single copies of the DNA, compared 
to the mitotic cells of G2/M phase with two copies of DNA (double fluorescence 
intensity). Cells in the S-phase contains intermediate amount of DNA, between the 




Figure 2.2 Dot plot of propidium iodide fluorescence detected by FL-2 
to distinguish single cells from cellular aggregates and debris (adapted 
from Cell Cycle Basics, Lerner Research Institute, Cleveland Clinic, 
Ohio, United States). The single cell population will have a recognisable pattern 
on the FL-2/Width versus FL-2/Area dot plot, with the values of maximum 
fluorescence emission and total cell fluorescence to be in lower than the doublets or 
aggregated cells, but higher than cellular debris. DNA analysis of the selected single 
cell population will result in a histogram with better resolution of the DNA peaks 
(seen in Fig. 2.1).  


































2.15.6 Detection of proliferating cells 
 Caco-2 and T84 cells were stimulated with PStx2 for 6 and 24 h and cell 
culture were prepared as described above. At the end of the PStx2 treatment, the cells 
were washed in PBS and fixed following the same fixation protocol as for PI staining 
of cellular DNA (refer to 2.15.4). The fixed cells were stained with mouse anti-
human Proliferating Cell Nuclear Antigen (anti-PCNA, Clone PC10, Phycoerythrin 
(PE)-conjugated, sc-56-PE, Insight Biotechnology), diluted in flow cytometry buffer 
at 1:100 in 500 µl of sample per tube. The cells were left at 4°C for 30 min before 
washed in flow cytometry buffer twice. The PCNA-labelled cells were detected by 
flow cytometry according to the procedure described above with FL-2 as the 








































2.1 Gb3 expression on different immortalised cell lines 
 Vero cells have been established to be highly positive for Gb3 expression 
[131]. Therefore for the purpose of testing and optimising antibodies for detection of 
Gb3 expression at the bovine terminal rectum, Vero cells were used as a positive 
control. In contrast, Chinese hamster ovary (CHO) cells have been previously 
demonstrated to be deficient of Gb3 cell surface expression [123, 329] therefore 
these cells were used as a negative Gb3 expression control. In addition, human Caco-
2 and T84 cells were investigated for Gb3 expression due their intestinal origin and 
epithelial phenotype. Bovine EBL cells were used as reference cells for the bovine 
system. In a first set of experiments, the Gb3 surface expression of all cell lines was 
investigated by flow cytometry analysis. 
 
 Figure 2.1 presents the flow cytometry results shown as compilation of all 
histograms for the cell lines analysed for Gb3 surface expression. Data analysis was 
done in Flowjo programme to produce median of fluorescence intensity (MFI) values 
to enable comparison of the FL2-channel signals among the different cell lines 
relative to the control (secondary antibody only stained cells). Cell lines with MFI 
values of more than that for the secondary antibody staining only control were 
assumed to be positive for Gb3 staining. On average, the MFI values for Gb3 
detection on Vero, HeLa and Caco-2 cells from the two experiments were 
approximately 4.5 - 5.8 times more than that of the secondary antibody only control 
value, indicating that the three cell lines had similar Gb3 expression. Gb3 expression 
on T84 cells were relatively 2 - 2.6 times more than the control MFI, while CHO 














           Experiment 1           Experiment 2 
Figure 2.1 Histograms and median of fluorescence intensity (MFI) of 
Gb3 surface expression on different cell lines. The cells (Vero in red, Caco-
2 in blue, HeLa in magenta, T84 in green, Embryonic Bovine Lung (EBL) in yellow 
and Chinese Hamster Ovary in dark grey) were stained for surface Gb3 and 
acquired on a BD FACS Calibur™ instrument. 10,000 events were collected for 
each cell line. Data were analysed with Flowjo software (Treestar Inc., City, USA) by 
placing a gate to exclude cellular debris, followed by setting the cut-off point for 
positive staining based on cells stained with only the secondary antibody (Goat anti-
Rat IgM PE-conjugated) before calculating the median of fluorescence intensity 
(MFI) values from the statistical toolbar. The histogram plots were then overlaid and 
set for half offset display producing above plots, each plot indicates a different set of 
replicate for the experiment. 











 Secondary antibody staining 9.47 9.45 
 




Embryonic Bovine Lung 
(EBL) 
9.47 10.5 
 T84 24.6 19.8 
 HeLa 42.9 55.2 
 Caco-2 52.8 42.9 
 Vero 50.9 42.9 
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2.2 Sensitivity of different immortalised cell lines towards 
Shiga toxins 
 To investigate the influence of Shiga toxin treatment on Gb3 expression 
levels, the cell lines were treated with purified Stx1 and purified Stx2. The aim of 
these experiments was to confirm the expression of Gb3 and to analyse the 
functionality of Gb3 as a Stx receptor, since sensitivity towards Stx is correlated with 
Gb3 expression on the surface of the cells [132, 330]. Shiga toxin cytotoxicity assay 
were done for all cell lines using purified Stx1 and Stx2 (Fig. 2.2), except for HeLa 
cells due to the limited availability of purified toxins at later stages of my thesis 
work. To overcome this issue, sensitivity of HeLa cells to the toxin was instead 
tested with filtered lysates of Mitomycin C-induced EHEC O157:H7 Strain 9000. 
Strain 9000 possesses Stx2a and Stx2c-encoding prophages, therefore the lysate of 
this strain is expected to contain high levels of Stx2a and Stx2c. On the other hand, 
MMC-induced culture lysate was also generated for a strain derived from EHEC 
O157:H7 Strain 9000 with phages encoding for Stx2a and Stx2c deleted. The 
absence of the two Stx-encoding phages in the isogenic Strain 9000 mutant, in theory 
would produce Stx-free lysates, serving as negative control for HeLa cytotoxicity, 
apart from the other negative assay control (serum-free medium) (Fig. 2.2). As 
expected, Vero cells were the most sensitive cells tested towards the toxicity effect 
after treatment with both purified Stx1 and purified Stx2. Even at the lowest 
treatment dose (0.1 ng/ml), nearly 50% of Vero cells were killed post 72 h exposure 
to the purified toxins. This result is consistent with the flow cytometry results in Fig. 
2.1 which showed that Vero cells had high expression levels of Gb3. Caco-2 cells 
showed a dose-response cytotoxicity effect when treated with purified Stx1, however 
this effect was not observed when the cells were treated with purified Stx2. T84 cells 
were resistant to lower doses of both purified toxins but approximately 5% - 20% of 
the cells succumbed to PStx1 and PStx2 treatment at higher doses (500-1000 ng/ml). 
EBL cells were neither affected by purified Stx1 nor purified Stx2 treatments at the 
end of the 72 h incubation, while only less than 5% of CHO cells were sensitive to 
both toxins.  
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 Incubation of HeLa cells with filtered supernatants of LB-grown EHEC 
O157:H7 Strain 9000 and its isogenic Stx phage deficient cultures for 72 h revealed 
that the HeLa cells were sensitive to the treatment of the Stx-positive supernatant. 
The HeLa cells receiving supernatant of the Stx phage mutant remained as viable as 
the negative control cells (DMEM medium with LB diluted 1:100).  
 
 No statistical analyses were done on the Shiga toxin-cytotoxocity assay data 
since values obtained were mean of technical repeats (ranging from three or six or 
nine wells per treatment). Due to the limited amount of purified Stx2 available and 
time constraint, independent repeats of the cytotoxicity assays were not done. 
However, it was observed that technical replicates of the individual cytotoxicity 



































Figure 2.2 Shiga toxin cytotoxicity assay plates of immortalised cell 
lines with different Gb3 surface expression. Bar plots present the absorption 
values (O.D. 595 nm) from at least three replicate wells signifying viable cells 
remaining in the plate post 72 hours incubation with either purified Shiga toxin 1 
(PStx1), pink bars; purified Shiga toxin 2 (PStx2), green bars, 0.2% Triton-X100 
(positive control), black bar and DMEM (negative control), white bar, at 37°C, 5% 
CO2. At the end of incubation, the cells were washed with PBS and fixed in 2% 
formalin and stained with crystal violet staining solution for 18 hours at room 
temperature. The fixed cells were washed in distilled water before dissolving the 



























































Figure 2.2 Continued. Shiga toxin cytotoxicity assay plates of 
immortalised cell lines with different Gb3 surface expression status. Bar 
plots for EBL and CHO cells present the average of absorption values at O.D. 595 
nm from at least three replicate wells signifying viable cells remaining in the plate 
post 72 hours incubation with either purified Shiga toxin 1 (PStx1), pink bars; 
purified Shiga toxin 2 (PStx2), green bars, 0.2% Triton-X100 (positive control), black 
bar and DMEM for EBL, Ham's F-12 media for CHO cells (negative control), white 
bar, at 37°C, 5% CO2. The bottom bar plot represents the absorption values at O.D. 
595 nm for viable HeLa cells after 72 hours under similar incubation conditions as 
above in filtered lysate of EHEC O157:H7 Strain 9000 (dark green bar), EHEC 






















































 2.3 Gb3 expression by cells of the bovine primary terminal 
rectal culture 
 There was a huge difference in the flow cytometry results of Gb3+/PCK+  
dot plots from two independent batches of bovine primary terminal rectal cells (Fig. 
2.3). The results from the first experiment showed on average 44.2% surface 
detection for Gb3+/PCK+cells, while 47.2% of permeabilised cells stained for 
surface and intracellular Gb3+/ PCK+. On the other hand, in the second experiment 
bovine primary terminal rectal cells showed a much lower staining for Gb3+ and 
PCK+, both regarding surface and total expression levels (on average 2.80% and 
7.81%, respectively). Double staining the cells for Gb3 and vimentin antibodies 
revealed very low detection in both experiments, with 0.88% of surface and 0.93% of 
total Gb3+/Vimentin+ cells detected in batch 1, whilst only the second batch 
provided negligible values of detection for both surface and intracellular 













Figure 2.3 Flow cytometry results for Gb3, Pancytokeratin (PCK) (pink 
boxes) and Vimentin (brown boxes) on bovine primary terminal rectal 
cells. The dot plots show the output from two different primary terminal rectal cell 
independent batches, with the plots within the pink boxes as Gb3+/PCK+ 
populations, surface (all plots in the top row in the pink box) and total (cell 
permeabilised to obtain signals from both surface and intracellular) (all plots in the 
bottom row of the pink box) detection. While the four dot plots within the bottom 
brown boxes are bovine terminal rectal cells stained for Gb3+ and vimentin, surface 
and total detection. Gb3 antibody staining of the cells were followed by staining with 
anti-rat-IgM-PE (AbD Serotec) (FL2 channel) and the PCK-stained cells were 
probed with anti-mouse FITC-conjugated antibody (Sigma) detected by channel 









2.4 Gb3 detection on bovine cryosections  
Fig. 2.5 - 2.10 shows the bovine cryosections stained for immunofluorescence 
analysis of Gb3, PCK (epithelial cells), vimentin (non-epithelial/mesenchymal cells), 
major histocompatibility class II (MHC II) and DAPI (nucleic acid/DNA staining). 
Fig. 2.4 presents immune-staining control tissue sections, nasal mucosa from the 
same calf where the rest of the cryosections were obtained from. At least three 
sections were independently stained for both bovine terminal rectal and colonic 
mucosae and thoroughly examined ensuring all parts of the sections were analysed 
by fluorescence microscope. The fluorescence microscopy images presented in this 
chapter are from the third set of cryosections examined and are representative of the 
appearance of the cryosections consistently observed in all three independent 
examinations. Due to limited availability of cryosections and time constraint, 
Haematoxylin and Eosin (H&E) staining were only done on cryosections from the 
third set of tissues stained for fluorescence microscopy. H&E staining images are of 
cryosections that were cut consecutive (before or after) to the fluorescence-stained 
sections providing information on the histological structures present in the sectioned 
tissues examined.  
2.4.1 Gb3 and Pancytokeratin co-staining  
To identify if Gb3 is expressed at the terminal rectum in bovine, the terminal 
rectal and colonic cryosections were stained with rat anti-Gb3-IgM antibody, 
followed by the secondary goat anti-rat IgM-AF 594 conjugated antibody. In order to 
discriminate Gb3 expression on bovine terminal rectal and colonis mucosa, the 
cryosections were co-stained with one of the two different classes of cellular 
microfilaments, the Type I and II keratins (cytokeratins) or Type III mesenchymal 
microfilaments (vimentin) [331, 332].  
 
The anti-PCK antibody comprise of a broad range of monoclonal antibodies 
that reacts with the cytoplasmic cytokeratins. These cytokeratin intermediate 
filaments are important in cell structure maintenance by providing mechanical 
support to the epithelial cells [333, 334]. The PCK antibody also does not react with 
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non-epithelial normal human tissues, therefore suitably used as the ‘epithelial cell 
marker’ [334, 335]. Immunofluorescence analysis of Gb3+/PCK+ staining of bovine 
terminal rectal cryosections revealed the lack of epithelial-associated Gb3 expression 
(Fig. 2.9-2.10). However, the appearance of randomised, positive signals from some 
colonic crypts and within the inter-crypt areas of terminal rectal and colon 
cryosections (refer to split channels for Gb3 staining in Fig. 2.5) might suggest for 
actual presence of Gb3. To address this, immunofluorescence analysis of the 
cryosections were performed with co-staining Gb3 with either vimentin or major 


























Figure 2.4 Bovine nasal associated lymphoid tissue (NALT) cryosections stained for Gb3 and Pancytokeratin (PCK). DAPI staining of the DNA 
(blue), PCK staining with secondary goat anti-rabbit conjugated to Alexa Fluor® 488 (green) and Gb3 staining with secondary goat anti-rat IgM 
conjugated to Alexa Fluor® 594 (red) are shown in colour (merge) and in greyscale (separate channels). Haematoxylin and Eosin (H&E) stained 
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Figure 2.5 Bovine colon mucosa cryosections stained for Gb3 and Pancytokeratin (PCK). DAPI staining of the DNA (blue), PCK staining with 
secondary goat anti-rabbit conjugated to Alexa Fluor® 488 (green) and Gb3 staining with secondary goat anti-rat IgM conjugated to Alexa Fluor® 594 
(red) are shown in colour (merge) and in greyscale (separate channels). Haematoxylin and Eosin (H&E) stained cryosection and DAPI co-stained 
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Figure 2.6 Bovine terminal rectal mucosa cryosections stained for Gb3 and Pancytokeratin (PCK). DAPI staining of the DNA (blue), PCK staining 
with secondary goat anti-rabbit conjugated to Alexa Fluor® 488 (green) and Gb3 staining with secondary goat anti-rat IgM conjugated to Alexa Fluor® 
594 (red) are shown in colour (merge) and in greyscale (separate channels). Haematoxylin and Eosin (H&E) stained cryosections and DAPI co-stained 
cryosections with secondary antibodies only and rat IgM isotype are also presented.  
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2.4.2 Gb3 and Vimentin co-staining 
 
Vimentin is expressed in a wide range of cell types including fibroblasts, 
endothelial cells, macrophages, neutrophils, leukocytes, mesangial cells and renal 
stromal cells, making it as a good marker for non-epithelial cells [336]. Vimentin has 
also been recognised as the marker for epithelial-mesenchymal transition (EMT), a 
cellular reprogramming process whereby epithelial cells acquire mesenchymal 
phenotype with increased mobility [337]. It is also used as the M cell marker present 
within the intestinal follicle-associated-epithelium (FAE) in rabbits [338]. With 
regards to this study, positive vimentin staining could represent non-epithelial cells 
present within the inter-cryptic areas in the terminal rectal and colonic mucosa 
including fibroblasts, macrophages and neutrophils.  
 
Results for Gb3+/Vimentin+ immunofluorescence staining are shown in Fig. 
2.7-2.8. The strongest signal for mesenchymal-associated Gb3 staining were seen in 
the terminal rectal cryosection within areas resembling lamina propria, with the 
presence of structures presumed to be blood vessels based on the H&E staining, 
distant from the crypts and surface of the terminal rectal mucosa. No evidence of 
positive Gb3 staining were observed on the terminal rectal crypts. Such findings 
suggest that the Stx receptor within the terminal rectum might be associated with the 
lamina propria bearing blood vessels and possibly the deeper part of the sub-mucosal 
layer, rather than on the epithelium. The presence of areas with positive signals of 
the Gb3 fluorescence were also observed around structures suspected as blood 
vessels in several cryosections of the colonic mucosa, further supporting that Gb3, if 
expressed, is not associated with the epithelium. The connective tissue surrounding 








Figure 2.7 Bovine colon cryosections stained for Gb3 and vimentin. DAPI staining of the DNA (blue), vimentin staining with secondary donkey anti-
mouse conjugated to Alexa Fluor® 488 (green) and Gb3 staining with secondary goat anti-rat IgM conjugated to Alexa Fluor® 594 (red) are shown in 
colour (merge) and in greyscale (separate channels). Haematoxylin and Eosin (H&E) stained cryosections and DAPI co-stained cryosections with 
secondary antibodies only and rat IgM isotype are also presented. 
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Figure 2.8 Bovine terminal rectal mucosal cryosections stained for Gb3 and vimentin. DAPI staining of the DNA (blue), vimentin staining with 
secondary donkey anti-mouse conjugated to Alexa Fluor® 488 (green) and Gb3 staining with secondary goat anti-rat IgM conjugated to Alexa Fluor® 
594 (red) are shown in colour (merge) and in greyscale (separate channels). Haematoxylin and Eosin (H&E) stained cryosections and DAPI co-stained 




















DAPI and Rat IgM 
Isotype Control  
DAPI and secondary 
antibodies 
 113 
2.4.3 Gb3 and Major Histocompatibility Class II (MHC II) co-staining  
MHC II is constitutively expressed by professional antigen-presenting cells 
(APCs) primarily macrophages, dendritic cells and B cells [339], all of which could 
be present scattered within the crypt areas, particularly at the FAE region. Following 
the findings in Fig. 2.5-2.8 for positive Gb3 staining within the connective tissue 
surrounding the crypts and vessels, co-staining with MHC II antibody would help to 
clarify if the professional APCs, present within the mucosal layer of the intestinal 
lumen expresses the Stx receptor. The findings for immunofluorescence analysis of 
Gb3+/MHC II+ co-stained bovine cryosections are presented in Fig. 2.9-2.10. Weak 
Gb3 staining around areas resembling blood vessels are seen for both terminal rectal 
and colonic mucosa sections. However, no corroboration for Gb3 and MHC II 
staining was observed in the two large intestinal parts examined, implying that Gb3 
is most likely not expressed by the professional APCs.  
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Figure 2.9 Bovine colon mucosa cryosections stained for Gb3 and major histocompatibility complex class II (MHC II). DAPI staining of the DNA 
(blue), MHC II staining with secondary donkey anti-mouse conjugated to Alexa Fluor® 488 (green) and Gb3 staining with secondary goat anti-rat IgM 
conjugated to Alexa Fluor® 594 (red) are shown in colour (merge) and in greyscale (separate channels). Haematoxylin and Eosin (H&E) stained 
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Figure 2.10 Bovine terminal rectal mucosa cryosections stained for Gb3 and major histocompatibility complex class II (MHC II). DAPI staining 
of the DNA (blue), MHC II staining with secondary donkey anti-mouse conjugated to Alexa Fluor® 488 (green) and Gb3 staining with secondary goat 
anti-rat IgM conjugated to Alexa Fluor® 594 (red) are shown in colour (merge) and in greyscale (separate channels). Haematoxylin and Eosin (H&E) 
stained cryosections and DAPI co-stained cryosections with secondary antibodies only and rat IgM isotype are also presented.
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2.5 The effect of Stx on intestinal epithelial cell cycle and 
proliferation 
 DNA staining with propidium iodide in cells treated with purified Stx2 for 6 
h did not cause significant changes of the cell cycle in either Caco-2 or T84 cells, as 
shown in Fig. 2.11. The average percentages of cells in G1, S and G2/M phases were 
similar for Caco-2 cells treated with purified Stx2 or not as analysed by multiple t-
test with Holm-Sidak method (alpha=5%) without assuming consistent standard 
deviations, with G1-phase [t( 4)=0.251 (p-value=0.814)]; S-phase [t (4)=0.879 (p-
value=0.429)] and G2/M phase [t (4)=0.475 (p-value=0.660)]. T84 cells had a slight 
increase in the proportion of cells in G1 and S phases, compared to the untreated 
group. The differences however were not statistically significant when analysed with 
multiple t-test using the Holm-Sidak method (alpha value of 5%, without assuming 
consistent standard deviations) with statistical analysis for G1 phase [t (4)=2.41 (p-
value=0.07)], S-phase [t (4)=2.78 (p-value=0.05) and G2/M-phase [t (4)=2.72 (p-
value=0.05)]. 
 
  To analyse specific effects of purified Stx2 on cellular proliferation, cells 
were stained with antibody against the proliferation cellular nuclear antigen (PCNA). 
Again, neither Caco-2 nor T84 cells showed a significant different response at 6 and 
24 h after treatment when compared to untreated controls (Fig. 2.12). Since this 
experiment was only performed once, statistical analysis could not be done on the 
data. However, as no difference was observed between purified Stx2 and untreated 
cells in DNA staining cell cycle profiles under similar conditions, this suggests that 

















Figure 2.11 DNA staining profile with propidium iodide of cells treated 
with purified Shiga toxin 2 (PStx2). Bar plots showing the average (n=3) of 
Caco-2 (Fig. 2.11a) and T84 (Fig. 2.11b) cells present in each cell cycle phase. The 
cells were incubated in PStx2 (100 ng/ml) or serum-free media for 6 hours at 37°C, 
5% CO2. Data were analysed with multiple t-test corrected for multiple comparison 
using the Holm-Sidak method, alpha=5%, without assuming a consistent standard 


















Figure 2.12 Proliferation cellular nuclear antigen staining of purified 
Shiga toxin 2 (PStx2) treated Caco-2 and T84 cells.  Flow cytometry results 
(n=1) presented in bar plots for Caco-2 and T84 cells stained for proliferating cell 
nuclear antigen either treated with 100 ng/ml of PStx2 (orange) or serum-free media 
(white), for 6 hours (Fig. 2.12 a,b) and 24 hours (Fig. 2.12 c,d) at 37°C, 5% CO2. 



































 Although Stx has been demonstrated to be the causal virulence factor 
associated with HUS clinical syndromes in human patients, little is still known about 
its role in bovine intestinal EHEC O157:H7 colonisation. To date, few studies 
support for the toxin to function in a manner that benefits EHEC O157:H7 adherence 
by upregulation of the Nucleolin (eukaryotic intimin receptor) [241] or possibly 
targeting the bovine immune centres at the bovine intestine to modulate the immune 
response raised against the bacteria to prevent expulsion from cattle [275]. However, 
certain aspects at the primary colonisation site of EHEC O157:H7 in cattle have yet 
to be explored. This includes examining the principal colonisation site of the cattle 
by EHEC O157:H7; the terminal rectum. Previous studies have investigated for the 
presence of the toxin receptor on bovine colon mucosa which resulted in no 
significant findings pertaining to Gb3 associated with the surface colonic epithelium 
[272, 273], rather intracellular Gb3 were detected in the crypt cells of the bovine 
primary colon cell culture which turned out to be resistant to Stx1 as the toxin was 
redirected to destruction via lysosomal compartments [142, 328]. Perhaps if Stxs are 
important for EHEC O157:H7 colonisation at the terminal rectum in cattle, one 
should expect for higher levels of Gb3 expressed by cells of the primary colonisation 
site. On the other hand, the receptor may not be required for the toxin to exert effects 
in facilitating bacterial attachment and persistence at the site since the toxin have 
been shown to cross the mucosal epithelial border to the lamina propria in a Gb3-
independent manner as that described in human intestinal epithelial cells [159, 165]. 
In another set of experiments in Chapter 2, this study also attempted to answer if Stxs 
were able to manipulate the proliferation and cell cycle machinery of intestinal 
epithelial cells, knowing that certain types of cells especially the highly proliferative 
crypt cells are targeted by effectors and toxins released from bacteria [340]. 
Interrupting with the host cell cycle or modulating the proliferation machinery could 
benefit EHEC O157:H7 during intestinal colonisation, for example, by delaying the 





2.1 Gb3 expression in continuous cell lines 
 The presence of surface Gb3 renders a cell susceptible to Stx1 or Stx2 
induced cytotoxicity [133]. Vero, HeLa, T84, and CHO cells responded to the toxins 
in a presumably Gb3 dependent manner since more cytotoxicity were observed in 
highly positive cells and vice versa which is in line with published studies [95, 133, 
159, 276, 341-343]. An interesting observation was recorded for Caco-2 cells Stx-
toxicity assays where the cells responded to Stx1 as anticipated (positive association 
of Gb3 and cytotoxicity) but not Stx2 despite strongly expressing Gb3. This study 
has not gone further to investigate the paradoxical resistance of Caco-2 cells to Stx2 
although this might be due to a number and combination of factors discussed below. 
 
  Several properties of the Shiga toxins could provide arguable explanations 
on why differential toxicity between Stx1 and Stx2 were observed in Caco-2 cells. 
The ribosomal phosphoproteins of Caco-2 cells targeted by the A subunits of Stx1 
and Stx2 may be different according to Chiou et al. [344]. This may cause the A 
subunits to go through different ribosomal binding pathways leading to distinctive 
levels of toxin potency. Furthermore, it has been hypothesised that the difference in 
potency between Stx1 and Stx2 could be attributed to the binding kinetics and 
affinity of the B subunits to Gb3 [279]. Different rates of the Stx1 and Stx2 uptake 
by Caco-2 cells may also be a reason underlying the different toxicity effects 
observed, as previously reported by Schuller et al. [159]. Conceivably the Stx1 B 
subunit had higher binding affinity to the Caco-2 cells compared to the Stx2 B 
subunit leading to higher death of Caco-2 cells. This hypothesis may be plausible as 
in human renal tissues, Stx1 had a 10-fold higher affinity for Gb3 extracted from 
human renal tissues [345] and in another study, Stx1 was able to bound and 
dissociate from the Gb3 faster than Stx2 [346]. The difference in the preferred 
structure of the Stx B subunit during binding to Gb3 could also result in differential 
cytotoxicity between the two toxin subtypes. This was based on findings that the 
Stx1 B subunit is more stringent in binding to Gb3 as it could only interact with Gb3 
in  stable pentamer structure, as opposed to the Stx2 B subunit which are able to bind 
to Gb3 even in lower oligomeric states [347]. It may be that absolute toxicity is best 
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achieved via the Gb3-pentamer B subunit interaction, rather than with the 
presumably unstable lower oligomeric structures. 
 
 Caco-2 cells have been described to spontaneously differentiate upon 
reaching confluence [348-351]. This could result in differential expression of Gb3 on 
Caco-2 cells within the same culture,  which is dependant on the maturity level of the 
cells and thus influence the overall Stx toxicity. If the Caco-2 cell culture treated 
with purified Stx2 in this study were predominantly immature cells not expressing 
surface Gb3, then this may explain the resistance towards Stx2. However the cells 
used for Stx1 and Stx2 cytotoxicity assays originated from the same tissue culture 
flask and sub-cultured at the same time under similar culture conditions, making this 
hypothesis less likely to explain the different toxicity levels between the two toxin 
types. 
 
The different levels in potency between Stx1 and Stx2 were only observed in 
Caco-2 cells, rather than in other Gb3 positive cells including the Vero and HeLa 
cells. Earlier studies have reported that Gb3 on the cellular membrane does not 
always correlate with cytotoxicity [136, 286, 325]. Perhaps, differences in the 
structures and properties of Caco-2 cells in comparison to Vero and HeLa cells may 
contribute to the observed differences in the response between both cells to Stx1 and 
Stx2. Furthermore, the presence of Gb3 within lipid rafts on cell membrane was 
shown to significantly increase cell sensitivity towards Stx. Variations in the lipid 
raft structures were suggested to affect cellular responses to Stxs [136, 323]. 
Additionally, different signalling of the Stxs occur between Gb3+ and Gb3- 
epithelial cells, as reported by Schuller and colleagues where they investigated the 
intracellular trafficking of Stx1 and Stx2 in Caco-2 and T84 cells [159]. They found 
that although both Stx1 and 2 were able to reach the endoplasmic reticulum of T84 
cells and the A-subunit of both toxins were cleaved in a furin-dependent manner, 
suggesting for an alternative cellular entrance mechanism taken by the Stxs into the 
Gb3-deficient cells.  
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Lastly, instability of the purified Stx2 (PStx2) used may have been a possible 
factor, although this is unlikely because Vero cells reacted to the same batch of 
PStx2 as much as they did react to PStx1. 
2.2 Gb3 expression at the bovine terminal rectum 
Flow cytometry analyses of bovine primary colon epithelial cells [272] 
identified a small population of Gb3-positive epithelial cells that were able to bind to 
the B-subunit of the toxin. Despite this the authors were not able to detect Gb3-
positive epithelial cells in primary colon culture when investigated further by 
conventional and confocal microscopy, leading to inconclusion on the Gb3 status in 
bovine epithelial cells of the colon. Similarly, the results of flow cytometry analyses 
to detect the expression of Gb3 by primary bovine terminal rectal cells failed to 
provide a solid evidence as the results were inconsistent. Deriving the primary cells 
from different individual animals may very well be a major contributor to the 
observed flow cytometry analyses. Additionally, the uncertainty on the phenotype of 
the cells present after three or five days in culture posed some difficulty in reaching a 
solid interpretation. The receptor of interest might either be already expressed on the 
crypt cells isolated or the receptor was expressed post-seeding upon receiving 
synthetic cell culture medium or other stimulants. Fibroblast overgrowing within the 
primary cell culture was also another factor that could influence the outcome of such 
experiments [272]. 
 
 To visualise the evidence for the presence or absence of Gb3 on cells of the 
bovine terminal rectum, this study proceeded with fluorescence microscopy 
examination of mucosal sections from the terminal rectum of a calf. Fluorescence 
microscopy images provided no evidence of Gb3 being expressed on both the 
intestinal epithelial cells (PCK-positive cells) or the underlying lamina propria 
(vimentin-positive cells). The lack of detection particularly on epithelial cells 
contradicts the results obtained from the flow cytometry examination of the bovine 
primary terminal rectal cells in the first batch of cells processed, but similar to what 
was reported for bovine primary colon epithelial culture cells [272]. In the bovine 
primary colon epithelial cell culture, there was no evidence on surface expression of 
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Gb3 which corroborated with the absence of significant anti-Gb3 staining in the 
histological sections of the epithelial layers of the colon. 
 
Gb3 were reported to be expressed by intra-epithelial leukocytes of the ileum  
[275] as well as mitogen-stimulated lymphocytes of colon in cattle [271]. These 
findings may implicate that Shiga toxins preferentially targets the host immune cells 
than the absorptive epithelial cells as this may result in more beneficial effects to 
host colonisation by EHEC O157:H7. Furthermore, the Stx1 and Stx2 were found to 
bind to the Gb3-expressing Paneth cells, in addition to the endothelial cells and 
myofibroblasts around the crypts of human duodenal mucosa, in contrast to the 
colonic mucosa [161]. Paneth cells are highly specialised epithelial cells of the small 
intestine which functions as part of the innate immune response by expressing 
antimicrobial peptides including lysozyme and alpha-defensins [317]. Taken together 
my data and others, it is most likely that direct Gb3-Stx interaction does not occur at 
the bovine terminal rectal mucosa particularly along the epithelial cell layer and that 
if the toxin does indeed contributes to lesion formation at the site [352], the 
mechanism would be Gb3-independent.  
 
 During the investigation of Gb3 co-expression with PCK and vimentin-
positive cells of the bovine terminal rectum, it was also observed for several 
dispersed areas with positive signals of Gb3-fluorescence near structures which 
resembled blood vessels. Further staining with anti-MHC class II antibody did 
revealed co-expression of Gb3+/MHC II+ staining around some, but not all of the 
blood vessels. This indicates that a specific group of MHC II positive cells do 
express Gb3, but in low numbers as Gb3+/MHC II+ cells were not consistently 
observed across all terminal rectal mucosal sections. The lack of time hindered from 
further phenotyping the Gb3+/MHC II+ cells examined.  
 
 Certain factors might limit Gb3 detection from the cryosections, for instance 
storage condition at -80ºC or use of ice-cold absolute ethanol which can potentially 
cause over-drying of the tissue material thereby disrupting Gb3 structure, which 
might result in false-negative Gb3 detection. However, this is unlikely since the 
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positive control for the cryosections (nasal mucosa associated lymphoid tissue of the 
same animal, containing germinal centres with B cells and antigen presenting cells) 
had detectable levels of Gb3. The cryosections examined in this study were just 
sourced from one animal and therefore a different outcome may have been observed 
if tissues from more animals would have been analysed and compared. It would be 
useful to examine Gb3 on cryosections from EHEC O157:H7 colonised animals and 
to compare such results with the data obtained in this study. In addition, the rat-
derived anti-Gb3 antibody was derived for specific use on human tissues, however 
this particular antibody was also shown to react with bovine tissues in a previous 
study [272]. The anti-Gb3 antibody is also an IgM, an isotype with five binding sites 
which could easily bound to or trapped within the structures of the mucosal sections, 
in particular where part of the cryosections, mainly the outmost area, appears to be 
dry with a loss in structure integrity. These disintegrated areas were easily identified 
and excluded from examination. A rat IgM-isotype control was also used to ensure 
that the Gb3+ signals detected were normalised to the isotype control.  
2.3 Shiga toxin and epithelial cell cycle/proliferation 
 Despite the absence of Gb3 expression at the principal colonisation site, the 
question of whether the growth of intestinal epithelial cells are affected by Stx 
exposure was investigated. This was based on the belief that Stxs could still 
translocate across Gb3-negative cells [157-159] and by doing so, may interact with 
certain components of the epithelial cells that may alter epithelial cell homeostasis, 
for example epithelial layer integrity [159, 353] and water/ion transport systems 
[171]. In vitro assays testing for cellular proliferation and DNA profiles were 
performed on both Gb3-positive and Gb3-deficient intestinal epithelial cell lines. 
Stx2 treatment of both Caco-2 and T84 cells neither showed any evidence which 
supported the initial hypothesis that the toxin might target and hijack the 
proliferating machinery of the eukaryotic cell to the benefit of the bacteria, regardless 
of the Gb3 status of the cells tested. This was opposite to what was observed for Stx1 
as it was reported that the Stx1 arrested HCT116 colon cells in the S phase after 24 
hours of exposure [289]. In another study, intra-epithelial lymphocytes expressing 
Gb3 responded to the effect of Stx1 by showing inhibited proliferation [253, 275]. 
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The lack of significant results from both the cell cycle (DNA-Propidium iodide 
staining plots) and proliferation marker analyses prevented further work to be 
continued on this subject. Otherwise follow up experiments could have been 
undertaken with cells synchronised in a particular cell cycle phase to examine which 
cycle regulator might have been affected by Stx treatment [294, 295]. 
 
Although the usage of intestinal cancerous cell lines to study cell cycle seems 
questionable owing to the erratic/infinite proliferating capacity, these cells have been 
widely accepted and used as appropriate intestinal epithelial models in a vast number 
of studies including those involving STEC as well as cell cycle [155, 349, 351, 353-
355]. Caco-2 phenotypically resemble epithelial cells as they are polarised and 
express mature villi whereas the T84 resemble the phenotype of highly proliferating 
crypts [351, 355]. The different Gb3 status between these two cell lines provided 
comparison from another angle, in addition to crypt versus differentiated 
comparison.  
 
The lack of effects on epithelial intestinal cell lines following Stx2 treatment 
may be due to insufficient stimulation time, which should be stretched further 
beyond 24 hours, for example, before the toxin could assert perturbations in the cell 
cycle. Stx2 was used at a sub-lethal dose (100 ng/ml), a dosage which has been 
commonly used in our laboratory for the Stx-stimulation of eukaryotic cells in 
immunology-based assays. Therefore, testing Stx on Caco-2 cells for cell cycle based 
assays performed in this study should be regarded as valid. It is therefore fair to 
conclude that Stx, at least Stx2, does not target the growth and development of the 
intestinal epithelial cells both the mature, Gb3 positive cells and the Gb3-deficient, 
under in vitro conditions. Actively proliferating crypt-like cells were observed to still 
continue proliferating as usual within 6 and 24 hours post-Stx2 treatment.  
 
This study did not detected any profound Gb3 expression at the bovine 
terminal rectal epithelium which may suggest that: i) Stxs preferentially target the 
Gb3 positive bovine lymphocytes present in the underlying lamina propria, instead of 
the intestinal epithelial cells [253]; ii) Stxs are not able to exert cytototoxicity in the 
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bovine terminal rectal epithelial cells and iii) Stxs may exert effects other than 
cytotoxicity on the bovine terminal rectal epithelial cells (such as cellular integrity or 
water/ion channel functions [159, 170]). Cell cycle progression and cellular 
proliferation were unaffected in Stx2-treated Caco-2 and T84 cells, in contrast to 
Stx1 which halted the cell cycle progression at the S-phase [289]. It is however 
acknowledged that results obtained here should be interpreted with caution as further 
work are needed to support and confirm the findings here, particularly carried out 
under in vivo conditions which could not be realised here due to time and resource 
limitations. In addition, there is a need to establish continuously dividing intestinal 
epithelial cells of bovine origin to allow a more relevant system to be used since 
bovine primary cells, although valuable for its high degree of similarity to the cells 
present in situ in the cattle, have also certain issues to be resolved particularly with 
regards to consistency between culture batches and fibroblast contamination. 
Although there was a report on the establishment of a bovine intestinal epithelial cell 
line [356], the authors are still in the process of characterising the cells and testing 
for routine use in the laboratory [357]. By employing bovine intestinal epithelial 
cells, this would provide more confidence in the findings as i) originated from cattle, 
appropriate species, ii) easier to handle, homogenous cell culture system that will 
improve consistency between experiments and iii) a more in-depth understanding of 
events occurring intracellularly as changes in gene and protein expression could be 
studied with minimal heterogeneity, with the ease of obtaining higher sample 
amounts (as opposed to sorting primary cells into different types). Furthermore, the 
in vitro system of these continuous cells could be transformed to mimic the 
conditions in vivo by providing other elements such as aerobic/anaerobic conditions 
[165] or supplementing with different types of nutrients/proteins/others depending on 
the experiment requirements. Regardless, this chapter provides preliminary 
information on Gb3 expression at the primary EHEC O157:H7 colonisation site, as 
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3.1 Overview of the rectum  
The rectum is part of the distal large intestine, positioned between the sigmoid 
colon and the anal canal. It functions as a storage vessel for faeces passed from the 
descending colon and participates in faecal evacuation through the anus via a series 
of neuromuscular sphincter mechanisms [358]. In cattle, rectal palpation has been 
routinely used in procedures such as pregnancy diagnosis, examination of the 
reproductive organs and artificial insemination. 
 
The outer or serosal layer of the rectal wall is composed of epithelial and 
connective tissue covered with the mesentery providing blood supply and innervation 
to the rectum. This is followed by the external muscularis layer consisting of the 
longitudinal and circular muscular layers. The submucosa layer containing glands 
and nerve plexuses lies beneath the final layer which makes up the rectal lumen; the 
mucosal layer. Continuous columnar epithelial cells line the rectal mucosa until the 
recto-anal junction. This junction is demarcated by a change in the mucosal 
epithelium from columnar to stratified squamous epithelial cells. The absence of 
intestinal villi (projections of the mucosal epithelium present in the small intestine up 
to the ileo-caecal valve and involved in increasing surface for absorption) and the 
presence of numerous goblet cells are two characteristics typically observed for 
rectal mucosa. Most water from the faecal content has already been absorbed by the 
time it reaches the rectum, explaining the absence of villous membrane on the 
mucosal layer. Lubrication of the faeces is provided by mucus secreted from the 
goblet cells, with the mucus layer at the rectum observed to be denser among other 
sections of the intestinal tract [359]. 
 
Blood is supplied to the rectum via the superior rectal artery branching from 
the inferior mesenteric artery, while drainage for the proximal rectum is provided by 
the superior rectal vein which continues to the inferior mesenteric vein towards the 
hepatic portal system. The middle and inferior rectal veins carry deoxygenated blood 
from the terminal rectum to the internal iliac veins. Lymphatic vessels are present 
within the submucous and subserosa layers of the rectum which drain into the 
lymphatic vessels present on the outer rectal wall [360]. 
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3.2 Gut-associated lymphoid tissue (GALT) 
The mucosal epithelium lines the inner lumen of the intestine, with the lamina 
propria containing mucosal-associated lymphoid tissue (MALT) interposed between 
the epithelium and muscularis mucosae. MALT of the intestine also known as gut-
associated lymphoid tissue (GALT) is an organized collection of isolated and 
aggregated lymphoid follicles that serves a critical role as inductive sites for priming 
the mucosal immune response following antigen recognition and uptake by the 
follicle-associated-epithelium (FAE) [361-363].  
 
The FAE is identified by the presence of specialised cells named microfold or 
membranous cells (M cells) (will be discussed further in Introduction Chapter 3, 
section 3.11) separating the intestinal lumen and the underlying lymphoid follicles of 
GALT. Parsons et al. (1991) studied GALT of the bovine small intestine and 
reported the presence of follicles within the lamina propria underneath the dome-
shaped FAE consisting of a single layer of homogenous specialised cells (M cells), 
with the absence of mucus-secreting goblet cell [364]. In the same study, the authors 
classified aggregation of lymphoid follicles known as Peyer's Patches (PP) into 
continuous and discrete. Continuous PP were observed only in the ileum of calves 
with subsets of lymphocytes, particularly B cells (discussed in detail in Introduction 
Chapter 3, section 3.9) undergoing lymphopoiesis, which involutes as the animal 
ages, hence proposed to be a primary lymphoid organ in cattle, similar to that of the 
Bursa of Fabricius in birds [365, 366]. Discrete PP were observed to be present in 
jejunum, distal ileum, caecum and colon which contained lymphoid follicles mainly 
associated with mucosal immune reactions, enlarged in older animals and which 
persist throughout the lifetime as a secondary lymphoid organ [361, 365, 366]. 
3.3 Recto-anal mucosal associated lymphoid tissue 
(RAMALT) 
It has been estimated that 2.4% of the intestinal wall at the terminal rectum in 
calves is comprised of GALT [367, 368].  Published studies reported the presence of 
single lymphoid follicles being more apparent towards the terminal rectum, with a 
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raised rectal mucosa appearance, adjacent to the anus of calves and cattle [33, 250, 
364, 367]. Similarly in humans, the presence of single lymphoid follicles increases in 
frequency towards the end of the rectum and was shown to correlate with the 
abundance of microbiota at the site [369]. In addition, small triangular patches of 
lymphoid tissue were seen to be evenly distributed around the bovine anus [367]. 
Such patches were also described to be present at the ileo-caecal entrance 
(continuous with ileal Peyer's Patches and extends to the colon) and proximal colon 
of calves [367]. Histological examination of the GALT structures at the terminal 
rectum identified two distinct phenotypes. The first described lymphoid follicles that 
were scattered within the lamina propria, which was more frequently observed. The 
other type identified was lymphoid follicles extending from the lamina propria to the 
muscularis mucosae of the submucosal layer, also known as lymphoglandular 
complexes. The latter phenotype was associated with older calves raised on 
conventional farms normally associated with large scale production and confined 
housing systems [367].  
 
The single and patches of lymphoid follicles present at the terminal rectal or 
recto-anal area are collectively termed as recto-anal mucosal associated lymphoid 
tissue (RAMALT) or ’rectal tonsils’ [370-372]. In sheep and deer, RAMALT is 
present as well and is often used to examine for the presence of abnormal prion 
protein accumulated within the lymphoid tissues in diagnosing transmissible 
spongiform encelopathies (González et al., 2006; Wolfe et al., 2007). While in cattle, 
RAMALT is apparent at the bovine terminal rectum and serves as the primary 
colonisation site of EHEC O157:H7. Cells cultured from the bovine terminal rectal 
mucosa are therefore useful for studying EHEC O157:H7 colonisation factors. 
Epithelial crypts harvested from the rectal mucosa were successfully cultured to 
produce primary recto-anal epithelial cells [234, 373-375]. Direct application of 
bacterial colonies at the recto-anal junction of calves has also been previously 












Figure 3.1 The bovine terminal rectal mucosa [Images courtesy of Dr. 
Arvind Mahajan and [33]]. (A) The anatomical position of the terminal rectum 
(blue box) and the rectoanal junction (red dotted line) in a calf is shown. (B) H&E-
stained section of the terminal rectum to the rectoanal junction (RAJ). The RAJ is 
easily identified by the demarcation between stratified squamous epithelium (SSE) 
(the beginning of anus) and the columnar epithelium folded into pseudocrypts (PC) 
(the end of the rectum). The primary colonisation site of EHEC O157:H7 in cattle is 








3.4 Leukocyte composition of the GALT 
 This section briefly summarises previous findings in published literature on 
bovine GALT. Further description on the characteristics and activities of different 
leukocytes mentioned and focused in this study is provided later on (refer Chapter 3 
Introduction Sections 3.5 - 3.10).  
 
The composition of the inter-epithelial leukocytes (IELs) differed significantly 
between the lamina propria and lymphoid patches of the ruminant intestine [377, 
378]. The IELs in the bovine small intestine is dominated by T cytotoxic cells 
(properties further described in Introduction Chapter 3 section 3.6), with fewer B 
lymphocytes and total T lymphocytes [379]. Whereas the Peyer's Patches contained 
similar proportions of T cytotoxic, T helper (Introduction Chapter 3, section 3.5), B 
lymphocytes and monocytes (Introduction Chapter 3, section 3.10) [379]. The 
Peyer's Patches also contain more major histocompatibility complex (MHC) class II-
expressing cells than the lamina propria [379].  
 
 T cytotoxic cells detection was limited to only within the interfollicular 
region of all the intestinal patches and none were observed to be inside the follicles 
[377]. The large intestinal patches contained 74% of cells expressing the B cell 
marker, p220, while 25% of the follicular lymphocytes were detected as T helper 
cells [365, 377]. Major histocompatibility complex (MHC) I is expressed by almost 
all of the subsets in the patches of the large intestine, while 75% of the cells in the 
large intestinal patches expresses MHC II [379].  
 
 Previous work on characterisation of the leukocytes of bovine RAMALT 
provided evidence for the presence of main players in mucosal immunity including T 
helper, T cytotoxic, IEL T γδ cells, monocytes, dendritic cells, B lymphocytes and 
Natural Killer cells specifically at this site [250]. In addition, close examination of 
the histology and phenotype of bovine rectal FAE had identified the presence of 
specialised cells among the enterocytes overlying the lymphoid follicles, with the 
capacity to engulf particulates, assigned by the authors as the M-like cells [250]. It 
has yet to be determined on how the different immune cells present at the terminal 
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rectal mucosa of EHEC O157:H7-infected calves respond to following a thirty-day 
challenge with the bacteria and is therefore one of the objective of this chapter. By 
studying the proportion of different type of immune cells commonly present at the 
primary colonisation site in EHEC O157:H7 infected calves, we may obtain further 
understanding of the immune responses taking place in vivo and if any of the 
observations play a signficant role for the maintenance of the bacterial colonies in the 
bovine host. The following section briefly introduces subsets of leukocytes 












Figure 3.2 Lymphocytes associated with the lymphoid follicles of the 
bovine terminal rectal mucosa, taken from Mahajan et al. [250]. 
Immunohistological analysis by the authors identified for the presence of (a) T 
helper cells (CD4), (b) T cytotoxic cells (CD8), (c) WC1+ γδ T-cells, (d) αβ-T cells 
and natural killer cells (CD2) and (e) mature B-cells and follicular dendritic cells 
(CD21). The B lymphocytes were mainly found within the follicles, while T 











3.5 T helper lymphocyte (CD3+/CD4+) 
 CD3 is a complex of protein subunits belonging to the Ig superfamily, 
expressed on all T cells and is involved in transducing signal upon binding of the 
major histocompatibility complex (MHC)-antigen complex to the T cell receptors. 
CD4 is the co-receptor expressed on T helper (Th) cells with the MHC II molecule as 
the ligand. It is involved in promoting adhesion of the T helper cells to target cells as 
well as helping in T cell signal transduction [380]. Naive Th cells are activated by 
antigen-presenting cells (APCs) in peripheral lymphoid tissue, thereby differentiating 
into two functionally distinct subclasses of effector cells; Th1 or Th2 depending on 
the nature of antigen presented.  
3.5.1 Th1 response 
 The Th1 response is activated by intracellular microbes leading to naive 
CD3+/CD4+ cells to differentiate to Th1 cells. Th1 activity is mediated by the master 
regulator T-bet, involving interleukin-12 (IL-12) and interferon-gamma (IFN-γ) via 
the Signal Transducer and Activators of Transcription 1 and 4 (STAT 1, STAT 4) 
pathways [381]. Th1 cells mainly secrete IFN-γ leading to pro-inflammatory 
responses including upregulation of monocyte and neutrophil production by the bone 
marrow, stimulation of endothelial cells to express adhesion molecules assisting in 
leukocyte binding and induction of chemokines to direct leukocyte migration from 
blood vessel into the infection site [382, 383]. Binding of IFN-γ to the Interferon-γ 
Receptor (IFNGR) present on macrophages will activate microbiocidal action via 
oxygen radicals and nitric oxide. IFN-γ released from Th1 cells may also activate 
dendritic cells (DCs) via activation of the CD40 receptor on DCs leading to 
upregulation of MHC II and IL-12, further enhancing the already activated Th1 
response. Th1 cells are also involved in activation of the T cytotoxic and Natural 
Killer cells in killing tumour and virus infected cells. IFN-γ counteracts the Th2 
response via a positive feedback loop further augmenting the Th1 immune response. 
Recent findings have indicated for in vivo activation of the Th1 immune response in 
calves infected with EHEC O157:H7 [384]. The induction of IFN-γ and T-bet were 
evident in EHEC O157:H7-infected calves, which peaked at different days post 
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infection between two groups of calves receiving EHEC O157:H7 strains of different 
Stx-encoding phage contents. The second half of Chapter 3 (introduced in 
Introduction Section 3.13) focuses on several potential aspects on the impact of the 
released IFN-γ and Th1 response induction on the bovine terminal rectal mucosa in 
EHEC O157:H7 infected animals. 
3.5.2 Th2 response 
 In contrast to the inflammatory-phagocytosis Th1-mediated response 
targeting intracellular pathogens, Th2 effector cells activate and mediate humoral 
(antibody) immune response towards extracellular parasites, bacteria, allergens and 
toxins. GATA binding protein 3 (GATA3) is the master regulator of Th2 
differentiation. Exposure to the aforementioned stimuli will activate GATA3 
resulting in production of Th2-cytokines including IL-4, IL-5 and IL-13, invoking 
strong antibody response by B cells leading to expulsion of the extracellular antigens 
from the host [385-388]. IL-10 is another Th2-cytokine produced with anti-
inflammatory characteristics where it inhibits the secretion of pro-inflammatory Th1-
cytokines from Th1 cells, macrophages and DCs. In addition, Th2 cells are capable 
of producing IL-24 and amphoregulin, both of which have anti-tumor properties 
[389, 390]. Balance between both arms of the Th effector response is crucial to 
maintain homeostasis and well-being of the host [391].  
3.6 T cytotoxic lymphocyte (CD3+/CD8+) 
 The T cytotoxic lymphocyte co-expressing CD3 and CD8 receptors is the 
most studied subset among the known CD8+ subsets. The CD3+/CD8+ lymphocytes 
possess the ability to kill host cells infected with intracellular pathogens or 
transformed tumor cells thereby protecting the host from further damage. 
CD3+/CD8+ cells are also major producers of the pro-inflammatory cytokine, 
Interferon-gamma (IFN-γ) in humans and cattle [392-394]. The naive T cytotoxic 
lymphocyte travels through lymph nodes scanning for the presence of cognate 
antigen presented by MHC I molecules on APCs. In addition, the transcription factor 
eomesodermin (EOMES) has recently been identified as another transcription factor 
driving human T cytotoxic lymphocyte differentiation [395].  
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 Cytotoxic lymphocytes (CTLs) confer the ability to kill infected and tumor 
cells via the dual action of perforin and granzymes. Granules containing perforin and 
granzymes are synthesised in CTLs, which are released via exocytosis into the 
extracellular space between a CTL and the target cell in a Calcium-dependent 
manner. Polymerisation of perforin will form polyperforin that functions to create 
pores in the cellular membrane of infected host cells allowing granzymes to enter the 
target cell. There have been many groups of granzymes identified, however the best 
characterised to date is Granzyme B, described to exert strong pro-apoptotic 
(programmed cellular death) activities. An alternative pathway leading to apoptosis 
by CTLs is induced by ligation of the Fas ligand (type 2 transmembrane protein of 
the Tumor Necrosis Factor family) expressed on activated T cells to the Fas receptor, 
a transmembrane glycoprotein with the structure resembling to the Tumor Necrosis 
Factor-alpha (TNF-α), present on most lymphoid cells including CTLs [396].  
3.7 Natural Killer cell (CD16+/NKp46+) 
 The Natural Killer (NK) cells are morphologically described as large granular 
lymphocytes with the capacity to lyse target cells including tumor, viral-infected and 
allogenic cells. In addition, NK cells are also major producers of IFN-γ thereby 
contributing to Th1-polarisation of T cells in lymph nodes and mediating immune 
responses upon interaction with dendritic cells to eliminate infection and non-self 
marker-expressing cells as well as reducing the spread of cancerous, transformed 
cells [394, 397-399]. The pathways leading to cytotoxicity are similar to that as 
described for CD3+/CD8+ cells above. Despite similar mechanisms used to kill 
target cells, the cytotoxic activities of NK cells are differently induced to that of the 
CTLs. NK cells rely on normal or self-MHC I recognition by the germline-encoded 
inhibitory receptor recognisation of MHC I, namely the Killer Cell Immunoglobulin-
like Receptors (KIR), to arrest tyrosine kinase based activation signals, thereby 
sparing the normal, MHC I-expressing cells from being killed [400, 401]. Upon 
encountering non-MHC I expressing cells including tumorigenic (morphologically 
transformed) and viral-infected (due to the ability of viruses to remove MHC I from 
infected cells) cells, NK cells are not able to inhibit the tyrosine kinase activating 
signals triggering the onset of apoptotic pathways [402].   
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 The phenotypic definition of an NK cell in humans and rodents is surface 
expression of CD56 and CD16 (FCγRIIIA) from CD3-/TCR- lymphocytes [398, 
403]. However, recent studies have proposed for NKp46 (also known as CD335), a 
type I transmembrane glycoprotein with two extracellular C2-type Immunoglobulin-
like domains, as the most definite NK cell marker across many species including 
cattle [404, 405]. NKp46 is a member of the natural cytotoxicity receptors (NCR) 
family expressed on tumor cells, transplanted cells derived from a different host 
(xenogeneic transplantation) as well as viral-encoded ligands [406, 407].  
 
 Bovine NK cells are developed in the bone marrow and distributed through 
out the spleen, liver, lung and lymph nodes, similar to the distribution in humans and 
mice [408]. Knowledge at the transcriptional levels of NK cell development, 
regulation and function is currently limited to mice. 1 to 10% of bovine peripheral 
blood mononuclear cells and 1.3 - 3.9% of mesenterial lymph node cells express 
NKp46 [405]. Majority of the NK cells identified in cattle are CD2-/NKp46+ that 
rapidly proliferates in response to Interleukin-2 and demonstrate cytotoxicity [405, 
409, 410]. There was also evidence for CD16 transcribed within the CD2-/NKp46+ 
population [409]. CD16 is encoded by the low affinity Fc region receptor III-A 
(FCRIIIA) gene, is a receptor for the Fc portion of ImmunoglobulinG (IgG), able to 
induce antibody-dependent cellular cytotoxicity (ADCC) upon interacting with target 
cells coated with IgG [406]. CD16 was found to be expressed on lymphocytes from 
lymph nodes of healthy calves exhibiting NK cell functions; cytotoxicity and 
cytokine-production [410]. Therefore in this study, I have utilised co-expression of 
CD16+/NKp46+ as markers for immuno-phenotyping bovine NK cells from the 
terminal rectal mucosa.  
3.8 T Gamma Delta cell (CD3+/γδ+)   
 Intra-epithelial lymphocytes (IEL), as the name implies, are lymphocytes 
present in between adjacent epithelial cells, have been identified in the epithelium of 
the skin, intestinal, genito-urinary and respiratory tracts [411]. The functions of IEL 
residing locally within the epithelium were described to provide immediate 
protection to the host from incoming pathogens or malignant cells through its 
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cytolytic and cytokine-expressing immunoregulatory properties [412]. Interaction 
between IEL and epithelial cells, particularly that described in the intestine of mice 
following exposure to Salmonella, commensals and microbial antigens leads to the 
production of the Angiogenin 4 (Ang 4) antimicrobial peptides by Paneth cells [413]. 
IEL are also able to express fibroblast growth factors (FGF) including keratinocyte 
growth factor (KGF) to support wound healing in mice, as well as regulating 
proliferation of enterocytes in monkeys, guinea pigs and mice [414, 415].  
   
 A review paper proposed for classification of IEL into Type a and Type b 
[412]. Type a refers to T cells expressing TCR αβ+, primarily involved in the 
adaptive immune system via its MHC I and II recognition with long term memory. 
The IEL are mainly intestinal IEL scattered within the epithelium of small and large 
intestine of mice. While Type b IEL are T cells expressing TCR αβ+ CD8αα+ and T 
cells with TCR γδ. Functionally, the Type b IEL are not restricted by the 
conventional MHC recognition system and mainly associated with the epithelium of 
murine skin, vagina and small intestine.  
 
 The current study chose to focus on the IEL TCR γδ cells since in cattle these 
cells are significantly present in bovine peripheral blood (15-60%) and in the 
epithelium of the skin and intestinal mucosa [416, 417]. These cells were also 
detected in significant amounts around the lymph node trabeculae, but sparsely 
present in B and T cell domains of lymph nodes [416, 418]. Bovine TCR γδ cells 
were phenotypically characterised as CD4-/CD8-/TCR γδ+ lymphocytes and recently 
have been proposed to be a major regulatory T cell subset in bovine immune system 
[417, 419]. The circulating TCR γδ cells in bovine peripheral blood are able to 
spontaneously produce Interleukin-10 (IL-10), a cytokine involved in 
immunoregulation exerting anti-inflammatory effects [420]. In addition, exposure to 
mycobacterial products caused significant proliferative activities of T γδ and 




3.9 B lymphocytes (CD21+) 
 The naive and memory B lymphocytes are activated upon contact with 
specific foreign antigens and antigenic peptides presented by the T helper cells. 
Stimulation of the resting B lymphocytes leads to proliferation and differentiation of 
the effector B cells that then mature to become antibody-secreting plasma cells. B 
cell receptor (BCR) are involved in many B cell biological processes including B cell 
developmental regulations and transduction and interpretation of signals from the 
extracellular environment [421]. Among the recognised BCR are CD79 (CD79a and 
CD79b; noth present exclusively on B cells and B cell neoplasms) [422], CD19 
(positive regulator of BCR signalling in proliferation and survival of B cells) [423], 
CD72 (negative regulator of B cell responsiveness) [424] and CD21. CD21 mainly is 
surface-expressed by mature B cells and was described to be involved in B cell 
activation and homotypic aggregation of human B lymphocytes [425]. CD21 also 
binds to IFN-α [426] and serves as a receptor for the Epstein-Barr virus [427]. The 
anti-bovine CD21 antibody was used in the current study to detect B lymphocytes 
present in the harvested bovine terminal rectal mucosal tissue since this antibody was 
shown to react with bovine B cells in a previous study [250]. In addition, a 
specialised APC, the follicular dendritic cell also expresses CD21 [428].  
3.10 Monocytes and macrophages (Signal Regulatory 
Protein-alpha, SiRP-α+ or SiRP-1α+) 
 The final group of immune cells to be described in this section are the SiRP-
1α-expressing cells, which includes monocytes, dendritic cells and macrophages. 
SiRP-1α or Signal Regulatory Protein-1 alpha is a 55 kDa type I membrane protein 
and member of the Ig superfamily with three Ig-like domains in its extracellular 
compartment. Other names for SiRP-1α includes macrophage fusion receptor, 
CD172a and MyD-1 antigen. It is implicated in mycobacterial infection in tissue 
culture particularly in the formation of multinucleated giant cell [429]. The early 
secretory antigenic target-6 (ESAT-6) and culture filtrate protein-10 (CFP-10) co-
secreted by Mycobacterium tuberculosis complex mycobacteria together increase the 
proliferation of SiRP-1α+ cells in bovine peripheral blood with dendritic 
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cell/macrophage morphology and induces multi-nucleated giant cell formation 
expressing SiRP-1α [429]. SiRP-1α has also been shown to be a better marker for 
detecting monocytes of the bovine peripheral blood than CD14 [430].  
 
 Monocytes are a subset of leukocyte with the ability to differentiate to 
dendritic cells (DC) or macrophages of different phenotypic and functional subsets. 
Monocytes develop from the common leukocyte progenitors in the bone marrow and 
depending on the type of monocyte subset (based on the combination of surface 
receptors including chemokine CC receptors CCR2 or CCR7, CD14 and CD16 
expressed), these monocytes will either function in surveillance throughout the 
peripheral blood and non-inflammed tissue or emigrate from the bone marrow 
directly towards the inflammed tissue [431]. Pro-inflammatory cytokines and 
chemokines released at the inflammed site, along with microbial factors, adhesins 
and local growth factors influence the fate of the monocytes to either be 
differentiated into DC or macrophages. In particular, IL-6 and TNF have each been 
shown to be key players in determining if monocytes from healthy human peripheral 
blood will differentiate into macrophage or DC, respectively [432, 433]. Under non-
inflammed conditions, monocytes differentiate into macrophages in a IL-6 and 
macrophages-colony stimulating factor (M-CSF) dependent manner [432]. 
Interaction with bacterial endotoxin and IFN-γ within the microenvironment will 
activate the classical macrophage activation pathway, pre-dominantly exerting pro-
inflammatory effects while in the presence of IL-4 and IL-13, the alternative 
macrophage activation pathway is activated producing anti-inflammatory effects 
[434, 435].   
3.11 Interaction of bacterial pathogens with the follicle-
associated-epithelium (FAE)  
Interest towards understanding interactions at the bovine terminal rectum 
during an EHEC O157:H7 colonisation began once this site was identified as the 
principal colonisation site of the pathogen [33]. In particular the presence of 
lymphoid follicles has led to the hypothesis that EHEC O157:H7 might be targeting 
this niche to interact with host immune cells and further manipulate their responses 
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as a mean to gain colonisation advantage. Such immune-regulation might result in 
inducing host tolerance to bacterial factors that could be essential for ensuring 
persistence. The lymphoid-follicle rich area has been characterised to contain 
heterogeneous cell populations, with the presence of cells that morphologically and 
functionally resemble M cells [250]. The authors proposed specific FAE interaction 
with EHEC O157:H7 during colonisation. They also provided evidence of A/E lesion 
formation, neutrophil infiltration and induction of specific humoral immune response 
during EHEC O157:H7 infection at the FAE [352]. In vitro organ cultures (IVOC) of 
human and bovine ileum infected with EHEC O157:H7 strain 85-170 revealed the 
formation of A/E lesions specifically on FAE [436]. In another study, EPEC 
O127:H6 diffusely bound to the proximal and distal parts of the small intestine [437]. 
The authors demonstrated that the type of bacterial intimin expressed (EHEC and 
EPEC produces intimin-γ and intimin-α, respectively) dictates the preferred site for 
bacterial localisation and attachment [438].  
 
The M or microfold cells are specialised epithelial cells that differ 
morphologically and enzymatically from the adjacent absorptive enterocytes. These 
cells act as entrance portal for luminal antigens and particles before being 
translocated into the effector sites within the underlying lamina propria for 
processing and induction or repression of immune responses [439, 440].  
 
The features of a typical M cell include absence of irregular brush border on 
the apical surface and basolateral cytoplasmic invagination forming pockets 
containing B and T lymphocytes, macrophages and dendritic cells. The surface 
glycocalyx and mucus layer appears thinner than the absorptive epithelium, allowing 
rapid and easy luminal particle and antigen uptake. The beta-integrin (β-integrin) 
transmembrane receptor is present on the surfaces of M cells allowing binding to the 
extracellular matrix as well as bacterial strains expressing intimin-gamma (Intimin-γ) 
[441-443]. M cells lack apical surface glycoproteins including alkaline phosphatase 
and sucrose-isomaltase, as well as polymeric immunoglobulin (Ig) receptor with low 
levels of secretory Immunoglobulin A (sIgA) [444]. The capability to translocate 
intestinal luminal particles or antigens into the FAE makes the M cell a convenient 
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target for several enteropathogenic bacteria to gain access into the deeper parts of the 
mucosa before spreading systemically. Salmonella enterica serovar Typhimurium, 
Yersinia pseudotuberculosis, Shigella flexneri and a rabbit EPEC strain (RDEC-1) 
are among the pathogens previously shown to exploit M cells in order to cross the 
intestinal epithelial border [445-448].  
 
One study employed Caco-2 and Burkitt's lymphoma Raji B cells co-culture 
to generate cells with M cell phenotypes. This was obtained by culturing Caco-2 
cells on the apical side of transwells and Burkitt’s lymphoma Raji B cells at the 
basolateral side until Caco-2 cells reached full confluence, spontaneously 
differentiating and produced Caco-2 cells resembling M cells at the FAE This in 
vitro co-culture model was used to study EHEC O157:H7 mobility across the FAE, 
where they successfully demonstrated the ability of EHEC O157:H7 strains to 
translocate across M cells in vitro [449]. The same study also observed EHEC 
O157:H7 survival, replication and Stx production before inducing apoptosis in THP-
1 macrophages. They concluded that following successful translocation across 
intestinal FAE, some EHEC will interact with the underlying immune cells 
immediately beneath the FAE. EHEC continues to survive and release Stx into the 
lamina propria before systemically circulating to renal and brain endothelium.  
 
 Despite the encouraging findings from in vitro studies linking lymphoid 
follicles and M cells mentioned above, close examination of tissue sections from 
EHEC O157:H7-challenged calves did not reveal any evidence to correlate the 
lymphoid dense area at the terminal rectum and bacterial tropism [352]. Since M 
cells only cover about 0.01% of the total intestinal epithelial surface [450], it is most 
likely that the host-bacterial interactions occur at the absorptive intestinal epithelial 
cells. EHEC O157:H7 tropism towards bovine terminal rectum may reflect non-
cellular factors including quorum sensing, nutrient availability and various factors 
expressed by EHEC O157:H7 including genes for efficient nutrient utilisation or 




3.12 Shiga toxin and host immunomodulation 
Stx2 was shown to influence bovine cellular immune response as demonstrated 
in calves challenged with Stx2-producing EHEC O157 Strain 86-24 [452]. In the 
study, the calves were intra-rumenally challenged with either EHEC O157 Strain 86-
24 (Stx2+), Stx-2 negative O157 or non-pathogenic E. coli and observed for three 
weeks before re-infecting all animals with EHEC O157 Strain 86-24. Significant 
suppression in the proliferation of concanvalin A (conA)-stimulated peripheral blood 
mononuclear cells (PBMC) of animals in the group that was twicely challenged with 
EHEC Strain 86-24 (Stx2+) were reported, with the proliferative rates reported to be 
similar to the PBMC from animals challenged with the non-pathogenic strain. In 
contrast, a significant increase was observed in the proliferative activity of the 
PBMC isolated from the animals initially inoculated with the Stx negative strain. The 
humoral responses were similar in all three groups, with comparable levels of anti-
O157 antibodies were detected in all animals. These results are in accord with the in 
vitro experimental findings for which a Stx1-expressing EHEC O157:H7 strain 
reduced the proportion of bovine phytohaemagglutinin (PHA)-stimulated CD8+ T 
lymphocytes, but not CD4+ T while LPS-stimulated CD21+ B lymphocytes which 
were only slightly affected [252, 453]. Stx1 inhibited the activation of LPS and conA 
stimulated-PBMC, as indicated by the absence of CD71 (transferin receptor, co-
expressed with CD25 on activated lymphocytes) expression, further supporting Stx-
dependent immune-regulating mechanism in the host. In addition, activated bovine 
PBMC CD8+ T and B lymphocytes expresses Gb3 rendering these cells susceptible 
to the effects of Stx compared to other subpopulations of the PBMC [271].  
 
Earlier studies of differentiated human monocytes revealed that while resistant 
to the toxic effect of purified Stx1 and Stx2e, monocyte-derived macrophages were 
stimulated to express pro-inflammatory cytokines including TNF-α and IL-1β [186, 
268, 454]. TNF-α and IL-1β released by macrophages during inflammation could 
enhance the expression of enzymes involved in Gb3 synthesis (ceramide 
glucosyltransferase, lactosylceramide synthase and Gb3 synthase) on microvascular 
endothelial cells of the brain and kidney, leading to increased Stx binding and 
exacerbation of inflammation [137, 186, 455-457].  
 147 
In contrast to human microvascular endothelial cells, the sensitivity to Stx1 of 
Gb3+ bovine lymphocytes (CD8+ T) from PBMC is not dependent on TNF-α, IFN-α 
and IL-2 [253]. While Stx1 stimulation of bovine ileal IELs resulted in 40% of cells 
responding by secreting IFN-γ, with a small proportion (less than 10%) produced 
either IL-4 or tumour growth factor-beta 1 (TGF-β1) [458]. The mRNA and 
production of pro-inflammatory IL-8, growth-regulated oncogene-alpha (GRO-α), 
monocyte-chemoattractant protein-1 (MCP-1) and Regulated on Activation, Normal 
T Expressed and Secreted (RANTES) were significantly increased upon treatment of 
bovine colon mesenchymal cells with Stx1. Conversely, bovine primary colon 
epithelial cells were resistant and non-responsive to Stx1 [272].  
 
In a Gb3-deficient human intestinal epithelial cell line (T84 cells), the 
phosphatidylinositol 3-kinase/Akt/Nuclear factor kappa B (PI3K/Akt/NFκB) 
pathway was strongly enhanced after treatment with EHEC O157:H7 Strain EDL 
933 Δ stx1/stx2 (Stx-), but was only weakly induced in cells infected with wild type 
Strain EDL 933 (Stx+) [459]. Results from their study suggests that EHEC infection 
weakly activate NFκB pathway in T84 cells, however the consecutive signalling 
pathways will be inhibited upon Stx1/Stx2 expression. This, with the studies 
described above indicates that EHEC strains do manipulate immune responses in 
specific types of cells in a Stx-dependent manner to potentially promote their 
persistence in the bovine host following colonisation.  
 
This chapter aims to investigate the consequences of Stx presence on the 
mucosal immune response in bovine terminal rectum following exposure to EHEC 
O157:H7 strains in an attempt to investigate if Stx influences the colonisation 
process. Bovine terminal rectal tissues were obtained from cattle slaughtered after a 
thirty-day challenge experiment with either EHEC O157:H7 Strain 9000 (PT21/28) 
or Strain 10671 (PT32) performed by collaborators at the Moredun Research Institute 
(Pentlands Science Park, UK). These two most commonly isolated strains from cattle 
farms in Scotland differ in Stx-prophage carriage, providing an opportunity not only 
to examine differences between infected and non-infected tissue samples, but also 
between samples of animals challenged with strains varying in Stx subtypes [60]. 
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Different subsets of immune cells present at the FAE of bovine terminal rectum 
previously characterised [250] were immunophenotyped and compared among the 
calves to determine the impact of EHEC O157:H7 presence on mucosal immune 
responses at the colonisation site. 
3.13 Interferon-gamma (IFN-γ) and EHEC O157:H7 
colonisation 
A common feature shared amongst the immunophenotyped cells in this chapter 
is the ability to either express or be responsive to the pleiotrophic type II Interferon, 
IFN-γ. IFN-γ is one of the key mediators of immunity and inflammation. It plays 
significant roles in regulating the mechanisms and balance in an array of diverse 
biological processes. Macrophages, fibroblast and epithelial cells have been shown to 
respond to IFN-γ. The most common properties of IFN-γ described are anti-
proliferative, anti-viral, anti-tumour and roles in immunosurveillance [460].  
 
IFN-γ is predominantly produced by activated Th1 CD4+ cells upon interaction 
with antigens presented by major histocompatibility complex (MHC) class II, while 
antigens presented by MHC class I are able to induce IFN-γ in CD3+/CD8+ 
cytotoxic T lymphocytes [461]. Other sources of IFN-γ includes natural killer (NK) 
cells, natural killer T (NKT) cells and T cell receptor gamma delta (TCRγδ+) cells 
[462-464].  
 
Among the roles of this cytokine include activating macrophage and Natural 
Killer (NK) cells, enhancing CD3/CD8 cell cytotoxicity, upregulating the expression 
of Major Histocompatibility Complex (MHC) I and II in macrophages, tumour cell 
surveillance and inhibiting growth of non-haematopoietic cell types including 
epithelial (further explained in the following in Section 3.14), endothelial cells and 
fibroblast [465, 466]. IFN-γ could also be involved in regulatory functions to limit 
tissue damage following inflammation for example in skeletal muscle cells [467], as 
well as modulating Th1 [468] and regulatory T (Treg) differentiation [469].  
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 The main intracellular transduction pathway activated by IFN-γ is via the 
Janus kinase (JAK) and signal transducer and activator of transcription (STAT) 
transduction pathways, before activating the transcription of IFN-γ activated genes 
involved the transcription of various cytokines and growth factors. The major STAT 
protein activated by IFN-γ is STAT1 [470]. Interaction between the IFN-γ and the 
heterodimeric Interferon-gamma receptor (IFNGR) induces conformational change 
in the receptor, which then activates the Janus protein tyrosine kinase (Jak) 2, 
followed by transphosphorylation of Jak1 [471]. The activated Jak1 then 
phosphorylates the critical tyrosine residue 440 on each IFNGR chain to form 
docking sites for STAT1 [472]. Phosphorylation of two STAT1 proteins leads to 
dissociation of the STAT1 homodimer from the IFNGR that will then translocate 
into the nucleus, to bind to the promoters of the IFN-γ transcription factors (gamma 
activating site or GAS) initiating or suppressing the many IFN-γ regulated genes 
[465]. During the early phase of activation, Stat1 is also phosphorylated on serine 
727 by a process involving phosphatidylinositol 3-kinase (PI3K) and Akt that is 
required for maximal transcriptional activity [460, 473, 474]. Stat1-deficient mice 
showed normal development but were highly susceptible to bacterial and viral 
infection [475, 476]. The repertoire of regulated genes in eukaryotic cells that are 
IFN-γ-JAK/STAT1 pathway-dependent is large. This includes genes that activate 
macrophage during the later stages of inflammation such as monocyte chemo-
attractant protein-1 (MCP-1) and macrophage inflammatory protein-1 (MIP-1) [477]. 
In addition, IFN-γ activates the suppressor of cytokine signalling-1 (SOCS-1) gene 
providing negative feedback to cytokine production [478]. The genes coding for the 
anti-viral resistance property of IFN-γ, conferred by the T cell specific GTPase 
(TGTP) is also regulated via the JAK/STAT1 pathway [479]. 
 
Multiple Shiga toxin-expressing E. coli strains were able to interfere with the 
activation of JAK/STAT1 pathway, most probably due to involvement of Stx [480-
483]. Therefore, it was investigated if culture supernatants of EHEC O157:H7 strain 
EDL 933 are able to inhibit the JAK/STAT1 signal transductions in Caco-2 cells. If 
the outcomes are in agreement with the published findings, further experiments could 
be performed on bovine intestinal cells and bovine-adapted strains to check if this 
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phenotype is common across different strains of EHEC O157:H7. Furthermore, it is 
anticipated that implications following EHEC O157:H7 inhibition of an important 
intracellular pathway involved in various downstream effects including immune 
responses and epithelial functions would profoundly affect the colonisation process, 
particularly directed towards the survival of the pathogenic bacteria. 
3.14 IFN-γ and epithelial cell proliferation/cell cycle 
Epithelial cell proliferation is an important part of innate immunity, ensuring 
continuous supply of new cells to refill gaps along the intestinal lining left by cell 
removal from the tip following programmed cell death at the intestinal villi surface. 
Many genes regulating cell growth, differentiation and apoptosis are activated by the 
IFN-γ pathway including MYC [484] and caspase 1, apoptosis-related cysteine 
peptidase (CASP1) [485], as well as cyclin-dependent kinase inhibitor-encoding 
genes in regulating cell cycle, for example p21, a kinase inhibitor arresting the cell 
cycle at G1-S phase [298, 486, 487]. It was shown that IFN-γ inhibited the 
proliferation of rat intestinal crypt cells in vitro [254]. STAT1 induction following 
IFN-γ or epidermal growth factor (EGF) binding to the IFNGR inhibited the growth 
of cells via activation of cyclin-dependent kinase inhibitor (CDK) p21 WAF1/CIP1, 
but not in a STAT1-deficient cell line, U3A (human epithelial fibrosarcoma cell line) 
[488]. Epithelial cell growth could also be regulated by IFN-γ in the presence of 
TNF-α during inflammation in a STAT1-independent pathway by converging the 
AKT-β-catenin and Wnt-β-catenin pathways resulting in changes to cellular 
proliferation and induction of apoptosis [489].  
 
 To investigate the effects of IFN-γ on the proliferation of intestinal epithelial 
cells, the two widely used immortalized epithelial cell lines T84 and Caco-2 were 
used in my research. Both cell lines were exposed to both IFN-γ and Stx to examine 
if the toxin could further increase or suppress the anti-proliferative effect of the 
cytokine. As cellular proliferation is closely associated with the cell cycle, 
simultaneous assays examining the effect of IFN-γ treatment on the intestinal 
epithelial cells were carried out. Any significant departure from the normal cell cycle 
pattern (based on DNA staining by propidium iodide) exposure to IFN-γ warrants 
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further investigation in identifying the possible cell cycle regulatory proteins affected 
and the specific mechanisms or pathways involved. A recent published article 
highlighted the involvement of IFN-γ in a novel mechanism of host 
immunomodulation of epithelial homeostasis following exposure to Citrobacter 
rodentium in mice [490]. Significant depletion in the number of mucus-secreting 
goblet cells of infected murine colon were observed. Further examination revealed 
that C. rodentium preferred to colonise at the non-hyperplastic crypts, rich in goblet 
cells rather than on the highly proliferative, goblet cell-depleted epithelium. 
Presumably as a response to protect from damage by the C. rodentium in the host 
intestine, a reduction in the numbers of goblet cells is modulated by IFN-γ signalling 
pathways causing depletion of anchoring sites for attachment by the bacteria [490]. 
 
 To investigate if Stx plays a role in EHEC O157:H7 colonisation at the 
bovine terminal rectum, the objectives addressed in Chapter 3 were:  
 
1. To examine by flow cytometry, mucosal immune cells previously 
characterised [250] to be present at the follicle-associated-epithelium of 
bovine terminal rectum and to determine whether EHEC O157:H7 infection 
alters the proportions of these sub-populations at the colonisation site. 
 
2. To compare the expression of IFN-γ by bovine terminal rectal mucosal cells 
between EHEC O157-challenged and control calves. 
 
3. To examine and verify the potential effect of Stx on the IFN-γ activated 
JAK/STAT1 signalling pathway in intestinal epithelial cell lines. 
 
4. To assess direct interaction between intestinal epithelial cells and IFN-γ 
































3.1 Harvest of terminal rectal mucosal cells  
 To study the impact of EHEC O157:H7 colonisation specifically towards the 
mucosal cells of the bovine terminal rectum, immunophenotyping of selected cell 
surface markers was performed on tissues from colonised and control cattle. Post-
mortem samples of terminal rectal tissue (defined as part of the rectum at 4 cm distal 
to the recto-anal junction) were kindly provided by Dr. Tom McNeilly and 
Alexander Corbishley of the Moredun Research Institute (MRI, Pentlands Science 
Park, Midlothian, UK) as part of a study assessing immune response in EHEC 
O157:H7-challenged calves [384]. Two groups of six male dairy (Holstein-Friesian 
or Ayrshire breeds) calves with an average age of 12 ± 2 weeks were randomly 
assigned to separate rooms in the MRI High Security Unit (HSU). Two calves were 
housed in conventional pens, while five additional age-matched calves previously 
used as control in other studies were used as sources of additional lymph node and 
rectal mucosal samples. All calves were confirmed negative for EHEC O157:H7 
from faecal samples cultured on Cefixime-Tellurite Sorbitol MacConkey (CT-
SMAC) agar plates. Non-sorbitol fermenters (colourless colonies) were further tested 
with the immune-magnetic separation (IMS) technique, a week prior to the 
commencement of the experiment. Four calves in one HSU room were orally 
challenged by orogastric intubation with 500 ml PBS containing 10 ml of an 
overnight LB culture of EHEC O157:H7 Strain 9000 (ϕStx2a/ϕStx2c) and its 
naturally derived Naladixic (Nal)-resistant variant. Four calves in the other HSU 
room were challenged in the same manner with EHEC O157:H7 Strain 10671 
(ϕStx2c). The other two calves (sentinels) in each HSU room received 500 ml PBS 
only. Faecal samples were collected on a daily basis in the first 2 weeks of the 
experiment and every other day from then on for enumeration of colony forming 
units (C.F.U.) to produce bacterial shedding curves. Rectal tissue biopsies were also 
obtained on a weekly basis for gene expression studies. All animals were killed at the 
end of the trial (31-33 days) by intravenous pentobarbital (60 ml) before post-mortem 
examination was performed. Rectal, mesenteric and pre-scapular lymph nodes were 
collected for ex-vivo restimulation (concanavalin A and LPS) experiments. For 
immunophenotyping experiments presented in this chapter, the rectal mucosal layer 
were collected and immersed in Polymyxin B sulfate (Sigma), diluted 2 mg/ml in 
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normal saline for 30 min in a 150 ml polystyrene straight-sided metal cap container 
(Starlab) before transported to the Roslin Institute according to biosafety regulations. 
  
 The rectal tissues were cut into approximately 1 cm x 2-2.5 cm (length x 
width) in size in a petri dish and transferred into a 50 ml Falcon™ tube (Fisher 
Scientific) pre-filled with 10 ml of digestion medium base [Dulbecco’s Modified 
Eagle’s Medium (DMEM) (Life Technologies), 1% fetal calf serum (FCS) (Sigma), 
1% Penicillin-Streptomycin (10,000 U/ml, Invitrogen) and 25 µg/ml Gentamicin 
(Sigma)]. More digestion medium was added to a final volume of 25 ml, followed by 
the enzymes required for tissue digestion, 250 µl of Collagenase (75 U/ml, Sigma) 
and 250 µl of Dispase I Neutral Protease, Grade 1 (20 µg/ml, Roche). Tubes were 
manually agitated for five times before being placed in a shaker incubator (INFORS 
HT Multitron Standard, Company) for 90 min at 37°C, 200 R.P.M. At the end of 
digestion, tissues appeared to be disintegrated, physically characterised by a 
liquefied, coagulated appearance as opposed to an intact tissue. This is accompanied 
by a much darker colour of the digestion medium (change from red to dark red or 
brown). The tubes were again manually agitated, vigorously for approximately five 
times to separate the disintegrated and coagulated fibrous tissue materials allowing 
mucosal cells to be further released into the medium, before centrifuging the tubes at 
260 x g for 5 min. Supernatants were filtered through individual cell strainers (pore 
size of 0.22 µm, Millipore) into a 50 ml Falcon™ tube. Both tubes (supernatant- and 
digested tissue-containing tubes) were added with 50 ml of lymphocyte medium 
[80%  RPMI-1640 medium (R0883, Sigma), 10% FCS (Sigma), 1% L-glutamine 
(Invitrogen), 4 µl of  -Mercaptoethanol (Sigma) and 1 ml of Penicillin-
Streptomycin (10,000 U/ml) (Invitrogen)] and centrifuged again under the same 
conditions described above. The differential centrifugation steps were repeated until 
the supernatants appeared clear (characterised by a pale red colour, with the absence 
of tissue material) and the cell pellet size resembles to that of a pellet containing 
approximately 1 x 106 cells/ml. Cells were stained with 0.2% Trypan Blue solution 
(Invitrogen) in PBS. 10 µl of the stained cells were transferred onto Neubauer 
Chamber Slide (Marienfeld) for cell counting. 
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3.2 Immunostaining bovine terminal rectal mucosal cells for 
flow cytometry 
 Cells were transferred into a Nunc® 96-Well Polystyrene Conical Bottom 
Microwell™ plate (Thermo Scientific) at a density of 1 x 106 cells/ml and washed 
once in flow cytometry buffer (2% FCS in PBS), centrifuged at 1200 R.P.M. for 5 
min before staining with primary antibodies obtained in-house from Timothy 
Connelley's laboratory of The Roslin Institute and Alexander Corbishley (Table 3.1) 
raised against different combination of established bovine cell surface markers. Nagi 
and Babiuk (1987) were among the earliest researchers to publish on techniques for 
extracting and characterising leukocytes from the epithelium and lamina propria of 
the bovine small intestine [378]. They were able to identify surface immune cell 
markers of the T helper (CD3+/CD4+) and cytotoxic T cells (CD3+/CD8+) by 
immunofluorescent characterisation using mouse monoclonal antibodies on 
lymphocytes of the bovine small intestinal intra-epithelium, lamina propria and 
Peyer’s Patches. While intraepithelial Gamma Delta T cells (CD3+/ γδ+), first 
described in cattle in 1989 [491], were detected in my study with a Pan TCR γδ 
antibody, GB21a [492, 493].  Detection of CD16+/NkP46+ co-expressing cells 
represents the Natural Killer (NK) cells [401, 405, 409], while B cells and follicular 
dendritic cells were detected with anti-CD21 antibody (CD21) [364, 494]. 
Monocytes, monocyte-derived macrophages and dendritic cells were identified with 
the antibody against Sirp-1-α (CD172a) [430]  for 30 min at 4°C.  
 
 The cells were washed three times in flow cytometry buffer (2 min at 1200 
R.P.M.) followed by staining with undiluted secondary antibodies (anti-mouse IgG1 
Alexa Fluor® 647-conjugated, anti-mouse IgG2α Pycoerythrin-conjugated, anti-
mouse IgG2β Alexa Fluor® 488-conjugated, Timothy Connelley, The Roslin 
Institute, Edinburgh, UK), 100 µl/well. After 20 min of incubation at 4°C protected 
from light, the cells were washed as described above three times for 2 min and 
finally re-suspended in 450 µl of flow cytometry buffer for data acquisition with BD 
FACSCalibur™ machine.  
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3.3 Flow cytometry data acquisition and analyses 
 Data on fluorescence detection of immune-stained cells was acquired by BD 
FACSCALIBUR™ flow cytometry machine according to the standard operating 
procedure. Briefly, 10,000 events were collected during acquisition with the BD 
CELLQUEST™ (BD Biosciences) and saved in the Unix Executable File format for 
analyses in FlowJo software (Treestar, Inc.). Cells labelled with goat anti-mouse 
conjugated to Alexa Fluor® 488 were detected by green or fluorescence channel 1 
(FL-1), goat anti-mouse conjugated to Pycoerythrin by the yellow or fluorescence 
channel 2 (FL-2) and goat-anti mouse conjugated to Alexa Fluor® 647 in 
fluorescence red or channel 4 (FL-4). Compensation between FL-1 and FL-2 was 
performed before acquisition of data from all samples. Since no viable staining was 
used prior to loading the samples into the flow cytometry machine, cells were 
visually assessed from the forward scatter (FSC) versus side scatter (SSC) dot plots 
to exclude potential cellular debris (typically characterised by the presence of a small 
group in the bottom left quarter of the dot plot with low FSC and SSC values), 
therefore selecting presumably ‘viable’ cells in the next steps of analyses. Gating on 
‘viable’ cells was also based on typical pattern of lymphocytes in an FSC-SSC dot 
plot, with the help and technical advice from an experienced immunologist. Double 
fluorescence staining populations were derived from the ‘viable’ cell population to 
obtain the proportion of cells in the sample with the select cell surface markers and 
used for statistical analyses in GraphPad Prism version 6 (GraphPad Software Inc.). 
Proportion values were log-transformed (log10) before analysed with One-way 
ANOVA (p-value at 0.05) corrected for multiple comparisons (Dunnett’s test) 
between EHEC O157:H7 challenged animals (EHEC O157:H7 Strain 9000 or Strain 
10671) with the control (unexposed) group. To validate the ANOVA results, Brown-
Forsythe test on standard deviation (S.D.) among data were assessed to meet one of 
the assumption in ANOVA that data were sampled from populations with the same 
S.D. or variance. All combination of select cell surface markers met this assumption 
except for CD3+/CD4+, therefore Kruskal-Wallis test was used to analyse the 
median values instead for comparison of CD3+/CD4+ proportions between each 
challenged groups and the control group.  
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Table 3.1 List of primary and secondary antibodies used to stain lymphocytes and macrophages/monocytes 
harvested from bovine terminal rectum. 
Antigen Clone Isotype Source Concentration  
CD3 MM1A IgG1 Tim Connelley [384, 495] 1:4 
CD4 
 
ILA12 IgG2a Tim Connelley [384, 495] 1:4 
CD8 
 
ILA105 IgG2a Tim Connelley [384, 496, 497] 1:4 
Gamma delta  GB21A IgG2b Alexander Corbishley [377, 384] 1:20 










Table 3.1 Continued. List of primary and secondary* antibodies used to stain lymphocytes and 
macrophages/monocytes harvested from bovine terminal rectum. 
Antigen Clone 
 
Isotype Source Concentration  
NKp46 AKS6 IgG2b Tim Connelley [384, 405] 1:4 
CD21 
 
CC21 IgG1 Dr.Yolanda Corripio-Miyar [250, 384] 
 
1:400 
SiRP-1- ILA24 IgG1 Tim Connelley [250, 384] 1:4 
IgG1-Alexa Fluor® 






488 (AF 488)* 
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3.4 Measurement of IFN-γ levels released by bovine terminal 
rectal mucosal cells 
 Mucosal cells of the bovine terminal rectal tissue (from the same set of tissue 
samples of the immunophenotyping procedure as described above in Section 3.1) 
were cultured at 1 x 105 cells/ml in lymphocyte medium in a Nunc® 96-Well 
Polystyrene Round Bottom Microwell™ Plate (Thermo Scientific) at 37°C, 5% CO2 
for 48 h. At the end of the 48-h incubation, supernatants were transferred into 
Greiner 96-Well Polystyrene Flat Bottom Microwell plate (Sigma) for quantitation of 
IFN-γ released by the cells using the Bovine IFN-γ VetSet ELISA development kit 
(VS0257B-002, Kingfisher Biotech, Inc.). Bar plot of the mean with standard error 
of IFN-γ released from the cells of non-infected control calves, EHEC O157:H7 
Strain 9000 or Strain 10671-exposed calves were plotted and shown in the results 
section (Fig. 3.7).  
3.5 Interferon-γ stimulation of intestinal epithelial cell lines 
 To ensure the cells stimulated with IFN-γ were in a proliferating state, a low 
density cell culture maintenance protocol was adapted from Natoli et al. [350]. The 
authors have shown that Caco-2 cells cultured at a low density had higher 
proportions of cells within the S and G2/M phases of the cell cycle as compared to 
cells in high density culture. Briefly, Caco-2 and T84 cells were seeded at 6.2 x 103 
cells/cm2 and sub-cultured upon reaching 50% confluence. Caco-2 and T84 cells of 
this low density culture were then sub-cultured into 6-well-plates (Corning® 
Costar®, Sigma) at a seeding rate of 1 x 104 cells/ml and incubated at 37°C, 5% CO2 
for 40 h. At the end of incubation, the cells received cell culture medium 
supplemented with 1000 U/ml of Recombinant human IFN-γ (Merck Millipore), 2 
ml per well, while control cells received Caco-2 or T84 cell culture medium. The 




3.6 Cell fixation for propidium iodide staining of DNA  
 Following IFN-γ stimulation of intestinal epithelial continuous cell lines 
(described above in Materials and Methods Section 3.4), cells were washed twice 
with sterile PBS and incubated in 600 µl of undiluted TrypLE™ Express (Sigma) at 
37°C for 5 min to dissociate the cells from the tissue culture flask surface. 500 µl of 
cell culture medium was added to each well to stop the trypsinisation of cells by 
TrypLE™ Express. The dissociated cells were transferred into a sterile 30 ml 
Polystyrene Universal Container (Starlab Group) for washing (centrifuged at 1500 
R.P.M., 5 min) and re-suspended in 300 µl of PBS. 10 µl of cell suspension was 
added into 10 µl of 0.2% (in PBS) Trypan Blue solution (Invitrogen) and gently 
mixed. 10 µl of the mixture was then loaded into the counting chamber slides for cell 
counting (Bio-Rad) using the TC20™ automated cell counter (Bio-Rad). Cell 
concentration was adjusted to obtain at least 1 x 105 cells in 300 µl of PBS per tube 
(15 ml Falcon™ tube) . To fix the cells, 700 µl of 100% ethanol (ice-cold) was added 
to each tube followed by incubation at 4°C for 24 h before proceeding with 
propidium iodide (PI) staining of the DNA. 
3.7 DNA staining by propidium iodide for flow cytometry 
analysis 
 Prior to staining, the cells were washed by centrifuging at 5000 R.P.M., 5 
min, 18°C. Supernatants were gently removed before re-suspending the cells in 0.5% 
bovine serum albumin (BSA) (Sigma) in PBS to promote the fixed cells to sediment 
after centrifuging. Cells were washed again as described above before adding 1 ml of 
DNA staining solution to approximately 1 x 105 cells per tube and incubated at 4°C 
for 24 h before acquiring data with BD FACSCalibur™ flow cytometry machine. 
The DNA staining solution consisted of 0.2% propidium iodide (1 mg/ml, Biotium) 
and 5% RNAse A (1 mg/ml) (Sigma) in PBS.  
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3.8 Data acquisition and DNA content analysis by flow 
cytometry 
 Acquisition was performed as described above in Chapter 2, Materials and 
Methods Section 2.15.5. 
3.9 Detection of proliferating cells 
 Caco-2 and T84 cells were cultured into 6-well plates as described above and 
stimulated with recombinant human IFN-γ (1000 U/ml) for 6 and 24 h. At the end of 
stimulation, the cells were washed (1500 R.P.M., 5 min) in PBS once and fixed 
according to the protocol described above for propidium iodide (PI) staining of 
DNA. The fixed cells were stained with a mouse anti-human Proliferating Cell 
Nuclear Antigen antibody (anti-PCNA, Clone PC10, Pycoerythrin (PE)-conjugated, 
sc-56-PE, Insight Biotechnology), diluted in flow cytometry buffer (2% FCS in PBS) 
at 1:100 in 500 µl of sample per tube. The cells were incubated at 4°C for 30 min 
followed by two steps of washing (as above). The PCNA-labelled cells were detected 
by BD FACSCALIBUR™ flow cytometry machine with FL-2 as the fluorochrome 
detection channel. 10,000 cells were collected for each sample with BD 
CELLQUEST™ (BD Biosciences) software and saved before analysis with FlowJo 
(Treestar, Inc). A forward scatter versus side scatter (FSC-SSC) dot plot was 
produced to derive the ‘viable’ cell population, as described in Materials and 
Methods Section 3.3. Histograms of PCNA-labelled cells were plotted from cells 
within the ‘viable’ population, with positive staining determined based on the 
histograms of the unstained cells. Percentages of PCNA-positive cells were 
compared across different IFN-γ treatment time (6 and 24 h). No statistical test was 
performed on data as the experiment was not repeated. 
3.10 Caco-2 cell stimulation with purified Shiga toxin 2 or 
culture supernatants from Stx-producing strains and IFN-γ 
 Caco-2 cells were seeded at a density rate of 1.5 x 104 cells/ml in complete 
culture medium in 6-well-plates and incubated at 37°C, 5% CO2 until they reached 
100% cell confluence. The cells were treated with purified Shiga toxin 2 (Stx2, 
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Toxin Technology, Inc.), diluted in Caco-2 culture medium at 100 ng/ml for 6 h at 
37°C, 5% CO2. Control cells received Caco-2 cell culture medium. At the end of the 
6-h IFN-γ stimulation, the spent medium was replaced with Caco-2 cell medium 
containing 250 U/ml or 62.5 ng/ml of recombinant human IFN-γ (Merck Millipore) 
and incubated at 37°C, 5% CO2 for either 15 or 30 min. To study the effect of 
secreted Shiga toxins from EHEC O157:H7 on IFN-γ activated JAK/STAT1 
pathway, similar experiment was performed with filtered non-induced and 
Mitomycin C (MMC) induced culture supernatants of EHEC O157:H7 strain 
EDL933 and EDL 933 ΔΦStx1/ΦStx2 to treat Caco-2 cells. EHEC O157:H7 Strain 
EDL 933 was isolated in 1982 from ground beef associated with human clinical 
cases of severe abdominal pain and haemorrhagic colitis with little or no fever [51]. 
The outbreak occurred in Oregon and Michigan involving restaurants of the same 
fast food chain serving hamburgers, among others, which was incriminated as the 
vehicle of transmission. Strain EDL 933 possesses two Stx-encoding bacteriophages, 
933J and 933W encoding for Stx1 and Stx2 expression, respectively [109]. Two to 
three single colonies of EHEC O157:H7 EDL 933 and its isogenic strain were 
transferred from an LB agar plate and cultured in minimum essential medium (MEM 
with L-glutamine, Invitrogen) for 24 h, 37°C, 200 R.P.M. At the end of incubation, 
the cultures were filtered (0.22 µm) through filtration membrane units (Millipore) 
and stored at -20°C until used (non-induced culture supernatants). To produce MMC 
induced-culture supernatants, both bacterial strains were cultured as mentioned 
above for non-induced cultures with additional steps. Following the 24-h incubation, 
cultures were diluted 1:100 in MEM and incubated at 37°C, 200 R.P.M. until the 
optical density (O.D.) 600 nm readings reached 0.25 before further incubating the 
cultures in MEM with 5 µg/ml of MMC (Tocris), 37°C, 200 R.P.M., 18 h. Induced 
cultures were filtered and stored as mentioned for non-induced culture supernatants. 
The filtered bacterial culture supernatants were used undiluted on Caco-2 cells. 
3.11 Cell lysate collection and storage 
 At the end of the 6-h treatment period with PStx2 or bacterial culture 
supernatants, Caco-2 cells were lysed. The 6-well-plates were placed on ice for this 
procedure to prevent protein denaturation. The spent media were removed and the 
 163 
cells were washed twice in ice-cold PBS before adding 700 µl of cell lysis buffer 
[3% Triton™X-100 (Sigma), 1X Halt Protease Inhibitor Cocktail (Thermo 
Scientific) and 1X Halt Phosphatase Inhibitor Cocktail (Thermo Scientific)] across 
three wells of a 6-well-plate for 30 seconds. The cells were observed under light 
microscope for visual signs of cell lysis (visualised as dissociation from the plate 
surface, loss of cell membrane structure and cell-to-cell contact). Corning® Cell 
scrapers (Corning Life Sciences) were used to maximise the amount of cell lysate 
harvested by manually dissociating lysates from the wells before transferring into 
ice-cold 1.5 ml Eppendorf Tubes® (Eppendorf). The process was repeated for other 
wells before the lysates were centrifuged at 13,000 R.P.M.) for 5 min. The 
supernatant harbouring protein mixture were then carefully transferred into sterile 
micro-centrifuge tubes and immediately stored at -20°C until use.  
3.12 Estimation of total protein content in cell lysate 
 To determine the total protein concentration in cell lysates, the Direct 
Detect® Spectrometer (Millipore) was used. This spectrometer measures amide bond 
absorbance of the electromagnetic radiation of the mid-Infrared spectrum. Amide 
bond is present within a protein structure as it serves to link the building blocks of 
protein, amino acids. Therefore, measurement of amide bond absorbance of the 
electromagnetic radiation provides a direct quantification of the total protein present 
in the sample as compared to BCA or Bradford Assay which measures the product of 
secondary reactions [498].  
 
 To quantify the amount of protein present in cell lysates from Materials and 
Methods Section 3.11, for every sample, 2 µl of lysate was dispensed on the Direct 
Detect™ Assay-free Sample Card and left to dry at room temperature. Instrument 
settings of the Direct Detect™ Spectrometer were set according to sample type 
(protein) and the internal standard curve (NIST BSA method I) settings, based on the 
reagents present in the cell lysis buffer (refer to section 3.11). Once the circle on the 
card containing the lysate sample appeared opaque (an indication of properly dried 
card), the card was ready inserted into the machine to obtain measurements of 
protein concentration in mg/ml. The amount of cell lysate and sample buffer to be 
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loaded into the wells of the Sodium Dodecyl Sulfate-Polyacrylamide Gel 
Electrophoresis (SDS-PAGE) gel was calculated based on the quantified total 
protein. 
3.13 Separation of protein bands by Sodium Dodecyl Sulfate-
Polyacrylamide Electrophoresis (SDS-PAGE) 
 Equal volumes of Laemmli Sample Buffer (Sigma) were mixed with cell 
lysate samples from Section 3.12 before heated at 95°C for 5 min. The tubes 
containing the mixture were immediately placed on ice while samples were loaded 
onto the handcast SDS-PAGE gel (12% resolving gel, 4% stacking gel, 1 mm). 15 µg 
of protein sample was loaded into each well before the gel was assembled to the 
components of the Mini-PROTEAN® Tetra Cell (Bio-Rad) electrophoresis kit. A 
loading guide was used to position the 100 µl pipette tip direction to ensure that the 
samples were properly loaded into the wells while avoiding mixture of samples from 
the neighbouring wells. The first well from the left was always loaded with the 
molecular weight marker (Precision Plus Protein™ Dual Colour Standards, 161-
0374, Bio-Rad) for every group of samples. The clamping frame with the glass plates 
holding the gels were placed accordingly inside the running chamber. 1X electrode 
buffer was poured into the space inside the running chamber up to the appropriate 
levels indicated on the tank (2 or 4 gels) and the tank was closed. The colour-coded 
electrodes were fixed into the power supply and electrophoresis to resolve proteins 
within cell lysate was set at 150 Volt (V) for 1 to 1.5 h.  
3.14 Semi-dry membrane transfer of proteins from SDS-PAGE 
gel to nitrocellulose membrane 
 Nitrocellulose membrane (Amersham Hybond ECL Nitrocellulose 
Membrane, GE Healthcare Life Sciences), SDS-PAGE gels (from Section 3.13) and 
thick blot papers (Bio-Rad) were soaked for 15 min in transfer buffer [1 litre (L) of 
transfer buffer contains 5.82 g of Tris, 2.93 g of glycine and 0.375 g of SDS in 
deionised water with 200 ml of methanol, pH adjusted to 9.2 before adding more 
deionised water to 1 L]. The soaked components were then placed on the Trans-
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Blot® SD Semi-Dry Electrophoretic Transfer Cell (Bio-Rad) with the nitrocellulose 
membrane and electrophoresis gel placed in between two thick blot papers. To 
prevent the presence of air bubbles, a wet and clean plastic tube was used to press 
and flatten the layers to remove air. The semi-dry membrane transfer unit was set at 
15 V, limit 0.6 for 40 min. At the end of the run, protein transfer from SDS-PAGE 
gels to the nitrocellulose membranes were checked by immersing the nitrocellulose 
membranes in Ponceau S (Sigma) protein stain for 3 min. The presence of red bands 
on the nitrocellulose membrane indicates the presence of protein and successful 
protein transfer. Distilled water was used to wash the Ponceau S stain from the 
membranes before proceeding to the procedure described in Section 3.15 below. 
3.15 Immuno-staining of proteins on nitrocellulose 
membrane 
 The nitrocellulose membranes were blocked in 5% BSA in PBS, on an orbital 
shaker at 4°C, overnight or at room temperature for 1 h. The membranes were 
washed in Tris-Buffered-Saline with 0.1% Tween®20 (TBST) with two time quick 
rinse followed by a 20 min incubation (orbital shaker) and two times 5 min washes 
(orbital shaker) at room temperature. The nitrocellulose membranes were incubated 
in primary antibodies (rabbit anti-human STAT1, rabbit anti-human phosphorylated 
STAT1 and rabbit anti-human β-actin, all from Cell Signalling, used at 1:1000) 
diluted in TBST for 18 h at 4°C, orbital shaker. The membranes were washed as 
described above and incubated in secondary antibodies at room temperature for 1 h 
on an orbital shaker. At the end of the secondary antibody incubation, the 
membranes were washed again with TBST buffer as described above with an 
addition of two more extra washing steps (four times 5 min washes).  
3.16 Protein band detection 
 An equal amount of the Supersignal West Pico Chemiluminescent substrates 
(Thermo Scientific) was added to the nitrocellulose membranes (approximately 1 ml 
per 8 cm x 15 cm membrane), incubated at room temperature for 5 min. Excess 
detection reagent was drained off and the nitrocellulose membranes were carefully 
 166 
placed in between two acetate sheets, avoiding air bubble formation. Detection of 
protein bands was performed with both radiograph developer and G-box 
Chemiluminescence Detection System (Syngene).  
3.17 Nitrocellulose membrane reprobing 
Following film exposure, the rabbit anti-human STAT1 was stripped of the 
nitrocellulose membrane for the first two repeats of Western blotting to allow 
reprobing with rabbit anti-human phosphorylated STAT1 and rabbit anti-human β-
actin. The nitrocellulose membrane was washed for four times in washing buffer 
(TBST), 5 min per wash. This was followed by an incubation step in protein 
stripping buffer (100 mL of stripping buffer consists of 6.25 ml of 1M Tris-HCl pH 
6.8, 10 mL of 20% SDS, 700 μL β-mercaptoethanol and deionized water added to 
100 mL) for 30 min, at room temperature. The membrane was washed again for six 
times (5 min per wash) in TBST. To confirm for the removal of the original signal 
probed, the membrane was incubated again with the secondary antibody against the 
intial signal detected followed by the steps described above for detection by film 
exposure to x-ray, which should reveal no signal from the membrane to signify a 
succesful membrane stripping procedure. The membrane was washed again in TBST 





































3.1 Immuno-phenotyping select mucosal terminal rectal cells 
EHEC O157:H7 has been demonstrated to show a tropism towards the terminal 
rectum in colonised cattle [33]. One particular characteristic of the terminal rectum 
observed is the presence and abundance of lymphoid follicles on the mucosa [352]. 
This chapter attempts to compare how certain groups of immune cells previously 
shown to be present at the site respond in calves exposed to EHEC O157:H7 [250]. 
Therefore, rectal mucosal cells were phenotyped to examine expression of a 
combination of cell markers from calves of different EHEC O157:H7-exposure 
status. 
 
Figures 3.1 to 3.6 present the results obtained from all three groups (calves 
challenged with EHEC O157:H7 Strain 9000 (ΦStx2a+/ΦStx2c+) or Strain 10671 
(ΦStx2c+) and unchallenged calves serving as controls) for T helper cells 
(CD3+/CD4+), T Cytotoxic cells (CD3+/CD8+), IEL γδ T cells (CD3+/γδ+), NK 
cells (CD16+/NKp46+), B cells and follicular dendritic cells (CD21+) and 
monocytes/macrophages (SiRP-1-α+).  
 
Analysis with 1-way ANOVA in comparing the percentages of the immune 
cells detected among the three different groups of calves showed statistically 
significant differences for CD3+/CD8+ (Fig. 3.2) [F (2, 15) = 7.19, p-value=0.0065], 
CD3+/γδ+ (Fig. 3.3.) [F (2, 15) = 4.37, p-value=0.032] and CD21 (Fig. 3.5) [F (2, 
15) = 4.23, p-value=0.035]. The proportion of T helper cells, NK cells and 
monocytes/macrophages among the three groups were not significantly different 
from each other as seen in Fig. 3.1, 3.4 and 3.6. 
  
Post-hoc Dunnett’s multiple comparison tests (alpha=5.00%) to identify which 
pairwise comparison against the unchallenged control calves were statitically 
significant indicated differences of the CD3+/CD8+ and CD3+/γδ expressing cells 
in the EHEC O157:H7 Strain 9000-infected calves compared to the control group 
[mean differences of 0.3513 (p-value=0.004) and 0.3624 (p-value=0.02), 
respectively] (Table 3.1). On the other hand, CD21+ expressing cells were 
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significantly increased in the terminal rectal cells of calves exposed to EHEC 
O157:H7 Strain 9000 compared to the control calves [mean difference of -0.2763, p-











































Figure 3.1 Flow cytometry dot plots of CD3+/CD4+ cells detected from 
EHEC O157:H7-challenged and unchallenged calves. (A) Dot plots with 
total CD3+/CD4+ population (shown in the red upper right quarter) derived from the 
‘viable’ population of immune-labeled terminal rectal mucosal cells of calves 
challenged with EHEC O157:H7 Strain 9000 or EHEC O157:H7 Strain 10671 and 
unchallenged control calves (six individual animals per group). (B) Bar plot presents 
the mean ± standard deviation for each group and individual values (total 







   
 
Figure 3.2 Flow cytometry dot plots of CD3+/CD8+ cells detected from 
EHEC O157:H7-challenged and unchallenged calves. (A) Dot plots with 
total CD3+/CD8+ population (shown in the red upper right quarter) derived from the 
‘viable’ population of immune-labeled terminal rectal mucosal cells of calves 
challenged with EHEC O157:H7 Strain 9000 or EHEC O157:H7 Strain 10671 and 
unchallenged control calves (six individual animals per group). (B) Bar plot presents 
the mean ± standard deviation for each group and individual values (total 















12.5% 9.45% 7.15% 5.24% 3.85% 5.59% 
7.99% 9.79% 6.26% 8.35% 13.2% 12.4% 
19.3% 10.4% 22.5% 21.5% 14.3% 8.92% 
EHEC O157:H7 Strain 9000 









Figure 3.3 Flow cytometry dot plots of CD3+/ γδ+ cells detected from 
EHEC O157:H7-challenged and unchallenged calves. (A) Dot plots with the 
CD3+/CD3+ population (shown in the red upper right quarter) derived from the 
‘viable’ population of immune-labeled terminal rectal mucosal cells of calves 
challenged with EHEC O157:H7 Strain 9000 or EHEC O157:H7 Strain 10671 and 
unchallenged control calves (six individual animals per group). (B) Bar plot presents 
the mean ± standard deviation for each group and individual values (total CD3+/ CD















TCR γδ-Alexa Fluor® 488  
2.20% 7.36% 5.61% 2.84% 3.92% 3.03% 
4.93% 6.81% 4.17% 3.84% 13.1% 11.5% 
15.8% 3.82% 7.78% 9.94% 13.7% 7.16% 
EHEC O157:H7 Strain 9000 





















Figure 3.4 Flow cytometry dot plots of CD16+/ NkP46+ cells detected 
from EHEC O157:H7-challenged and unchallenged calves. (A) Dot plots 
with the CD16+/NkP46+ population (shown in the red upper right quarter) derived 
from the ‘viable’ population of immune-labeled terminal rectal mucosal cells of 
calves challenged with EHEC O157:H7 Strain 9000 or EHEC O157:H7 Strain 10671 
and unchallenged control calves (six individual animals per group except for 
unchallenged group). (B) Bar plot presents the mean ± standard deviation for each 

















0.83% 3.65% 2.76% 1.57% 1.25% 1.95% 
3.76% 2.31% 2.72% 0.88% 6.21% 3.25% 
0.30% 6.37% 2.54% 
EHEC O157:H7 Strain 9000 











Figure 3.5 Flow cytometry dot plots of CD21+ cells detected from EHEC 
O157:H7-challenged and unchallenged calves. (A) Dot plots with the CD21+ 
population (shown in the red upper right quarter) derived from the ‘viable’ population 
of immune-labeled terminal rectal mucosal cells of calves challenged with EHEC 
O157:H7 Strain 9000 or EHEC O157:H7 Strain 10671 and unchallenged control 
calves (six individual animals per group). (B) Bar plot presents the mean ± standard 
deviation for each group and individual values (total CD21+ per total ‘viable’ terminal 



















Figure 3.6 Flow cytometry dot plots of SIRP-alpha (SIRP-α)+ cells 
detected from EHEC O157:H7-challenged and unchallenged calves. (A) 
Dot plots with the SIRP-α+ population (shown in the red upper right quarter) derived 
from the ‘viable’ population of immune-labeled terminal rectal mucosal cells of 
calves challenged with EHEC O157:H7 Strain 9000 or EHEC O157:H7 Strain 10671 
and unchallenged control calves (six individual animals per group). (B) Bar plot 
presents the mean ± standard deviation for each group and individual values (total 
SIRP-α+ per total ‘viable’ terminal rectal cells, %). 
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Table 3.1. Statistical analysis of bovine terminal rectal cells immune-labelled and detected for different cell surface 
marker combinations by flow cytometry. Percentages of cells with selected cell surface marker combinations from FlowJo analysis 
were log10-transformed to obtain a Gaussian distribution before performing one-way Analysis of Variance to compare the means of 
samples from three groups (calves exposed to EHEC-O157:H7 Strain 9000, Strain 10671 and unchallenged control calves). Post-hoc 
Dunnett’s multiple comparison test was used to compare each EHEC O157:H7-challenged groups against the unchallenged control 
calves. Validity of the ANOVA results was checked with Brown-Forsythe test to ensure equal standard deviation (S.D.) among data. All 
data complied with the assumption of equal S.D. except for CD3+/CD4+ data (refer Table 3.2).  
 
Surface marker Group n Mean S.D. F (1-way ANOVA) P-value 
Post-hoc Dunnett's 
multiple comparison test 
Mean 
Difference  P-value 
CD3+/CD8+ Strain 9000 6 7.297 3.186 7.187 0.007** Unchallenged vs Strain 9000 0.351 0.004** 
 Strain 10671 6 9.665 2.688   
Unchallenged vs Strain 
10671 0.210 0.071 
 Unchallenged 6 16.12 5.803      
          
CD3+/γδ+ Strain 9000 6 4.16 1.963 4.368 0.032* Unchallenged vs Strain 9000 0.362 0.020* 
 Strain 10671 6 7.392 3.971   
Unchallenged vs Strain 
10671 0.125 0.513 
 Unchallenged 6 9.700 4.427      
          
CD16+/NkP46+ Strain 9000 6 2.002 1.041 0.493 0.627 Unchallenged vs Strain 9000 -0.022 0.995 
 Strain 10671 6 3.183 1.784   
Unchallenged vs Strain 
10671 -0.206 0.652 
 Unchallenged 3 3.070 3.070      
          
CD21+ Strain 9000 6 44.68 10.66 4.225 0.035* Unchallenged vs Strain 9000 -0.276 0.037* 
 Strain 10671 6 42.07 5.528   
Unchallenged vs Strain 
10671 -0.259 0.051 
 Unchallenged 6 27.65 18.95      
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Table 3.2. Statistical analysis of CD3+/CD4+ and SiRP-1-alpha flow cytometry data. Data was analysed by Kruskal-Wallis 
test and post-hoc Dunn’s multiple comparisons test to compare the mean ranks between the EHEC O157:H7-challenged and 













CD3+/CD4+ Strain 9000 6 30.30 8.03 4.72 0.09 Unchallenged vs Strain 9000  -3.833 0.427 
 Strain 10671 6 31.75 5.43   
Unchallenged vs Strain 
10671 -6.667 0.061 
 Unchallenged 6 21.77 7.83      
 
 
SiRP-α Strain 9000 6 3.26 3.664 2.89 0.248 Unchallenged vs Strain 9000 3.333   0.559 
 Strain 10671 6 7.688 6.310   
Unchallenged vs Strain 
10671 -1.833   >0.999 
  Unchallenged 6 11.09 17.99           
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3.2 ELISA measurement of IFN-γ release by cultured terminal 
rectum mucosal cells 
To analyse production of the pro-inflammatory cytokine, IFN-γ which has been 
previously reported to affect EHEC O157:H7 colonisation  [481, 482, 499] release 
was measured from the cultured terminal rectal mucosal cells harvested from EHEC 
O157:H7 challenged and control calves. Total IFN-γ quantified from supernatants of 
the 48-h cultured cells, after normalising to the blank controls, with a standard curve 
fitted are shown in Fig. 3.7. IFN-γ released from terminal rectal mucosal cells of 
calves exposed to EHEC O157 :H7 Strain 10671 was 1.07 ng/ml, 0.59 ng/ml from 
cells of the EHEC O157 Strain 9000-exposed group and 0.09 ng/ml from the cells of 
the non-infected control group. The results could not be supported by statistics as the 
experiment was done only once due to the lack of terminal rectal cells to be used for 





































Figure 3.7 IFN-γ released by bovine terminal rectal cells quantified by 
ELISA. Bar plot showing levels of quantified Interferon-γ (IFN-γ) measured from 
supernatant of the isolated cells cultured in lymphocyte medium for 48 h, 37°C, 5% 
CO2. Error bars indicate standard error of mean (S.E.M.) for calves exposed to 
EHEC O157:H7 Strain 9000 and Strain 10671 (both n=6) and unchallenged, non-



































3.3 The effect of Interferon-γ on the cell cycle of epithelial cell 
lines 
 The next question asked was how does the epithelial barrier of the terminal 
rectum respond to the presence of IFN-γ in the event of an EHEC O157:H7 
colonisaton (Fig. 3.7). The current study focused on the effect of IFN-γ on the 
epithelial cell cycle. IFN-γ have been shown to act as a modulator of epithelial 
homeostasis by interfering with the epithelial barrier renewal process [489]. 
Furthermore, the cytokine was reported to block the proliferation of a rat intestinal 
crypt cell line, IEC-6 [254]. It was therefore hypothesised that during the early stages 
of EHEC O157:H7 colonisation at the terminal rectal mucosa, immune cells at the 
immediate epithelial surface (for example IEL TCR γδ cells) and cells of the lamina 
propria (T helper, T cytotoxic and NK cells) were stimulated to release IFN-γ. The 
released IFN-γ will bind to surface IFN-γ receptor, presumably present on intestinal 
epithelial surface (since IFNGR is expressed by Caco-2 and T84 cells) [500, 501] 
and exert its anti-proliferative effect. 
 
 However, IFN-γ stimulation at 1000 U/ml of both Caco-2 and T84 cells at all 
three time-points tested (30 min, 6 h and 24 h) did not cause any apparent 
perturbation in the DNA-propidium iodide (P.I.) staining profile (Fig. 3.8). Statistical 
analyses as shown in Table 3.3 and Table 3.4 of the data shows that there was no 
significant difference between the IFN-γ stimulated and non-stimulated Caco-2 and 
T84 cells at each analysed cell cycle phase (multiple t-tests comparison corrected for 
multiple comparison using the Holm-Sidak method, with alpha=5.00%).  
 
  The specific effect of IFN-γon Caco-2 and T84 cellular proliferation was 
investigated by PCNA staining (Fig. 3.9). This experiment was performed only once, 
therefore not allowing statistical analyses of the data. Regardless of the intestinal 
epithelial cell line (Caco-2 resembles the matured epithelial cells at the villi, while 
T84 resembles the intestinal crypt cells) and the Gb3 surface expression (more on 
Caco-2 than T84, refer to Fig. 2.1 in Chapter 2), no difference was observed in 
proliferation after IFN-γtreatment for either 6 or 24 h. Although there seems to be a 
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slight decrease in the total cells stained positive for PCNA after 24 h of stimulation 
with IFN-γin both cell lines, there was not enough evidence for further investigation 





































Figure 3.8 DNA staining profile with propidium iodide of cells treated 
with Interferon-γ (IFN-γ). Bar plots showing the average of Caco-2 and T84 cells 
in each cell cycle phase after IFN-γ(1000 U/ml) treatment (green) for a, b) 30 min 
(n=3), c, d) 6 h (n=3) and e, f) 24 h (n=2) at 37°C, 5% CO2. The gray bars represent 
DNA staining profile of cells receiving cell culture medium only (control). Data were 
analysed with multiple t-tests corrected for multiple comparison using the Holm-
Sidak method, alpha=5.00%, without assuming a consistent standard deviation. The 





















Figure 3.9 Proliferation cellular nuclear antigen staining of Interferon-γ 
(IFN-γ) treated Caco-2 and T84 cells. Flow cytometry results (n=1) presented 
in bar plots for Caco-2 and T84 cells stained for proliferating cell nuclear antigen 
either treated with 1000 U/ml of IFN-γ (purple) or serum-free media (white), for 6 h 
(a,b) and 24 h (c,d) at 37°C, 5% CO2. 
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Table 3.3. Statistical analysis of DNA staining profile for Caco-2 cells stimulated with IFN-γ. Mean of total cells in each cell 
cycle phase (per 100 cells) were compared between IFN-γ stimulated (1000 U/ml) and unstimulated control cells. Data was analysed with 
multiple t-test using Holm-Sidak method (alpha=5.00%) without assuming consistent standard deviation (S.D.) in GraphPad Prism version 
6. 
Cell line Treatment Phase n Mean S.E.M. t ratio  
(Control vs. IFN-γ treated) 
df P-value 
Caco-2 Control G1 3 71.07 2.91 0.791 4 0.473 
  S 3 20.87 1.18 1.233 4 0.285 
  G2/M 3 7.56 1.64 0.490 4 0.650 
 IFN-γ (30 mins) G1 3 74.23 2.74    
  S 3 18.83 1.17    
  G2/M 3 6.47 1.49    
         
 Control G1 3 64.18 3.97 0.816 4 0.460 
  S 3 24.86 0.81 1.533 4 0.200 
  G2/M 3 10.31 3.06 0.345 4 0.747 
 IFN-γ (6 h) G1 3 70.72 6.96    
  S 3 20.09 3.00    
  G2/M 3 8.64 3.74    
         
 Control G1 3 80.47 3.38 0.632 2 0.592 
  S 3 16.93 2.35 0.423 2 0.713 
  G2/M 3 2.36 0.91 1.511 2 0.270 
 IFN-γ (24 h)  G1 3 84.05 4.56    
  S 3 14.85 4.33    
  G2/M 3 0.97 0.16    
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Table 3.4. Statistical analysis of DNA staining profile for T84 cells stimulated with IFN-γ. Mean of total cells in each cell 
cycle phase (per 100 cells) were compared between IFN-γ stimulated (1000 U/ml) and unstimulated control cells. Data was analysed with 
multiple t-test using Holm-Sidak method (alpha=5.00%) without assuming consistent standard deviation (S.D.) in GraphPad Prism version 
6. 
Cell line Treatment Phase n Mean S.E.M. t ratio  
(Control vs. IFN-γ treated) 
df P-value 
T84 Control G1 3 58.32 1.87 0.493 4 0.648 
  S 3 27.46 0.20 0.323 4 0.763 
  G2/M 3 13.54 1.85 0.500 4 0.644 
 IFN-γ (30 
mins) 
G1 3 55.9 4.52    
  S 3 27.82 1.09    
  G2/M 3 15.42 3.30  
 
  
 Control G1 3 59.83 4.26 0.995 4 0.376 
  S 3 25.34 3.90 0.142 4 0.894 
  G2/M 3 13.98 6.97 0.510 4 0.637 
 IFN-γ (6 h) G1 3 65.46 3.73    
  S 3 24.67 2.72    
  G2/M 3 9.4 5.67  
 
  
 Control G1 3 80.5 6.18 0.013 4 0.990 
  S 3 15.93 5.55 0.043 4 0.968 
  G2/M 3 3.41 0.57 0.548 4 0.613 
 IFN-γ (24 h) G1 3 80.39 6.39    
  S 3 15.59 5.74    




3.4 The effect of Shiga toxin on IFN-γ-activated JAK/STAT1 
pathway 
  Published studies had suggested a role for Shiga toxin in supporting  E. coli 
colonisation by interfering with intracellular epithelial signalling pathways as 
mentioned in Chapter 3 Introduction section 3.4. To examine this EHEC O157 :H7 
strain EDL 933 supernatant (presumed to contain Stx1 and Stx2) [109] as well as 
purified Stx2 were added to IFN-γ stimulated Caco-2 cells and the  lysates examined 
by Western blotting to detect activated or phosphorylated STAT1 (pY-STAT1) and 
total STAT1. 
 
 Treatment of Caco-2 cells with purified Shiga toxin 2 (PStx2) for 6 h before 
exposing the cells to IFN-γ for either 15 min or 30 min failed to inhibit STAT1 
activation (Fig. 3.10). Further sets of experiments were then carried out by 
substituting PStx2 with two independent sets of EHEC O157:H7 Strain EDL 933 
culture supernatants; with or without MMC induction as the inhibiting effect 
proposed earlier [502] requires the toxin to be freshly generated from bacterial lysate 
as opposed to PStx2 (Fig. 3.11 and 3.12). In the first experiment (Fig. 3.11), STAT1 
activation was evident in all lysates receiving IFN-γtreatment with the exception of  
Caco-2 cells exposed to MMC-induced culture supernatant of Strain EDL 933, a 
finding that is anticipated and parallels the findings in previous publications [483]. 
The presence of a weak band for phosphorylated STAT1 could be observed for the 
lane with Caco-2 lysate treated with MMC-induced Stx-negative isogenic EDL 933 
(Stx1-/Stx2-) on the same blot (Fig. 3.11). This was unexpected since inhibition of 
STAT1 activation was only anticipated to be present in samples treated with Stx-
positive filtrate. In addition, the presence of this weak band may also be as a result of 
overloading the gel. To clarify this, the pY-STAT1 band for Caco-2 lysate receiving 
supernatant filtrate of the Stx-negative Strain EDL 933 culture was compared against 
the total STAT1 and β-actin bands. It was concluded that the weak detection was 
most probably the result of a much lower amount of sample loaded into that 




Findings from the first experiment prompted another experimental repeat  to be 
carried out to verify inhibition of STAT1 activation in Caco-2 cells upon treatment 
with Stx-positive filtrate (Fig. 3.12). Results of the second experiment (Fig. 3.12) 
however did not match the first (Fig. 3.11). No differences in the levels of STAT1 
activation were observed for all samples tested, which contrasted with the results 
from the previous blot (Fig. 3.11) in particular for the Caco-2 lysates treated with 
induced culture supernatants. Another repeat of experiment using a new batch of 
MMC-induced culture supernatants was performed (Fig. 3.13), supporting the results 
obtained in the second experiment (Fig. 3.12). Taken together, there was insufficient 
evidence to support the inhibition of JAK/STAT1 pathway by purified Stx2 or Shiga 










































Figure 3.10 Western blot results of Caco-2 cell lysates stimulated with 
Purified Shiga toxin 2 (PStx2) and Interferon-γ (IFN-γ).  Caco-2 cells 
received PStx2 (100 ng/ml) for 6 h before stimulated with IFN-γ(250 U/ml) for either 
15 min or 30 min at 37°C, 5% CO2. Immunoblotting detection for total STAT1 
(91kDa) and activated STAT1 (phosphorylated-STAT1 or pY-STAT1) (91kDa) are 
shown in the radiograph image. The signals were separately detected from the 
same membrane following membrane stripping and reprobing procedure. All signals 
detected following each reprobing steps were compiled in this figure for the purpose 
of visual comparison only and does not reflect the actual position (molecular 






















Figure 3.11 Western blot results of Caco-2 cell lysates stimulated with 
culture supernatants of EHEC O157:H7 strain EDL 933 or isogenic Stx1-
/Stx2- and Interferon-γ (IFN-γ) (i).  Caco-2 cells received non-induced or 
Mitomycin C-induced culture supernatants of EHEC O157:H7 strain EDL 933 or 
isogenic strain EDL 933 Stx1-/Stx2- for 6 h before stimulated with IFN-γ(250U/ml) 
for 30 min at 37°C, 5% CO2. Immunoblotting detection for total STAT1 (91 kda) and 
activated STAT1 (phosphorylated-STAT1 or pY-STAT1) (91 kda) are shown. The 
signals were separately detected from the same membrane following membrane 
stripping and reprobing procedure. All signals detected following each reprobing 
steps were compiled in this figure for the purpose of visual comparison only and 
does not reflect the actual position (molecular weight).  β-actin (45 kda) was used as 




















Figure 3.12 Western blot results of Caco-2 cell lysates stimulated with 
culture supernatants of EHEC O157:H7 strain EDL 933 or isogenic Stx1-
/Stx2- and Interferon-γ (IFN-γ) (ii).  Caco-2 cells received non-induced or 
Mitomycin C-induced culture supernatants of EHEC O157:H7 strain EDL 933 or 
isogenic strain EDL 933 Stx1-/Stx2- for 6 h before stimulated with IFN-γ(250U/ml) 
for 30 min at 37°C, 5% CO2. Immunoblotting detection for total STAT1 (91 kda) and 
activated STAT1 (phosphorylated-STAT1 or pY-STAT1) (91 kda) are shown. 
Nitrocellulose membranes for detecting STAT1 and pY-STAT1 were each cut into 
half horizontally for detection of β-actin (45 kda) as sample loading control. Images 
compiled in this figure are for the purpose of visual comparison only and do not 




















Figure 3.13 Western blot results of Caco-2 cell lysates stimulated with 
Mitomycin C-induced culture supernatants of EHEC O157:H7 strain EDL 
933 or isogenic Stx1-/Stx2- and Interferon-γ (IFNγ) (iii). Caco-2 cells 
received Mitomycin C-induced culture supernatants of EHEC O157:H7 strain EDL 
933 or isogenic strain EDL 933 Stx1-/Stx2- for 6 h before stimulated with IFNγ
(250U/ml) for 30 min at 37°C, 5% CO2. Immunoblotting detection for total STAT1 (91 
kda) and activated STAT1 (phosphorylated-STAT1 or pY-STAT1) (91 kda) are 
shown. Nitrocellulose membranes for detecting STAT1 and pY-STAT1 were each 
cut into half horizontally for detection of β-actin (45 kda) as sample loading control. 
Images compiled in this figure are for the purpose of visual comparison only and do 











































3.1 Cell surface marker expression and Interferon-gamma 
(IFN-γ) quantified from cells harvested from the bovine 
terminal rectal mucosa 
 The main difference known to date between Strain 9000 and Strain 10671 is 
the type of Stx-encoding phage(s) possessed and with potentially different Stx 
type(s) expressed [251]. Since the ability to produce Stxs is an important trait 
rendering virulence to the bacteria, it is anticipated that these highly conserved 
virulence components (phage and Stx) may play a role in modulating the bovine host 
immune response. Concurrent data from collaborators [384] had confirmed the 
presence of a strain-dependent response from the same group of animals of which the 
bovine terminal rectal tissue used in this chapter were sampled from. Rectal lymph 
nodes stimulated ex vivo with T3SS proteins caused significant increase in the 
proliferation of CD4+ cells of Strain 9000-challenged group, NK cells of Strain 
10671-infected animals, as well as CD8+ and T γδ cells, implying the involvement of 
a strain-dependent response in the host [384].  
 
 Overall, the proportion of immune cell subpopulations based on surface 
markers expression appeared similar between infected or exposed and non-exposed 
animals with the exception of three immune cell subsets from EHEC O157:H7 Strain 
9000-infected group. Statistically significant differences between EHEC O157:H7 
Strain 9000-exposed and non-exposed controls were determined for the 
CD3+/CD8+, CD3+/γδ+ and CD21+ cells. The proportion of CD3+/CD8+ and 
CD3+/γδ+ cells were significantly lower in animals challenged with Strain 9000 in 
comparison to the unchallenged control group. While the expression of CD21+ cells 
were statistically higher in animals receiving Strain 9000 than the unchallenged 
calves. It remains uncertain if these observations reflect the actual proportions 
occuring within the tissues from calves of the two groups (Strain 9000 and 
unchallenged control). The downregulation of the host immune response, particularly 
the cellular mediated immunity (CMI) by Stx+ EHEC O157 strain have been 
described by previous studies using both in vitro and in vivo assays. Stx1 is able to 




intraepithelial lymphocytes in a gut-loop intestinal infection model were shown to be 
sensitive to the anti-proliferative effect of purified Stx1 [453]. The proliferation of 
PBMC from cattle infected with Stx2+ EHEC O157 strain were reported to be 
significantly reduced when compared with a group infected with a non-pathogenic E. 
coli strain [503].  
 
Since the total number of cells sampled and analysed is unknown, relative 
comparison of the percentages between the groups becomes impossible. The 
percentages presented for each immune cells phenotyped were based on the number 
of cells within the positive quarters of the surface marker (or surface marker 
combinations) derived from cells within the 'viable/live' cells gated during 
acquisition of the 10,000 events. During the acquisition, the assumption was that 
each event corresponded to a single cell. Although the position of the gate used to 
include 'viable/live' cells across all samples was constant, the total number of cells 
within the 'viable/live' gates were different. To overcome this, the number of cells 
positive for the phenotype stained were converted into percentages, with the total 
'live' cells as the denominator. These percentages were then used for statistical 
analysis. In future experiments, it is suggested that the flow cytometry analysis to be 
done by gating on a constant number of known 'live' cells. To achieve this, an 
additional step of staining for the DNA or special staining of viable cells could be 
done prior to processing the samples for flow cytometry analysis of the immune cell 
populations. By performing this extra step, the data obtained could be improved as 
all the cellular debris or aggregates are excluded. During acquisition of the 'live' 
cells, setting the acquisition to 10,000 events within the cells positive for DNA 
staining will ensure that each event counted is considered a 'live' cell. Flow 
cytometry analysis of FACS-sorted viable cells (pre-stained with for example 
propidium iodide) into known total number of cells will improve the accuracy of the 
data produced.  
 
In addition, the lack of animals infected with a Stx2 negative strain and the 
absence of serological assays or mucosal IgA measurement hindered from reaching a 




low, if not absence, levels of Stx-specific antibodies being generated by the bovine 
host. Serological anti-Stx1 but not anti-Stx2, were detected in experimentally EHEC 
O157-infected cattle [452, 504]. Newborn calves also lack maternal and acquired 
Stx-specific antibodies in the serum, providing no protection against STEC infection 
upon first encounter with the bacteria [505]. In naturally infected calves, maternal 
and acquired anti-Stx1 antibodies were present only in a small proportion of calves, 
while no specific antibody against Stx2 were generated [505]. An exception to the 
lack of strong specific Stx antibodies was described in a study employing dams 
immunised during pregnancy against inactivated, purified Stx2. The dams were able 
to generate significant titres of anti-Stx2 and transfer passive immunity to their 
calves via colostrum [506].  
 
Perhaps, the generation of  bovine antibodies directed against Stx-phages and 
Stx is not a priority to the host as that previously described for other bacterial factors. 
In a study where calves were experimentally-infected with EHEC O157:H7, the 
authors detected increased levels of mucosal IgA production against H7 flagellin, as 
well as IgA which recognized type III secretion-dependent proteins (Esp A, B and 
D), O157 lipopolysaccharide, and outer membrane porin C (OmpC) [507]. Another 
study identified low titres of IgG and IgA against the O157 LPS in the faeces of 
orally challenged adult cattle [508]. In addition, serological findings from EHEC 
O157-infected cattle detected antibodies against the O157 LPS, intimin and secretory 
proteins of the T3SS [452]. Animals vaccinated with anti-T3SS proteins were shown 
to develop IgG and resulted in decreased shedding [216, 509, 510]. In vitro study on 
bovine PBMC detected only a minor influence of Stx1 on CD21+ cells, as compared 
to significantly suppressed T cytotoxic CD8+ cells [252]. The lack of data on the 
presence of Stx-phage components and Stx production in the bovine intestine further 
complicates the interpretation of the data obtained (further work in determining Stx 
production by Strain 9000 and Strain 10671 is presented in Chapter 4). 
 
  Ex vivo stimulation of rectal lymph node cells with EHEC type III secreting 
proteins and LPS revealed lower levels of IFN-γ in Strain 10671-infected calves than 




Th1-master regulator (T-bet) induction and IFN-γ expression from rectal lymph node 
cells, which peaked in parallel to bacterial shedding curves, at day seven post-
challenge in animals exposed to Strain 10671, and day twenty-one post-infection for 
Strain 9000-infected calves [384]. Despite observing the presence of IFN-γ 
indicating pro-inflammatory cells to be stimulated by the presence of EHEC 
O157:H7, data from the IFN-γ quantitation assay unfortunately remains inconclusive 
due to the lack of statistical data. Additionally, there was no significant difference 
detected between both infected groups and the unchallenged calves with regards to 
the expression of CD3+/CD4+, the main T lymphocytes involved in a Th1-biased 
response, although these results still require additional repeats of the 
immunophenotyping experiment with known total number of cells analysed. In 
addition, intracellular IFN-γ expression in immune cells by flow cytometry, 
immunoblotting or mRNA transcriptome analysis would provide a stronger and 
clearer evidence in discussing IFN-γ production by the bovine terminal rectal cells. 
Since tissue sample and time were limited, such experiments were not carried out in 
this study.  
 
 Since the terminal rectal cells were obtained at post-mortem, certain handling 
conditions and subsequent procedures performed might cause perturbations in the 
morphology and ability of the cells to express cytokines, as a result of changes in 
stimuli (cell culture medium and laboratory growth conditions). This work also did 
not further investigate the transcriptional levels of important regulators associated 
with IFN-γ expression since the initial goal was to identify and compare the different 
immune subsets present in EHEC O157:H7-challenged and control calves; 
determining the mechanisms causing differential cytokine expression would require 
more samples than those available at that time of this study. There was no 
examination of the rectal lymph nodes on similar immune subsets as those 
immunophenotyped at the FAE of the terminal rectum, which if performed would 






3.2 The effect of IFN-γ on epithelial cell proliferation 
 Since IFN-γ was shown to interrupt cell division in both macrophages and rat 
intestinal crypt cells (IEC-6), the potential growth inhibiting effect of this cytokine 
was studied on Caco-2 and T84 cells [460]. IFN-γ mediated cell cycle arrest could 
occur since IFN-γ is able to induce the expression of cyclin-kinase inhibitor 
p21WAF, suppressing cellular proliferation at mid-G1 phase [488]. The aim was to 
investigate if IFN-γ produced in response to EHEC O157:H7 presence affects the 
intestinal epithelial cells proliferating capacity. Based on the DNA-propidium iodide 
labelling across cell cycle phases and PCNA staining, it was concluded that neither 
Caco-2 nor T84 cells proliferation was changed upon exposure to IFN-γ. 
  
 Results obtained suggest that the intestinal epithelial cells are not sensitive to 
the anti-proliferative effect of IFN-γ, at least as observed under in vitro conditions on 
human intestinal cell lines. Despite the rat intestinal epithelial crypt cells shown to be 
sensitive to the anti-proliferative effect of IFN-γ, T84 cells with crypt-like features 
were resistant under the assay conditions. This could be related to diminished 
expression of IFN-γ signalling components in the T84 cell line as compared to other 
primary cells that have been used previously to assess effects of IFN-γ.  
3.3 Shiga toxin and IFN-γ influence on epithelial signalling of 
the JAK/STAT1 pathway 
 Initial evidence provided by a research group proposed that Stx of EHEC 
O157:H7 interferes with the activation of the JAK/STAT1 pathway [483, 511]. 
However, results obtained in my study have not been able to provide strong evidence 
of inhibition of STAT1 activation following IFN-γ stimulation and treatment with 
either purified Stx2 or Stx+ EHEC O157:H7 EDL 933 culture supernatant and lysate. 
Consecutive work published by the same authors claimed that Stx interrupts STAT1 
phosphorylation and showed that the inhibition effect of signal transduction 
following IFN-γ exposure required another unknown bacterial factor besides Stx 
[483]. The study proposed that this might be YodA, a type two secretion protein, to 




provide convincing evidence for such inhibitory activities remained inconclusive. 
The lack of consistent evidence seen in my study with regards to blocking IFN-γ 
transduction suggests that Stx do not primarily target disruption of the JAK/STAT1 
signalling pathway in intestinal epithelial cells. The reason underlying the different 
outcomes in the current study and by the published work [483] was not investigated. 
However factors that may contribute to the disparate observations may be due to the 
different culture conditions for the growth of Strain EDL 933 used. The current study 
directly cultured bacterial colonies from an LB agar, into MEM before preparing the 
filtered supernatant of the culture. Whereas in the published study, the authors pre-
cultured the bacteria in Penassay broth prior to adding the bacterial cells in MEM. 
Growth conditions may be very important in determining the transcriptome and 
phenotype induced type in the bacterial cells, as that determined for optimum T3SS 
expression by EHEC O157:H7 in MEM-HEPES [257] and in Salmonella enterica 
Serovar Typhimurium [512]. It may be that under the growth conditions adopted by 
my study hindered the expression of the necessary bacterial factors (for example 
YodA) required for the inhibition of STAT1 activation is observed. 
Conclusion 
At present, the known differences between Strain 9000 and Strain 10671 is in 
the carriage of different combination/types of Stx-prophages and the shedding 
abilities with Strain 9000 described as the more successful strain due to the super-
shedding phenomena [64] and possession of the Stx2a-prophage. Thus, it was 
thought for these factors to be closely associated to each other. However, based on 
the findings of this chapter, there was insufficient evidence to implicate the 
involvement of Stx-phages and Stx in host immunomodulation by EHEC O157:H7 
strains. Results obtained are preliminary and requires more experiments to be 
performed with the suggested additional protocol (Chapter Four, Discussion section 
3.1) to confirm if there is any significant suppression in the CD3+/CD8+ and 
CD3+/γδ+ cells and upregulation of the B cells and follicular dendritic cells (CD21+) 





Attempts to directly associate the interaction of EHEC O157:H7 and 
enterocytes to be mediated by either IFN-γ or Stx also produced no evidence to 
support the hypothesis tested. The intestinal epithelial cells remain viable with no 
signs of cell proliferation halted despite exposure to IFN-γ (1000 U/ml) for 6 or 24 h. 
Stx2 and filtered lysate of EHEC O157:H7 did not interfere with the JAK/STAT1 
intracellular signal transduction in epithelial cells. The latter most likely remain 
important as the site for bacterial anchor in establishing colonisation and maintaining 
intestinal barrier integrity, with its proliferating activity remain undisturbed. The 
JAK/STAT1 pathway however is just one of the numerous signalling pathways in 
which Stx-IFN-γ cross signalling might occur, therefore this study shall not limit the 
conclusion based on results obtained. Studies on the toll-like receptors (TLRs) 
particularly on bovine intestinal epithelial cells recently reported TLR4 expression 
by primary bovine colonocytes [513]. Bovine intestinal epithelial cells derived from 
fetal bovine intestinal epithelial cells were also confirmed to strongly express TLR4 
by real time-quantitative polymerase chain reaction (RT-qPCR) and 
immunofluorescence staining. TLR1, 3 and 6 were also significantly expressed by 
the bovine intestinal epithelial cells [514]. TLR4 is mainly associated with detection 
of Gram negative bacteria and initiation of inflammation by the NFκB signalling 
pathway, activated by mitogen-activated protein kinase (MAPK) proteins [515]. 
Further insight on EHEC O157:H7 and TLR4 signalling particularly focusing on Stx 
might be worth considered when studying intestinal epithelial cells response. Chapter 
4 will follow with more information and discussion specifically focusing on Stx and 
Stx-encoding phages of the two bovine strains used in this chapter, in an attempt to 























Chapter 4: Shiga toxin-encoding 
bacteriophages and EHEC O157:H7 















































 The significance of EHEC O157:H7 colonisation at the recto-anal junction 
was linked to super-shedders as these animals, identified to be colonised at the 
terminal rectum, tend to have prolonged colonisation and higher excretion [60, 516, 
517]. The concept of super-shedding for EHEC O157 as described in the discussion 
of the Naylor et al (2003) manuscript on the rectal localization of the organism: ‘One 
hypothesis is that among an E. coli O157:H7-positive group of animals there are a 
small number of "supershedders" that greatly enhance transmission and persistence 
within a herd’ [33]. A "supershedder" refers to an animal that excretes more than 104 
C.F.U. per gram of faces, a phenomenon observed not only in cattle, but in sheep as 
well [60]. This concept of "supershedders"  for EHEC O157:H7 colonisation was 
analysed in a model with findings indicating that the "supershedders" are more likely 
to be associated with PT21/28 strains of EHEC O157:H7, while strains of PT32 were 
more likely to be associated with "non-super-shedders" [64]. Another implication 
from the same study was that preventive measures specifically targeting the 
"supershedders" could most likely reduce the risk of transmission to humans [518].  
 
 In a more recent publication by collaborators working on experimental EHEC 
O157:H7 colonisation of  calves (as described in Chapter 3, Materials and Methods 
section 3.1), the shedding curves from two groups of animals receiving or exposed to 
either EHEC O157:H7 Strain PT21/28 or PT32 (Figure 4.1) were established [384]. 
All of the orally-challenged animals were able to shed at a high rate (>103 C.F.U. 
/gram of faeces). However, the animals orally challenged with Strain 9000 PT21/28 
maintained a longer shedding period (3 to 10 days post-challenge) of >103 
C.F.U./gram than Strain 10671 PT32 (day 3 to 8 days post-challenge). Sentinel 
animals of the PT21/28 group maintained shedding at higher numbers (>103 
C.F.U./gram) throughout the shedding period (10 days), with the highest colony 
count between day 6 and 8. From two of the sentinel animals of group exposed to 
PT32-challenged calves, shedding never exceeded 103 C.F.U./gram in one calf while 
the other sentinel calf shed at >103 CFU/gram only on day 8. These observations 
showed that although both strains were able to effectively colonise the intestine of all 
calves, the calves receiving Strain PT21/28 were able to consistently shed higher 




challenged group. Initial genome sequence screening of Strain 9000 PT21/28 and 
Strain 10671 PT32 showed that these two strains are genetically very similar except 
for the Stx-encoding prophage types possessed. PT21/28 strains usually contain both 
an Stx2a-encoding bacteriophage (ΦStx2a) and an Stx2c-encoding bacteriophage 
(ΦStx2c), while the PT32 strains were predominately ΦStx2c+ only. Although 
further work is needed to fully characterise these Stx-encoding phages, it may be that 
the different Stx prophage contents of PT21/28 and PT32 cattle strains significantly 
contribute to the variations observed in the shedding pattern mentioned above. This 
is supported by further epidemiological analysis [257]. Therefore, the aim of Chapter 
4 is to characterise the colonisation-associated phenotypes of bovine isolated EHEC 
O157:H7 strains (Strain 9000 PT21/28 and Strain 10671 PT32) in order to 
understand the contribution of different Stx-encoding prophages (and combination of 































Figure 4.1 Faecal shedding of EHEC O157:H7 by experimentally 
infected weaned calves, taken from Corbishley et al., 2014 [384]. Each 
group had six calves housed in two separate rooms, four calves in each group were 
orally challenged with EHEC O157:H7 Strain 9000 or Strain 10671. Two calves 



















Figure 4.2 Alignment of the EHEC O157:H7 Strain 9000 (PT21/28) and 
EHEC O157:H7 Strain 10671 (PT32) genomes to EHEC O157:H7 EC4115 
(Stx2a+/Stx2c+) [Image courtesy of Prof. Dr. David Gally, University 
of Edinburgh]. The main difference between PT21/28 and PT32 is the 
presence of Stx2a and Stx2c-encoding genes in PT21/28, while PT32 only 




4.1 Shiga toxin production and cytotoxicity of bovine and 
human associated EHEC O157:H7 strains 
 It will also be important, given one of the overall aims of this thesis research 
(to assign any role of the toxin in bovine intestinal colonisation) to identify if Stx 
production differs between strains with different Stx-prophage repertoires. 
Epidemiological studies strongly suggest that the amount of Stx produced during 
colonisation in the intestine is an important factor for disease severity [107]. 
Expression of Stx2a is considered a key factor associated with more virulent EHEC 
strains, leading to HUS and other severe clinical complications in humans [277]. 
Therefore Stx2a maybe associated with both increased excretion from cattle and 
increased pathology in humans. In the long run, this would provide better 
survivability of PT21/28 and continued propagation as compared to other EHEC 
O157:H7 strains. The relative contribution of the Stx toxin type to other genes 
encoded on the prophages is unknown. Similarly, the levels of Stx in colonised 
animals and even in human patients remains ambiguous, although Stx has been 
quantified from faecal samples of STEC-infected mice, which ranged between 25-
1000 ng/gram of faeces [519]. Efforts to accurately quantify the total Stx produced in 
vivo is regarded as technically impossible at this moment due to the complex nature 
of the intestine. The presence of Stx-encoding prophage combinations within a strain 
[520] is regarded as the main determinant for Stx production, however other factors 
present within the intestine are able to modulate the levels of toxin production such 
as phage sensitive or phage resistant commensal E. coli strains [519, 521] and Shiga 












4.2 The growth and fitness of EHEC O157:H7 in bovine 
terminal rectal mucus 
 The first hypothesis tested in this chapter is that the extra Stx-encoding 
bacteriophage (ΦStx2a) possessed by the EHEC O157:H7 strains of PT21/28 group 
would be able to increase the bacterial fitness and survival at the bovine terminal 
rectum, thereby increasing the rates of shedding and transmission to other animals, as 
compared to the strain with a single Stx-encoding phage, Strain PT32 (ΦStx2c) [256] 
[61, 66]. Part of this hypothesis was based on preliminary evidence from comparison 
of the growth curves of EHEC O157:H7 Strain 9000 PT21/28, Strain 10671 PT32 
and the Stx-phage negative strain, Walla 3 which suggested a shorter doubling time 
for the PT21/28 strain [256]. The presence of the Stx2a-prophage in PT21/28 strain 
is the only known difference that distinguishes PT21/28 and PT32 according to the 
data from initial genome sequencing of these strains and that PT21/28 were shed at a 
higher numbers with an extended time period compared to PT32, led this study to 
speculate for an association to exist between the possession of Stx2a-phage and 
'superior' colonisation-associated traits. This, in addition to the ability to encode two 
Stx types including the most potent Stx type, Stx2a [69, 78, 240, 523] may confer 
further advantage to the PT21/28 strain based on previous findings with regards to 
Stx-nucleolin upregulation [241].  
 
 Moreover, a thorough review on bacterial sialic acid metabolism questioned 
the presence of nanS genes within the Stx-prophage and prophage remnants of S. 
dysenteriae and certain EHEC O157:H7 strains [524]. NanS is an O-acetyl eterase, 
an enzyme required for utilisation of sialic acid that is present in the mucus and was 
shown to be utilised by E. coli [255]. One hypothesis is that certain Stx-prophages 
may result in more efficient use of mucin as an energy substrate by the host 
bacterium; if this was the case then this would provide another example of how Stx-
encoding phages could alter the bacterial host phenotype in order to maintain its 
presence within the genome, which in turn, benefits host survivability. These 
findings and hypotheses justify the use of bovine terminal rectal mucus as growth 




bovine terminal rectal mucus allows direct quantification and comparison in order to 
identify whether a strain is ‘fitter’ in this environment compared to another. This has 
to take into account factors such as phage infection/transfer between the competed 
populations [525]. Previously it was shown that the lambda phages of E. coli were 
able to kill competitor strains within the same environment, however this may only 
remain within the first ten generations. Following that, lysogenisation of the 
susceptible strains would cancel out the advantage of possessing the lambda phage as 
'biological weapon' [526].   
4.3 The binding capacity of EHEC O157:H7 strains 
possessing different Stx-prophages 
  Prior to establishing attachment to the host intestinal epithelial cells, EHEC 
O157:H7 has to overcome the two layers of mucus at the intestine; the thick, loose 
outer layer and the thinner, dense inner layer [527, 528]. Moreover EHEC O157:H7 
also needs to compete with the commensal species already residing in the outer 
mucus layer. StcE, a zinc metalloprotease secreted by EHEC O157:H7, was shown 
to act as a mucin-degrading enzyme thereby facilitating contact and adherence of the 
bacterial cell to the epithelium [529]. As observed by Naylor/Low et al., cattle 
colonised with EHEC O157:H7 generate micro-colonies on the terminal rectal 
mucosa that include actin re-arrangements and condensation associated with typical 
A&E lesions extensively documented for LEE-encoding EPEC and EHEC strains 
[33, 530]. Despite being described as non-invasive, recently it has been shown that 
the terminal rectal epithelial cells can contain EHEC O157:H7 cells intracellularly 
[373]. Intimate bacterial adherence with attaching and effacement lesion on the 
intestinal epithelial cell is a hallmark for the LEE-encoded proteins in establishing 
and maintaining successful colonisation. Other bacterial products could also enhance 
bacterial attachment to the host cells including Shiga toxin 2 [241]. The study 
reported that Stx2 treatment of HEp-2 cells upregulated nucleolin to the site of 
bacterial attachment which resulted in a stronger and more efficient colonisation with 
the nucleolin functioning as another receptor for intimin [241] (as introduced in 
Chapter 2, section 2.4). Whereas lysogenisation of the Stx2-phage in a PT21/28 




intimate attachment [257]. Furthermore, unpublished findings indicated that the 
PT21/28 strain adhered better than the PT32 and Walla 3 strains, which again 
indicates that the bovine-associated strains of the PT21/28 cluster are viewed as 
'superior' compared to other strains missing the Stx2a-prophage. Preliminary data 
from studies with Stx2-producing strains on the binding capacity lead the current 
study to re-examine the adherence of Strain 9000 (PT21/28), Strain 10671 (PT32) 
and in addition, analysis of the adherence of isogenic Stx2-phage mutants to 
eukaryotic cells. Results obtained from the binding assays could then be compared 
with the shedding data (Fig. 4.1) to assess if better adherence leads to higher 
shedding numbers. 
4.4 Assessing the effect of Stx-prophages on the virulence of 
EHEC O157:H7 in a Galleria mellonella infection model   
 Ideally, competition of strains in host colonization could be analysed in cattle 
challenge experiments with mixed inocula and in humans for effects on virulence.  
The former is very expensive and is limited to very specific questions, while the 
latter is ethically not possible.  As such some type of in vivo system/model is 
desirable to examine effects of altering the prophage content with regard to host-
pathogen interactions. Recently, Galleria mellonella, generally known as 
‘waxworms’, has been described as a good model to study pathogenesis as an 
alternative to experiments in mammals [531, 532]. G. mellonella larvae possess 
cellular (phagocytosis, nodulisation and encapsulation) and humoral (melanisation, 
haemolymph clotting and antimicrobial peptides) immune defense mechanisms 
[531]. This larvae infection model has been used to study aspects of virulence and 
innate immune responses following infection with different species of bacteria 
(Pseudomonas aeruginosa, Listeria monocytogenes, Burkholderia pseudomallei) and 
fungi (Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus) 
[533]. Advantages of this infection model includes incubation at 37ºC resembling 
normal body temperature, the ease of administering the infection dose, better 
statistical power of the data as large numbers of larvae can be used at a relatively low 
cost of maintenance. There are relatively simple assays available to assess the 




darkening of the body in response to the infection and/or larvae survival. By 
comparing isogenic pairs of strains with and without Stx-encoding prophages derived 
from Strain 9000 (PT21/28) and Strain 10671 (PT32), this assay could provide 
insights into whether the Stx-phages modulate pathways involved in bacterial 
virulence. 
 
 This chapter focuses on Stx-encoding bacteriophages and EHEC O157:H7 
colonisation and pathogenesis and it should complement the findings from part one 
of this thesis on Shiga toxin activity towards a combined understanding of how strain 
lysogeny with an Stx2-encoding bacteriophage can impact on bacterial growth, 
colonisation and pathogenesis. One could hypothesise that by harbouring both Stx2a- 
and Stx2c-encoding prophages, several advantages are gained, for example strains 
grouped under the PT21/28 cluster could be better colonisers, higher excretion and 
increased virulence following transmission into human hosts. The specific objectives 
for this chapter are: 
 
1. To quantify and compare total Shiga toxin production across EHEC 
O157:H7 strains of bovine and human origin possessing different Stx-
phage types. 
2. To examine the activity of Stx expressed by EHEC O157:H7 strains 
containing different repertoires of Stx-phages (wildtype and natural 
excision variants) under normal and induced conditions. 
3. To investigate if Stx-encoding bacteriophages provide any fitness or 
survival advantage when competed in 10% bovine terminal rectal 
mucus. 
4. To observe if Stx-encoding bacteriophages influence EHEC O157:H7 
binding to eukaryotic cells. 
5. To study if Stx-encoding bacteriophage positive strains are altered for 
virulence compared to their isogenic Stx-phage deletion strains in the  































Table 4.1 List of bacterial strains used in this study 
Strain name used 







(E. coli) O157:H7 
Bovine isolate from the IPRAVE study 
[64], Phage Type 21/28. 
Isolate code WS009000S01E. 
 
Strain 9000 
PT21/28 ΔΦ Stx2c 
E. coli O157:H7 Generated from WS009000S01E by 
partial deletion of phage in sbcB (RH 
junction present). Laboratory stock 
generated by Sean McAteer. 
 
Strain 9000 
PT21/28 ΔΦ Stx2a 
E. coli O157:H7 Generated from WS009000S01E by entire 
deletion of phage in argW. Laboratory 





E. coli O157:H7 Generated from E. coli serotype O157:H7 
Strain 9000 ΔΦ Stx2a by the entire 
deletion of phage in argW. Laboratory 
stock generated by Sean McAteer.  
 
Strain 10671 PT32 
(Φ Stx2c) 
 
E. coli O157:H7 Bovine isolate from the IPRAVE study 
[64], Phage Type 32. 
Isolate code WS0010671S01E. 
 
Strain 10671 PT32 
ΔΦ Stx2c 
 
E. coli O157:H7 Generated from E. coli serotype O157:H7 
Strain 10671 (WS0010671S01E) by the 
entire deletion of phage in sbcB. 






Table 4.1 List of bacterial strains used in this study (Continued). 
Strain name used 
in this study 
Strain Details 
Human Strain 1 
PT21/28 (ΦStx2a/Φ 
Stx2c) 
E. coli O157:H7 
Human isolate of E. coli O157:H7 
provided by Public Health England (Strain 
number 122900512). Phage Type 21/28.  
Human Strain 2 
PT21/28 (ΦStx2a/Φ 
Stx2c) 
E. coli O157:H7 Human isolate of E. coli O157:H7 
provided by Public Health England (Strain 




E. coli O157:H7 E. coli O157:H7 outbreak strain containing 
Sp5 phage, with the stx2A toxin gene 
replaced by a kanamycin cassette 
rendering a defunct Stx production. 
Laboratory stock generated by Sean 
McAteer. 
Sakai ΔSp5 E. coli O157:H7 Derivative of the Sakai outbreak strain 
with the Stx2a-encoding phage, Sp5 









stx2A::kan ΔlacZ  
(K-12-Sp5) 
E. coli K-12 Generated by transduction from Sakai 
stx2A::kan, contains Sp5 phage and with 
deletion of the lacZ gene. Laboratory 
stock generated by Sean McAteer. 
MG1655 NalR KanR   
(MG1655NK) 
 
E. coli K-12 Spontaneous KanR derivative from E. coli 









All of the work on Shiga-toxin producing Escherichia coli (STEC) strains was 
carried out in a Containment Level 3 (CL3) laboratory suite according to the 
guidelines. Subsequent steps of experiments using Shiga-toxigenic filtrates were 
undertaken in Containment Level 2 (CL2) laboratory once the filtrates were verified 
for the absence of live bacteria. Strains were typically cultured overnight at 37°C, 
with shaking (200 R.P.M.) in different culture media as described below for specific 
experiments. 
4.1 Production of culture supernatants  
Single colonies were inoculated into 5 ml of lysogeny broth (LB) broth and 
were incubated for 18 h at 37°C in a shaker incubator at 200 R.P.M. (Innova™ 4000 
Incubator Shaker, New Brunswick Scientific). For CL3 bacterial strains, to prevent 
spillage if the tube breaks during incubation, the culture tubes were placed in a leak-
proof container (similar to the container used to transport bacterial culture), 
cushioned with paper towels to absorb spillage, if any were to occur. All culture 
tubes and direct manipulation procedures of the bacterial cultures were within a 
microbiology safety cabinet unit in the CL3 facility. 
 
The overnight cultures were pelleted at maximum speed, 4°C for 10 min 
(Heraeus Instruments Megafuge 1.0R). Individual culture tubes were placed in 
bucket of suitable size within the microbiology safety cabinet unit and sealed with 
the bucket cover that was then disinfected with 70% ethanol before transferring the 
buckets into the centrifuge. At the end of the spin, the buckets were carefully lifted 
out from the rotor and carried into the microbiology safety cabinet unit for further 
procedure. Supernatants were filter-sterilised (Millex® GV-syringe filter unit 
membrane, pore size 0.22 µm, Merck Millipore) and a loopful of it was spread onto 
an LB agar plate for verification of ‘zero live bacterial cell’ presence inside the 
filtered-supernatant. The filtered-supernatants were stored at -20°C for at least 24 h 
(i.e. the time frame to observe any growth on the incubated LB agar plate) or until 
use.  
The same protocol was adopted for bacterial strains grown in 10% bovine 




were obtained from five calves used as control animals in an animal challenge 
experiment at the Moredun Research Institute (MRI). Briefly, terminal rectal tissue 
was obtained from the animals during post-mortem at the MRI, immersed in 
Polymyxin B sulfate (Sigma), diluted 2 mg/ml in normal saline for 30 min in a 150 
ml polystyrene straight-sided metal cap container (Starlab) and transferred to the 
post-mortem room at the Royal (Dick) Veterinary School, Easter Bush campus. The 
mucus layer was then scraped using glass slide into a clean, labelled 50 mL 
polysterene tube with screw cap before stored in a -20°C freezer at the Roslin 
Institute. Prior to use, the mucus samples were thawed at room temperature before 
preparing the diluted form (10% mucus in sterile distilled water) for further use in 
the experiments in this chapter. 
 
To generate Mitomycin C (MMC)-induced bacterial lysates in LB broth, 50 µl 
of the overnight culture was diluted in 5 ml of sterile LB broth and incubated at 
37°C, 200 R.P.M. until the optical density (O.D.) 600nm readings (Ultraspec 10 Cell 
Density Meter, Amersham Biosciences) reached 0.2 - 0.25. 10 µg/ml of MMC was 
added into each bacterial culture and was further incubated in the dark at 37°C, 200 
R.P.M. for 18 h. The overnight MMC-induced lysate were then filter-sterilised as 
described for the non-induced cultures. 
4.2 Shiga toxin ELISA 
The total Shiga toxin (Stx) present in the culture supernatants and lysates were 
measured using a commercial ELISA kit according to the manufacturer’s instructions 
(RIDASCREEN® Verotoxin ELISA, R-Biopharm AG, Darmstadt, Germany). 
Samples were used for ELISA prior to the Verocytotoxicity assay to verify the 
presence of Stx in samples. Inactivated Stxs serve as the positive control for this 
assay which was supplied by the manufacturer. The negative controls used were 
either 10% bovine terminal rectal mucus or LB, depending on sample type (mucus or 
LB-grown bacterial culture). The results were read at O.D. 450nm and were plotted 





4.3 Verocytotoxicity assay 
The African green monkey cells also known as the Vero cells express the Stx 
receptor, Globotriaosylceramide (Gb3) and therefore have been widely used to test 
the toxic effects of Stx. Vero cells used in this work were obtained from the Leibniz 
Institute DSMZ-German Collection of Microorganisms and Cell Cultures 
(Braunschweig, Germany). The cells were seeded in 96-multi-well plates at a rate of 
1 x 10 5 cells/well and incubated at 37°C with 5% CO2 until confluent. On the day of 
challenge, the spent media were removed from the wells and the EHEC O157:H7-
filter-sterilised culture supernatants, diluted 1:100 in Roswell Park Memorial 
Institute (RPMI) 1640 medium were added to the Vero cells. 0.2% Triton™X-100 
(Sigma-Aldrich) and LB broth both diluted in RPMI 1640 served as positive and 
negative controls respectively. Another set of Vero cells received RPMI 1640 only as 
another negative control. All treatments were carried out in triplicate and the assay 
was repeated at least three times with different batches of culture 
supernatants/lysates. The cells were placed in the incubator at 37°C, 5% CO2 for a 
maximum of 72 h. Daily checks of the cells were performed by observing the cells 
under light microscopy to determine if the cells were already responding to the toxin. 
After 72 h, the toxin containing serum-free media was discarded and the cells were 
gently washed in pre-warmed PBS (37°C) once.  
 
65 µl of 2% formalin in PBS was added to each well for 1 min at room 
temperature to fix the cells. The fixative was replaced with 65 µl/well of crystal 
violet tissue culture stain (52 ml of 0.5% crystal violet (Sigma), 10 ml of absolute 
ethanol, 10.8 ml of 37% formaldehyde and 127.2 ml of PBS) and incubated at room 
temperature for 24 h. The fixed cells were then washed gently with distilled water 
until the water appeared clear and were air-dried. The plate was scanned for visual 
record. 100 µl of 10% acetic acid was added per well and the plate was placed on an 
orbital shaker for 15 min at room temperature to dissolve the crystal violet stain. The 
values of absorption at O.D. 595nm were obtained using a plate-reader (FLUOstar 





4.4 Growth competition assay 
To observe if a strain possessing фStx2 is more competitive than a strain 
without the фStx2, growth competition assay were carried out in 10% bovine 
terminal rectal mucus (BTRM) diluted in sterile water. This growth medium was 
chosen to mimic as close as possible the environment from where the bacteria are 
mainly present in the bovine host, as opposed to growing in an artificial growth 
media such as LB broth or M9 medium.  
 
Each of the paired of EHEC O157:H7 strains to be competed were separately 
inoculated in 10% BTRM overnight and incubated at 37°C with shaking (200 
R.P.M.). One of each pair of competed strains was ensured to be Naladixic acid 
resistant (NalR); either readily available from the ZAP laboratory freezer stock or 
resistance was generated by growing on LB agar containing Naladixic acid (15 
µg/ml) and sub-culturing colonies developing resistance towards Naladixic acid 
again on LB-Nal agar plates. The overnight cultures of the paired strains to be 
competed were then diluted 10-4 together in 1ml of fresh 10% BTRM. The co-
cultures were then left at 37°C, 200 R.P.M. for 24 h. At the end of the 24 h, 10 µl of 
the co-culture was then diluted in 1 ml of fresh 10% BTRM. The 24-hour-co-culture 
was also diluted in a 10-fold dilution series in PBS before spreading on Cefixime and 
Tellurite-Sorbitol MacConkey (CT-SMAC) plates. The CT-SMAC plates were 
incubated at 37°C for 18 h. From the colonies growing on the CT-SMAC plates, 100 
single colonies were then picked and patched onto a selective agar plate, Luria-
Bertani agar supplemented with 15 µg/ml Naladixic acid (LB-Nal). The LB-Nal 
plates were then incubated at 37°C overnight before the proportions of each 
compared strain were counted and compared. This procedure was continued for at 
least 72 -120 h (with approximately 13 generations of bacteria per 24 h).  
 
The protocol described was similarly used for growth competition assays 
involving other competed paired strains (E. coli MG1655NK and E. coli K-12-SP5, 
E. coli O157:H7 strain Sakai stx2A::kan and E. coli O157:H7 strain Sakai ΔSP5), 
with the selective LB agar plates supplemented with Kanamycin at (50 µg/ml). In 




cultures were initially plated out on LB-Naladixic acid and CT-SMAC agar plates 
respectively, to prevent background growth of other organisms present in the mucus 
samples.  
 
For growth competition assays involving E. coli MG1655NK and E. coli K-12-
SP5 strains, the co-culture was initially spread on LB-Naladixic acid to prevent 
background growth in the mucus sample, and were then picked and patched 
simultaneously on LB-Kanamycin agar plates and 1% lactose-MacConkey agar 
plates.  The latter agar plate was used to check if any lysogenisation of the 
susceptible bacterial cells (E .coli MG1655NK) by the free Sp5 phage released from 
lysed E. coli K-12-SP5 occurred throughout the co-culture period. 
 
All steps involving Stx positive strains were performed in the CL3 laboratory 
suite and handling of the CL3 bacterial strains was carried out according to defined 
rules and regulations, for example placing cultures in a second leak-proof container 
and proper handling of culture tubes before and after centrifugation. 
 
The results are presented as stacked bar plots across the time of co-culture and 
statistically analysed in GraphPad Prism 6 (GraphPad Software, Inc., La Jolla, CA, 
USA) using multiple t-tests for each time point, with Holm-Sidak method, assuming 
that all rows were sampled from populations with similar scatter. 
4.5 Bacterial adherence assay 
Gb3 expressing HeLa cells were used to evaluate the binding potential of 
bacteria to an epithelial cell line, while the Embryonic Bovine Lung (EBL) cells 
were used to compare the binding potential of different mucus-grown Stx2-phage 
types-containing EHEC O157:H7 strains to Gb3-negative epithelial-like cells. The 
cells were seeded at 1 x 105 cells/ml in 24-multi-well plates and incubated at 37°C 
with 5% CO2 until reaching full confluence.  
 
EHEC O157:H7 IPRAVE Strain 9000, Strain 10671, Strain 9000 




200 R.P.M. for 18 h. The cultures were diluted 1:100 in fresh 10% BTRM and were 
further incubated for approximately 2.5 h at 37°C, 200 R.P.M. to generate cultures at 
the exponential phase [256].  
 
Prior to cell infection, the spent cell media were removed from the wells, the 
cells washed once in PBS before 100 µl/well of 10% BTRM were added to the cells. 
450 µl of the exponential-phase bacterial cultures (multiplicity of infection (M.O.I.) 
of approximately 10 bacteria to 1 epithelial cell) were then added to each well 
accordingly, in triplicate. Three wells that did not receive any bacterial challenge 
served as controls to ensure that the eukaryotic cell line remained viable in 10% 
BTRM throughout the infection period. 
 
Infected cells were incubated at 37°C with 5% CO2 for 30 min. This 30 min 
time point was chosen based on the optimisation process by a previous study [256]. 
Any incubation time beyond 30 min will kill most of the epithelial cells in the 
culture. The plates were covered with an adhesive plate seal with pores before 
placing the plate cover on top and to prevent spillage of the bacterial cultures during 
transporting the plate to and from the microbiology safety unit, the plate was then 
placed into a leak-proof container (polystyrene container of appropriate size).  
 
At the end of challenge time, the 10% BTRM with bacteria were removed and 
the cells were washed in PBS twice. Then, 250 µl of 0.2% of Triton™X-100 (Sigma-
Aldrich) in PBS were added to all wells and incubated at 37°C, 5% CO2 for 10 min 
to dissociate the bacterial-bound cells from the surface of the wells. To harvest the 
bacterial-bound cells, another 250 µl of 0.2% Triton™X-100 (Sigma-Aldrich) were 
added to the set of triplicates and using a pipette tip, the bottom of the wells were 
scratched to remove the cells from the wells, avoiding froth formation. The cell 
suspension was transferred from the first well to the second and to the third well 
cumulatively before collecting all in a 1.5 ml screw-cap tube.  
 
The pooled bacterial-bound cell suspensions were serially diluted (10-fold) and 




incubated at 37°C for 18 h before counting the colonies present on the plate. Results 
are presented as individual dot plots, each dot represents the percentage of binding, 
normalised to the total number of bacteria added from independently repeated 
experiments with technical replicates of three and analysed in GraphPad Prism 6 
(GraphPad Software, Inc. USA).  The normalised percentage of binding were 
analysed using the Friedman test of repeated one-way ANOVA. 
4.6 Immunofluorescence staining for H7 and EspA (T3SS 
effectors)  
 Bacterial strains were grown as described for bacterial binding assay and 
fixed in 4% (volume/volume) paraformaldehyde (PFA). After verifying no live 
bacterial cell present, the fixed cultures were given to Dr. Amin Tahoun to be 
processed for immunofluorescence staining with primary antibodies [mouse 
monoclonal anti-O157 IgG (Mast Assure), 1:100, rabbit polyclonal anti-H7 IgG 
(Abcam) 1:1000 and mouse monoclonal anti-EspA [534], 1:100], and secondary 
conjugated antibodies [anti-mouse IgG-Alexa Fluor® 568 (Molecular Probes), anti-
rabbit IgG-FITC (R&D Systems) and anti-mouse IgG-FITC (R&D Systems); all 
1:1000]. Examination of the cultures by confocal microscope were performed by Dr. 
Amin Tahoun and he has given his consent to show the images in the Results section. 
These immuno-stained bacterial cells will help determine if there is any significant 
difference in the expression of the bacterial factors potentially playing a role in 
binding within the bacterial binding assay time frame. 
4.7 Western blotting for H7 and EspD (T3SS effectors)  
EHEC O157:H7 IPRAVE strains 9000, 10671 and their Stx2-phage mutants 
were grown under the same conditions as described above in the experimental 
method for bacterial adherence assay. Another tube containing the same volume of 
10% mucus was also incubated under the same conditions to serve as a background 
control. At the end of the 2.5 h incubation at 37°C with shaking at 200 R.P.M., the 
cultures were pelleted at high speed (4300 R.C.F) for 10 min at 4°C before decanting 




centrifuged again before gently pipetting out the PBS-supernatant, ensuring the pellet 
was left undisturbed. The pellet was again re-suspended in PBS, the O.D. 600nm 
measured to ensure similar pellet concentration, centrifuged and re-suspended in 250 
µl of PBS and 250 µl of sample buffer (Laemmli buffer, Sigma) before incubating it 
at 100°C for 10 min. The extra washing steps were done to reduce any background 
proteins that might interfere with the Western blot process, due to the nature of the 
sample cultured in 10% mucus. The bacterial lysate was then stored at -20°C until 
completion of the verification step, as described above to ensure no live bacterial 
cells were present within the lysate since the next steps were carried out in the CL2 
laboratory.  
 
Another set of cultures were grown under conditions previously shown by Xu, 
et al. [257] to induce the expression of the type three secretion system (T3SS) in 
EHEC O157:H7 strains. Briefly, all of the strains examined were grown in MEM-
HEPES for 18 h, 200 R.P.M. at 37°C. The cultures were then diluted 1:100 in fresh 
MEM-HEPES medium and re-incubated under similar conditions but for 2.5 h until 
the OD600 nm readings reached 0.8. At this point of time, the bacterial cells should be 
expressing components of the T3SS. The bacterial cultures were then processed to 
produce filtered bacterial lysate as described above. 
 
Protein concentration was estimated with the Direct Detect™ IR Spectrometer 
system (Merck Millipore) (described in detail under Section 3.12 in the Materials 
and Methods section for Chapter 3). Once the amount to be loaded per lane per 
sample was calculated, samples were loaded into wells of the SDS-PAGE gel (4% 
stacking gel, 10% resolving gel). The clamping frame with the glass plates holding 
the gels were placed inside the running chamber. Electrode buffer (1X) was poured 
into the space inside the running chamber up to the appropriate levels (2 or 4 gels) 
and the lid was properly placed to close the chamber. The colour-coded electrodes 
were fixed into the power supply and set to run at 130Volt, for 80 min. The gels were 
then soaked in transfer buffer (refer Section 3.14, Materials and Methods section in 
Chapter 3) as well as the nitrocellulose membrane and thick blot papers for at least 




Transfer Cell (Bio-Rad) in the order of thick blot paper, nitrocellulose membrane, gel 
and thick blot paper, at 15 V, 0.7 h with limit set at 0.6. 
 
At the end of the transfer process, the nitrocellulose membranes were stained 
with the reversible Ponceau stain to check for successful protein transfer (visualised 
as separate lines in lanes corresponding to each lane with protein sample). The 
membranes were washed with distilled water to remove the stain and immediately 
placed in blocking buffer (2.5% skimmed milk powder in 0.1% PBS-Tween 20) for 
an hour, room temperature, shaking (20 Rev/min, Platform Shaker STRG). The 
nitrocellulose membranes were then washed in 0.1% PBS-T (two quick rinses, one 
10 min wash followed by two times of 5 min washes). This was followed with 
incubation in primary antibody diluted in 5% skimmed milk powder and 0.1% PBS-
Tween 20 [mouse anti-RecA (Stressgen/Enzo Life Sciences) at 1:5000 and mouse 
monoclonal anti-EspD [535] at 1:3000] at 4°C, overnight, on an orbital shaker. The 
membranes were washed in 0.1% PBS-Tween 20 (two quick rinses, followed by a 30 
min wash and two times 5 min washes). Secondary antibody (anti-mouse 
Horseradish Peroxidase, Dako, Cambridge, United Kingdom) diluted at 1:1000 in 
5% skimmed milk powder and 0.1% PBS-Tween20 was added to the membranes for 
an hour at room temperature, shaking (20 Rev/min). Washing steps were as 
described following primary antibody incubation with the addition of two more 5 
min washes.  
 
An equal amount of the Supersignal West Pico Chemiluminescent substrates 
(Thermo Scientific) were added onto the surface of the nitrocellulose membranes 
(approximately 1 ml per 8cm x 15cm membrane), incubated at room temperature for 
5 min. The excess detection reagent was drained off and the nitrocellulose 
membranes were placed in between two acetate sheets. Detection was subsequently 
done with radiograph developer and the G-box chemiluminescence detection system.  
4.8 Galleria mellonella larvae killing assay 
The G. mellonella moth larvae killing assay was used as an infection model to 




overnight, at 37°C, shaking at 200 R.P.M. The overnight cultures were then pelleted 
at speed 4300, 10 min at 4°C and washed twice in PBS. The O.D. 600nm of the 
cultures were adjusted to 0.1 in Dulbecco’s Phosphate Buffer Saline (DPBS, Life 
Technologies 14190-094). 10 µl of the re-suspended cultures were injected into each 
larva, directly into the posterior segment of the body using a 10 µl Hamilton Syringe, 
point style 5, needle 25 gauge. Larvae used weighed between 0.25-0.30 grams and 
each treatment group contained 20 larvae. The control groups received DPBS or 
nothing. The larvae were incubated at 37°C, with 5% CO2. The number of dead 
larvae was counted at 18, 24, 48, 72, 96 h and for some experiments 120 h post 
challenge. Survival analyses were plotted and analysed in GraphPad Prism Version 
6.0 to compare the trends of different survival curves using the Log-rank (Mantel-
Cox) test. For analyses with significantly different survival trends, multiple pairwise 
comparisons were done with a corrected p-value threshold based on the Bonferroni 
method; 
!"#$%&&"#'!!"##$!%$&!!ℎ!"#ℎ!"# = !.!"! , 
where K equals to the total number of pairwise comparisons made. 
 
The median and median ratio (with 95% confidence limits) for pairwise comparison 
























































 This section presents results obtained from a series of phenotypic assays 
carried out with EHEC O157:H7 strains of bovine origin (Strain 9000 and Strain 
10671), along with isogenic mutants (Strain 9000 ΔΦStx2a, Strain 9000ΔΦStx2c, 
Strain 9000ΔΦStx2a/ΦStx2c, Strain 10671ΔΦStx2c). For Shiga toxin ELISA and 
Verocytotoxicity assays, two human isolates of EHEC O157:H7 belonging to the 
Phage Type 21/28 (PT21/28) cluster were also tested side by side with the bovine 
strains. Three types of growth media were used, the first was 10% bovine terminal 
rectal mucus (BTRM) which should provide the bacteria with nutrients similar to 
those found at its main colonisation site.  The two other laboratory growth conditions 
were LB and LB supplemented with Mitomycin C (MMC) to induce the bacterial 
SOS response and lysis, therefore allowing induced levels of Shiga toxin to be 
assessed.  
4.1 Shiga toxin levels detected by ELISA from different 
growth conditions 
4.1.1 Bovine-isolated strains 
 Overall, the bovine terminal rectal mucus does not provide an environment in 
favour of Shiga toxin production as seen in Fig. 4.1a. In lysogeny broth (LB)-
cultured bacteria, both of the wild type bovine-originating strains produced relatively 
more toxin than the phage-deleted derivatives (Fig. 4.1b). The difference between the 
wild type and the Stx-phage-mutant strains was more evident from the results of 
experiments where the strains were grown in LB, supplemented with Mitomycin C 
(Fig. 4.1c). An important finding was that the capacity of EHEC O157:H7 strain 
9000 ΔΦStx2a to produce toxin seemed equivalent to the parental strain. In line with 
this, EHEC O157:H7 strain 9000 ΔΦStx2c failed to produce detectable levels of 
toxin despite possessing ΦStx2a. As anticipated the double Stx phage deletion of 
strain 9000 had no detectable Stx activity, indicating that all the activity was derived 
from the Stx2c. To reaffirm the lack in Stx production by EHEC O157:H7 Strain 
9000 Stx2c, four clones of this strain were examined for Stx production with 











Figure 4.1 ELISA detection of Stx expressed by EHEC O157:H7 in 
different culture media (bovine-isolated strains). Bar plots represent the 
absorptive values at O.D. 450nm indicating the levels of Shiga toxin detected in 
the supernatants of bacterial cultures grown in (a) 10% bovine terminal rectal 
mucus, (b) LB and (c) LB with MMC (10 µg/ml ). The positive control (black) 








































4.1.2 Comparison of Stx production between bovine and 
human-isolated strains 
 The bovine strains were also compared with two human isolates for 
production of Stx by ELISA; EHEC O157:H7 Strain number 122900512 (Human 
Strain 1, Phage Type 21/28) and EHEC O157:H7 Strain number 132020426 (Human 
Strain 2; Phage Type 21/28) (Fig. 4.2). Fig. 4.2a presents the results for the strains 
cultured in LB while Fig. 4.2b shows total Stx levels when bacterial strains were 
cultured in LB with Mitomycin C-induction (10 µg/ml). In both bar plots, the total 
Stx levels for the human strains were higher (6.5 fold) compared with the bovine 
EHEC O157:H7 Strain 9000 (belonging to the Phage Type 21/28 cluster). The 
induced levels for the bovine strains observed in Fig. 4.2b agree with the results from 
Fig. 4.1c. 
 
 One-way ANOVA of LB-cultured strains revealed that the level of total Stx 
present was statistically significant as a function of bacterial strain with F (8, 9) = 
52.56, p-value<0.0001. Post-hoc Sidak’s multiple comparison tests identified 
statistically different levels of Stx between both bovine Strain 9000 and Strain 10671 
with the two human isolates (all p-values <0.0001). Similar analyses were carried out 
with datasets from the MMC-induced cultures revealing significant differences 
between the Stx levels of all bacterial strains tested (F=36.20 (8, 9), p-value<0.0001). 
Multiple comparisons with Sidak’s correction found that all strains compared were 
statistically significant when analysed pairwise (p=value<0.05) except for 






















Figure 4.2 ELISA detection of Stx production by EHEC O157:H7 in 
different culture media (bovine-associated compared with human-
isolated strains). Bar plots represent the absorptive values at O.D. 450nm 
indicating the levels of Shiga toxin detected in the supernatants of bacterial cultures 
grown in (a) LB and (b) LB with MMC (10 µg/ml). Error bars indicate the standard 
error of the mean (S.E.M.) from two experiments. Data were analysed by One-way 
ANOVA followed by post-hoc multiple comparison (pairwise) with Sidak's correction 
(p<0.05 *). The positive control (black) comprised of inactivated Stxs supplied by the 




4.2 Verocytotoxicity assay  
Besides testing bacterial culture supernatants for total Shiga toxin (Stx) by 
ELISA, the samples were also tested for their toxicity on Vero cells. The extra step 
of testing the capacity to kill Vero cells was based on previous findings in the 
laboratory for which it was demonstrated that ELISA is not as sensitive as this 
activity-based assay. This also provides an opportunity to compare the relative 
toxicity and Stx production levels among the strains. Vero cells have been routinely 
used to assess Stx toxicity and are known to be highly sensitive to Stx even at very 
low levels of the toxin, therefore providing further insight into Stx activity. Results 
obtained were initially captured in the form of absorption values at O.D. 595nm, 
based on cell viability and these values were then transformed into a percentage of 
killed Vero cells based on positive (0.2% Triton-X100) and negative (RPMI 1640 
medium) control values. 
4.2.1 EHEC O157:H7 strains grown in 10% bovine terminal 
rectal mucus 
 Following negative detection of total Stx by ELISA described earlier for 
cultures grown in 10% BTRM, the toxicity levels on Vero cells compiled from four 
independent experiments are shown in Fig. 4.3a for EHEC O157:H7 Strain 9000 and 
two of its single Stx-phage mutants, together with Strain 10671. Differences in the 
toxicity levels towards Vero cells among the strains tested were observed, with 
Strain 10671 killing the highest percentage (13.04%) of cells followed by Strain 
9000 (6.18%) and Strain 9000ΔΦStx2a (5.68%). Strain 9000ΔΦStx2c (1.75%) was 
not toxic for the Vero cells, with values similar to that of the negative control (RPMI 
1640 medium) (1.42%). These differences were not statistically significant when the 
means of different strains were compared by one-way ANOVA [F (4, 15) = 2.027, p-
value=0.1421], reflecting the variation between experiments. However, it must be 
noted that these different levels do agree with the ELISA data (Fig. 4.1a), with strain 





 Another Verocytotoxicity assay was carried out for the EHEC O157:H7 
strains isolated from cattle, with the testing of four clones of the single Stx2c-phage 
mutant (Strain 9000ΔΦStx2c) to confirm the results obtained in Fig. 4.3a for which 
this strain did not kill Vero cells raising the possibility that there was no Stx in the 
mucus culture. The results, as shown in Fig. 4.3b, appeared similar to those observed 
in Fig. 4.3a. Interestingly, all clones of Strain 9000ΔΦStx2c (with the exception of 
clone 3) failed to induced toxicity on Vero cells beyond the negative control values. 
Clone 3 of Strain 9000ΔΦStx2c and Strain 10671ΔΦStx2c both had low percentages 
of Vero cell killing (8.93% and 8.40%, respectively). EHEC O157:H7 Strain 9000, 
Strain 10671 and Strain 9000ΔΦStx2a all had comparable Verocytotoxicity levels 
(34.18%, 39.78% and 43.73%, respectively). Statistical analysis was not performed 












































Figure 4.3 The toxicity of mucus-cultured EHEC O157:H7 filtered 
supernatants to Vero cells. (a) The mean (n=4) and standard error of the mean 
(S.E.M.) of total dead Vero cells (%) at the end of the 72 h incubation in filtered 
supernatants of EHEC O157:H7 (diluted 1:100 in RPMI 1640) at 37°C, 5% CO2. (b) 
Dead Vero cells (%) of a single verotoxicity assay comparing bovine EHEC 
O157:H7 isolates with different combinations of isogenic stx phage mutants. All data 
presented were generated by transforming the absorptive values of the crystal violet 
staining (viable cells) at O.D. 595nm to percentages of dead cells, based on the 






4.2.2 Toxicity assays for EHEC O157:H7 strains cultured in 
lysogeny broth (LB)  
 In order to compare Shiga toxin (Stx) production in 10% bovine terminal 
rectal mucus (BTRM) with laboratory growth media, Verocytotoxicity assay were 
performed with culture supernatants of bovine EHEC O157:H7 strains cultured in 
LB (37°C, with shaking). The bar plots shown in Fig. 4.4a was generated from 
results compiled from four independent repeats. Again, the toxicity levels of LB-
cultured strains resemble the results obtained for EHEC O157:H7 strains grown in 
10% BTRM (Fig. 4.3). One-way ANOVA analysis of the data, however failed to 
support any significant differences among the mean of all samples compared [F (4, 
15) = 0.7278, p-value=0.5867]. 
 
 The toxicity levels of LB-grown culture supernatants from EHEC O157:H7 
bovine strains to Vero cells were tested again as in Fig. 4.4b, with the addition of 
four clones of EHEC O157:H7 Strain 9000ΔΦStx2c. It is apparent that all clones of 
Strain 9000 ΔΦStx2c failed to kill the Vero cells with results comparable to that of 
the Stx-phage negative strains (Strain 9000ΔΦStx2a/ΦStx2c and Strain 
10671ΔΦStx2c). Strain 9000, Strain 10671 and Strain 9000ΔΦStx2a were all highly 
toxic to the Vero cells tested. No statistical test was used to analyse this particular 



























Figure 4.4 The toxicity of LB-cultured EHEC O157:H7 filtered 
supernatants to Vero cells. (a) The mean (n=4) and standard error of the mean 
(S.E.M.) of total dead Vero cells (%) at the end of the 72 h incubation in filtered 
supernatants of EHEC O157:H7 (diluted 1:100 in RPMI 1640) at 37°C, 5% CO2. (b) 
Dead Vero cells (%) of a single verotoxicity assay comparing bovine EHEC 
O157:H7 isolates with different combinations of isogenic stx phage mutants. All data 
presented were generated by transforming the absorptive values of the crystal violet 
staining (viable cells) at O.D. 595nm to percentages of dead cells, based on the 









4.2.3 Toxicity of EHEC O157:H7 strains cultured in lysogeny 
broth (LB) supplemented with Mitomycin C (MMC) 
 To further assess the maximal capacity for the bovine EHEC O157:H7 strains 
to produce Shiga toxin, Verocytotoxicity assays were carried out. The bacterial 
strains were grown overnight in LB, diluted and then supplemented with Mitomycin 
C to induce DNA damage along with the SOS response in bacterial cells that later 
leads to a generation and release of Shiga toxins and phage particles.  
 
 Fig. 4.5a provides results generated from three independent experiments 
involving cultures of EHEC O157:H7 Strain 9000, Strain 10671 and the two single 
Stx-phage isogenic mutants of Strain 9000. Analysis of variance showed that the 
cytotoxicity effect on Vero cells was dependent on which bacterial strain produces 
the culture supernatant incubated with the Vero cells, [F(4,10)=14.46, p-
value=0.0004]. Post-hoc Tukey’s test (p-value 0.05) showed that the toxicity of 
Strain 9000, Strain 10671 and Strain 9000 Stx2c were significantly higher than 
Strain 9000ΔΦStx2c. Strain 9000Stx2a induced the highest toxicity among all 
strains compared, however statistical analysis did not  reveal significant results when 
compared against Strain 9000 and Strain 10671.    
 
 Another Verocytotoxicity assay was carried out with MMC-induced bovine 
strains, with the addition of four clones of Strain 9000ΔΦStx2c (Fig. 4.5b). In this 
particular experiment, all of the strains with at least one Stx-phage produced very 
high levels of Shiga toxin, with the exception of all clones of Strain 9000ΔΦStx2c. 
With growth conditions optimised to generate high levels of Stx, the failure to 
produce toxicity in Vero cells receiving the filtered lysate preparation from Strain 
9000ΔΦStx2c strongly suggest for the absence of Stx2a production despite the strain 


















Figure 4.5 The toxicity of MMC-induced LB-cultured EHEC O157:H7 
filtered supernatants to Vero cells. (a) The mean (n=4) and standard error of 
the mean (S.E.M.) of total dead Vero cells (%) at the end of the 72 h incubation in 
filtered supernatants of EHEC O157:H7 (diluted 1:100 in RPMI 1640) at 37°C, 5% 
CO2. (b) Dead Vero cells (%) of a single verotoxicity assay comparing bovine EHEC 
O157:H7 isolates with different combinations of isogenic stx phage mutants. All data 
presented were generated by transforming the absorptive values of the crystal violet 
staining (viable cells) at O.D. 595nm to percentages of dead cells, based on the 






4.2.4 Verocytotoxicity levels of bovine and human strains of 
EHEC O157:H7 in lysogeny broth (LB) under non-induced 
and induced culture conditions 
 Apart from making comparisons of Shiga toxin production and activity 
among bovine-originated EHEC O157:H7 strains, Verocytotoxicity levels were also 
tested for two human isolates of EHEC O157:H7 belonging to the Phage Type 21/28 
cluster. All strains were cultured overnight in LB broth with or without Mitomycin C 
(MMC) induction, before being filtered and added to the Vero cells.  
 
 The toxicity level towards Vero cells for EHEC O157:H7 strains grown in 
LB are as presented in Fig. 4.6a. It is clear that the two human-origin strains were 
highly toxic to the Vero cells, at levels by comparison to the bovine strains. The 
mean (n=2) percentage of dead Vero cells for Human PT21/28 (122900512) was 
28.47% (S.E. =2.8), Human PT21/28 (132020426) was 17.85% (S.E. =8.6), while 
bovine Strain 9000 was 0.41% (S.E. =0.41) and the rest of the bovine strains 
compared did not kill the Vero cells tested. One-way ANOVA of the datasets of 
Vero cells receiving non-induced cultures (Fig. 4.6a) showed that the toxicity levels 
on Vero cells were significantly different depending on the strain supernatant used F 
(8, 9) =12.07 (p-value<0.001). Holm-Sidak’s multiple comparison tests identified 
significant mean differences when the human isolates when compared to both of the 
bovine wild-type strains (p-value <0.05). 
 
 Following MMC-induction, the filtered lysates for all strains carrying at least 
one Stx2-phage were able to kill at least 20% of the Vero cells (Fig. 4.6b). The 
highest average (n=2) in Vero cell killing was recorded for both of the human 
isolates, Strain 122900512 (mean=78.8%, S.E. =3.0) and Strain 132020426 
(mean=78.7%, S.E. =1.5). EHEC O157:H7 Strain 9000ΔΦStx2a killed 62.3% (S.E. 
=1.9) of the Vero cells receiving its filtered lysate, while the lysate from another 
isogenic of Strain 9000, the single Stx2c-phage mutant were not toxic. The rest of the 
strains not possessing any Stx2a or Stx2c-phage were only able to kill less than 7% 




induced-cultures (Fig. 4.6b) resulted in highly significant differences among the 
toxicity levels of all strains compared, F (8,9)=88.53 (p-value <0.0001). Post-hoc 
Holm-Sidak’s test strongly suggest significant differences (p-value<0.005) for both 
of the human isolates than the rest of the strains. Moreover, Strain 9000ΔΦStx2a had 
significantly higher toxic levels than Strain 9000 and Strain 10671 (p-value<0.05). 
Lysates of strain 10671 were significantly higher than Strain 9000, while Strain 9000 
induced significantly higher toxicity than Strain 9000ΔΦStx2c and two of its Stx-



















































Figure 4.6 Comparison of the toxicity of bovine and human isolated 
EHEC O157:H7 strains to Vero cells. The mean of the percentage of dead 
Vero cells at the end of the 72 h incubation in filtered supernatants of (a) LB-
cultured and (b) MMC-induced LB culture of EHEC O157:H7 (diluted 1:100 in RPMI 
1640 medium) at 37°C, CO2. The data presented were generated by transforming 
the absorptive values of the crystal violet staining (viable cells) at O.D. 595nm to 
percentages of dead cells, based on the positive (0.2% Triton-X100) and negative 





4.3 Growth Competition Assay 
4.3.1 Pairwise comparison of E. coli strains in 10% bovine 
terminal rectal mucus (BTRM) 
 The aim of this series of experiments was to determine if the presence or 
absence of Stx2-encoding bacteriophages resulted in competitive advantage or 
disadvantage under the culture conditions used. 
4.3.1.1 E. coli MG1655NK and E. coli K-12-Sp5 stx2A::kan (K-12-Sp5) 
 After 192 h of co-culture, the K-12-Sp5 strain (despite possessing Sp5 phage, 
this strain is unable to produce Stx as the stx genes were removed and replaced with 
kanamycin resistance cassette) were able to outgrow the Stx phage-susceptible 
MG1655NK strain (Fig. 4.7, Table 4.1). This was an interesting outcome since the  
number of K-12-Sp5 cells recorded dropped progressively between 24 to 72 h of the 
competition. This was then followed by a sudden surge in the K-12-Sp5 population 
at 96 h co-culture. When the colonies from the selective plate were competed again 
(120 h- 192 h) the growth advantage was again clearly observed for the K-12 strain 
containing the Stx2 prophage, Sp5 (K-12-Sp5).  
4.3.1.2 E. coli MG1655NK and E. coli K-12-Sp5 stx2A::kan ΔlacZ (K-12-
Sp5) 
 Following the results obtained from competing the MG1655NK and K-12-
Sp5 pair, the next step was to see if the rise in the strain possessing Sp5 was due to 
an increase in the susceptible MG1655NK strain lysogenized with the Sp5 phage. 
Bacterial co-culture of E. coli MG1655NK and K-12-Sp5 was significantly 
dominated by Sp5-positive cells at all time points following the first 24 h of 
incubation (Fig. 4.8). All colonies growing on the kanamycin plate (Sp5+) were then 
tracked for the ability to ferment lactose, with the proportion of lactose-fermenting, 
kanamycin resistant strains identified as the Sp5-lysogenised MG1655 (MG1655NK-
Sp5) cells. However, as presented in Fig. 4.8 and Table 4.2, the results seems to be 

































Figure 4.7 Competitive growth assay between E. coli MG1655NK and E. 
coli K-12-Sp5 in 10% bovine terminal rectal mucus (BTRM). At every 24-
hour time points, co-cultures were serially diluted and spread on LB-Naladixic acid 
supplemented agar. After overnight incubation, one hundred single colonies were 
chosen to be placed on LB-Kanamycin agar to select for E. coli K-12-Sp5 (pink). 
The absence of growth was recorded as E. coli MG1655NK (blue). Asterisk marks 
are used for time points with significant differences (Table 4.1) between the strains 
with respect to the proportion of colonies present in the co-culture. 
 
Time (h) p-value MG1655
NK 
K-12-Sp5 t ratio     df 
0 0.003 19 81 3.40 18 
24 < 0.0001* 1 99 5.38 18 
48 < 0.0001* 2 98 5.27 18 
72 0.037* 71 30 2.25 18 
96 0.057 32 69 2.03 18 
120 0.004 20 80 3.30 18 
144 0.001* 15 86 3.90 18 
168 0.0001* 94 7 4.78 18 
192 0.003* 19 81 3.40 18 
 
Table 4.1 Statistical analysis of data from competitive growth assay 
between E. coli MG1655NK and E. coli K-12-Sp5 in 10% BTRM. Data from 
two independent experiments were analysed at each time point by multiple t-tests 
with assumption that all rows of data were sampled from populations of same 
scatter. Statistical significance was corrected for multiple comparisons using the 
Holm-Sidak method with alpha value set at 0.05.  









































Figure 4.8 Competitive growth assay between E. coli MG1655NK and E. 
coli K-12-Sp5 stx2A::kan ΔlacZ (E. coli K-12-Sp5) in 10% BTRM. At every 
24-hour time points, co-cultures were serially diluted and spread on LB-Naladixic 
acid supplemented agar. After overnight incubation, one hundred single colonies 
were chosen to be placed on LB-Kanamycin agar plate to select for E. coli K-12-Sp5 
(pink) with absence of growth recorded as E. coli MG1655NK (orange). 
Simultaneously, single colonies were also placed onto 1% lactose-MacConkey agar 
to detect any susceptible E. coli MG1655NK lysogenized with the Sp5 phage (MG 
1655NK-Sp5, green). Asterisks are used to indicate time points with significant 
differences (Table 4.2) between the E. coli MG1655NK (orange) and E. coli K-12-
Sp5 (pink) strains present in the co-culture. 
 
 
Time (h) p-value MG1655NK K-12-
Sp5 
 
t ratio df 
0 0.112 43 57 1.71 12 
24 0.002* 34 67 4.04 12 
48 < 0.0001* 26 74 5.88 12 
72 < 0.0001* 70 31 4.78 12 
96 < 0.0001* 88 13 9.19 12 
120 < 0.0001* 95 6 10.90 12 
 
Table 4.2 Statistical analysis of data from competitive growth assay 
between E. coli MG1655NK and E. coli K-12-Sp5 in 10% BTRM. Data were 
analysed at each time point by multiple t-tests with assumption that all rows of data 
were sampled from populations of same scatter. Statistical significance was 
corrected for multiple comparisons using the Holm-Sidak method with alpha value 





4.3.1.3 EHEC O157:H7 Sakai stx2A::kan and EHEC O157:H7 SakaiΔSp5 
 To further assess if the Stx-phage confers growth advantage to a strain, 
another growth assay in 10% BTRM was carried out by competing EHEC O157:H7 
Strain Sakai stx2A::kan which possesses a Stx2a prophage, Sp5, with its isogenic Sp5 
mutant Sakai strain. In contrast to the K-12 strains competed earlier, the Sakai 
stx2A::kan and Sakai ΔSp5 co-culture seemed to be able to maintain an almost 'equal' 
proportion throughout the entire competition (Fig. 4.9), with the exception at time 
points 48, 96 and 168 h of co-culture. At these time points, it was determined that the 
mean differences between the two strains competed were statistically significant 
(Sakai Sp5 mutant dominating the co-culture), however the extent was not as 
pronounced as that observed for the K-12 co-culture (Table 4.3). 
4.3.1.4 EHEC O157:H7 Strain 9000 and EHEC O157:H7 Strain 10671 
 Having observed the competition growth assay results for laboratory strain E. 
coli (K-12) and a human outbreak strain (Sakai), this section will present the data 
obtained from competing pairs of bovine-isolated EHEC O157:H7 strains to compare 
the behaviour of different strains when co-cultured in 10% BTRM. The first pair to 
be compared was the IPRAVE EHEC O157:H7 Strain 9000 possessing dual 
Stx2a/Stx2c-phages and IPRAVE EHEC O157:H7 Strain 10671 with only one Stx-
phage, Stx2c. Data compiled from six repeats of this competition experiment showed 
that having dual Stx2-phage combination in a strain does not seem to provide any 
growth advantage or make the strain fitter than a strain carrying only one Stx2-phage 
(Fig. 4.10). If anything the strain might be at a slight disadvantage. Although there 
were statistically different proportions between the two strains (time points 24 and 96 
h), the ratio of the two populations within the culture were around 1:1 (Table 4.4). 
The results observed is similar to what was observed for the Sakai strains where 
there was fluctuations in the proportion, each strains was able to compete at a similar 
rate resulting in a stable alternating fluctuations and that both strains were able to 






4.3.1.5 EHEC O157:H7 Strain 9000 and EHEC O157:H7 Strain 
9000ΔΦStx2a/ΦStx2c 
 Since co-culturing both bovine isolates (Strain 9000 and Strain 10671) 
demonstrated no growth advantages for Strain 9000 despite carrying an extra Stx2a 
phage gene in its chromosome, the next step was to compete isogenic strains in order 
to obtain a more appropriate and valid comparison. EHEC O157:H7 Strain 9000 and 
its isogenic double Stx2a/Stx2c prophage knockout strain were co-cultured for 96 h 
in 10% BTRM (Fig. 4.11 and Table 4.5). The ‘wild-type’Strain 9000 did not have 
an advantage or disadvantage over its isogenic mutant, despite the absence of 
Stx2a/Stx2c-phages in the latter strain Although it should be noted that Strain 9000 
did have a statistically higher number of colonies at 96 h of co-culture; this was not 






















Figure 4.9 Competitive growth assay between EHEC O157:H7 Sakai 
stx2A::kan and Sakai Sp5 in 10% BTRM. At every 24-hour time points, co-
cultures were serially diluted and spread on CT-SMAC agar. After overnight 
incubation, one hundred single colonies were chosen to be placed on LB-
Kanamycin agar plate to select for EHEC O157:H7 Sakai stx2A::kan (red). The 
absence of growth was recorded as EHEC O157:H7 Sakai Sp5 (grey). Asterisk 
marks are used for time point with significant differences (Table 4.3) between both 
strains. 
 





t ratio df 
0 < 0.0001* 70 31 7.00 16 
24 0.860 50 51 0.18 16 
48 0.004* 41 60 3.41 16 
72 0.383 48 53 0.90 16 
96 0.006* 41 59 3.14 16 
120 0.033 44 57 2.33 16 
144 0.860 51 50 0.18 16 
168 0.002* 40 60 3.59 16 
 
Table 4.3 Statistical analysis of data from competitive growth assay 
between EHEC O157:H7 Sakai stx2A::kan and SakaiΔSp5 in 10% BTRM. 
Data from two independent experiments were analysed at each time point by 
multiple t-tests with assumption that all rows of data were sampled from populations 
of same scatter were met. Statistical significance was corrected for multiple 







Figure 4.10 Competitive growth assay between EHEC O157:H7 Strain 
9000 and EHEC O157:H7 Strain 10671 in 10% BTRM. At every 24-hour time 
points, co-cultures were serially diluted before plating on CT-SMAC agar. After 
overnight incubation, one hundred single colonies were chosen to be placed on LB-
Naladixic acid supplemented agar to select for EHEC O157:H7 Strain 9000 NalR. 
The absence of growth was recorded as EHEC O157:H7 Strain 10671. The 
experiment was repeated again using EHEC O157:H7 Strain 10671NalR and EHEC 
O157:H7 Strain 9000. Asterisk marks for time point with significant differences 























24 0.001* 65 35 3.68 50 
48 0.357! 46 54 0.93 50 
72 0.263! 45 55 1.13 50 
96 0.001* 35 65 3.56 50 
 
Table 4.4 Statistical analysis of data from competitive growth assay 
between EHEC O157:H7 Strain 9000 and EHEC O157:H7 Strain 10671 in 
10% BTRM.  Data from the six experiments were analysed at each time point by 
multiple t-tests with assumption that all rows of data were sampled from populations 
of same scatter. Statistical significance was corrected for multiple comparisons 








Figure 4.11 Competitive growth assay between EHEC O157:H7 Strain 
9000 and EHEC O157:H7 Strain 9000ΔΦStx2a/ΦStx2c in 10% BTRM. At 
every 24-hour time points, co-cultures were serially diluted before plating on CT-
SMAC agar. After overnight incubation, one hundred single colonies were chosen to 
be placed on LB-Naladixic acid supplemented agar to select for EHEC O157:H7 
Strain 9000NalR. The absence of growth was recorded as EHEC O157:H7 Strain 
9000ΔΦStx2a/ΦStx2c. Asterisk marks for time point with significant differences 











t ratio df 
0 0.001* 38 62 3.72 20 
24 0.039 43 57 2.21 20 
48 0.206 54 46 1.31 20 
72 0.001* 63 37 3.92 20 
96 0.490 52 48 0.70 20 
 
Table 4.5 Statistical analysis of data from competitive growth assay 
between EHEC O157:H7 Strain 9000 and EHEC O157:H7 Strain 
9000ΔΦStx2a/ΦStx2c in 10% BTRM. Data from three experiments were 
analysed at each time point by multiple t-tests with assumption that all rows of data 
were sampled from populations of same scatter. Statistical significance was 
corrected for multiple comparisons using the Holm-Sidak method with alpha value 






4.4 Bacterial adherence to epithelial cells 
4.4.1 Bovine EHEC O157:H7 strains binding to HeLa cells 
 Another bacterial phenotype closely associated with colonisation assessed 
among the bovine O157:H7 strains was binding to epithelial cells. The objective was 
to compare the binding capacity of each bovine-isolated strain (Strain 9000 and 
Strain 10671) with their Stx-phage-free isogenic strains. The first cell line used was 
HeLa cells, proven to express Gb3 on its surface. 10% BTRM was used as the 
growth and incubation media for bacterial culture and cell infection. Fig. 4.12 
presents the results from three independent experiments showing the percentages of 
bacterial cells binding to HeLa cells, normalised to the number of total bacteria 
added. The percentages of total number of bound bacteria per total bacteria added 
were log-transformed and each isogenic pairs were analysed with an unpaired t-test 
using Welch’s correction without assuming similar standard deviations, with alpha 
set at 0.05. The HeLa cell binding percentages between Strain 9000 (0.13%) and its 
isogenic strain (0.58%) was not statistically different [t (2.5)=1.52, p-value=0.243]. 
Similarly there was no significant difference detected between the binding rate of 
Strain 10671 (0.09%) and its isogenic strain (0.69%). 
4.4.2 Bovine EHEC O157:H7 strains binding to EBL cells 
 Bacterial binding capacity to a Gb3 negative cell line, EBLs, was also 
assessed under similar experimental conditions as for HeLa cells. The percentage of 
total cell bound bacteria over total bacterial cell added were log-transformed before 
analysis with an unpaired t-test using Welch’s correction without assuming similar 
standard deviations, alpha=0.05. There was no difference in the adherence capacities 
between the wild type strains and the stx-phage negative strains. Statistical analysis 
for the adherence rate between Strain 9000 (0.84%) and Strain 9000ΔΦStx2a/ΦStx2c 
(6.41%) revealed no significant difference [t (2.4)=2.7, p-value=0.09]. Strain 10671 
(1.3%) and its isogenic Stx2c-phage-negative strain (5.92%) also did not differ in 


















Figure 4.12 EHEC O157:H7 adherence to HeLa cells. Individual dot plot 
represents the percentage of bacteria bound to HeLa cells over total bacteria added 
after thirty minutes of incubation at 37°C, 5% CO2, obtained from three independent 
experiments. Data were analysed by unpaired two-tailed t-test (with Welch’s 
correction) applied between EHEC O157:H7 Strain 9000 and EHEC O157:H7 Strain 
9000ΔΦStx2a/ΦStx2c; and  EHEC O157:H7 Strain 10671 and EHEC O157:H7 
Strain 10671ΔΦStx2c, at alpha=0.05. Error bars represents the 95% confidence 





















Figure 4.13 EHEC O157:H7 adherence to Embryonic Bovine Lung cells.  
Individual dot plot represents the percentage of bacteria bound to EBL cells over 
total bacteria added after thirty minutes of incubation at 37°C, 5% CO2, obtained 
from three independent experiments. Data were analysed by unpaired two-tailed t-
test (with Welch’s correction) applied between EHEC O157:H7 Strain 9000 and 
EHEC O157:H7 Strain 9000Stx2a/Stx2c; and  EHEC O157:H7 Strain 10671 
and EHEC O157:H7 Strain 10671Stx2c, at alpha=0.05. Error bars represents 












4.5 Expression of H7 and EspA (Type Three Secretion) in 10% 
bovine terminal rectal mucus (BTRM)  
 Having identified evidence of increased adherence capacity in the Stx-phage 
free isogenic strains of Strain 9000 and Strain 10671, the next step was to see if the 
difference was due to differential expression of early attaching factors including 
flagella and the type three secretion system (T3SS) upon removal of the Stx-phages 
from the bovine isolates. The strains were grown under similar conditions as for 
bacterial adherence assay in 10% BTRM and were then processed for 
immunofluorescence staining to detect for bacterial cell (O157), flagella (H7) or 
EspA (T3SS). The fluorescence microscopy images in Fig. 4.14 show the mucus-
cultured bacterial strains (O157-red) co-stained with H7 (green) antibody, while Fig. 
4.15 presents the images for bacterial cells (O157-red) co-stained with anti-EspA 
(green). There seemed to be an increase in H7 signals in Fig. 4.14 for the stx-phage 
mutant EHEC O157:H7 strains compared to the isogenic wild type strains. Visual 
comparison of EspA expression by EHEC O157:H7 strains (Fig. 4.15) indicated 
more signals of EspA in Stx2c phage mutants of both wild type EHEC O157:H7 
strains. However, the presence of fixed mucus on most of the slides examined 
hindered further conclusion from these results. Therefore, expression of H7 and the 
T3SS were analysed by Western blotting for all bacterial strains, cultured under the 
same conditions as for binding assay. 
 
 As seen in Fig. 4.16, similar levels of H7 were expressed by all strains 
regardless of the Stx2-encoding bacteriophage status, while EspD could not be 
detected. EspD was used rather than EspA since the antibody against EspD was 
shown to be better for immunoblot detection and gives a better signal than anti-
EspA. This indicated that in the mucus the bacteria were generally expressing 
flagella but not the T3SS. The next step was culturing the bacterial strains under 
conditions previously shown to promote expression of T3SS proteins [257] and 
compare the levels of EspD. EHEC O157:H7 Strain 9000 and Strain 10671 were 
both able to express EspD under T3SS conditions at similar levels, however no EspD 
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Figure 4.14 H7 expression in mucus-cultured bovine strains of EHEC 
O157:H7 examined by fluorescence microscopy. EHEC O157:H7 strains 
were grown in 10% bovine terminal rectal mucus under similar conditions as 
described for bacterial adherence assay. The mucus culture were then fixed in 4% 
PFA before immuno-staining procedure performed by Dr. Amin Tahoun. Bacterial 
cells were labelled with anti-O157-Alexa Fluor® 568 (red) and flagella (H7) with anti-
H7-FITC (green). The images were taken with Leica DMLB fluorescence 
microscope with the help of Dr. Tahoun, before processed and analysed with Image 
J (U.S. National Institute of Health, Maryland). 
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Figure 4.15 EspA expression in mucus-cultured bovine strains of EHEC 
O157:H7 examined by fluorescence microscopy. EHEC O157:H7 strains 
were grown in 10% bovine terminal rectal mucus under similar conditions as 
described for bacterial adherence assay. Bacterial cells were labelled with anti-
O157-Alexa Fluor® 568 (red) and anti-EspA-FITC (green). The mucus culture were 
then fixed in 4% PFA before immuno-staining procedure performed by Dr. Amin 
Tahoun. The images were taken with Leica DMLB fluorescence microscope with the 
help of Dr. Tahoun, before processed and analysed with Image J (U.S. National 
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Figure 4.16 Western blot of bacterial cytosolic lysate grown in 10% 
bovine terminal rectal mucus. Bacterial pellet from EHEC O157:H7 bovine 
strains grown under similar conditions as described for bacterial adherence assay 
were checked for H7 and EspD expession levels. RecA served as the loading 




















Figure 4.17 Western blot of bacterial cytosolic lysate grown under T3SS 
conditions. The membranes of four bovine strains of EHEC O157:H7 were probed 
against EspD antibody (1:3000) to check for the expression of type 3 secretion 
proteins after cultured under conditions previously shown to enhance T3SS 
expression. RecA was used to the loading control. Protein were detected by 











4.6 Galleria mellonella larvae survival upon EHEC O157:H7 
challenge 
4.6.1 EHEC O157:H7 Strain 9000 and isogenic Stx2-phage 
mutants 
 To assess and compare virulence between EHEC O157:H7 Strain 9000 and 
its isogenic Stx2-phage knock outs, an infection model using Galleria mellonella 
larvae at 37°C, 5% CO2 was investigated. Data consisted of the number of dead 
larvae recorded at 18- and 24-hour post-infection, which were then analysed by 
producing Kaplan-Meier survival plots (Fig. 4.18).   The survival curves between all 
of the larvae groups receiving different strain were significantly different, when 
analysed with Log-rank Mantel-Cox test, with the alpha=0.0083, based on 
Bonferroni corrected threshold [Chi square (4)=62.85, p-value <0.0001].  
 
 Further pairwise analyses of each isogenic-Stx2-phage mutants to Strain 9000 
revealed that the survival curves of the larvae group treated with Strain 9000 were 
significantly different than the group challenged with Strain 9000ΔΦStx2a/ΦStx2c 
[Chi-square (1)=12.15, p-value<0.001]. The median survival time of the larvae 
receiving Strain 9000 was 48 h and 42 h for Strain 9000ΔΦStx2a/ΦStx2c challenge, 
with a ratio of 1.143 (95% C.I. between 0.6435-2.030), while were undefined for 
larvae groups receiving Strain 9000ΔΦStx2a or Strain 9000ΔΦStx2c. 
4.6.2 EHEC O157:H7 Strain 10671 and Strain 10671ΔΦStx2c 
 EHEC Strain 10671 and its Stx2c-phage mutant isogenic strain were injected 
into the larvae and similarly as described above for Strain 9000, the number of 
deaths recorded at every 18 and 24 h. The Kaplan-Meier survival plot are shown in 
Fig. 4.19. Survival analysis revealed that the survival curves for the group challenged 
with the Strain 10671 and Strain 10671ΔΦStx2c were not statistically different when 
analysed with Log-ran Mantel-Cox test [Chi square(1)=0.1260, p-value=0.723]. 
Median survival time for larvae challenged with Strain 10671 was 42 h and for Strain 




4.6.3 EHEC O157:H7 Sakai and Sakai ΔSp5 
 Virulence in G. mellonella larvae was also assessed for EHEC O157:H7 
Sakai and its Stx2-phage mutant isogenic strain. Number of larvae deaths were 
recorded and analysed as mentioned for the other EHEC O157:H7 strains revealing a 
Kaplan-Meier plot as presented in Fig. 4.20. Survival analysis by Log-rank Mantel-
Cox test identified statistically different survival curves between the two larvae 
group receiving the wild-type Sakai and the SakaiΔSp5 mutant [Chi square (1)=7.04, 
p-value=0.008]. Median survival time for SakaiΔSp5 infection in larvae was 48 h 
but undefined for those infected with the Sakai strain since there were still more than 








































Figure 4.18 Survival of G. mellonella larvae challenged with EHEC 
O157:H7 Strain 9000 strains. At each time point (marked by symbol), the 
number of dead larvae were recorded and transformed into survival rate (%), as 
shown in this Kaplan-Meier plot. Each line denotes the bacterial strain used to infect 
the group, with larvae receiving PBS serves as assay control. Survival analysis was 







Figure 4.19 Survival of G. mellonella larvae challenged with EHEC 
O157:H7 Strain 10671 strains. At each time point (marked by symbol), the 
number of dead larvae were recorded and transformed into survival rate (%), as 
shown in this Kaplan-Meier plot. Each line denotes the bacterial strain used to infect 
the group, with larvae receiving PBS serves as assay control. Survival analysis was 
















Figure 4.20 Survival of G. mellonella larvae challenged with EHEC 
O157:H7 Sakai strains. At each time point (marked by symbol), the number of 
dead larvae were recorded and transformed into survival rate (%), as shown in this 
Kaplan-Meier plot. Each line denotes the bacterial strain used to infect the group, 
with larvae receiving PBS serves as assay control. Survival analysis was done using 

















































 Epidemiological studies indicate that EHEC O157:H7 PT21/28 strains are 
more likely to be associated with higher excretion levels from cattle than many other 
phage types, including PT32. In addition PT21/28 strains are implicated with severe 
disease symptoms in human patients. Among the Scottish cattle O157:H7 strains 
isolated, the PT21/28 strains are more likely to contain a Stx2a-encoding prophage in 
addition to a Stx2c-encoding prophage which is generally present in both phage 
types.  PT32 strains can contain both Stx2-encoding phages but this combination 
appears more common in certain other European countries and we have no 
information on how this then relates to excretion levels of the strains from cattle.    
 
 Recent research in collaboration with scientists at the Moredun Research 
Institute and Scottish Rural College (SRUC), has orally challenged calves with two 
strains originally isolated in the Wellcome Trust-funded IPRAVE study that fitted 
the epidemiological profile of the phage types. In two different experiments the 
PT21/28 strain was excreted at higher levels from the calves than the PT32 strain 
(Figure 4.1, Chapter 4 Introduction). This validated the choice of these strains for 
comparative studies. In addition, the T3SS expression was shown to be significantly 
higher in the PT32 strain compared to PT21/28 [257]. 
 
 Our group has also sequenced and analysed differences between the genomes 
of these two strains.  While minor differences do exist, the main difference between 
the two is the Stx2a prophage in the PT21/28 strain.  To support this, Stx2a and 
Stx2c phages were individually removed from the PT21/28 strain. Phage typing of 
these isogenic mutants of PT21/28 revealed that the PT21/28 ΔΦStx2c remains in the 
PT21/28 cluster, whereas the isogenic PT21/28 ΔΦStx2a switched to the PT32 
cluster. This is in line with recent evolutionary analysis of EHEC O157 strains in the 
UK (Dallman et al submitted to PloS Pathogens) indicating that PT21/28 strains have 
evolved from PT32 strains.  Again this information indicates that the higher shedding 
is most likely to be associated with the Stx2a prophage. This chapter has investigated 
different in vitro phenotypes in an attempt to understand how the phage insertion 





4.1 Shiga toxin production and potency on Vero cells 
 As part of the STEC grouping, presumably these bovine EHEC O157:H7 
strains should be able to express Stx of the Stx type demonstrated to be present by 
the genotyping method. Three different growth media were used routinely to 
generate culture lysates to assay for toxin production and toxicity: i) LB (artificial, 
laboratory media), ii) LB supplemented with Mitomycin C (to assess the full 
potential of tested strains to produce Stx) and iii) 10% bovine terminal rectal mucus 
(to provide growth media that resembles the in vivo situation). Overall, under normal 
laboratory (LB) and lysis-induction (LB + MMC) growth conditions, most of the 
strains behaved as expected according to their Stx-phage status with the exception of 
Strain 9000ΔɸStx2c. It was interesting that 10% BTRM did not provide a permissive 
environment for Stx production for all the bovine strains compared. In some respects 
the absence of Stx production under these conditions corroborates the findings in 
Chapter 2 and Chapter 3 of this thesis where it was suggested that direct Stx 
interactions with the intestinal epithelium during EHEC O157:H7 colonisation in the 
bovine rectum is unlikely to result in significant changes with regard to bacterial 
persistence.  There was no clear cellular target for the toxin in terms of the Gb3 
receptor and no robust data to indicate an involvement of the toxin in modulating 
direct epithelial interactions. If negligible levels of Stx are being produced at the 
bovine terminal rectum in vivo, then this indicates that bovine-adapted strains may 
not be relying on Stx to impose a direct effect on the rectal epithelium for 
establishing successful colonisation and a high shedding profile. This does not rule 
out other effects in a more subtle manner, such as immuno-modulation. 
 
 Strain 9000ΔɸStx2c and all of this strain's four clones (saved during the 
selection protocol for removal of the prophage) failed to produce any detectable 
levels of Stx or toxicity on Vero cells. It was assumed that by removing Stx2c-phage 
from Strain 9000, that these strains would still express Stx2a with a potent effect on 
Vero cells, however this was clearly not observed. Very recently, we have obtained 
Pacific Biosciences sequence data for a number of the cattle EHEC O157 strains. 
These have been provisionally analysed by Sharif Shaaban (a PhD student in our 




in the A subunit gene of the Stx2a-encoding gene. Clearly, this is very likely to 
account for the lack of Stx2a expression in this strain.  It was not something we were 
able to discern from the Illumina-based (short read) sequencing and highlights the 
value of the long read sequencing technology.  Insertion sequences (IS) are the 
smallest and most abundant transposable elements in prokaryotes [536]. IS have been 
implicated as significantly contributing to the evolution and diversity of prokaryotes 
by promoting gene inactivation and chromosomal rearrangements [537]. Further 
experiments and analyses by the group is ongoing to provide more evidence in order 
to understand the mechanisms and regulation of IS insertion resulting in such 
phenotypes. This specific finding has obvious implications for both the in vivo and in 
vitro studies, including the likelihood that the increased excretion of strain 9000 is 
not likely to be due to Stx2a toxin and in fact may be more related to the impact of 
the remaining prophage, in line with the experiments conducted in this chapter. 
 
 Human isolated strains of PT21/28 produced significantly higher levels of Stx 
compared to the bovine-associated strains, which is in agreement with the findings 
from a previous study comparing Stx production from HUS-associated and bovine 
isolated STEC strains [242]. This seems to coincide with the pathology differences 
between the susceptible humans and the reservoir host, indicating strain adaptability 
depending on its host. Vero cell killing was relatively higher for both human strains, 
however the two bovine adapted strains in particular Strain 9000ΔɸStx2a showed 
comparable levels of toxicity despite producing less Stx (determined by ELISA) than 
the human-associated strains, suggesting that the Stx2c produced was potent enough 
to kill Vero cells despite being produced at potentially lower amounts than from the 
human isolates. Strain 9000ΔɸStx2a, when compared against its parental Strain 9000 
and PT32 Strain 10671, at times was shown to produce higher Stx levels. It might be 
that the presence of two Stx-encoding phages in Strain 9000 results in interactions 
resulting in repression rather than synergy in total Stx production. The Stx2a-phage 
of Strain 9000 may suppress the production of Stx2c in the parental strain.   
 
 Toxin production in this assay was measured relatively based on detection by 




different Stx types and variants, therefore it is not known which Stx is actually 
present in each lysate preparation and only presumed based on the genotype. This is 
especially an important point to be considered when detecting total Stx from Strain 
9000 (PT21/28). Quantitative real-time polymerase chain reaction (qRT-PCR) to 
assess the copies of each toxin type present in the supernatant/lysate preparation 
would be valuable as this will accurately measure and assign the contribution to each 
Stx-type and phage. Measuring Shiga toxin levels and toxicity from the human 
strains in 10% mucus from human colon, for example, might shed some light on how 
much toxin is produced in vivo. It would be interesting to compare toxicity of more 
human and bovine strains and to study the interactions between Stx-encoding 
prophages in terms of final Stx production and toxicity.  
4.2 Growth of EHEC O157:H7 in competitive environments 
 It has been observed that bacterial interaction with intestinal epithelial cells 
surrounded in mucus most likely contains very low, if not negative, levels of Stx and 
that there was preliminary evidence of control by Stx-phages in determining how 
much Stx is produced by the strains. Owing to its complex structure and contents, 
mucus not only protects the intestinal epithelium as part of the innate defense, but 
also provides nutrients for the colonising bacteria, commensals and pathogens alike. 
Certain EHEC O157:H7 strains were shown to have different preference over 
commensals concerning preferred mucin content and carbon resources [36, 199]. The 
position of nanS adjacent to stx genes might indicate a role for Stx-encoding phages 
in increasing the fitness of EHEC O157:H7 to survive in a complex ecosystem in the 
bovine intestine [255]. Bacteriophages were also suggested to have the power in 
controlling diversity of a steady state bacterial community indicating the 
manipulative side of these infectious particles [538]. Based on this, it was then 
hypothesised that the parental strains harbouring Stx2-phages would perform better 
in a competition setting with prophage deleted derivatives or strains with a different 
complement of Stx phages. At the simplest level this might account for the increased 
excretion of Strain 9000 compared to Strain 10671. The data from the competition 
assays however is complicated and it is difficult to reach a simple conclusion about 




significantly provide growth advantage over the Strain 10671 (PT32) strain. This 
inter-strain competition (PT21/28 and PT32) indicates that both are equivalent in 
terms of fitness and survival, despite the presence of different Stx2-phages in the co-
culture. No benefit was conferred to the bacteria by the presence of Stx-phages as the 
proportion of each paired strains maintained minor fluctuations enabling the paired 
strains to grow and replicate at similar levels, at least within the time frame of the 
assays performed.  
 
 To further assess the interactions occurring in the co-culture, the laboratory  
E. coli strain K-12 and its derivative strains were further employed for similar 
growth competition assays. In the early phase of co-culture, the naive K-12 strain 
were able to dominate over the SP5-lysogenised K-12 strain until day four, where 
there was a surge in the K-12-SP5+ population making up approximately 90% of the 
co-culture. This was observed again when the strains were re-competed in fresh 
culture. Initially it was suspected that the observations occurred as a result of 
lysogenisation of the naive K-12 SP5 mutants. Incorporation of the prophage into the 
susceptible host genome would consequently give rise to SP5 phage-resistant 
population in the formerly susceptible strain, thereby explaining the sudden increase 
in the SP5+ culture on day 4. However this theory seems to be less likely to explain 
the fluctuations observed as results of sub-culturing the kanamycin-resistant (SP5+) 
colonies on lactose-MacConkey agar to check for lysogenised 'naive' K-12 strain 
revealed otherwise, with the lack of such colonies (marked by the ability to ferment 
lactose and appear pinkish on the lactose MacConkey agar) on day 4 of co-culture. 
An alternative explanation for the observed fluctuations would be that initially the 
total K-12 SP5+ levels dropped due to spontaneous lysis (possibly stressors present 
in the competitive environment such as waste products or competing over the same 
nutrient source) or that the SP5 phage-bearing K-12 cells indeed had a slower growth 
rate than the isogenic SP5 mutant. However, the remaining fraction of the K-12 
SP5+ cells would then continue to replicate and vertically transfer the SP5+ genome 
into the daughter cells. Some of these SP5+ cells then undergo lysis due to stressful 
conditions in the co-culture (e.g. starvation), releasing infective phages that quickly 




resembling the 'predator-prey' relationships and oscillations [539]. As a consequence, 
majority of the non-resistant, infected naive K-12 cells were killed, possibly 
explaining the sudden plunge in the isogenic SP5 mutant cells. This could be viewed 
as a strategy used by the prophage-bearing strains to outcompete the competitors in 
the same environment, where the phages were manipulated to the advantage of the 
strain [526]. A computer simulation of bacterial strain replacement in the presence of 
phages predicts that the strain that is able to use the most abundant nutrient or 
metabolise more than one substrate is the preferentially target for phage to attack, 
resulting in selection against the fitter strain and establishing a fluctuating density of 
bacterial strains competed around stable levels [539]. This description fits well in 
terms of explaining the fluctuations observed in the co-cultures.  
 
 Competition of the Sakai pair, although showed some oscillations but the 
peaks were much less pronounced as that observed for the K-12 pair. Although the 
exact reason is unknown, the findings for the Sakai pair seems similar to that 
observed in the Strain 9000-double Stx-phage mutants competition. One factor that 
could lead to this outcome is the fact that the isogenic Stx-phage negative strains 
were derived from Stx-phage positive strains (Strain 9000), and have some resistance 
from phage infection conferred by the original phage. While the co-culture bearing 
Strain 9000 and Strain 10671 failed to produce dramatic peaks as that seen in the K-
12 pairs, despite the presumption that Strain 10671 is 'naive' to the Stx2a (and 
probably Stx2c) phage(s) of Strain 9000. The findings observed could also not 
explain the different shedding profiles of the two strains (Chapter 4, Introduction Fig. 
4.1). Further experiments on determining the sensitivity or resistance of Strain 9000 
and Strain 10671 to each of the possessed Stx-encoding phages would facilitate our 
understanding of the competition growth assays presented. 
 
 More valuable insight could be gained by competing the strains on a longer 
time scale, for hundreds or thousands of generations, to see if the fluctuations 
observed stablised. Had there been more inputs to serve as variables such as lysis 
rate and burst size, it would be of interest to predict the dynamics displayed by the 




was observed that EHEC strains deleted of AgvB, an sRNA present in two Lambda-
like bacteriophage regions in the EHEC genome and identified as an antagonist 
sRNA to GcvB (core genome regulator), decreased the competitiveness of the strains 
in 10% bovine terminal rectal mucus, but not M9 or LB media [540]. AgvB also 
interacts with Hfq, a post-transcriptional regulator involved in bacterial virulence and 
stress response [541]. Such evidence implicates the involvement of phage factors in 
regulating important bacterial growth phenotypes, with the outcome dependent on 
the strain and environment.  
4.3 EHEC O157:H7 adherence to epithelial cell lines 
 There was no significant difference found in the initial binding rates between 
Strain 9000 (PT21/28) and Strain 10671 (PT32), despite data from unpublished work 
[256] which identified that Strain 9000 (PT21/28) bound better than Strain 10671 
(PT32) to bovine primary terminal rectal epithelial cells in 10% BTRM. The 
expression of two bacterial virulence factors closely associated with host cell 
attachment, flagella and the T3SS were also studied. Ensuring that the bacteria were 
grown under similar conditions as when prepared for the epithelial binding assays, 
flagella (H7) and T3SS (EspA/D) expression was examined by confocal microscopy 
along with Western blotting. Flagella are considered to be involved in the early 
phases of bacterial attachment and are able to bind to freshly isolated bovine mucus 
and to mucin components [213, 375].  T3SS was assessed since it is established as an 
important system for intimate cellular attachment although its role in the early phase 
(30 min) interactions with epithelial cells is less clear. By confocal microscopy, there 
seemed to be a higher H7 expression in all of the stx phage mutant EHEC O157:H7 
strains and higher EspA in Stx2c phage mutants of Strain 9000 and Strain 10671. 
However the presence of mucus remnants visualised on most of the slides hindered 
full view of the bacterial cells trapped within or underneath the mucus. The study 
then proceeded with immuno-blotting to further compare the levels of H7 and EspA 
expression in the wild type and stx-phage mutant strains.  It was then clear that the 
H7 levels were similar for all bovine EHEC O157:H7 strains regardless of Stx2-
phage status, while there were no signs of T3SS expression which agreed with the 




Since H7 levels were similar between strains of different Stx-phage status, the 
involvement of other potential bacterial factors acting as adhesins expressed in the 
early phases of attachment may explain the non-significant variations in the binding 
percentages. Examples include the outer membrane protein A (ompA) shown to be 
important in EHEC O157:H7 86-24 binding to HeLa and Caco-2 cells [542], 
enterohaemolysin (Iha) implicated in binding of K-12 to HeLa cells [543], the highly 
aggregated fibres known as Curli [544] or the F9 fimbriae [545], the Lpf1 [219], the 
laminin binding fimbriae (YcbQ) [546] or even the zinc metalloprotease (StcE) [228, 
529].Future work will examine the complete gene expression profiles of the isogenic 
strains to identify the full complement of genes, including adhesins, that might be 
controlled by Stx2-phage insertion.  
 
The strains were also grown in conditions shown to promote T3SS expression 
[257] which revealed detectable levels of EspD. These were shown to be similar for 
both Strain 9000 and Strain 10671, but was absent in their Stx-phage free isogenic 
strains. This is though in line with findings that T3SS is not expressed in the bovine 
rectal mucus and not relevant in the early interactions with cells since the expression 
of T3SS is initiated once the bacterial population reaches the stationary phase [194]. 
The findings are contrary to those found in an earlier study by our group which 
demonstrated that T3SS is repressed in the presence of Stx2a-encoding phages in 
EHEC O157:H7 PT21/28 strains and was up-regulated the Δ ɸStx2a strains [257]. 
The EspD levels of PT32 was also determined to be significantly higher than that of 
PT21/28. It was determined at that time that following Stx2 lysogenisation, the 
expression of the cII regulatory protein (transcription activator of genes involved in 
regulating the fate of the phage to enter either the lysogeny or lytic pathway) was 
detected and resulted in the repression of Ler (LEE genes regulator) activities which 
coincided with repressed EspD secretion. Deletion of the cII protein from the Stx2-
phage significantly (p<0.001) increased the activation of Ler. Contrasting results at 
the translational level of T3SS components observed by Xu et al. (2012) and the 
current study highlights the fact that the behaviour of the strains even within the 
same PT cluster could be differentially regulated depending on the prophage type 




failed to express EspD requires further specific examination at both the 
transcriptional and translational levels.  
 
 There are some drawbacks with the methods used in the bacterial adherence 
assay. The epithelial cells were cultured in 10% bovine terminal rectal mucus which 
prevented longer infection time as the eukaryotic cells start to die in 10% BTRM. If 
possible, it would be good to prolong bacterial and epithelial cell interactions to 
analyse A&E lesion formation by the strains with the different Stx-phage 
composition. Another point to consider is the use of total plate counts as the output to 
assess adherence of bacteria to epithelial cells. There was also considerable levels of 
experimental variations leading to a range of total bacterial count across different 
repeats. If the bacterial cells are not properly removed during washing after the 30 
min infection period then this would definitely lead to false positive results, or vice 
versa if the trypsinising agent added might have adverse effects on the adherent 
bacteria, possibly killing the bacterial cells. To improve the findings, further work 
should incorporate more efficient methods such as flow cytometry to accurately 
count total bacteria bound to cells and also determine the number of bacterial cells 
attached to each individual eukaryotic cells. This microscopic examination would not 
only help in enumerating adhered bacterial cells, but also examine any lesion 
formation on the epithelial cells. By combining findings from the different suggested 
methods, this will definitely increase confidence in the data.  
4.4 Assessing virulence between different EHEC O157:H7 
strains in Galleria mellonella larvae infection model 
 The next phenotype assessed was virulence between strains with different 
Stx2-phage complements. Galleria mellonella larvae, as described in further details 
in the introduction section, were used as an alternative to a large animal model and 
serve as a relatively convenient and quantifiable infection model to establish some 
aspects of preliminary virulence interactions. A priori hypothesis was that Stx-phage 
carrying strains would be able to induce more damage and higher death rates in the 




larvae based on the fact that the parental strain genome have intact prophages that 
confer ‘maximum’ virulence, including Shiga toxin expression. 
 
  The data obtained indicated otherwise, the isogenic Stx-phage mutant strains 
for EHEC O157:H7 Strain 9000 and Sakai were able to kill more larvae than their 
parental strains containing Stx2a-phage(s). It is not known if Stx2 is expressed by the 
strains inside the larvae, or which virulence factor(s) is(are) responsible for causing 
fatal lesions as this warrants further experiments to be performed. Interestingly, the 
outcome was different for Strain 10671, where the survival rates were similar 
between Strain 10671 and its Stx2c-phage deficient strain. There were clearly strain-
dependent effects on the larvae. It has been suggested that prophages are able to 
impact on expression of virulence factors in its bacterial host and in the presence of 
more than one prophage in the genome, this could result in potentiation of virulence 
as a result of interaction between the prophages present [547]. From the survival 
curves obtained in this study however, it can be proposed that the Stx2a prophages 
may repress or down regulate certain virulence traits, which are then expressed at a 
higher level upon curing of the Stx-phage. As discussed above for toxin production, 
competitive growth and adherence to epithelial cells, the differences in the outcome 
displayed among strains of different Stx-prophage carriage suggests that these 
prophages are somehow interacting with some of the key virulence and survival 
traits, manipulating the behaviour of the bacterial host in order to promote its own 
survivability. Further studies applying this model could incorporate total bacterial 
count from the haemolymph of the larvae, inspection of histological sections of 
infected larvae to confirm colonisation, detection for any presence of Stx and Gb3, 
among others would supply useful information in explaining how Stx-phage cured 
strains, supposedly thought to be less virulent, caused higher death rate in the larvae, 
as compared to the ‘wild-type’ strains. Considering the fact that this infection model 
utilises a dramatically different host species than cattle, careful interpretation of data 
obtained is needed. From the data, it is evident that Stx2a phage integration can 
actually pacify certain strains in terms of innate interactions, although it appears the 




situation. Perhaps a less aggressive strain can colonise to higher levels and for longer 
and this is promoted by the phage-bacterium relationship. 
4.5 Conclusion 
 This chapter discussed the characterisation of several key traits of EHEC 
O157:H7 strains with the aim to assess if Stx-encoding phages contribute to the 
phenotypes displayed by its bacterial host. The relationship between the Stx-phage 
and EHEC O157:H7 could be viewed as mutually symbiotic as both entities are 
believed to positively support the survival of one another. The ability for the 
temperate Stx-phage to manipulate the bacterial host to ensure continuous 
propagation of the phage genes could simultaneously contribute to the survival of the 
bacteria. Vice versa, the prophages are more likely to be conserved in the bacterial 
genome as the genes provide superior traits. Under certain conditions, the balanced 
mutual symbiosis may change direction to either become parasitic (e.g. Stx-phage 
undergoing lytic phase which directly kills the bacterial hosts) or commensalism 
(e.g. lysogenisation ensuring maintenance and propagation of phage genes and at the 
same time, conferring resistance to the infected bacterial host that may also be used 
as a 'weapon' to attack competing bacterial strains). The impact of Stx-encoding 
phages and the EHEC O157:H7 host is believed to be complex, and the absence or 
presence of the Stx-phage does not necessarily result in modification of bacterial 
traits in the expected manner. The similar competitive growth and binding capacities 
of the two bovine isolates (Strain 9000 and Strain 10671) and the lack of synergism 
in total Stx production, despite the former strain containing an extra Stx2a-phage, 
and pacification (for 2 strains) of virulence in the G. mellonella larvae strongly 
suggest that the Stx-prophages interact with and are capable of altering the 
colonisation and virulence associated phenotypes of the host EHEC O157:H7 strain. 
Most of the findings here are preliminary as explanations of the regulatory 
mechanisms are missing. Moreover, the association between the Stx-phages and 
super-shedding remains unanswered. Several aspects of this chapter particularly on 
attachment and competitive growth warrants further investigation ideally carried out 
under in vivo conditions. As a start, cattle challenge experiments with EHEC 




provide crucial in vivo data on the phenotypic characteristics presented in this 
chapter for validation. It is also important at the same time to understand more about 
the biology of Stx-encoding phages from the Scottish EHEC O157:H7 strains which 
could then be merged with data from genomic analyses. Future findings from details 
of the sequencing data of the Stx-phages and the bovine EHEC strains carried out by 
other research group members, in addition to preliminary evolutionary work on Stx-
phages [548] would facilitate the current understanding on the involvement of Stx-
phages in EHEC O157:H7 colonisation at the bovine terminal rectum. Additionally, 
this would facilitate the development and improvement of current preventative 
strategies aimed at reducing EHEC O157:H7 shedding from cattle and ultimately 










































 Shiga toxin is the virulence factor directly associated with the development of 
haemorrhagic uraemic syndrome (HUS) in humans following an episode of bloody 
diarrhoea [341], while the Stx–encoding prophages themselves have been implicated 
as the source of lineage diversification, persistence and emergence of important 
pathogenic EHEC O157:H7 isolates from humans and cattle [85]. The current study 
aimed to address the contributions of Shiga toxin and Shiga toxin-encoding 
bacteriophages (phages) towards intestinal colonisation of EHEC O157:H7 in the 
asymptomatic cattle host. 
 
  Chapter 2 explored the possibility of toxin-Gb3 receptor interactions at the 
principal colonisation site, identified as the bovine terminal rectum [33], as this has 
yet to be addressed and that Gb3 presence may indicate a significant role for the 
toxin during the process. The findings obtained, particularly from histological 
examinations were indicated that Gb3 is not present at significant levels at the 
preferred colonisation site of EHEC O157:H7 in cattle. This was true in vivo for the 
samples studied although further work is needed to support and confirm the absence 
of Gb3 on the rectal epithelium by determining the levels of Gb3 synthase or Gb3 
lipid expression as well as histological evidence from a larger number of animals 
before completely ruling out the presence of Gb3 receptor at this site. Additionally, it 
was determined that Stx2, despite previous reports that it can initiate apoptosis and 
disrupt the cell cycle of epithelial cells, did not induce any obvious negative effects 
on the proliferation of intestinal epithelial cell lines investigated in this study, 
regardless of their Gb3 status and Stx sensitivity. It was not possible to assess the 
effects of Stx on proliferation of bovine terminal rectal cells, therefore generalisation 
of the findings with regard to cell proliferation needs further work to be carried out. 
Since it may not be feasible to examine effects of the toxin in  live cattle, future work 
could utilise alternative approaches such as the 3-dimensional (3D) cell culture 
systems [549] of the bovine terminal rectum which could provide a better in vitro 
system than the two-dimensional continuous or primary cells, based on issues 
discussed in the discussion section of Chapter 2. EHEC O157:H7 could be added 




assessment of the effects of the toxin, rather than stimulating the cells with 
commercially obtained purified toxins as these may not give accurate observations 
since the properties may be different from the ones released from bacterial lysis. 
Simultaneously, providing the 3D cell culture system with a microaerobic 
environment [165, 205] will most likely enhance and refine the in vitro system to 
achieve a more realistic model, resembling the conditions in vivo that will increase 
the relevance of these experimental observations.   
 
 Since there was no strong evidence to associate Stx and the intestinal 
epithelial cells in Chapter 2, the aim of the study was shifted to focus on the impact 
of Stx and Stx-expressing EHEC O157:H7 strains on the immune cells residing the 
mucosal layer of the bovine terminal rectum. The consequences of toxin activity on 
these immune cells largely depends on the type of cell that is encountered [272]. The 
present study attempted to assess the responses of selected immune cell types 
(included those based on the findings of a previous study [250]) from the rectal 
mucosa of calves infected with two commonly isolated EHEC O157:H7 strains from 
cattle farms in Scotland [64]. The EHEC O157:H7 strains used to challenge the 
calves differed mainly in the Stx-phage type possessed and it was hypothesised that 
the strain containing the extra Stx2a phage, in addition to the Stx2c phage (also 
present in the other EHEC O157:H7 strain introduced in another group of calves) 
would significantly alter the bovine mucosal immune response. This concept was 
based on Stx2a being more potent than Stx2c and other Stx variants [69].  Potentially 
higher levels of Stxs may also be generated from EHEC O157:H7 Strain 9000 
carrying two Stx phages (additive or synergistic), resulting in a more pronounced 
effect. Initially it was thought that the statistical differences could be associated with 
a down- or up-regulation of the expression of CD3+/CD4+, CD3+/γδ+ and CD21+ 
cells between calves in the group receiving EHEC O157:H7 Strain 9000 and control 
calves. However a closer look at the data revealed the lack in the total number of 
cells analysed (refer to Chapter 3, Discussion section 3.1). Had the total number of 
cells sampled for flow cytometry analysis determined, the direction of the bovine 





 The inability of Stx2 to interfere with IFN-γ activation of the JAK/STAT1 
pathway in intestinal epithelial cells contrasted with suppression previously reported 
[482, 483, 502]. It is believed that such inhibitory effects result from multifactorial, 
complex interactions between the bacteria and signalling system of intestinal 
epithelial cells [502]. To clarify the findings from Chapter 3, the EHEC O157:H7 
infection of calves needs to be repeated to obtain more terminal rectal mucosal tissue 
that can be examined under an improve protocol particularly with regards to 
immunophenotyping the select immune cells investigated in this study.  
 
 From the findings of Chapter 2 and 3 of the current study, Stx, if expressed 
during bovine intestinal colonisation, do not play any role as hypothesised earlier at 
both levels; the intestinal epithelial cells and the bovine intestinal immune cells of 
the terminal rectal mucosa. Chapter 4 then explored the possibility for the Stx-
encoding phages, rather than Stx production, in determining the successful 
colonisation of the bovine terminal rectum. Four phenotypic characteristics of EHEC 
O157:H7 associated with colonisation and virulence were examined; total Stx 
production and toxicity, competition growth assays, adherence to epithelial cells and 
pathogenicity in a larvae infection model. In order to achieve results that may 
describe how EHEC behaves in the bovine terminal rectum, 10% bovine terminal 
rectal mucus was used as an alternative growth medium in most of the assays (in 
addition to LB or LB and SOS inducing agent) to provide culture conditions 
resembling that during colonisation in vivo. Both human isolates of EHEC O157:H7 
PT21/28 grown in both LB and LB with MMC induction produced exceptionally 
high levels of total Stx compared to the defined bovine isolates assessed, which 
agrees with the findings of others [77, 78, 242, 550] and may explain why humans 
are more affected by the adverse effects of Stx than the cattle, apart from differences 
in Gb3 distribution and cellular susceptibility or resistance against the toxin [147, 
273, 275, 352, 551]. More importantly, mucus of the bovine terminal rectum may 
contain inhibitory components against the expression of Stx by EHEC O157:H7, 
compared to LB.  In addition, it was recently reported that microaerobic conditions 
provided to a vertical diffusion chamber system of human carcinoma intestinal cells 




(estimated to be low, at 1.4% atmospheric pressure) caused a reduction in total Stx 
production by EHEC O157:H7 [165]. This, taken together with the non-significant 
presence of Gb3 on bovine terminal rectal mucosa strongly indicates that Stx are not 
expressed or if expressed, only at very low levels at the colonisation site, presumably 
where the mucosal barrier is breached. In the event of Stx expression, the toxin 
would either enter the intestinal epithelial cells via a Gb3-independent manner and 
may follow a lysosomal degradation route [142] or travel across the epithelial layer 
to the lamina propria/lymph nodes via an interrupted epithelial barrier (e.g. due to the 
A/E lesions or Stx-induced damage) [159] or transcytose across epithelial monolayer 
efficiently under microaerobic conditions, enhanced in the presence of EHEC 
O157:H7 colonisation [165]. Then it can be presumed that the translocated toxins 
may modulate the immune responses ensuring persistence of replicating bacterial 
colonies without reduced interference from the bovine immune system, leading to 
higher numbers of bacterial shedding. Based on studies and modelling of individual 
animal shedding curves, it was estimated that the bovine innate immune response 
will negate bacterial replication and reduce bacterial attachment or increase epithelial 
detachment from the terminal rectum between 5 to 9 days after bacterial challenge 
[552]. The shedding curves in the calves infected with EHEC O157:H7 Strain 9000 
PT21/28 peaked between 3 to 10 days post challenge at high levels (> 103 
C.F.U/gram of faeces) [384]. It is therefore important for EHEC to be able to 
immediately establish intimate attachment as soon as it reaches the terminal rectum 
to allow ample time to replicate at a higher rate.  It should however be reminded that 
these infection models were carried out with a large bolus of bacteria (1010) which do 
not reflect infection events occurring in the real world and therefore may induce a 
much stronger response that might overwhelm and mask the immunomodulation 
events occurring within the animals. Transmission studies employing an improved 
calves infection model with EHEC O157:H7 of different Stx phage types is currently 
on going to clarify the shedding curves and further the understanding of such 
complex interaction during colonisation in vivo. 
 
As “super-shedder” cattle tend to be associated with excreting Strain PT21/28 




faster than other strains due to the double Stx phage content present on its genome. 
Having assessed the competition growth rate assay results, the growth rate and 
fitness of PT21/28, its double Stx phage mutant strain as well as PT32, these did not 
seem to differ. It is also not known if the Stx phage mutants of the bovine isolates 
have developed resistance towards the Stx phage(s) previously present on the 
genome. From another point of view, Stx phages could be used as a ‘weapon’ 
attacking the susceptible, Stx phage negative strains and directly inducing lysis 
resulting in killing the ‘weaker’ strain [526]. The alternating peaks seen in the 
competition growth curves between the K12 and K12-SP5+ strain may demonstrate 
the predator-prey relationship mentioned [539]. Despite not observing the PT21/28 
or PT32 as winners when competed against the isogenic Stx phage mutants, or 
between the two bovine isolates, the retention of the integrated prophages on the 
bacterial genome provides a strong basis for the phage to be beneficial to the 
bacterial host. More experiments are required, encompassing Stx phage 
characterisation and infectivity of EHEC O157:H7 strains to animal co-infection 
model with two strains (Stx phage + and mutants) that are able to reach and colonise 
the terminal rectum and similarly observe for any ‘winning’ strain, but in a highly 
complex environment, with the presence of commensal bacterial strains and other 
eukaryotes as well as other intestinal lumen conditions (oxygen levels, pH, 
temperature, nutrient availability).  
 
 EHEC O157:H7 adherence to intestinal epithelial cells was shown to be 
significantly be affected with the T3SS being repressed upon lysogeny, indicating the 
involvement of phage elements in the complex regulatory circuitry of T3SS [257]. In 
that study, the authors showed a significantly higher expression of EspD in PT32 
than PT21/28 and suggested for the presence of Stx2a-phage to repress the T3SS 
upon lysogeny. They also presented results associating the cII protein of the Stx2 
phage with the repression of the T3SS activation. The current findings in this study 
did not show striking differences in the binding capacities between the wild type and 
the Stx phage mutants of Strain PT21/28 and PT32. In addition, the Western blot for 
EspD expression in Strain PT21/28, Strain PT32 and the isogenic mutants for 




mutant strains, which contrasted with the findings by Xu, et al. [257]. At this point, it 
could only be speculated for the differences in phenotypes observed between the 
current and the previous studies to be related to the prophage and LEE regulatory  
networks, although evidence is required to prove this hypothesis. The insertion 
sequence recently detected by a member of the group that was proposed to contribute 
to the lack of Stxs production in the Strain 9000 ϕStx2c, could also be related to the 
T3SS and adherence phenotype observed in Strain 9000. Moreover, as indicated in 
the Discussion section of Chapter 4, there were issues encountered with the method 
used in this study to partly quantify bacterial binding to eukaryotic cells and 
therefore alternative ways to quantitate bound cells is required, such as flow 
cytometry which could produce more reliable, consistent and accurate results, in 
addition to providing other information including the number of bacterial cells 
attached to one host cell. Future work may also adopt the microaerobic, vertical 
chamber diffusion system protocol developed by Schuller and Phillips [205] to infect 
intestinal epithelial cells for a more optimised conditions and obtain better accuracy 
in assessing binding capacities between the EHEC O157:H7 strains. The authors also 
reported for an enhanced T3SS expression under low oxygen conditions, which may 
further optimise the experimental conditions and improve accuracy of the findings. 
Efforts to estimate important physiological parameters (oxygen levels, pH) at the 
bovine terminal rectum would therefore facilitate the development of a binding assay 
protocol that would produce results reflecting the actual binding conditions during a 
in vivo colonisation, in addition to using bovine intestinal epithelial cells rather than 
cells of human-origin. Lastly, the development of such in vitro models may be more 
cost-effective than carrying out experiments in live cattle. 
 
The Galleria mellonella infection model with EHEC O157:H7 isolates 
provided an insight into the relative virulence levels, especially between the bovine 
isolates and their Stx phage mutants. The most significant outcome obtained was that 
the double Stx phage mutants had higher virulence level than its parental strains 
(PT21/28 and Sakai strains). This seems to contrast with the expectation that any 
strain that is able to produce Stx, in particular, Stx2a, should be able to induce severe 




highly likely that the G. mellonella larvae are not susceptible to the adverse effects of 
Stxs. Moreover, the T3SS does not appear to be a factor contributing to virulence 
observed in the moth model (personal communications with Andy Roe, University of 
Glasgow, U.K.). This may explain the findings from Chapter 4 where despite having 
similar negligible levels of T3SS, the double Stx-phage knockout of Strain 9000 
produced higher mortality rates than the single Stx-phage mutants and the parental 
Strain 9000. The differences in virulence levels of the strains are believed to be of 
other, unidentified factors which remains to be investigated. Little is known with 
regard to the innate and adaptive immune system of the G. mellonella, in addition to 
the lack of information on the real fate of the bacterial cells once inoculated into the 
larvae. Indeed we are still far in understanding and explaining the differences 
between the pathogenicity levels of EHEC O157:H7 in the larvae, justifying the need 
to unravel the events post-inoculation both in the bacteria and in the larvae.  
 
Moving forward, perhaps the answer for other factors involved in the 
persistence and super-shedding behaviour of Stx-phage bearing EHEC O157:H7 
strains lies in the bacterial-grazing protozoa residing in the bovine gut as eukaryotic 
commensals [553]. Published reports suggested that the bacterial predatory protozoa 
is an important factor in shaping the structure of bacterial strains inhabiting a 
particular ecosystem including that of EHEC O157:H7 [554-556]. Since the 
predatory-prey interactions could seriously reduce the population size of the EHEC 
O157:H7 in the ruminant reservoir, it was hypothesised that EHEC have evolved and 
developed anti-predatory mechanisms including Stx to primarily escape death by 
protozoan ingestion, before the Stx phages were maintained in the bacteria due to the 
benefits conferred. Later, Stx would have then evolved and adapted as a virulence 
factor creating pathogenesis in humans [557]. Stx was shown to be toxic to the 
predatory protozoa, Tetrahymena thermophila [558]. Moreover, EHEC O157:H7 
cells were able to survive in the food vacuoles of T. thermophila following ingestion 
up to 90 min, a time length that is ample for the delivery of Stx to the protozoa [554, 
559]. Interestingly, EHEC O157:H7 strains containing Stx prophages were favoured 
for ingestion by the T. thermophila over strains lacking the Stx phages [554]. To 




needed. The strategy used by EHEC O157:H7 to survive and outlast the protozoa is 
probably akin to the macrophage ingestion of the bacteria where EHEC O157:H7 
were able to survive and produce Stx whilst inside the macrophages [449]. This 
could also be used as a strategy to increase the affinity of immune cells towards the 
EHEC O157:H7-ingested protozoa for destruction, which will release Stxs produced 
by the ingested bacteria. The more aggressive a strain is, the more toxins will be 
expressed and therefore increasing the mortality rate of the protozoa while at the 
same time releasing higher magnitudes of Stxs in the intestine. There is going to be a 
very interesting ‘trade-off’ between the value of the toxin to the strain, prophage and 
the obvious point that the strain has to lyse to release Stxs. It may therefore be 
important for the strain to modify the behaviour to become less aggressive as a way 
to address that balance.   
Conclusion 
 This thesis was dedicated to unravel the association between bovine intestinal 
colonisation by EHEC O157:H7 with both Stx and bacteriophages carrying the Stx 
genes. It was hypothesised that the successful propagation of EHEC O157:H7 is 
impacted by the integrated Stx prophages on the bacterial chromosome. However, 
despite carrying the stx genes encoding for the major virulence factor implicated in 
human infections, there was no evidence to support toxin production from EHEC 
O157:H7 by phage-directed lysis within the mucus of the terminal rectum. Besides, 
many non-EHEC strains are able to produce Stxs, including non-pathogenic, 
commensals or environmental strains by acquisition of the stx genes via lateral gene 
transfer events [94, 560, 561] and this may indicate for the presence of other more 
important factors that dictates the persistence of EHEC O157:H7 at the bovine gut. 
At the same time, Gb3, the Stx receptor acting as cell surface marker on toxin-
sensitive cells, was not found to be significantly present along the terminal rectal 
epithelial mucosa layer. The lack of convincing evidence so far to support the role of 
Stxs together with the lack of significant Stx expression by the bovine isolated 
EHEC O157:H7 strains in bovine terminal rectal mucus strongly suggest that Stx 
production is not an important bacterial factor in determining the success of the 




facilitating the bacterial colonisation process via enhancement of bacterial adherence 
to the host cells (nucleolin upregulation acting as intimin receptor [241]) may be 
significant under circumstances where Stx production is evident, particularly in 
susceptible, Gb3 positive human tissues.  
 
On the role of Stx phages in EHEC O157:H7 colonisation, despite the lack of 
mechanistic explanation for alterations observed in colonisation and virulence traits 
among bacteria possessing different Stx phage types, evidence presented in Chapter 
4 shows that different types of Stx-encoding phages are able to influence 
important phenotypic traits of EHEC O157:H7 during colonisation at the 
bovine intestine. Interactions involving the Stx phage, bacterial host and the bovine 
terminal rectum presumably occurs via a complex regulatory network to facilitate 
bacterial adaptation to the niche. Perhaps the Stx prophages are expressed in a 
chronological manner, for example by only a small subset of bacteria in the early 
hours of the interaction, to produce Stx which promotes the upregulation of the 
intimin receptor, nucleolin to strengthen the A/E lesion or by the act of infective 
phage particles infecting and killing the commensal species residing on the outer 
mucosal layer of the rectum, allowing replacement of the commensal flora by EHEC 
O157:H7. After a while a Stx phage could pose as a liability to the survival of EHEC 
O157:H7 as some of the susceptible strains could then be lysogenized and become 
resistant to Stx phages creating a new competitor that will receive all benefits 
conferred by the Stx phage. To overcome this, the EHEC O157:H7 may lose the Stx 
phage to avoid losing out to the emerging lysogen-converted strains which have been 
described to occur during certain phases of the life cycle of the non-motile sorbitol-
fermenting E. coli O157 isolated from human stools [562]. The Stx phages could be 
regained into EHEC O157:H7 when the situation requires it to happen, for example 
before excretion out of the cattle to ensure possessing the correct repertoire of genes 
for survival and virulence upon transmission to human hosts.  
 
 The final conclusion of my work is i) different Stx-encoding phages are 
able to control different phenotypic traits of EHEC O157:H7 during 




play a role in EHEC O157:H7 colonisation at the bovine terminal rectum. On 
going work aims to understand Stx phage epidemiology and the differences 
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Strain-Dependent Cellular Immune Responses in Cattle following
Escherichia coli O157:H7 Colonization
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Enterohemorrhagic Escherichia coli (EHEC) O157:H7 causes hemorrhagic diarrhea and potentially fatal renal failure in humans.
Ruminants are considered to be the primary reservoir for human infection. Vaccines that reduce shedding in cattle are only par-
tially protective, and their underlying protective mechanisms are unknown. Studies investigating the response of cattle to colo-
nization generally focus on humoral immunity, leaving the role of cellular immunity unclear. To inform future vaccine develop-
ment, we studied the cellular immune responses of cattle during EHEC O157:H7 colonization. Calves were challenged either
with a phage type 21/28 (PT21/28) strain possessing the Shiga toxin 2a (Stx2a) and Stx2c genes or with a PT32 strain possessing
the Stx2c gene only. T-helper cell-associated transcripts at the terminal rectum were analyzed by reverse transcription-quantita-
tive PCR (RT-qPCR). Induction of gamma interferon (IFN-!) and T-bet was observed with peak expression of both genes at 7
days in PT32-challenged calves, while upregulation was delayed, peaking at 21 days, in PT21/28-challenged calves. Cells isolated
from gastrointestinal lymph nodes demonstrated antigen-specific proliferation and IFN-! release in response to type III secreted
proteins (T3SPs); however, responsiveness was suppressed in cells isolated from PT32-challenged calves. Lymph node cells
showed increased expression of the proliferation marker Ki67 in CD4" T cells from PT21/28-challenged calves, NK cells from
PT32-challenged calves, and CD8" and !# T cells from both PT21/28- and PT32-challenged calves following ex vivo restimula-
tion with T3SPs. This study demonstrates that cattle mount cellular immune responses during colonization with EHEC O157:
H7, the temporality of which is strain dependent, with further evidence of strain-specific immunomodulation.
Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a bac-terial zoonotic disease of global importance (1). Ruminants,
particularly cattle, are the predominant reservoir, and humans
become infected following fecal contamination of food, the envi-
ronment, and water (2–6). Many cases are sporadic (7); however,
large outbreaks occur periodically. While colonization of cattle is
largely asymptomatic (8), humans typically develop painful hem-
orrhagic diarrhea. A significant minority of patients progress to
potentially fatal hemolytic-uremic syndrome (HUS), a form of
renal failure resulting from Shiga toxin (Stx; also known as vero-
toxin)-induced endothelial dysfunction (9).
Significant efforts have been made in abattoirs and meat-pro-
cessing plants to reduce the contamination of beef produce
reaching the consumer. While these efforts have been partially
successful, food-borne outbreaks have not been eliminated,
and environmental transmission remains unmitigated. A range of
on-farm interventions have been proposed to reduce bacterial
shedding by cattle, including dietary manipulation, phage ther-
apy, antimicrobial treatment, probiotic administration, and vac-
cination (10–15). Recent reviews and meta-analyses have identi-
fied probiotics and vaccines as the most tractable and efficacious
control measures (12, 16, 17). Two commercial vaccines have
been developed to date. One involves a method of extraction from
bacteria cultured under iron-restricted conditions that enriches
for membrane components (Epitopix, Willmar, MN, USA). The
other is a supernatant preparation that contains type III secreted
proteins (T3SPs) (Econiche; Bioniche Life Sciences, Belleville,
Ontario, Canada). Vaccination of cattle with recombinant T3SPs
has been demonstrated to reduce colonization rates in cattle, an
effect enhanced by the addition of H7 flagellin (18, 19).
To our knowledge, the mechanism of protection of these vac-
cines has not been demonstrated. EHEC O157:H7 uses its type III
secretion system (T3SS) to deliver a range of effector proteins to
host epithelial cells (20, 21). The T3SS includes an EspA translo-
con filament, capped by the pore-forming EspB/EspD (EspB/D)
complex. The construction of the translocon and the delivery of
effector proteins by the T3SS are carefully regulated (22). Injected
effectors include the translocated intimin receptor (Tir), which
binds to the bacterial surface protein intimin and is central to the
formation of actin pedestals and intimate attaching and effacing
(A/E) lesions (23). It is reasonable to hypothesize that antibodies
directed against the structural components of the T3SS, such as
EspA/B/D, or against adhesion factors, such as intimin and its
cognate receptor Tir, may block bacterial binding. In support of
this hypothesis, vaccination of sows with intimin has been shown
to reduce the level of EHEC O157:H7 colonization of suckling
piglets (24), presumably through antibody-mediated blocking of
bacterial binding. In addition, bovine colostrum has been shown
to reduce T3SS-mediated hemolysis in vitro (25), and passive
transfer of EspB, intimin, and neutralizing antibodies against Stx2
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to calves has been demonstrated following maternal vaccination
(26). H7 flagellin has also been demonstrated to act as an adhesion
factor, and anti-H7 antibodies reduce the level of binding of bac-
teria to primary cell cultures (27).
Despite high antibody titers following vaccination with these
antigens, vaccination is only partially protective (13, 14, 28–31),
while antibody titers are inconsistently correlated with bacterial
shedding (32–34). The serological response of cattle to coloniza-
tion has also been studied extensively, and antibodies against
O157 lipopolysaccharide (LPS), H7, Tir, intimin, EspA, EspB,
EspD, EspM2, NleA, TccP, Stx1, and Stx2 have been demonstrated
(25, 33–36). Despite this, prior exposure to EHEC O157:H7 re-
sults in only partial and transient protection against reinfection
(33, 34, 37).
While cattle can shed detectable levels of EHEC O157:H7 for a
considerable period, most animals are able to clear the infection
successfully (37–39). Given the limitations of antibody-mediated
protection, it is likely that other innate and adaptive responses
play important roles in bacterial clearance. It is also rational to
hypothesize that once a microcolony has formed on an epithelial
cell, and its cellular processes are thus being manipulated by se-
creted bacterial effectors, the best way of effectively clearing the
infection is to dispose of the colonized cell. This raises the prospect
of an important role for cellular immunity in bacterial clearance.
However, to our knowledge, only two studies have considered the
role of cellular immunity during EHEC O157:H7 colonization in
ruminants; these identified lymphoproliferative cellular responses
to heat-killed EHEC O157:H7 (40) and recombinant antigens
(41) in bovine peripheral blood mononuclear cells and ovine rec-
tal lymph node cells, respectively. The case for a protective cellular
immune response is further strengthened by the observations that
colonized bovine epithelial cells are exfoliated in vivo (42) and that
some strains are efficiently internalized by bovine epithelial cells
both in vivo and in vitro (43).
While colonization of mice by Citrobacter rodentium has been
used as a model for study of the interaction of an A/E lesion-
forming bacterium with its mammalian host (44), none of the
mouse models reported to date have demonstrated convincing
colonization and A/E lesion formation with EHEC O157:H7 (45–
51). The relevance of studies on mice to the interaction of EHEC
O157:H7 with its natural bovine host is therefore unclear. In ad-
dition to being the natural reservoir of infection, cattle can also be
sampled repeatedly during colonization, allowing one to control
for interanimal variation resulting from the use of outbred popu-
lations.
We hypothesized that by quantifying T-helper cell-associated
gene transcripts at the terminal rectums of cattle during the course
of EHEC O157:H7 colonization, it would be possible to identify
and determine the direction of the cellular immune response at
the primary site of colonization. Our results show that there is a
TH type 1 skew to the response at the rectal mucosa, the temporal
nature of which differs by strain, and that colonization with both
the PT21/28 and the PT32 strain results in an increase in the pro-
portion of CD4! T cells within the rectal mucosal T-cell popula-
tion. We also present data analyzing regional lymph node re-
sponses to bacterial proteins that suggest a role for both innate and
adaptive cellular immunity in the bovine response to coloniza-
tion.
MATERIALS AND METHODS
Bacterial strains, inocula, and T3SP preparation. The strains used in this
study are listed in Table 1. Glycerol stocks were resuscitated on lysogeny
broth (LB) agar and were incubated at 37°C overnight. To generate the
inocula for the calf studies, a single colony of strain 9000 (phage type 21/28
[PT21/28]), PT32 strain 10671, Zap1380 (a naturally derived nalidixic
acid [Nal]-resistant variant of 9000), or Zap1381 (a naturally derived
Nal-resistant variant of 10671) was used to inoculate separate flasks of LB,
which were incubated at 37°C overnight. Inocula for each calf were pre-
pared by mixing 5 ml of an overnight LB culture of 9000 with 5 ml of an
overnight LB culture of Zap1380 or by mixing 5 ml of an overnight LB
culture of 10671 with 5 ml of an overnight LB culture of Zap1381, repre-
senting a final dose of "1 # 109 CFU per calf.
To generate the T3SP preparations for the study of antigen recall re-
sponses, a single colony of Zap193 (wild type [WT]) or Zap1143 ($sepL)
was used to inoculate 10 ml LB, which was incubated at 37°C (200 rpm)
overnight. The WT strain secretes predominantly structural components
of the T3SS, while the $sepL strain instead secretes a wider variety of
effector proteins (52). Two milliliters of the overnight culture was used to
inoculate 500 ml minimal essential medium (MEM)-HEPES (Sigma-Al-
drich, Gillingham, United Kingdom), which was cultured at 37°C (200
rpm) to an optical density at 600 nm (OD600) of 0.8. Bacteria were pel-
leted, and supernatants were filter sterilized (0.2-%m low protein binding
filters; Millipore, Watford, United Kingdom). Proteins were precipitated
overnight at 4°C using trichloroacetic acid (VWR International, Lutter-
worth, United Kingdom) at a final concentration of 10% (vol/vol). Pre-
cipitated proteins were pelleted at 5,000 # g for 30 min at 4°C and the
supernatant discarded. Pellets were suspended in 1.5 M Tris-HCl (pH 8.8)
and were dialyzed in phosphate-buffered saline (PBS) across a regener-
ated cellulose membrane with a molecular size cutoff rating of 3.5 kDa
(Spectrum Labs, Breda, The Netherlands). Protein preparations were
checked by separation using sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and were stained with Coomassie blue (In-
vitrogen, Paisley, United Kingdom) (see Fig. S1 in the supplemental ma-
terial). The total-protein concentration was estimated using a bicin-
choninic protein assay kit (Pierce Biotechnology, Rockford, IL, USA) and
was read using a microplate reader at 562 nm (Dynex Technologies,
Worthing, United Kingdom). The lipopolysaccharide (LPS) concentra-








9000 (WX009000S01E) stx2a, stx2c PT21/28 Cattle feces None 86
Zap1380 stx2a, stx2c PT21/28 Strain 9000 Nal
r This study
10671 (WX010671S01E) stx2c PT32 Cattle feces None 86
Zap1381 stx2c PT32 Strain 10671 Nal
r This study
Zap193 (NCTC 12900) (WT) None NAb NCTCa None NCTC
Zap1143 ($sepL mutant) None NA Strain Zap193 Nalr, $sepL 52
a National Collection of Type Cultures (NCTC), Public Health England (https://www.phe-culturecollections.org.uk/collections/nctc.aspx).
b NA, not available.
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tion was estimated using the EndoLISA kit (Hyglos GmbH, Bernried,
Germany) and was read using a Synergy HT microplate reader (BioTek,
Winooski, VT, USA) fitted with 360/40-nm wavelength excitation and
460/40-nm wavelength emission filters.
Animal experiments. Oral bacterial challenge was performed at the
Moredun Research Institute (MRI) under Home Office license 60/3179.
Ethical approval was obtained from the MRI Animal Experiments Com-
mittee. Two groups of six conventionally reared male dairy calves were
randomly assigned to separate rooms in the MRI High Security Unit
(HSU). Two calves were housed in conventional pens. The average age of
the calves at the time of challenge was 12 ! 2 weeks. At this age, all the
animals were weaned, i.e., they were ruminants yet small enough to be
handled safely in the HSU. Fecal samples obtained from each calf prior to
challenge were confirmed to be negative for EHEC O157:H7 by immuno-
magnetic separation (IMS) performed according to the manufacturer’s
instructions (anti-EHEC O157 Dynabeads; Invitrogen). Five additional
age-matched calves that had been used as controls in other studies were
used as sources of additional lymph node and rectal mucosal samples.
Fecal samples collected postmortem from these calves were screened for
the presence of EHEC O157:H7 using IMS. EHEC O157:H7 was not iso-
lated from any of the samples.
Four calves in one HSU room were orally challenged by orogastric
intubation with 500 ml PBS containing 10 ml of an overnight LB culture of
strain 9000 and its naturally derived Nal-resistant variant. Four calves in
the other HSU room were orally challenged in the same way with strain
10671 and its naturally derived Nal-resistant variant. The other two calves
(sentinels) in each HSU room were administered 500 ml PBS only.
Three days after oral challenge, 10 g surface feces taken directly from
the rectum was suspended in 90 ml sterile PBS. Samples were collected
daily for the first 2 weeks and then every other day. Tenfold serial dilutions
were prepared in PBS, and 100 "l from three dilutions across a 1,000-fold
range of dilutions was plated out in triplicate onto cefixime-tellurite sor-
bitol MacConkey agar (CT-SMAC) plates. Resuspended feces were stored
at 4°C overnight. Plates were incubated at 37°C overnight and colonies
enumerated at the most suitable dilution. Five to 10 colonies from each
plate were confirmed as O157 positive by using a latex agglutination kit
(Oxoid, Basingstoke, United Kingdom). The CFU per gram of feces was
calculated by multiplying the mean colony count of the triplicate plates by
the appropriate dilution factor. Where no colonies were observed, broth
enrichment was carried out with 1 ml of the resuspended feces added to 9
ml tryptone soya broth (TSB; Oxoid). TSBs were incubated at 37°C over-
night and were plated onto CT-SMAC plates. Overnight bacterial growth
was tested for O157 by latex agglutination. Feces that were negative by
direct plating but positive after broth enrichment were assigned a value of
10 CFU/g.
Rectal biopsy specimens were taken at #5, 7, 14, 21, and 31 days
postchallenge. A local anesthetic was applied to the anal sphincter (5%
EMLA; Astra Zeneca, Luton, United Kingdom). A rectal speculum (Vet-
erinary Instrumentation, Sheffield, United Kingdom) was used to access
the rectal mucosa. Pinch biopsy specimens from the rectal mucosa were
taken from two opposing sites approximately 5 cm proximal to the recto-
anal junction. The position of each biopsy specimen was recorded, and the
site was avoided at subsequent samplings. Biopsy specimens were imme-
diately placed into RNAlater (Ambion, Paisley, United Kingdom) and
were stored at 4°C overnight before storage at #80°C.
At the end of the trial (31 to 33 days), calves were killed using 60 ml
intravenous pentobarbital (Animalcare, York, United Kingdom). Rectal
lymph nodes (RLN), mesenteric lymph nodes (MLN) (100 cm proximal
to the ileocecocolic junction) and prescapular lymph nodes (PsLN) were
collected and were transported in 35 ml preparation medium (Hanks
buffered saline solution [HBSS] without calcium and magnesium, 2%
heat-inactivated [56°C, 30 min] fetal calf serum [HI-FCS], 10 mg/ml gen-
tamicin [Sigma-Aldrich], 200 IU/ml penicillin, and 200 "g/ml streptomy-
cin). A 0.5-cm-wide strip of rectal mucosa was dissected and was placed in
PBS containing 2 mg/ml polymyxin B (Sigma-Aldrich) for subsequent
isolation of rectal mucosal lymphocytes.
Assessment of gene expression. RNA was extracted from the rectal
biopsy specimens using the RNeasy Plus minikit (Qiagen, Hilden, Ger-
many). Biopsy specimens were disrupted in Precellys CK28 tubes using 5
23-s cycles at 6,200 rpm in a tissue homogenizer (Peqlab, Salisbury Green,
United Kingdom). Tubes were put on ice for 2 min between cycles. Re-
sidual DNA was digested on the column with DNase I (Qiagen). The RNA
yield was measured using a NanoDrop ND1000 spectrophotometer
(Thermo Scientific, Waltham, MA, USA) and RNA quality assessed using
an RNA 6000 Nano kit for total RNA and a model 2100 Bioanalyzer
(Agilent Technologies, Wokingham, United Kingdom). All RNA samples
had an RNA integrity number (RIN) score of $7.0.
cDNA was synthesized as per the manufacturer’s instructions, using
SuperScript II (Invitrogen) reverse transcriptase (RT), RNAseOUT (In-
vitrogen), a deoxynucleoside triphosphate (dNTP) mixture (Invitrogen),
and oligo(dT)23 primers (Sigma-Aldrich), from 1 "g RNA, where 0.5 "g
was pooled from each of the two biopsy specimens taken at each time
point. The reaction volume was 20 "l. Cycling conditions were as follows:
42°C for 2 min followed by the addition of reverse transcriptase, 42°C for
50 min, and 70°C for 15 min. cDNA was diluted 3-fold using PCR water
and was stored at #20°C prior to use.
Quantitative PCR (qPCR) was conducted in triplicate in 96-well qPCR
plates using Precision master mix with ROX (Primer Design, Southamp-
ton, United Kingdom) and an ABI Prism 7000 or ABI Prism 7500 (Ap-
plied Biosystems, Paisley, United Kingdom) qPCR instrument as per the
manufacturer’s instructions. The reaction volume was 20 "l. Cycling con-
ditions were 95°C for 15 min and 50 cycles of 95°C for 15 s and 60°C for 60
s, during which time fluorescence was read, followed by melting curve
analysis.
Reference genes were selected using the bovine geNorm kit (Primer
Design) containing primers for ATP5B, eukaryotic initiation factor 2,
subunit beta (EIF2B2), actin, beta (ACTB), succinate dehydrogenase
complex, subunit A (SDHA), RPL12, and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). qPCRs were prepared using 5 "l cDNA from
each time point for three animals. qBasePLUS2 software, version 2.4
(Biogazelle, Zwijnaarde, Belgium), was used to select the GAPDH and
ATP5B genes as the most stably expressed genes. Primers and standard
curve plasmids for GAPDH and ATP5B were supplied by Primer Design
and were used as per the manufacturer’s instructions. All other primers in
this study were supplied by Eurofins Genomics (Acton, United King-
dom).
Plasmids for standard curve generation for bovine interleukin 10 (IL-
10), transforming growth factor %1 (TGF-%1), gamma interferon (IFN-
&), tumor necrosis factor alpha (TNF-'), IL-4, and IL-13 were available
in-house. Fragments of bovine FoxP3, RAR-related orphan receptor C
(RORC), IL-17, IL-22, T-bet, and GATA3 were cloned using the external
primers shown in Table S1 in the supplemental material, which were
designed using Primer BLAST (NCBI, Bethesda, MD, USA), and their
specificity was checked against the Bos taurus RefSeq mRNA database.
Gene fragments were generated using KOD Hot Start (Millipore) DNA
polymerase, a dNTP mixture (Invitrogen), and bovine cDNA synthesized
from one rectal biopsy sample as per the manufacturer’s instructions. The
reaction volume was 50 "l. Cycling was carried out according to the fol-
lowing touchdown PCR (53) protocol: 95°C for 3 min; 15 cycles of 95°C
for 30 s, 70°C decreasing by 1°C per cycle for 45 s, and 72°C for 60 s; 20
cycles of 95°C for 30 s, 55°C for 45 s, and 72°C for 60 s; and 70°C for 10
min. PCR products were run on a 2% agarose gel and bands of the ex-
pected size excised and purified using the QIAquick gel extraction kit
(Qiagen). Two microliters of the purified amplicon mixture was A-tailed
by incubation with 5 U of GoTaq DNA polymerase (Promega, Southam-
pton, United Kingdom), 2 "l 5( GoTaq DNA master mix (Promega), 1
"l 2 mM dATP (Invitrogen), and 4 "l PCR water for 30 min at 70°C.
A-tailed amplicons were ligated into pGEM-T Easy vector plasmids (Pro-
mega) as per the manufacturer’s instructions.
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Plasmids were used to transform JM109 competent cells (Promega) as
per the manufacturer’s instructions, and the transformed cells were plated
onto LB agar containing 100 !g/ml ampicillin, 80 !g/ml 5-bromo-4-
chloro-3-indolyl-"-D-galactopyranoside (X-gal), and 500 !M isopropyl-
"-D-thiogalactopyranoside (IPTG). Two white colonies for each transfor-
mation were checked by colony PCR using the internal primers shown in
Table S2 in the supplemental material. Internal primers were taken from
the literature or were designed using Primer BLAST (NCBI). Specificity
was checked against the Bos taurus RefSeq mRNA database. One PCR-
positive colony for each gene was used to inoculate 10 ml LB, and the
mixture was incubated at 37°C (200 rpm) overnight. Plasmids were puri-
fied using the Wizard Plus SV Miniprep DNA purification system (Pro-
mega). Plasmids were sequenced by Eurofins Genomics using the T7 and
M13 rev (#29) primers. Sequences were checked against the Bos taurus
RefSeq RNA database using BLAST (NCBI), and internal primers (see
Table S2) were checked using the Sequence Manipulation Suite, version 2
(Bioinformatics Organization, MA, USA). Plasmid molecular weight was
estimated using the Sequence Manipulation Suite by updating the pub-
lished plasmid sequence with the inserted sequences. One microgram of
plasmid DNA was linearized using the restriction enzyme NdeI (Pro-
mega) at 37°C for 30 min. Linearization was confirmed by agarose gel
electrophoresis. Digests were purified using the QIAquick PCR purifica-
tion kit (Qiagen); DNA was quantified; and linearized plasmids were di-
luted using PCR water to 109 copies per !l.
Plasmids were diluted across the dynamic ranges indicated in Table S3
in the supplemental material and were used to generate a standard curve
for each gene on each qPCR plate run. qPCR mixtures were prepared
using 1 !l cDNA/well. For ATP5B, GAPDH, IFN-$, T-bet, IL-17, RORC,
TNF-%, and IL-10, Precision master mix was used as per the geNorm
experiment described above. For the lower-copy-number transcripts
GATA3, FoxP3, IL-4, IL-22, IL-13, and TGF-"1, the SYBR GreenER
qPCR SuperMix (Invitrogen) was used as per the manufacturer’s instruc-
tions. Reactions were performed in duplicate, and the reaction volume
was 25 !l. Cycling conditions were 50°C for 2 min, 95°C for 10 min, and
40 cycles of 95°C for 15 s and 60°C for 60 s, during which time fluorescence
was read, followed by melting curve analysis.
Standard curves were calculated from the threshold cycle (CT) values
using ABI Prism 7000 SDS software, version 1.2.3 (Applied Biosystems),
and the calculated gene copies/!l cDNA were exported in comma-sepa-
rated variable files. An SQL script (MySQL Community Server, version
5.1) was used to calculate the arithmetic mean for the technical repeats
and then to normalize the copy number/!l cDNA for each gene to the
geometric mean copy number/!l cDNA for the reference genes ATP5B
and GAPDH as described previously (54).
Analysis of mucosal T-cell populations. Rectal mucosal strips col-
lected postmortem were cut into 1-cm by 2-cm pieces, placed in 25 ml
digestion medium consisting of Dulbecco’s modified Eagle medium
(DMEM; Sigma-Aldrich) supplemented with 10% HI-FCS, 75 IU/ml col-
lagenase (Sigma-Aldrich), and 20 !g/ml dispase I neutral protease, grade
1 (Roche, Basel, Switzerland), and incubated at 37°C (200 rpm) for 90
min. The digested samples were shaken vigorously and were centrifuged at
405 & g for 5 min. The supernatant was passed through a 100-!m filter
(BD Biosciences, San Jose, CA), made up to 50 ml with lymphocyte me-
dium (RPMI 1640 [Gibco], 10% HI-FCS, 200 mM L-glutamine [Invitro-
gen], 0.004% "-mercaptoethanol [Sigma-Aldrich], 100 IU/ml penicillin,
and 100 !g/ml streptomycin [Invitrogen]), and centrifuged at 405 & g for
5 min. The supernatant was discarded and the pellet resuspended in 50 ml
lymphocyte medium. This process was repeated until the supernatant was
clear after centrifugation. The pellet was resuspended in 10 ml lymphocyte
medium; cells were enumerated; and a V bottom 96-well plate was seeded
with 1 & 106 cells/well. Unless otherwise stated, incubations were carried
out for 30 min at 4°C, and 2% fluorescence-activated cell sorting (FACS)
buffer (2% HI-FCS in PBS) was used for washes and antibody dilutions.
The antibodies used are listed in Table 2. Unstained, no-primary-anti-
body, and single-stained controls were prepared. The cells were washed
once, resuspended, and incubated with anti-bovine CD3 and anti-bovine
CD4, CD8, or TcR1-N24('). The cells were washed three times, resus-
pended, and incubated with anti-mouse IgG1 and anti-mouse IgG2a or
anti-mouse IgG2b for 20 min. The cells were subsequently washed and
were resuspended in 2% FACS buffer. Data were acquired using a FAC-
SCalibur flow cytometer (BD Biosciences) with a total of 10,000 events
collected in the gated region. Compensation and analysis were conducted
using FlowJo, version 7.5 (Tree Star, Ashland, OR, USA).
Ex vivo restimulation experiments. Lymph nodes extracted post-
mortem were first washed twice with 25 ml preparation medium and then
placed in a 100-mm by 25-mm petri dish containing 15 ml preparation
medium. The nodes were repeatedly incised and were then transferred to
a stomacher bag and placed in a stomacher for 30 s. The contents were
then filtered through a 70-!m nylon filter (Fisher Scientific, Loughbor-
ough, United Kingdom) and were made up to 20 ml with preparation
medium. The suspension was underlaid with 10 ml Ficoll-Paque (GE
Healthcare, Little Chalfont, United Kingdom) and was centrifuged at
800 & g for 30 min at 4°C. The mononuclear cells were harvested from the
top of the Ficoll layer and were washed twice in PBS before being resus-
pended in lymphocyte medium. Spare cells were resuspended in 10%
(vol/vol) dimethyl sulfoxide (DMSO; Sigma-Aldrich) in HI-FCS and were
stored in cryovials at 1 & 107 cells/ml in liquid nitrogen. Round-bottom
96-well plates were seeded with 1 & 105 cells/well and were stimulated
with 5 !g/ml WT or (sepL T3SPs. Controls included concanavalin A
(ConA: 5 !g/ml; Sigma-Aldrich), lymphocyte medium, and 38 or 78 en-
dotoxin units (EU)/ml O111:B4 LPS (Sigma-Aldrich), corresponding to
the LPS concentration of the WT or (sepL T3SPs, respectively. Cultures
were incubated for 5 days under a humidified 5% CO2 atmosphere at
37°C. Cultures were pulsed with 1 !Ci/well of [3H]thymidine (PerkinEl-
mer, Waltham, MA) for the final 18 h of incubation by removing 50 !l of
the supernatant and replacing it with [3H]thymidine-containing lympho-
TABLE 2 Antibodies used in this study
Reactivity Clone/host Isotype Conjugate Supplier
Bovine CD3 MM1A IgG1 None Washington State University, Pullman, WA
Bovine CD4 ILA12 IgG2a None In-house
Bovine CD8 ILA105 IgG2a None In-house
Bovine TcR1-N24(') GB21A IgG2b None Washington State University, Pullman, WA
Bovine NKp46 AKS1 IgG1 Alexa Fluor 488 AbD Serotec, Oxford, UK
Bovine IFN-$ CC302 IgG1 Alexa Fluor 647 AbD Serotec, Oxford, UK
Mouse IgG Goat NAa Alexa Fluor 488 Molecular Probes, Paisley, UK
Ki67 Rabbit NA None Abcam, Cambridge, UK
Rabbit Ig Goat NA Alexa Fluor 405 Molecular Probes
Mouse IgG1 Goat NA Alexa Fluor 647 Molecular Probes
Mouse IgG2a Goat NA Phycoerythrin Molecular Probes
Mouse IgG2b Goat NA Alexa Fluor 488 Molecular Probes
a NA, not applicable.
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cyte medium. The removed supernatants were stored at !20°C prior to
use. Cells were harvested onto glass fiber filters (PerkinElmer, Waltham,
MA, USA). [3H]thymidine incorporation was quantified using an auto-
mated scintillation counter (PerkinElmer) and was expressed as counts
per minute, with each test performed in triplicate. Stimulation indices (SI)
were calculated by dividing the mean value for ConA by the mean value
for the medium control or by dividing the mean value for the T3SPs by the
mean value for the relevant LPS control.
IFN-" release was measured using high-binding 96-well enzyme-
linked immunosorbent assay (ELISA) plates (Corning, Amsterdam, The
Netherlands) and a commercial bovine IFN-" ELISA kit (Mabtech AB,
Nacka Strand, Sweden) as per the manufacturers’ instructions. Results
below the limit of detection were assigned a value of 16 pg/ml. The super-
natants of triplicate wells harvested as described above were pooled, and
IFN-" was assayed in duplicate. IFN-" release indices were calculated by
dividing the mean value for ConA by the mean value for the medium
control or by dividing the mean value for the T3SPs by the mean value for
the relevant LPS control.
Proliferation marker expression. For each animal, one vial of rectal
lymph node cells stored in liquid nitrogen was resuscitated in lymphocyte
medium and was used to seed round-bottom 96-well plates at 5 # 105
cells/well. Cells were stimulated in duplicate with 5 $g/ml heat-treated
(110°C for 30 min) WT T3SPs. Controls and culture conditions were as
described above. Brefeldin A (10 $g/ml; Sigma-Aldrich) was added for the
final 5 h of incubation by removing 50 $l of the supernatant and replacing
it with spiked lymphocyte medium. Duplicate stimulated cultures were
first pooled and then split evenly between 6 wells of a 96 well round-
bottom plate.
The antibodies used are listed in Table 2. Unless stated otherwise,
incubation was carried out for 30 min at 4°C, and 5% FACS buffer (5%
HI-FCS, 0.02% sodium azide in PBS) was used for washes and antibody
dilutions. Unstained, no-primary-antibody, single-stained, and fluores-
cence-minus-one (FMO) controls were prepared. Cells were pelleted, re-
suspended, and incubated with anti-bovine CD4, CD8, TcR1-N24(%), or
NKp46. Cells were washed twice, resuspended, and incubated with anti-
mouse IgG. Cells were washed twice with PBS and were incubated with
Live/Dead Fixable Near-IR reactive dye (Invitrogen) in 0.1% DMSO in
PBS. Cells were washed in PBS and were fixed using 1% paraformaldehyde
for 10 min at room temperature. Cells were washed in PBS and were
permeabilized overnight in permeabilization/block buffer (5% FACS buf-
fer, 0.2% saponin [Sigma-Aldrich], 20% heat-inactivated mouse serum
[Invitrogen]). Cells were pelleted, resuspended, and incubated for 1 h
with anti-bovine IFN-" and anti-Ki67 in permeabilization buffer (5%
FACS buffer, 0.2% saponin). Cells were washed twice in permeabilization
buffer, resuspended, and incubated for 1 h with anti-rabbit Ig in permea-
bilization buffer. Cells were washed twice in permeabilization buffer and
were resuspended in PBS. The entire sample was analyzed using a MACS-
Quant flow cytometer (Miltenyi Biotec, Surrey, United Kingdom). Com-
pensation and data analysis were conducted using FlowJo, version 10.0.7
(Tree Star). The gating strategy is shown in Fig. S2 in the supplemental
material.
Statistical analysis. Statistical analysis of RT-qPCR data was per-
formed using SAS, version 9.3 (SAS Institute Inc., Cary, NC, USA). All
other statistical analyses and plotting of graphs were performed using R,
version 3.1.0 (55), and the ggplot2 (56), lattice (57), nlme (58), lme4 (59),
plyr (60), reshape (61), multcomp (62), grid (55), gridExtra (63), and
lsmeans (64) packages.
T-helper cell-associated gene copy numbers were analyzed for the four
orally challenged calves in each group and the two control calves. The fold
change in gene expression from the prechallenge level was calculated for
each gene and was log10 transformed. These log values were analyzed
using linear mixed models, with log10 prechallenge gene copies, experi-
mental group, days postchallenge, and the interaction of the experimental
group with the number of days postchallenge fitted as fixed effects. Ani-
mals were fitted as random effects. The use of log values ensured that
normality requirements for the mixed model were satisfied.
Flow cytometry counts of surface marker-positive versus surface
marker-negative CD3& T cells isolated from the terminal rectum were
analyzed using generalized linear models. These fitted the experimental
group as the only explanatory variable and fitted a dispersion parameter to
allow for overdispersion in the data. Comparisons between each pair of
experimental groups were made using Tukey tests. Flow cytometry counts
of Ki67-positive versus Ki67-negative, surface marker-positive rectal
lymph node cells were also analyzed using generalized linear models with
the experimental group, the ex vivo stimulant, and the interaction of the
experimental group with the ex vivo stimulant fitted as explanatory vari-
ables, and a dispersion parameter was included to allow for overdisper-
sion in the binomial data. Comparisons between each pair of experimen-
tal groups were made using Tukey tests.
Log10-transformed thymidine incorporation, IFN-" release, stimula-
tion indices, and IFN-" release indices were analyzed using linear mixed
models with restricted maximum likelihood. The models fitted the exper-
imental group, ex vivo stimulant, and lymph node as fixed effects. Addi-
tionally, two-way interactions between every two main effects were tested
and were retained in the model if significant. The animal, the interaction
of the animal with the lymph node, and the interaction of the animal with
the stimulant were fitted as random effects. Comparisons between each
pair of experimental groups were made using Tukey tests. When there was
a significant interaction between the experimental group and the lymph
node or stimulant, pairwise comparisons were made within the results for
each lymph node or stimulant, again using Tukey tests.
RESULTS
Bacterial shedding. Individual shedding curves for each calf are
shown in Fig. 1. EHEC O157:H7 was detectable at '103 CFU/g
feces in all orally challenged calves from the first sampling at 3 days
postchallenge until days 8 and 10 for the PT32 and PT21/28
strains, respectively, with peak shedding occurring between days 3
and 7. Bacteria were present at '103 CFU/g in both sentinel calves
in the PT21/28 group from the first sampling until day 10, with
peak shedding occurring at days 6 and 8. Shedding did not exceed
103 CFU/g until day 4 for one of the two PT32 sentinel calves and
exceeded 103 CFU/g only on day 8 for the other, with peak shed-
ding occurring at days 7 and 8. Shedding after day 10 was more
heterogeneous in all calves, with some animals exceeding 103
CFU/g at multiple samplings while others remained below 103
CFU/g for the remainder of the study. These results confirm that
the subsequent immunological analyses were conducted on suc-
cessfully colonized animals.
Gene expression at the terminal rectum during colonization.
The inflammatory transcript TNF-(, TH1-associated transcripts
IFN-" and T-bet, TH2-associated transcripts IL-4, IL-13, and
GATA3, TH17-associated transcripts IL-17, IL-22, and RORC,
and regulatory T cell (TReg)-associated transcripts IL-10, TGF-)1,
and FoxP3 were quantified in rectal biopsy specimens taken from
orally challenged calves at !5, 7, 14, 21, and 31 days postchallenge.
Since the exact time of challenge was unknown for the sentinel
animals, only transcript data from the orally challenged calves
were analyzed. Transcripts for IL-4 and IL-13 were below the limit
of quantification of 100 and 1,000 copies per $l of cDNA, respec-
tively (data not shown). The log10-transformed relative change in
expression from the prechallenge level was calculated for the re-
maining data and was analyzed using linear mixed models for each
transcript of interest. The tests of the fixed effects for each model
are shown in Table S4 in the supplemental material. The predicted
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means and 95% confidence intervals (95% CI) of the model out-
puts are shown in Fig. 2 and Table S5 in the supplemental material.
Analysis of TNF-! as a general inflammatory indicator was
included. There was no statistically significant change in expres-
sion at any time point in either control or challenge groups, indi-
cating that the biopsy procedure and challenge did not induce a
detectable inflammatory response. Levels of GATA3, the only
TH2-associated transcript that could be quantified, increased
gradually and peaked with 2.23-fold (95% CI, 1.20- to 4.14-fold;
P " 0.0134) and 2.65-fold (95% CI, 1.56- to 4.50-fold; P " 0.001)
increases at 21 days postchallenge in the PT21/28 and PT32
groups, respectively. There was no statistically significant change
in the control group.
The patterns of expression of the TH1-associated transcripts
were noticeably different for the two strains. IFN-# expression in
the PT32-challenged calves increased 2.79-fold (95% CI, 1.72- to
4.52-fold; P " 0.0002) by 7 days postchallenge and declined grad-
ually, remaining significantly above prechallenge levels until 21
days postchallenge. This was in stark contrast to induction in the
PT21/28-challenged calves, where IFN-# expression remained
unchanged until its peak at 21 days of 2.47 times prechallenge
levels (95% CI, 1.51 to 4.04 times prechallenge levels; P " 0.001).
There was no change in IFN-# expression in the control animals.
Changes in T-bet expression in PT32-challenged calves also
peaked at 7 days (2.93-fold; 95% CI, 1.93- to 4.44-fold; P $
0.0001), but T-bet expression declined more rapidly than IFN-#
expression, to below prechallenge levels by 14 days (0.61-fold;
95% CI, 0.4- to 0.92-fold; P " 0.0214), where it remained until the
end of the trial. T-bet expression in the PT21/28-challenged group
was noticeably different, with biphasic induction at 7 days (1.69-
fold; 95% CI, 1.11- to 2.59-fold; P " 0.0169) and 21 days (2.09-
fold; 95% CI, 1.37- to 3.19-fold; P " 0.0016). In the control group,
T-bet expression was significantly lower than prechallenge levels
at 7 (0.38-fold; 95% CI, 0.21- to 0.69-fold; P " 0.0026), 21 (0.22-
fold; 95% CI, 0.12- to 0.39-fold; P $ 0.0001), and 31 (0.53-fold;
95% CI, 0.29- to 0.95-fold; P " 0.0346) days postchallenge. For all
three groups, T-bet expression was significantly below prechal-
lenge levels by day 31. Taken together, these results suggest a
strong TH type 1 skew in the response to colonization, the tempo-
ral dynamics of which differed by strain.
None of the three TH17-associated transcripts IL-17, IL-22,
and RORC demonstrated a statistically significant increase in ex-
pression following challenge. IL-22 expression was somewhat
variable within the control and PT32-challenged groups, as evi-
denced by the wide 95% CI. IL-17 expression remained un-
changed until day 31, when it was significantly lower than prechal-
lenge levels in the control group (0.57-fold; 95% CI, 0.32- to
0.99-fold; P " 0.0467) and in PT21/28-challenged calves (0.55-
fold; 95% CI, 0.37- to 0.81-fold; P " 0.0047). RORC expression
followed a similar pattern, with statistically significant downregu-
lation in PT21/28-challenged calves (0.56-fold; 95% CI, 0.37- to
0.85-fold; P " 0.0089), PT32-challenged calves (0.57-fold; 95%
CI, 0.38- to 0.87-fold; P " 0.0111), and control calves (0.50-fold;
95% CI, 0.28- to 0.89-fold; P " 0.0218) by 14 days. IL-22 expres-
sion in the PT21/28 group was down at day 7 (0.43-fold; 95% CI,
0.20- to 0.89-fold; P " 0.0257), with no other statistically signifi-
cant changes in expression until day 31, when it was reduced in the
PT21/28 (0.36-fold; 95% CI, 0.17- to 0.76-fold; P " 0.0094) and
PT32 (0.44-fold; 95% CI, 0.21- to 0.92-fold; P " 0.0314) groups.
The TReg-associated transcripts TGF-%1 and FoxP3 demon-
strated strong induction in control calves at 7 days, with changes
of 12.64-fold (95% CI, 4.89- to 32.70-fold; P $ 0.0001) and 4.67-
fold (95% CI, 1.50- to 14.54-fold; P " 0.0102), respectively. Un-
like FoxP3 expression, which returned to baseline, TGF-%1 ex-
pression remained elevated until the end of the study. This was in
contrast to IL-10 expression, which was unchanged in the control
calves until it was downregulated on day 31 (0.42-fold; 95% CI,
0.24- to 0.74-fold; P " 0.0047). All three genes were downregu-
lated at various time points relative to prechallenge levels in PT21/
28-challenged calves: IL-10 was downregulated on days 7 (0.58-
fold; 95% CI, 0.40- to 0.84-fold; P " 0.0062) and 21 (0.66-fold;
95% CI, 0.46- to 0.96-fold; P " 0.0295), TGF-%1 was downregu-
lated from day 7 (0.05-fold; 95% CI, 0.02- to 0.11-fold; P $
0.0001) until the end of the trial, and FoxP3 was downregulated on
day 7 only (0.35-fold; 95% CI, 0.13- to 0.96-fold; P " 0.0423). In
contrast, IL-10 expression remained unchanged in PT32-chal-
lenged calves; however, TGF-%1 expression was upregulated from
day 14 (2.38-fold; 95% CI, 1.53- to 3.71-fold; P " 0.0005) until the
end of the trial, and FoxP3 was upregulated on day 21 only (2.77-
fold; 95% CI, 1.15- to 6.67-fold; P " 0.0249) in this group.
T cell subsets at the terminal rectum after colonization. Lym-
phocytes were isolated from the terminal rectum postmortem and
were analyzed by flow cytometry. The numbers of CD4&, CD8&,
and #' T-cell receptor-positive (#'TCR&) T cells as proportions
FIG 1 Fecal shedding of EHEC O157:H7 by experimentally infected weaned calves. Six calves were housed in each of two separate HSU rooms. Four calves in
each HSU room were dosed with EHEC O157:H7 (strain 9000 in one room and strain 10671 in the other) by orogastric intubation (challenged), while two calves
in each room received PBS only (sentinel). Each curve represents an individual animal. Arrowheads indicate rectal biopsy time points.
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of CD3! cells are presented in Fig. 3. The experimental group was
a statistically significant variable for the proportions of CD4! (de-
grees of freedom [df] " 2; deviance " 7,852.1; P " 0.0009) and
CD8! (df " 2; deviance " 1,209.1; P " 0.0335) T cells but not for
the proportions of #$TCR! T cells (df " 2; deviance " 1,290.1;
P " 0.1006). Tukey comparisons confirmed that the proportions
of CD4! cells were significantly higher at 58.8% (95% CI, 48.4 to
68.5%; Z-score [z] " 3.602; P " 0.0009) in the PT21/28-chal-
lenged calves and 63.5% (95% CI, 54.8 to 71.4%; z " 4.496; P %
0.0001) in the PT32-challenged calves than in the control group
(31.4%; 95% CI, 22.5 to 41.9%), suggesting a CD4! T-cell infil-
trate into the rectal mucosa in challenged calves. The proportion
of CD8! cells was significantly lower, at 15.8% (95% CI, 11.5 to
21.2%; z " &2.892; P " 0.0106), in the PT21/28-challenged calves
than in the control group (27.5%; 95% CI, 21.8 to 34.1%).
Ex vivo restimulation of regional lymph node cells. Fresh
lymph node cells were extracted postmortem and were restimu-
lated for 5 days with concentrated bacterial secreted protein prep-
arations that include primarily T3SPs. Responses to a wild-type
(WT) T3SP preparation consisting predominantly of translocon
proteins were compared to responses to a T3SP preparation from
an isogenic 'sepL mutant containing minimal translocon-associ-
ated proteins but increased amounts of secreted effector proteins
(52). To distinguish between antigen-specific responses and non-
FIG 2 Gene expression at the terminal rectums of calves orally challenged with EHEC O157:H7. Data represent predicted means and 95% confidence intervals
from linear-mixed-model analyses of changes in log10-transformed gene expression from prechallenge levels. Statistically significant differences from prechal-
lenge levels are indicated for control (black symbols), strain 9000 (PT21/28)-challenged (blue symbols), and strain 10671 (PT32)-challenged (red symbols)
calves. *, P % 0.05; **, P % 0.01; ***, P % 0.001.
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specific proliferation in response to LPS, control wells were spiked
with EHEC O111:B4 LPS, so that the final concentration of LPS in
control wells was matched to that in the T3SP preparations (WT
LPS and !sepL LPS). Levels of thymidine incorporation and
IFN-" release are presented in Fig. 4 as the fold change from the
level for the respective LPS control (Fig. 4A and B) and as absolute
thymidine incorporation (Fig. 4C) and IFN-" concentration
(Fig. 4D).
Antigen-specific responses. The stimulation index (fold
change in thymidine incorporation from that for the relevant LPS
control) provides an assessment of antigen-specific proliferation
in response to the two T3SP preparations. Model selection showed
that the interaction between the ex vivo stimulant and the lymph
node was significant (P # 0.0078), demonstrating that the anti-
gen-specific responses were different within each lymph node.
Tukey comparisons (see Table S6 in the supplemental material)
show that the stimulation index for the !sepL T3SPs was 1.77-fold
higher (standard error [SE] # 1.16; t ratio [TR] # 3.8; P # 0.0058)
than that for the WT T3SPs at the RLN and 2.83-fold higher (SE #
1.16; TR # 6.9; P $ 0.0001) at the MLN, but there was no differ-
ence at the control PsLN (SE # 1.16; TR # 2.5; P # 0.1391). The
stimulation index for the !sepL T3SP was 15.7-fold higher (SE #
1.28; TR # 11.0; P $ 0.0001) at the RLN and 8.9-fold higher (SE #
1.28; TR # 8.7; P $ 0.0001) at the MLN than at the PsLN, but
there was no difference between the RLN and MLN (SE # 1.28;
TR # 2.3; P # 0.2342). The stimulation index values for the WT
T3SP, however, differed for the three different types of lymph
nodes, with 2.8-fold (SE # 1.28; TR # 4.1; P # 0.0024) and 13.0-
fold (SE # 1.28; TR # 10.2; P $ 0.0001) higher values at the RLN
than at the MLN and PsLN, respectively, and a 4.6-fold higher
value (SE # 1.28; TR # 6.1; P $ 0.0001) at the MLN than at the
PsLN.
Given the TH type 1 skew identified by RT-qPCR in response to
colonization, IFN-" release was used as a second readout for lym-
phocyte activation and was again expressed as the fold increase
over the level for the relevant LPS control (IFN-" release index).
None of the mixed-model interactions were significant, indicating
that the difference between the T3SP preparations was the same
across all the lymph nodes. Tukey comparisons (see Table S7 in
the supplemental material) demonstrate that the IFN-" release
index was 2.4-fold higher (SE # 1.21; z # 4.5; P $ 0.0001) for the
!sepL T3SP than for the WT T3SP. The index was also 7.2-fold
higher (SE # 1.58; z # 4.3; P $ 0.0001) at the RLN and 4.3-fold
higher (SE # 1.58; z # 3.2; P # 0.00578) at the MLN than at the
PsLN. There was no difference between the RLN and MLN (SE #
1.58; z # 1.1; P # 0.61659).
Overall responsiveness of regional lymph node cells. The in-
teraction plots (Fig. 4C and D) indicate that both total thymidine
incorporation and IFN-" release (i.e., values not normalized to
the LPS control) in response to the T3SP preparations and LPS
were lower at the RLN and PsLN in PT32-challenged calves than
in PT21/28-challenged calves. This observation was confirmed by
formal statistical testing. For thymidine incorporation, the inter-
actions between the experimental group and the lymph node (P #
0.0079) and between the ex vivo stimulant and the lymph node
(P $ 0.0001) were significant. Tukey comparisons between exper-
imental groups within each type of lymph node (see Table S8 in
the supplemental material) show lower levels of thymidine incor-
poration—2.64-fold lower (SE # 1.44; TR # 2.6; P # 0.0355) at
the RLN and 3.4-fold lower (SE # 1.44; TR # 3.3; P # 0.0071) at
the PsLN—across all ex vivo stimulant groups (ConA, medium
only, WT T3SP, WT LPS, !sepL T3SP, and !sepL LPS) for PT32-
challenged calves than for PT21/28-challenged calves.
For IFN-" release, the interactions between the experimental
group and the ex vivo stimulant (P # 0.0061), between the exper-
imental group and the lymph node (P # 0.0043), and between the
ex vivo stimulant and the lymph node (P $ 0.0001) were all sig-
nificant. Tukey comparisons of IFN-" release between experi-
mental groups within each node–ex vivo stimulant combination
(see Table S9 in the supplemental material) showed that at the
RLN, only the antigen-specific responses varied by experimental
group. The WT T3SPs resulted in a 12.2-fold (SE # 2.06; TR #
3.5; P # 0.0035) reduction in IFN-" release in PT32-challenged
calves from that in PT21/28-challenged calves. As with thymidine
incorporation, there were no significant differences at the MLN,
while at the PsLN, IFN-" release was 7.1-fold (SE # 2.06; TR #
2.7; P # 0.0251), 28.7-fold (SE # 2.06; TR # 4.7; P # 0.0001),
10.6-fold (SE # 2.06; TR # 3.3; P # 0.0061), 13.4-fold (SE # 2.06;
TR # 3.6; P # 0.0025), and 8.8-fold (SE # 2.06; TR # 3.0; P #
0.0119) higher in PT21/28-challenged calves than in PT32-chal-
lenged calves in response to medium only, WT T3SPs, WT LPS,
!sepL T3SPs, and !sepL LPS, respectively.
Immunophenotyping of proliferating rectal lymph node
cells in response to WT T3SP. Resuscitated RLN cells were incu-
bated for 5 days with ConA, medium only, treated WT T3SPs, or
EHEC O111:B4 LPS. The proportions within each subset of cells
expressing the proliferation marker Ki67 are presented in Fig. 5.
Data were analyzed using generalized linear models, and analysis-
of-deviance tables are shown in Table S10 in the supplemental
FIG 3 Flow cytometry analysis of CD3% T-cell subsets at the terminal rectums
of EHEC O157:H7-colonized calves postmortem. Circles represent results for
individual animals. Error bars represent the predicted means and 95% confi-
dence intervals from generalized linear model analysis for each T-cell subset.
The significance of differences found by Tukey comparisons between chal-
lenged and age-matched control calves is indicated as follows: *, P $ 0.05; **,
P $ 0.01; ***, P $ 0.001.
Corbishley et al.
5124 iai.asm.org Infection and Immunity
 on Septem







FIG 4 Proliferation of, and IFN-! release by, bovine lymph node cells isolated postmortem and restimulated ex vivo for 5 days with either 5 "g/ml ConA, medium only,
5 "g/ml EHEC O157:H7 T3SPs from the sepL deletion strain Zap1143 (#sepL) or its isogenic wild-type (WT) strain Zap193, or medium containing a matched
concentration of commercial EHEC O111:B4 LPS. #sepL T3SP preparations contain mainly secreted effector proteins, while WT T3SP preparations consist mainly of
structural translocon components. The use of these two different T3SP preparations allows the relative contributions of structural and effector proteins to antigen recall
responses to be compared. Cells were isolated from rectal lymph nodes (RLN), mesenteric lymph nodes (MLN), and prescapular lymph nodes (PsLN). (A and B)
Proliferation (A) and IFN-! release (B) are expressed as indices, representing fold changes in the response to T3SPs from levels with the relevant LPS controls. Circles
represent individual animals. (C and D) Interaction plots illustrate mean thymidine incorporation (C) and IFN-! release (D) by lymph node cells from each experimental
group in response to different stimuli. Error bars represent predicted means and 95% confidence intervals from linear-mixed-model analysis.
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FIG 5 Flow cytometry analysis of proliferation marker (Ki67) expression by different lymphocyte subsets isolated postmortem from the rectal lymph nodes of
control and EHEC O157:H7-challenged calves. Frozen cells were resuscitated and were restimulated ex vivo for 5 days with 5 !g/ml ConA, medium only, 5 !g/ml
treated EHEC O157:H7 T3SPs (WT), or medium containing a matched concentration of commercial EHEC O111:B4 LPS (LPS). Circles represent individual
animals. Error bars represent predicted means and 95% confidence intervals from generalized-linear-model analysis for each lymphocyte subset.
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material. Retaining the interaction between the experimental
group and the ex vivo stimulant in the models caused comparisons
between experimental groups to be based on unweighted averages
across the stimulants.
Tukey comparisons for each model are shown in Table S11 in
the supplemental material. For all four cell types, there was no
significant change in the proportion of cells staining positive for
Ki67 in response to LPS compared to the medium control, while
the proportions of CD4! and CD8! cells, but not "#TCR! or
NKp46! cells, staining Ki67 positive increased in response to
ConA. These results confirm that none of the cell types prolifer-
ated in response to LPS, while only the CD4! and CD8! T cells
proliferated in response to ConA.
In PT21/28- but not PT32-challenged animals, a significantly
higher proportion of CD4! T cells stained Ki67 positive in re-
sponse to WT T3SPs than in response to the LPS control. Con-
versely, in PT32- but not PT21/28-challenged animals, there was a
significantly higher proportion of NKp46! cells staining Ki67
positive in response to WT T3SPs than in response to the LPS
control. In both groups of challenged calves, a higher proportion
of CD8! and "#TCR! T cells stained Ki67 positive in response to
WT T3SPs than in response to the LPS control.
DISCUSSION
The objective of this study was to characterize the temporal pat-
tern of expression of a panel of transcripts associated with differ-
ent T-helper cell polarizations at the terminal rectum, which is the
principal site of EHEC O157:H7 colonization in calves (65). These
results were then used to inform experiments in which regional
lymph node cells were extracted and restimulated ex vivo with
T3SP antigens.
Since the results of this study will be used to guide future vac-
cine development, the selection of clinically relevant strains was an
important consideration. In the United Kingdom, PT21/28
strains are associated with higher levels of shedding in cattle than
PT32 strains (66) and represent the predominant isolates from
human HUS cases (67). In addition, PT21/28 strains are more
likely to possess both Stx2a and Stx2c genes, whereas bovine PT32
strains are more likely to possess the Stx2c genes only (68). While
cattle do not suffer from the same severe endothelial sequelae of
Stx exposure as humans, there is a significant body of evidence
that Stx can affect bovine leukocyte function (40, 69–74). Given
the important epidemiological differences between these phage
types and their propensity to possess different Stx types, we
wanted to compare components of the cellular immune response
in cattle following colonization with representative PT21/28 and
PT32 strains. The strains used in this study were selected because
they had common characteristics of these phage types in cattle.
PT21/28 strain 9000 contains both Stx2a- and Stx2c-encoding
genes and was isolated from a bovine fecal pat with relatively high
EHEC O157:H7 levels, while PT32 strain 10671 contains Stx2c
only and was isolated from a bovine fecal pat with relatively low
EHEC O157:H7 levels.
Both these strains successfully colonized all the orally chal-
lenged cattle and were efficiently transmitted to the two sentinel
calves. This study does not have the power to make comparisons
between the shedding profiles of orally challenged and those of
sentinel calves or between the transmissibilities of the two strains;
however, these results will be used to inform power calculations
leading to larger trials that will specifically address these questions.
While EHEC O157:H7 can be isolated from multiple sites
within the bovine gastrointestinal tract, efficient colonization with
A/E lesion formation has been demonstrated at the terminal rec-
tum (65). This offers the opportunity to use minimally invasive
rectal biopsy specimens to study the interaction between the bac-
teria and the mucosal surface at different stages during coloniza-
tion. It was our hypothesis that by studying the expression of genes
associated with different T-helper cell polarizations, it would be
possible to determine whether a T-helper response is induced at
the site of infection, as well as the type of this response within the
TH1, TH2, TH17, and TReg paradigm. Since mathematical model-
ing of bacterial shedding dynamics suggests that bacterial replica-
tion on the mucosal surface declines precipitously 5 to 7 days
following oral challenge (75), biopsy specimens were taken at 7
days after challenge and weekly until the end of the study. Previous
work using a bovine-specific cDNA microarray to analyze rectal
biopsy specimens taken up to 7 days postchallenge demonstrated
differential expression of 49 genes in response to colonization
across a range of pathways (76). None of the genes analyzed in our
study were identified as differentially regulated by the previous
microarray approach. Because a subset of 1,676 genes was present
on the microarray and the list of these genes is no longer available
(Robert Collier, University of Arizona, personal communication),
we are unable to determine whether the T-helper cell-associated
transcripts we have analyzed were included in that previous study.
Rectal mucosal biopsy specimens were taken at different posi-
tions at each sampling time point to avoid resampling the same
sites. The stability of TNF-$ expression in the control animals
indicates that the experimental protocol did not result in a general
inflammatory response within the mucosa. In addition, the lack of
induction of TNF-$ in the challenge groups would also indicate
that this cytokine is not an important component of the bovine
response to colonization at the terminal rectum. This is signifi-
cant, because TNF-$ is upregulated during C. rodentium coloni-
zation in mice (77), while pretreatment of bovine colonic explants
with TNF-$ has been shown to upregulate mucin secretion and
reduce EHEC O157:H7 colonization (78). The observation that
TNF-$ is not induced at the terminal rectum would imply that
this pathway is not active in vivo and is likely to contribute to the
difference between the pathogenicity of C. rodentium in mice,
which results in weight loss, moderate mortality, and colonic hy-
perplasia (79, 80), and that of EHEC O157:H7 in cattle, where the
infection is asymptomatic and demonstrates only a mild neutro-
philic infiltrate, suggesting that while immunogenic, colonization
is not a major inflammatory event (42).
The induction of both IFN-" and T-bet during colonization is
indicative of a TH type 1 polarized response at the terminal rec-
tum, which is further supported by the inability to detect either
IL-4 or IL-13 transcripts. This is in keeping with studies of C.
rodentium in mice, which has been shown to induce IFN-" but not
IL-4 (77), while experiments using knockout mice have confirmed
the importance of IFN-" in bacterial clearance (81).
The lack of a detectable TH17 response in this study, in con-
junction with the significant downregulation of RORC, suggests
that there are additional important differences between the bovine
response to EHEC O157:H7 and the response to C. rodentium in
mice, where IL-22, IL17A, and IL-23 p19 are upregulated during
colonization (82), while IL-23 (p19%/%) (83), IL-22 (82), IL17A,
and IL17F (84) knockout mice demonstrate increased pathology
and deficiencies in controlling bacterial replication.
Cellular Immunity to EHEC O157:H7 in Cattle
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The strain differences in this study were striking. In PT32-
challenged calves, as might be anticipated, both IFN-! and T-bet
demonstrated maximal induction around the time of peak shed-
ding at 7 days postchallenge. In PT21/28-challenged calves, how-
ever, maximal induction for both genes occurred at 21 days post-
challenge, with moderate induction of T-bet but not IFN-! at 7
days. This strain-specific uncoupling of the IFN-! and T-bet re-
sponses in early infection and the delayed induction of a convinc-
ing TH type 1 response were surprising. IFN-! can be produced by
a wide variety of leukocytes, and T-bet can be expressed by both
innate lymphoid cells and lymphocytes (85). It is therefore not
possible to infer whether the differences in the dynamics of gene
expression observed in the PT21/28-challenged animals are due to
innate versus adaptive mechanisms or to a change in the kinetics
of the response. While research to determine the complete ge-
nome sequences of the two challenge strains is ongoing, it is al-
ready known that the PT21/28 strain contains both Stx2a and
Stx2c lysogens, whereas the PT32 strain contains Stx2c only. The
toxin type and level of production may, in part, account for dif-
ferences, but we also know that there are complex regulatory in-
teractions between prophages and bacterial host gene expression,
including colonization factors (86) and core genome regulatory
elements (87). Additional in vitro and in vivo work with isogenic
Stx and Stx-encoding bateriophage knockout strains is planned to
explore these concepts in more detail.
TGF-"1 and FoxP3 were both upregulated in the control ani-
mals, suggesting a TReg skew. It is unclear whether this is inciden-
tal. Interestingly, the induction of both genes is dampened or ab-
sent in the challenged calves compared to unchallenged controls,
with only moderate induction in PT32-challenged animals and
downregulation in the PT21/28-challenged animals. This pro-
vides further evidence supporting a convincing TH1 skew and the
reciprocal downregulation of TReg responses.
The induction of GATA3 at 21 days postinfection suggests that
there may be a role for TH type 2 immunity later during the course
of infection. B-cell-deficient mice have demonstrated impaired
clearance of C. rodentium and reduced bacterial shedding follow-
ing systemic administration of immune sera (88), despite a strong
TH type 1 response during early stages of infection, suggesting that
while the initial response is biased toward cellular immunity, the
role of humoral immunity and/or the presence of a healing re-
sponse (89) may be important as colonization progresses.
In an attempt to understand the impact of colonization on the
T-cell subsets at the terminal rectum, lymphocytes were extracted
postmortem and were double stained for CD3 and either CD4,
CD8, or !#TCR. The increase in the proportion of CD4$ T cells is
indicative of a T-helper cell infiltrate and is strongly suggestive of
an adaptive component in the response to colonization. To inves-
tigate this further, regional lymph node cells were restimulated ex
vivo with two different T3SP preparations. Since we had identified
a strong TH type 1 response, IFN-! release was used alongside
thymidine incorporation as a readout of lymphocyte activation.
Previous studies using heat-killed bacteria to restimulate rumi-
nant lymphocytes have not controlled for the presence of LPS
(40), and our results show that the responsiveness of cells to LPS
differs by lymph node, with PsLN cells being more responsive than
intestinal lymph node cells. Once the effects of LPS had been con-
trolled for, antigen-specific proliferation and IFN-! release in re-
sponse to both T3SP preparations were significantly higher in cells
isolated from the two intestinal lymph nodes than in those from
the control PsLN, confirming enhanced recognition of EHEC
O157:H7 antigens at sites anatomically relevant to colonization.
There was no difference between the experimental groups, sug-
gesting that the experimental animals had previously been ex-
posed to some of the T3SP antigens and/or epitopes used in this
study, although the animals were screened for EHEC O157 colo-
nization at multiple times prior to the challenges. An alternative
but less likely explanation for the response is that these protein
preparations could contain effectors that drive lymphocyte prolif-
eration, as is the case with the staphylococcal superantigen TSST
(toxic shock syndrome toxin) (90), although one would predict
that proliferation would be equivalent throughout all lymph
nodes if this were the case. Of interest was the significantly stron-
ger response from all the lymph nodes to the %sepL T3SP. Since
LPS was controlled for and these preparations were matched by
protein concentration, it is reasonable to hypothesize that the se-
creted effectors are potentially more immunogenic than the struc-
tural components. While vaccines containing native secreted and
recombinant T3SP structural proteins have been shown to reduce
shedding in cattle (13, 28, 29), our current results lend further
weight to the consideration of secreted effector proteins in EHEC
O157:H7 cattle vaccines and work to define the most immuno-
genic of these in terms of a TH1 response.
The observation that cells from the RLN and PsLN of PT32-
challenged animals are less responsive than those from control
and PT21/28-challenged animals is suggestive of systemic immu-
nomodulation by this strain. Paradoxically, however, this effect
was not observed at the MLN. This effect was missed when we
were examining the stimulation and IFN-! release indices due to
the reduction in responsiveness also affecting the medium and
LPS controls. Currently, it is unclear what may be responsible for
this immunomodulation. While Stx activity is a prime candidate,
it is interesting that it was the Stx2c-positive PT32 strain, and not
the PT21/28 strain, which contains both Stx2a and Stx2c, that
demonstrated this repression, suggesting that factors other than
Stx may be involved.
In an effort to understand which cell types were involved in
responding to T3SPs at the RLN and consequently which cell types
might be attenuated by PT32 challenge, the proliferation of the
different lymphocyte subsets was characterized by flow cytometry.
Heat-inactivated protein preparations were used to exclude the
possibility of effector bioactivity driving proliferative responses.
CD8$ and !#TCR$ T cells from colonized animals demonstrated
statistically significant proliferation in response to the T3SPs, in-
dependently of LPS and any potential biological activity of the
preparations. It is interesting that these antigens are able to drive
both !#TCR$ and CD8$ T-cell proliferation, suggesting a role for
!# T cells in the response to colonization and the selection of CD8
T-cell clones that are responsive to major histocompatibility com-
plex (MHC) class I-presented EHEC O157:H7 peptides. While
CD8$ T-cell-depleted mice do not demonstrate a deficit in C.
rodentium clearance (91), the injection of bacterial effector pro-
teins into host cells via the T3SS means that bacterially derived
peptides may be presented on MHC class I molecules. Mathemat-
ical modeling of proteasome degradation, TAP processing, and
MHC class I loading in humans suggests that secreted EHEC
O157:H7 effectors have an altered amino acid composition like
that of viral proteins, enabling them to reduce the efficiency by
which they are presented by MHC class I molecules (92). The lack
of a protective CD8$ T-cell response in mice to an A/E lesion-
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forming organism does not necessarily mean that these cells do
not play an important role in host immunity to EHEC O157:H7 in
cattle.
The CD4! T-cell proliferative response to WT T3SPs seen in
PT21/28-challenged calves was absent in PT32-challenged calves,
while the NK cell proliferative response seen in PT32-challenged
calves was absent in PT21/28-challenged calves. This may indicate
that the PT32 strain is effectively cleared via innate mechanisms in
contrast to the PT21/28 strain, which may be able to evade com-
ponents of the innate response, resulting in a stronger adaptive
response. Alternatively, the PT32 strain may specifically target
adaptive immunity by suppressing CD4! T-cell function. NK cells
have recently been demonstrated to play an important role in C.
rodentium clearance (93). If innate immunity is an important
component of the immune response in cattle, it may explain why
rechallenge experiments demonstrate only a partial and short-
term protective effect following bacterial clearance (33). Further
work is required to better understand the interaction of these
strains with bovine leukocytes.
This study is the first to definitively demonstrate a TH type 1
immune response to EHEC O157:H7 in cattle. The temporal dif-
ferences in this response between the two strains studied raise
important questions about strain-dependent strategies used by
these pathogens to evade host immunity and prolong persistence
in the gastrointestinal tract. The roles of innate versus adaptive
cellular immunity have not been dissected in this study; however,
both are likely to be important, and the organism appears to be
directly targeting CD4! T-cell and/or NK cell function through as
yet unidentified mechanisms. The serological responses to EHEC
O157:H7 vaccination have been extensively studied; however, fu-
ture vaccine development will need to measure the impact of vac-
cination on cellular immunity and to test the hypothesis that while
high antibody titers may be important in blocking bacterial adhe-
sion, cellular immune responses are required for bacterial clear-
ance. In addition, the targeting of immunomodulatory virulence
factors to improve vaccine efficacy should be considered.
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